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Abstract 
The nucleolus is the most prominent structure within the eukaryotic cell nucleus and it 
was established to be the site where the majority of ribosomal RNAs (5.8S, 18S and 
28S) are transcribed, processed and assembled with ribosomal proteins to form 
ribosomal subunits. The sole role of ribosome biogenesis, however, cannot explain the 
specific nucleolar localisations of tumour suppressors, cell cycle-regulatory factors 
and viral proteins. Therefore, together with my colleagues in the laboratory of Prof. 
Angus Lamond, we carried out a proteomic approach with an aim to identify the core 
components of the human nucleolus isolated from HeLa cell nuclei. My role in this 
project includes verification of the newly identified components, database 
construction archiving the primary data and providing links to other related 
information in the public domain, and subsequent bioinformatics and microscopic 
analyses. So far, 400 proteins were identified in which -30% represents novel or 
uncharacterised proteins, partly reflecting the current poor status in the human 
genome annotation, but also reflecting the unknown complexity of the nucleolus. To 
facilitate the understanding of the functions of these novel proteins, I used deposited 
data of their gene activities and homologues across the species to identify in silico 
those novel proteins that are likely to be involved in ribosomal biogenesis. 
Like the nucleus, the nucleolus itself is subcompartmentalised into different domains, 
namely, the fibrillar centre, the dense fibrillar components and the granular 
components and these structures are disassembled and reassembled during mitosis in 
human cells. In order to understand the intricate mechanism behind these mitotic 
dynamics, I have generated a panel of 24 HeLa cell lines stably expressing one or 
more nucleolar marker to study the inter-relationships between these subnucleolar 
domains as well as their relationships with the chromosomes. The results suggest that 
- xl- 
(1) a core subunit of the RNA polymerase I dissociates from the chromosomes 
between prophase and metaphase and (2) the breakdown and reassembly are 
dependent on the dissociation and the recruitment of RNA polymerase I to the 
chromosomes respectively. 
As part of the follow-up to the nucleolar proteome identified, the study of one 
uncharacterised factor NHPX led to the discovery of a novel nucleolar targeting 
pathway that is observed in both primary and transformed cell lines. Although NHPX 
co-localises with the dense fibrillar component marker fibrillarin, NHPX transiently 
transits through the splicing speckles prior to the nucleolar accumulation whilst 
fibrillarin accumulates within the nucleolus immediately after the nuclear entry. The 
NHPX progression is dependent on pre-mRNA transcription and may link multiple 
RNA metabolic pathways that occur in distinct subnuclear domains. 
~xu- 
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CHAPTER I 
INTRODUCTION 
`7n jeder Zelle ohne Ausnahme befindet sich ein etwas dunklerer und compakter 
Nucleus von runder oder länglich runder Form. Er nimmt grösstenteils die Mitte einer 
jeden Zelle ein, besteht aus einem feinkörnigen Wesen, enthält aber in seinem Innern ein 
genau rundes Köiperrhen, welches auf diese Weise in ihm selbst wiederum eine Art von 
zweitem Nucleus bildet. " ý- G. Valentin, 1836 
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I. Introduction 
I. 1 Overview of NuclearArchitecture 
L 1.1 General 
Eukaryotic cells, by definition, keep their DNA in a separate internal compartment known 
as the nucleus. The observation of a nucleus was first documented on 3` 1 March, 1682 by 
Antoni van Leeuwenhoek (Van Leeuwenhoek, 1948). However, it was not until 1831 that 
the nucleus was accepted as a widespread constituent of different somatic cells (Brown, 
1833). The nucleus is separated from the cytoplasm by the nuclear envelope, which 
consists of a double-layered membrane (Burke and Ellenberg, 2002; Holaska et al., 2002). 
To facilitate the transport of macromolecules, such as RNA and proteins, across the 
nuclear membrane, aqueous channels, known as nuclear pore complexes (NPC), allow 
passive diffusion of small molecules (up to 40-60 kDa) and active transport of larger 
macromolecules (Gorlich and Kutay, 1999; Rabut and Ellenberg, 2001; Weis, 2002). These 
large macromolecules require appropriate transport signals and receptors, known as 
importins and exportins, for nucleocytoplasmic transport (Nigg, 1997; Weis, 1998). 
The nucleus of a typical human diploid cell is a spheroid with a volume of approximately 
500µm' (Carmo-Fonseca et aL, 1996). Within this space, there is approximately 6x 109 base 
pair (bp) of DNA segregated into 23 sets of chromosome pairs. The DNA together with 
RNA and protein gives rise to a nuclear viscosity that is - six- to few hundred-fold higher 
than the cytoplasm (Lang et al., 1986; Alexander and Rieder, 1991). However, this double- 
membraned compartment is not a homogenous soup of macromolecules (Moneron and 
Bernhard, 1969). Rather, by the early 1800s, it was already obvious from the light 
microscope that the nuclear interior was not uniform, most notably with the discovery of `a 
secondary nucleus within the first one', ie. the nucleolus (Section I. 2). 
Chapter I Introduction 
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The landscape within the nucleus was further charted with the arrivals of the electron 
microscope and the fluorescence microscope in the 1960s and by employing different dyes 
and fixation methods to reveal the subnuclear compartments containing the DNA. 
Moreover, it was revealed that there exist small particulate structures outside the DNA- 
containing territories and they were redefined with the arrival of different autoantigen 
antibodies in the 1990s. The recent advances in light microscopy and the use of live cell 
fluorophores revealed to (and mostly surprised) this generation of cell biologists that the 
components within the subnudear structures (Chen and Huang, 2001; Misteli, 2001; Reits 
and Neefjes, 2001), and sometimes these structures themselves, are not static but rather are 
dynamic (Boudonck et al., 1999; Platani et al, 2000; Snaar et al., 2000; Muratani et aL, 2001; 
Platani et al., 2002). At the same time, biochemical procedures have been developed to 
isolate different nuclear subcompartments, in particular the nucleolus, for functional 
studies (Section I. 3.1). So the underlying questions are (1) why is the nucleus 
subcompartmentalised? and (2) what are the respective functions of these 
subcompartments? This thesis is aimed at understanding more about the functions and 
dynamics of the human nucleolus, the most prominent subnuclear compartment 
Despite over 150 years of research, the nucleolus was first described as being a ribosome 
factory only 40 years ago; yet even today we know little about the components of the 
ribosome production machineries in human (Fatica, and Tollervey, 2002). Moreover, the 
idea of the nucleolus being a ribosome factory cannot explain the presence of viral, cell 
cycle regulatory and tumor-related proteins within this structure (Section 1.2.5). This 
chapter aims at giving an overview of the properties of different subnuclear structures 
(Section 1.1) and particularly will focus on the current status of our understanding of the 
nucleolus (Section 1.2). This is followed by an introduction of the analytic tools (Section 1.3) 
that were used during this PhD (Section 1.4). 
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L 1.2 Compartmentalisation of the Nucleus 
A compartment is mathematically defined as a quantity of a substance that has uniform and 
distinguishable kinetics of transport (Godfrey, 1983). Within the cell context, a 
compartment is often defined by a physical separation -a membrane - for example, the 
cytoplasmic organelles such as the mitochondria and the endoplasmic reticulum (ER). 
However, a membrane is not necessary for compartmentalisation provided that the 
contents within are homogenous, well-mixed and distinct from the surroundings. The 
mammalian nucleus is highly organised itself into different compartments (or subnuclear 
structures) that, even without intra-nuclear membranes, contain distinct set of proteins and 
are separate from one another (Figure I-1). 
Figure I-1 Model of Nuclear Architecture. This model illustrates two properties of the nucleus: (a) it 
is very compacted and dense; and (b) it is non-uniform and compartmentalized. Red: Cajal 
bodies; Green: Nucleoli; Blue: Chromosome territories; Yellow: PHIL bodies; Magenta: 
Paraspeckles and Cyan: Splicing speckles and the nuclear envelope and pores are denoted by 
a dashed circle. 
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Each chromosome, and even DNA sequences with differential timing of replication within 
the chromosomes, occupies a nuclear space or territory (Schul et aL, 1998; Boyle et al., 
2001; Cremer and Cremer, 2001; Dietzel and Belmont, 2001; Mahy et at, 2002a; Mahy et 
at, 2002b; Parada and Mistelf, 2002). Within the intrachromosomal spaces, a different set 
of proteins were identified in specific patterns (Lamond and Earnshaw, 1998; Matera, 1999; 
Dundr and Misteli, 2001; Spector, 2001; Swedlow and Lamond, 2001; Carmo-Fonseca, 
2002; Carmo-Fonseca et at, 2002); some are associated with chromosomes such as the 
nucleolus and OPT domain (Table I-1) and some are not such as PML bodies and splicing 
speckles; some structures such as Cajal bodies and PML bodies are continually moving 
within the nucleoplasm whilst others such as splicing speckles are relatively immobile in 
terms of their nuclear positions (Matera, 1999; Platani et at, 2000; Snaar et at., 2000; 
Muratani et al., 2001; Swedlow and Lamond, 2001; Carmo-Fonseca et at, 2002; Ogg and 
Lamond, 2002; Platani et at., 2002). However, whether the subnuclear structure itself is 
static or dynamic, associated with chromosomes or not, it seems that they share two 
interesting properties: (1) the subnuclear structures are disassembled when the nuclear 
envelope breaks down during mitosis and they are reassembled when the nuclear envelope 
reforms, and (2) most of the components studied so far are continuously exchanging 
between the nucleoplasm and the subnuclear structure, though each is comprised of a 
distinct sets of proteins. It is however beyond the scope of this thesis to discuss every 
subnuclear structure and I will only focus on a few structures that are related to the 
nucleolus (Section 1.1.3) and the nucleolus itself (Section 1.2). The properties of subnuclear 
structures are summarised in Table I-1 and recently reviewed elsewhere in detail (Singer 
and Green, 1997; Lamond and Earnshaw, 1998; Matera, 1999; Cremer and Cremer, 2001; 
Dundr and Mistelf, 2001; Gasser, 2001; Spector, 2001; Swedlow and Lamond, 2001; Wolffe 
and Hansen, 2001; Carmo-Fonseca, 2002; Carmo-Fonseca et at, 2002; Iborra and Cook, 
2002; Pederson, 2002). 
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Subnuclear structures Properties 
Cajal Body (section 1.1.3.1) Ribonucleoprotein particle (RNP) maturation; histone 
gene transcription? 
Chromosome territories Chromosomes occupy distinct nuclear space relative to the 
nuclear periphery 
Gems Colocalised with Cajal body in most cell types; containing 
marker protein SMN 
Nucleolus (section 1.2) Ribosome factories; cell cycle control; viral target 
OPT domain Foci containing Octl and PTF transcription factors; often 
associated with human chromosomes 6 and 7 
Paraspeckles (section 1.1.3.2) Transcriptional inhibition-dependent association with the 
nucleolus; often located next to splicing speckles; 
containing paraspeckle protein 1 (PSP1) 
Perinucleolar compartment Rarely found in primary cells or non-cancerous cells; 
(PNC; section I. 1.3.2) associated with the nucleolar periphery; containing 
polypyrimidine tract binding protein (PTB) and RNA 
polymerase III transcripts 
PcG domain Containing polycomb group proteins; probably involved in 
gene repression 
PML Body Anti-viral response; enriched for sumolyated protein; 
containing marker protein PML, splOO and CREB-binding 
protein (CBP) 
SAM68 bodies (section 1.1.3.2) Associated with the nucleolar periphery, containing 
proteins RNA-binding proteins with the STAR (signal 
transduction and activation of RNA) domain; commonly 
observed in cancerous cells. 
Splicing speckles Storage site of splicing factors? Recycling site of splicing 
factors? 
Table I-1 Subnuclear structures to the interphase nucleus. 
1.1.3 Cajal Bodies and other Nucleolus-related nuclear structures 
1.1.3.1 Cajal Bodies 
Cajal bodies, originally called nucleolar accessory bodies, or coiled bodies, were recently 
renamed after their discoverer, Ramon y Cajal (Cajal, 1903; Gall, 2000). They are usually 
defined by the presence of the marker protein, p80 coilin, and are often associated with the 
nucleolar periphery, or even located inside the nucleolus (Malatesta et aL, 1994; Ochs et aL, 
1994; Lyon et aL, 1997; Sleeman et al., 1998). Typically there are 1-10 Cajal bodies ranging 
from 0.2 to 1.0 µm or larger in size within a human cell (Lamond and Earnshaw, 1998; 
Platani et aL, 2000). They contain small nuclear ribonucleoprotein particles (snRNPs), some 
transcription factors and several nudeolar proteins, including fibrillarin, a component of 
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small nudeolar ribonucleoprotein particles, or snoRNPs, (Gall, 2000). However, they do 
not contain non-snRNP protein splicing factors or nascent pre-mRNA. Their snRNP 
components are specifically only the newly assembled particles (Carvalho et al., 1999; Gall 
et A, 1999; Sleeman and Lamond, 1999). Fluorescently labeled U3, U8 and U14 snoRNAs, 
when microinjected into Xenopus oocytes, accumulate transiently in Cajal bodies prior to 
nucleoli, suggesting that newly imported snoRNAs flow from the Cajal bodies to nucleoli 
(Narayanan et al., 1999a; Narayanan et al., 1999b). Therefore, Cajal bodies might be 
involved in transport and maturation of both snRNPs and snoRNPs. 
In addition to small nucleolar RNAs (snoRNAs) and small nuclear RNAs (snRNAs), a new 
class of RNAs which has two different types of classical snoRNA motifs (box C/D and 
H/ACA; section 1.2.3) was recently found to be exclusively localised in Cajal bodies, and 
was therefore named small Cajal body-specific RNA (scaRNAs) (Darzacq et at, 2002; Kiss 
et at, 2002). Analogous to the function of many snoRNAs which modify certain regions of 
ribosomal RNA (rRNA), scaRNAs contain a region that can potentially be base-paired 
with a complementary region of snRNA and hence may be involved in 2'-O-methylation 
and pseudouridylation of the spliceosomal snRNAs Ul, U2, U4 andU5 within Cajal bodies. 
An important aspect of subnuclear structures is their dynamic and regulated association 
with one another. This is especially evident for the nucleolus. Even at the light microscopy 
level back in the early 20' century, a dose association between Cajal bodies and nucleoli 
had been observed (Cajal, 1903; Gall, 2000). Recent studies suggest that a number of Cajal 
body components are shared with the nucleolus, particularly with the dense fibrillar 
component (Section I. 2.4). Dynamic tracking of Cajal bodies in plant and human cells 
showed that Cajal bodies can enter into nucleoli (Boudonck et aL, 1999; Platani et at., 2000; 
Snaar et al, 2000). 
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1.1.3.2 Parapeckles, Perinucleolar compartments and SAM68 bodies 
During the identification of the human nucleolar proteome, our group has identified a new 
subnuclear structure known as paraspeckles that are associated with the nucleous in a 
transcription inhibition-dependent manner (Fox et at, 2002). The marker protein 
paraspeckle protein 1 (PSP1) is continuously exchanging between the nucleolus and 
paraspeckles and PSP1 relocates to the nucleolar periphery upon transcriptional inhibition. 
In contrast, two structures which normally reside in the nucleolar periphery, namely the 
perinucleolar compartment (PNC) and the SAM68 nuclear body, are disassembled upon 
transcriptional inhibition (Huang, 2000). PNC is a subcompartment associated with 
nucleoli in cancer cell, but not in primary cells, that contains the marker protein 
polypyrimidine tract binding (PTB) proteins and polymerase III transcripts (Huang et at, 
1997; Huang, 2000). The presence of PNCs and the size of nucleoli have been used as a 
prognostic indicator of cell malignancy. Why do these subnuclear structures (or their 
individual components) associate with/depart from the nucleolus under different 
metabolic conditions? Which nucleolar components attract or repel them? The underlying 
basic question is, "what constitutes the nucleolus? " 
I. 2 Overview of the Nucleolus 
I. 2.1 Historical Per pectives 
Between 1835 and 1838, the nucleolus was discovered in different systems concurrently by 
Wagner, Valentin and Schleiden (Franke, 1988). Gabriel Gustav Valentin is the first person 
who described the nucleolus in somatic cells as stated in the quote in the beginning of this 
chapter, which translates as: `In every cell, without exception, there exists a somewhat darker-appearing 
and compact nucleus of a round or nearly round shape Mostly it is located in the centre of the specific cell 
composed of a finelygranular material and containing in its interior an exactly spheroidal body which in this 
way forms a kind of secondary nucleus within the first one (Valentin, 1836). Since the nucleus is 
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Figure 1-2 Nucleolus -'a secondary nucleus within the nucleus'. (A) An early drawing taken from 
Montgomery 1898, illustrating the location of nucleoli inside the nucleus and (B) A light 
micrograph taken using a DeltaVision Restoration microscope, illustrating nucleoli and the 
DNA content within the nucleus from a Heia cell line expressing GFP-I12B (green) which 
was stained with anti-fibrillarin antibody 72B9 (red). Scale bar =5µm. Courtesy of Prof. 
Thom Pederson for sharing the early publication regarding the nucleolus. 
dense and highly refractile, it was the first subnuclear organelle studied by microscopists 
(Figure 1-2). Both the variability in number and size and the disappearance and 
reappearance of this organelle during mitosis were noted as early as the late 19th century 
(Montgomery, 1898). 
In the 1930s, Heitz and subsequently McClintock have observed that the number and 
lengths of less compact regions or secondary constrictions in mitotic chromosomes are 
related to the number and sizes of nucleoli and these constrictions are now known as 
nucleolar organizing regions or NORs (Heitz, 1931; McClintock, 1934). However, the 
function of NORs was not clear until the 1960s when it was shown that the NOR contains 
genes encoding for ribosomal 18S, 5.8S and 28S RNAs and mutants that lack NORs are 
devoid of nucleoli (Ritossa and Spiegelman, 1965; Birnstiel and Chipchase, 1970). Soon 
thereafter the presence of ribosomal proteins and the assembly of nascent ribosomes in the 
nucleolus were also revealed, establishing that the nucleolus is the site of ribosomal RNA 
synthesis and ribosome assembly, i. e. a ribosome factory (Birnstiel and Hyde, 1963; Brown 
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and Gurdon, 1964; Ritossa and Spiegelman, 1965; Warner and Soeiro, 1967; Pederson and 
Kumar, 1971; Kumar and Warner, 1972). 
7.2.2 The Nucleolus: its DNA 
The NORs are located on the short arms of acrocentric chromosomes 13,14,15,21, and 
22 in human and -400 copies of ribosomal DNA (rDNA) repeats in tandem array are 
shared between these chromosomal regions (Shaw and Jordan, 1995; Pederson, 1998; 
Scheer and Hock, 1999; Carmo-Fonseca et at, 2000; Lyon and Lamond, 2000; Olson et at, 
2000; Pederson and Politz, 2000; Visintin and Amon, 2000). Each repeat of about 43 kbp 
contains the transcribed regions of 18S, 5.8S and 28S rRNA genes plus a non-transcribed 
spacer. The high number of repeats renders the rDNA loci difficult to analyse by 
sequencing from end to end (Labella and Schlessinger, 1989), and it is generally believed, 
but not proven, that the rDNA repeats are arranged as head-to-tail clusters in a telomere- 
to-centromere orientation. The gene that encodes the remaining ribosomal RNA, i. e. 5S 
rRNA is usually located outside the nucleolus in higher plant and animal cells, but the 
transcript itself is, surprisingly, localised in the nucleolus (Section 1.2.3). 
However, even in metabolically active cells, only a subset of rDNA copies is transcribed 
and at most only -50% of the copies are utilized (Moss and Stefanovsky, 2002). The ratio 
of active and inactive rRNA genes is tissue specific and is stably propagated through the 
cell cycle. Recent studies identified a nucleolar remodeling complex (NoRC) that mediates 
heterochromatin formation and silencing of ribosomal gene transcription by recruiting 
methyltransferase and histone deacetylase activities to the rDNA promoter (Strohher et al., 
2001; Santoro et aL, 2002; Zhou et aL, 2002a). It is hypothesised that this constitutive 
silencing of a significant fraction of the tandemly repeated rDNA genes is required to 
protect the genes against unwanted homologous recombination. 
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The rDNA organization as tandem repeats in heterochromatic regions is conserved 
amongst eukaryotes. However, these conserved features are not required for the proper 
function of rDNA. For example, a single rDNA gene inserted within a euchromatin region 
in the Drosophila genome is active in transcription and results in formation of a nucleolus 
at the integrated site (Kargen et a]., 1988). Similar results were obtained in human and 
higher plants provided that the promoter regions were included (Hadjiargyrou et al., 1994; 
Wannenbock et al., 1997). Transcription of plasmid containing a single rDNA locus driven 
by an RNA polymerase II promoter in a yeast mutant devoid of rDNA repeats, resulted in 
formation of multiple, mini-nucleoli throughout the nucleoplasm (Nomura, 1999). 
Conversely, if the plasmid was specifically designed to be transcribed by RNA polymerase 
I, a single large nucleolus formed. This raises an interesting issue of whether active 
transcription or a specific sequence in the repeat itself is responsible for the recruitment of 
rDNA and coalescence into nucleoli. In yeast, rDNAs are specifically associated with the 
Netl protein that can recruit a member of the Silent Information Regulatory (SIR) family, 
Sir2 (Straight et al., 1999; Carmo-Fonseca et al., 2000). SIR proteins are known for their 
association with the other family members and histones to orchestrate silencing in yeast 
heterochromatic regions, such as the silent mating-type (HM) loci and telomeres. Similarly, 
rDNAs in human or other higher organisms maintain a tight association with 
heterochromatin and this compartment contains DNA sequences from several 
chromosomes, including those that are devoid of NORs (Pluta et al., 1995; Carmo- 
Fonseca, 2002). Interestingly, it was shown that even transcriptionally silent human 
ribosomal genes within a murine cell environment are incorporated into nucleoli in vireo 
(Sullivan et al., 2001). This led to the suggestion that the clustering of rDNA may result 
from protein-protein interactions between nearby heterochromatin domains located in 
either the same, or distinct, chromosomes. 
Chapter I Introduction 
Page 12 
L 2.3 The Nucleolus: its RNA 
Another amazing aspect of the nucleolus is the plethora of RNA species which localise 
there, regardless of whether the RNA is transcribed there or not (Maxwell and Fournier, 
1995; Lafontaine and Tollervey, 1998; Weinstein and Steitz, 1999). An actively cycling 
eukaryotic cell expends -35-60% of its total transcriptional activity in transcribing the 
rDNA repeats and another 10-20% for transcribing 5S rDNA, -150 different species of 
snoRNAs and other RNAs such as tRNAs and signal recognition particle (SRP) RNAs. 
This constitutes -50% and -80% of the total transcriptional activity in mammal and yeast 
cells, respectively (Warner, 1999). 
In eukaryotes, RNA polymerase I is responsible for the rDNA transcription and is 
localised in a specific subnudeolar region known as the fibrillar centre (Section 1.2.4). 
Transcription requires the binding of transcription factors UBF and SL1 and these factors 
are phosphorylated and repressed by cyclin B-cdkl kinase during mitosis (Klein and 
Grummt, 1999; Voit et at, 1999; Sirri et at, 2000; Voit and Grummt, 2001; Hernandez- 
Verdun et at, 2002; Sirri et at, 2002). Surprisingly, both the polymerase itself and other 
accessory transcription factors are localised to mitotic chromosomes, notably at the NORs, 
and transcription at these sites can be artificially induced during mitosis by cdc2 kinase 
inhibitor (Scheer et at, 1984; Scheer and Rose, 1984; Roussel et at, 1993; Zatsepina et at, 
1993; Gilbert et at, 1995; Weisenberger and Scheer, 1995; Jordan et at, 1996; Gebrane- 
Younes et at, 1997; Sirri et at, 2000). During interphase, the rate of rDNA transcription is 
regulated in accordance with cell growth and the need for new ribosomes (Carmo-Fonseca 
et at, 1996; Warner, 1999; Moss and Stefanovsky, 2002). When cells approach a stationary 
phase or are serum-starved, rDNA transcription is down-regulated. There seems to be a 
direct relationship between nucleolar size and the transcriptional state of the cell 
(Stefanovsky et at, 2001). 
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Active ribosomal RNA genes can be visualized in EM by a simple hypotonic spreading 
technique, now known as "Miller spread", after the name of one of the investigators (Miller 
and Beatty, 1969). It was shown that the length of nascent transcripts are increasingly 
branching along the axis in one direction, with many engaged RNA polymerases on the 
transcribed regions of rDNA, resulting in a `Christmas tree pattern', whilst the spacer 
regions remain empty. Moreover, knob-like structures exist at the termini of the nascent 
transcripts and these structures contain proteins required for rRNA processing (Dragon et 
aL, 2002). 
The rRNA processing involves cleavage and modification steps to generate mature rRNA 
species that form the catalytic core of the ribosome (Warner, 2001). Various snoRNAs 
(http: //rna. wustl. edu/snoRNAdb/), for example U3 and U14, are needed for these 
separate rRNA cleavage steps, each snoRNA being required at specific steps. However, the 
exact nature of the cleavage sites in human is rather poorly understood, compared with 
yeast and mouse. It is also not dear whether rRNA processing requires the same level of 
precision as pre-mRNA splicing because there is no reading frame to maintain (Bowman et 
al., 1983; Eichler and Craig, 1994). Limited heterogeneity of a few nucleotides has been 
reported for the ends of 5.8S and 28S rRNA in functioning ribosomes; therefore the 
cleavages and trimming may be rather approximate. Similar to pre-mRNA splicing, the 
existence of alternative rRNA processing pathways is evident in different mammalian 
tissues (Akhinanova et al., 2000). 
The snoRNAs can be categorized into two main classes - box C/D (e. g. U3, U8, U14) and 
box H/ACA (e. g. U17, U19, U64) - according to conserved sequence elements and the 
way they are assumed to fold into defined secondary structures (Figure 1-3) (Weinstein and 
Steitz, 1999). These snoRNAs assemble together with protein factors to form snoRNPs 
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that have roles in guiding and catalyzing post-transcriptional RNA modifications. For 
example, box C/D snoRNPs direct 2'-O-ribose methylation and box H/ACA snoRNPs 
direct pseudouridylations of specific rRNA nucleotides (Lafontaine and Tollervey, 1998; 
Lewis and Tollervey, 2000). Interestingly, the modifications themselves are not all essential 
for cell growth, because a yeast strain lacking as many as eight different snoRNAs can still 
grow normally; however, the modifications are conserved and serve to enhance the 
conformational stability of the rRNA and hence the functional efficiency of the ribosome. 
Another interesting aspect of snoRNAs in vertebrates is that they are housed within the 
introns of pre-mRNAs that share the 5'- pyrimidine-rich terminus characteristic of the 5' 
Terminal OligoPyrimidine (5'TOP) family. Members of the 5' TOP family include 
ribosomal proteins and many other nucleolar proteins, such as the chaperone B23 
(Maxwell and Fournier, 1995; Lafontaine and Tollervey, 1998; Weinstein and Steitz, 1999). 
A Box n /Box( B 
m 
Bo xC AG .C 
U eGU 
BoxD 
m3Gppp p m3+ppp 
Figure 1-3 Conserved sequence and structural features of snoRNAs. (A) Box C/D snoRNAs form 
10-21nt duplexes with the substrate rRNA. The methyl group is added to the rRNA 
nucleotide paired to the fifth residue upstream of box D and/or D'. Boxes D' and C' are 
typically 3-9nt apart. (B) Box H/ACA snoRNAs have a conserved hairpin-hinge-hairpin-tail 
secondary structure. Each hairpin forms two short duplexes (4-1()nt) with the rRNA, leaving 
the target uridinc unpaired in the `pseudouridylation pocket V N, any nucleotide. Adapted 
from Kiss (2002). 
Chapter I Introduction 
Page 15 
Apart from all the ribosomal RNAs and snoRNAs, it was found that SRP RNA is also 
localised in nucleoli as are the SRP proteins SRPI 9, SRP68 and SRP72, but not ER-bound 
SRP54, which together they form a complex to direct proteins into ER for secretion 
(Pederson, 1999; Politz et al., 2000; Politz et at, 2002). Similarly, RNase P, the 
ribonucleoprotein enzyme that mediates the 5' processing of pre-tRNAs, and some tRNAs 
are present in nucleoli Qarrous et at, 1999; Jarrous et al., 2001). However, the roles that 
these classes of RNAs play in the nucleolus remain to be established, although it was 
speculated that these factors, which are required for translation in the cytoplasm, may be 
exported together with the ribosomal subunits in a preassembled state. The spliceosomal 
U6 snRNA has also been shown to enter the nucleolus where it is modified by snoRNAs 
(Lange and Gerbi, 2000; Lewis and Tollervey, 2000). A common feature shared by the 5S 
rRNA, tRNA, RNase P RNA, SRP RNA and U6 snRNA is that all RNAs are transcribed 
outside the nucleolus by RNA polymerase III (Carmo-Fonseca et al., 2000; Lewis and 
Tollervey, 2000). All newly synthesized polymerase III transcripts bind to a highly 
conserved nucleolar phosphoprotein known as the La autoantigen (Intine et aL, 2002). It 
was suggested that the La protein functions as a molecular chaperone during biogenesis but 
it is unclear whether this protein plays a role in targeting these RNA polymerase III 
transcripts. 
1.2.4 The Nucleolus: its proteins and internal organization 
In chromosome preparations, the NOR can be very clearly and rapidly visualized by 
ammoniacal or formic acid silver nitrate staining (Derenzini et al., 1998). The silver 
stainability of the NOR is due to the presence of a peculiar set of acidic proteins, which are 
highly argyrophilic. This led to the initial identification of a handful of human nucleolar 
autoantigens, including RNA polymerase I transcription factor UBF, the molecular 
chaperone for ribosomal assembly, B23, and the highly abundant and highly 
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phosphorylated protein C23, or nucleolin. Nucleolin/C23 alone constitutes -10% of total 
nucleolar proteins by mass. An exhaustive list of known nucleolar proteins was compiled in 
Chapter III. 
With the availability of the antibodies against nucleolar proteins, it was soon realized that 
these components localised specifically to morphologically distinct regions within the 
nucleolus as revealed by conventional thin section electron microscopy (Figure 1-4). These 
regions are the fibrillar centre (FC), the dense fibrillar component (DFC) and the granular 
component (GC). FCs are pale fibrillar regions that are enriched for RNA polymerase I, 
transcription factors involved in rDNA transcription, such as UBF and DNA 
topoisomerase I; DFCs are highly electron dense fibrillar regions that partially, or 
completely, surround FCs and are heavily labeled with antibodies that recognize pre-rRNA 
processing factors, such as fibrillarin; GC, the granular component, that is enriched for 
. s: , nucleolus 
Figure 1-4 Internal organization of the Nucleolus. Transmission electron micrograph of thin 
sections stained by uranium and lead salts showing the internal morphology of the nucleolus 
in. ritu on panel i; scale bar = 5µm; and the close up of different domains on panel ii; FC- 
fibrillar centre; DFC-dense fibrillar component; GC-granular component scale bar =1 
pm. Picture courtesy of Carol Lyon. 
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ribosomal proteins and ribosome subunit assembly factors, constitutes the rest of the 
nucleolus surrounding the DFCs and the FCs, (Shaw and Jordan, 1995; Scheer and Hock, 
1999; Carmo-Fonseca et aL, 2000). 
The location of the active rDNA genes, i. e. the `Christmas tree' pattern in vireo, within the 
nucleolus, however, remains controversial Early autoradiographic work at the EM level 
showed that the DFCs were the likely site of RNA synthesis and the granular component a 
site of late processing and pre-ribosome accumulation (Granboulan and Granboulan, 
1965). Subsequent pulse-chase experiments using the halogenated analogue of UTP, 
BrUTP, have suggested a mixed scenario. Depending on the protocols employed by 
different laboratories, the site of incorporation could be either at the FC, or FC/DFC 
borders or DFCs (Hozak et al., 1994, Thiry et at, 2000; Cheutin et at, 2002; Huang, 2002; 
Koberna et at, 2002). Nevertheless, it is obvious from all these experiments that the pre- 
rRNAs migrate from fibrillar regions to granular regions vectorially and subsequently into 
the nucleoplasm while maturing into preribosomal particles. 
The number of FCs is directly related to the rate of rRNA synthesis (Figure I-5A-B). For 
example, it may fall from -234 to -156 upon serum starvation of fibroblasts or rise from 
^'9 to -80 upon stimulation of a peripheral blood lymphocyte Qordan and McGovern, 
1981; Haaf et al., 1991). This suggests that each fibrillar centre represents an active 
transcription factory, and when transcription is upregulated, new factories assemble on the 
once silent rDNA repeat. However, the molecular mechanism involved in the rDNA 
switching from a repressed to an activated state remains to be established (Section 1.2.2). 
Aldn to other subnuclear structures, the nucleolus is very dynamic, showing great variability 
as a function of activity in animal and plant cells (Section 1.2.3; Figure I-5C- D). Fully active 
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Figure 1-5 Dynamic organization of Subnucleolar Domains. live cell analyses of I Iel: a cells stably 
expressing EYFP-RNA polymerase I subunit RPA39, which is localised in FCs, (A) upon 
release from serum starvation and (B) upon transcriptional inhibition (0.04µg/ml 
actinomycin D). Series showing (A) from 80-160min after release and (B)168-247min after 
inhibition; scale bar = 20µm. (A) Purple arrowheads indicate a splitting event of FCs and (B) 
red arrows indicate a merging event of FCs. HeLa cells stably expressing F, YFP-RPA39 were 
fixed (C) before and (D) after 3 hour of actinomycin D treatment (0.04µg/ml) and stained 
with anti-6brillarin antibodies 72B9 for DFC, and pyronin Y, a non-specific RNA dye, which 
stains the cytoplasm and GCs in the nucleolus; scale bar=5µm.. Green: FC (EYFP-RPA39); 
Blue: DFC (fibrillarin) and Red: GC (pyronin Y). 
nucleoli are large, with extensive intermingling of the FCs, the DFCs and the GCs, 
resulting in a reticulate-like structure (also termed nucleolonema). In contrast, in either 
some quiescent cells, or those with nucleolar inactivation following induced transcriptional 
arrest, the components of the FCs, the DFCs and the GCs are segregated out into adjacent 
blocks. 
For cells that undergo a `closed mitosis', such as budding yeast, the nucleolus remains 
intact during mitosis, ultimately being separated along the mitotic spindle during the late 
stage of division (Carmo-Fonseca et al., 2000). In contrast, the nucleolus from multicellular 
organisms disassembles during mitosis (Shaw and Jordan, 1995). It was previously shown 
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that nucleolar breakdown begins with the disappearance of the GC, followed by the DFC 
in higher plants (Lafontaine, 1968) and various nudeolar proteins leave the nucleolus in an 
apparently ordered progression (Gautier et aL, 1992). NORs are ultrastructurally very 
similar to FCs during mitosis and components such as DNA topoisomerase I, RNA 
polymerase I and other RNA polymerase I transcription factors remain associated with the 
condensed chromosomes, whereas other components are found either around the 
periphery of the condensed chromosomes, or else dispersed throughout the cytoplasm. At 
the end of mitosis, small round structures called pre-nucleolar bodies (PNBs) appear in the 
newly formed nuclei, before the resumption of transcription (Dundr et al., 2000; 
Hernandez-Verdun et al., 2002). Initiation of transcription by RNA polymerase I triggers 
the recruitment of PNBs to the NORs to form a complete nucleolus. Taken together, these 
data indicate that the assembly of a nucleolus requires the rRNA transcripts. 
Many proteins, such as ribosomal proteins, translocate once from the cytoplasm to the 
nucleolus and then travel back to the cytoplasm as pre-ribosomal particles (Section 1.2.5.1). 
Other nudeolar proteins surprisingly shuttle back and forth continually between the 
nucleolus and the cytoplasm. Intensive investigation has been carried out to identify a 
hypothetical nucleolar targeting signal. However, most of the sequences that have been 
found seem to function as nuclear targeting signals rather than nucleolar targeting signals 
(Hatanaka, 1990). Some nucleolar targeting signals identified, for example within the 
human retrovirus HIV-1 Rev and Tat proteins, seem to bind to endogenous nucleolar 
proteins such as the molecular chaperone B23, for nudeolar entry (Hiscox, 2002). Recent 
fluorescence recovery after photobleaching (FRAP) analyses have indicated that proteins 
related to ribosome biogenesis, including RNA polymerase I subunits, transcription factors, 
factors required for rRNA processing and ribosome assembly are rapidly shuttling between 
the nucleoplasm and the nucleolus (see Chapter VI). However, if that is the case, this raises 
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an interesting question as to whether the signal required for the apparent nucleolar 
accumulation is targeting proteins to the nucleolus either via `receptor' recognition, or by 
changing the rate of molecular interaction with other partners within the nucleolus. If the 
latter case is correct, as suggested by the FRAP analyses, then what are the molecular 
entities that attract protein to accumulate in the nucleolus? And why are those entities 
retained there in the first place? These two basic questions deserve to be answered, not 
only with regard to the nucleolus, but also for all other subnuclear structures. 
L2.5 Proposed roles of the Nucleolus 
L2.5.1 The Nucleolus as a ribosome factory 
As discussed in previous sections (Sections 1.2.1-1.2.4), both rDNA transcription and 
subsequently rRNA processing and modification occur within the nucleolus, which is 
followed by ribosome subunit assembly. Over the last decades, insight into ribosomal 
subunit assembly has mainly come from studies on budding yeast, especially after the 
introduction of a GFP-based ribosome export assay (Hurt et al., 1999). Currently, the 
export mechanism of the pre-40S particles (the small ribosomal subunit) is still poorly 
understood compared with the pre-60S particles (the large ribosomal subunit) (Rout et aL, 
1997). Recent large-scale systematic purification of protein-complexes using high affinity 
tags has led to tremendous progress on how the pre-60S particles are formed. This is even 
more impressive given that the half-lives of these transient structures are only about 1 
minute ix vitro (Aitchison and Rout, 2000; Ho et al., 2000; Gadal et al., 2001b; Nissan et al, 
2002). To better define the pathway of 60S subunit synthesis, a series of particles was 
pulled out using tagged version of several previously identified components from the pre- 
60S particles. These studies revealed a series of `snapshots' of the pre-60S ribosomes as 
they move from the nucleolus to the cytoplasm. 
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In these studies, a member of the `AAA' family of ATPases - $TPase associated with 
various cellular activities - Rix7 was identified (Gadal et al., 2001 a). The ATPase family is 
involved in many cellular functions, but in all cases they occur in situations where protein 
unfolding or dissociation occurs, e. g. at microtubules (Vale, 2000). It is currently proposed 
that Rix7 facilitates changes in either protein-RNA, or protein-protein, interactions within 
the pre-60S particles. As the complexes exit the nucleolus, Rix7 facilitates the shedding of 
processing factors during transit to the nuclear periphery (Brown, 2001). This allows the 
formation of an export-competent pre-60S particle, which is then complexed with a pre- 
ribosomal particle-specific adapter of an export receptor, Nmd3. The complex is then 
exported via the nuclear pore to the cytoplasm by a Ran-dependent nuclear export 
receptor, Xpol. Recently, Politz et al, used fluorescently labelled oligos that specifically 
hybridise to non-conserved regions of the 28S rRNA to show that large ribosomal subunits 
move out randomly from the nucleolus and into the nucleoplasm in all directions in human 
cells, with no evidence of concentrated movement along a directed path (Politz J, personal 
communication). Much remains to be done to solve the puzzle of ribosome biogenesis and 
export in yeast and, even more, in human. Nevertheless, the foundation laid in yeast and 
the availability of the soon-completed human genome may help speed up our 
understanding of these processes. 
L 2.5.2 The Nucleolus as a molecular `cafe' or `. rink' 
Data obtained in the past few years suggest that the nucleolus may play a role in cell cycle 
regulation by sequestration of proteins. The tumor-suppressor protein p53 is a 
transcription factor that switches on a series of protective genes when the cell is exposed to 
stress (Lohrum et aL, 2000; Sherr and Weber, 2000). Under normal conditions, p53 
activates the MDM2 gene for expression. MDM2 mediates the ubiquitination of p53 and 
hence its degradation in the cytoplasm. Both MDM2 and p53 shuttle between the nucleus 
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and the cytoplasm, but MDM2 contains a cryptic nucleolar signal that does not function in 
unstressed cells. This signal is necessary to cooperate with the nucleolar tumour suppressor 
ARF to allow the relocalisation of both proteins into the nucleolus, thereby releasing p53 
from the MDM2-degradation pathway to activate the stress response pathway. 
Recent studies, tagging GFP to the telomerase protein component TERT, revealed that 
telomerase activity is related to subnuclear localisation (Wong et al., 2002; Yang et al., 
2002). The release of sequestered telomerase to the nucleoplasm is enhanced at the 
expected time of telomere replication, Le. S-phase. By contrast, in tumor and transformed 
cells, there is an almost complete dissociation of telomerase from nucleoli at all stages of 
the cell cycle. Therefore, in normal cells, telomerase is sequestered from its potential 
substrate for most of the cell cycle, thus reducing its opportunity for access to chromatin. 
On the other hand, induced DNA double-stranded breaks cause the nucleolar association 
of telomerase in both primary and transformed cells and this sequestration was suggested 
to play a positive regulatory role in reducing the potential for inappropriate addition of 
telomeres to fragmented chromosomes. 
In budding yeast, the phosphatase CDC14 is essential for inactivation of a mitotic linse, 
i. e. cyclinB-cdkl kinase (Garcia and Pillus, 1999; Visintin et at, 1999; Visintin and Amon, 
2000; Shou et at, 2001; Geymonat et at, 2002). The inactivation of this kinase is a 
prerequisite for mitotic exit and cytoldnesis in all organisms so far examined. During 
interphase, Cdc14 is inactive and localises to the nucleolus by binding to Nett, the same 
component that recruits the repressor protein Sir2 to rDNA (Section 1.2.2). Following 
entry into mitosis, and specifically during anaphase when nucleoli segregate to daughter 
cells (Section 1.2.4), Cdc14 is liberated from Netl, which remains in the nucleolus, and 
becomes active. The release of Cdc14 occurs presumably in response to a signal 
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transduction cascade initiated by the anaphase promoting complex. In addition, the 
repressor protein Sir2 is also involved in monitoring appropriate progression through 
meiosis. Sir2 recruits a protein involved in the meiotic checkpoint to the nucleolus and 
thereby represses meiotic homologous recombination between rDNA (San-Segundo and 
Roeder, 1999). 
I. 2.5.3 Other functions of the Nucleolus 
The convergence of silencing and nucleolar proteins supports the idea that the nucleolus 
and other silenced or heterochromatic regions of the nucleus may be privileged regulatory 
sites. This has further developed by considering the potential mechanism of cellular ageing. 
Saccharomyces cerevisiae divides asymmetrically and the finite number of daughters produced 
by a mother cell is the measure of life span (Guarente, 1997; Kennedy et al., 1997; Sinclair 
et al., 1997; Johnson et al., 1998). A mutant screen revealed a gain-of-function allele of 
another SIR repressor family member, the Sir4 gene. Sir4 forms a complex with Sir2 and 
Sir3 to form a transcription silencing complex at telomeres and the silent mating type loci 
(Section 1.2.2). The effect of SIR4-42 redirects the Sir complex to the nucleolus, which 
lengthens life span, and the same translocation of the Sir complex was observed to occur in 
aging wild-type cells to promote longevity. 
Mutants in SGS1, the yeast homologue of the human gene which is defective in Werner 
Syndrome patients, cause a 60% shortening of life span. This yeast protein, like its human 
homologue, localises to the nucleolus and is involved in rDNA recombination (Marciniak 
et al., 1998; Carmo-Fonseca, 2002). Strikingly, examination of both sgsl ageing mutant and 
aged wild type mother cells revealed that the normally single nucleolus becomes 
fragmented and enlarged and contains abundant extrachromosomal rDNA circles (ERC). 
These ERCs are believed to be formed by occasional intrachromosomal homologous 
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recombination between rDNA repeats and they accumulate to high levels in ageing cells 
(Sinclair and Guarente, 1997; Sinclair et al., 1997). Even though so far no ERCs have been 
observed in mammalian cells, ageing may be related to the regulation of proper 
recombination between rDNA within the nucleolus. This may partly explain the usage of 
only half of the rDNA copies, even at maximal transcriptional output. Because transcribed 
genes are generally more accessible, they are therefore probably subjected to considerably 
more damage than inactive ones and this may be particularly true for the most intensely 
transcribed rDNA genes. The silenced rDNA repeats may hence be a source of reserves to 
replace irretrievably damaged repeats. Alternatively, these silenced genes may be involved 
in other functions of the nucleolus. 
Growing evidence suggests that viruses may target the nucleolus and its components to 
favour viral transcription, translation and perhaps alter the cell cycle in order to promote 
virus replication (Hiscox, 2002). Viruses can interact with the nucleolus by localising 
components to there that can then cause the endogenous nudeolar proteins to relocate to 
the cytoplasm during infection. It was recently suggested that this cytoplasmic 
redistribution of nucleolar proteins and subsequent virus-induced cell rupture may result in 
presenting antigens normally resident within the nucleolus to the immune system. This 
cascade of virus induced action is suggested to be the cause of autoimmune diseases such 
as scleroderma and systematic lupus erythematosus as a result of autoimmunity to 
nucleolin and fibrillarin, respectively. 
Many nucleolar phenomena still remain to be explained. For example, what are the 
functions of those RNA species that localise within the nucleolus but have no obvious 
relationship with ribosomal biogenesis, namely, the SRP RNAs, tRNAs and RNase P 
RNAs? And what other RNA modifications can occur in the nucleolus such as 
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modification of the spliceosomal U6 snRNA? What are the reasons behind the 
relocalisation of extracellular growth factors into the nucleolus? What is the role played by 
those proteins specifically localised in the nucleolus of stem cells, but not of differentiated 
cells? What more does the nucleolus have in store for us to discover? To answer these 
questions in my PhD, I have followed two parallel approaches aimed at understanding 
more about the function of the nucleolus: 
A. by investigating what protein components constitute the human nucleolus using 
a proteomic approach (Section 1.3.1); and 
B. by following how these proteins localise to the nucleolus and investigating the 
relationship between the assembly/disassembly of the subnucleolar domains as 
a function of activity, using high resolution light microscopy (Section 1.3.2). 
1.3 Analysis Tools 
I. 3.1 Proteomics 
L3.1.1 General 
Troteomics' is the large scale characterisation of the entire protein complement, i. e. the 
proteome, of a cell line, a tissue or even an organism (Roepstorff, 1997; Andersen and 
Mann, 2000; Pandey and Mann, 2000). Traditionally, it has been used to describe the 
analysis of protein components separated by 2-dimensional gel electrophoresis (Fey and 
Larsen, 2001). However, this method cannot easily determine the identities of proteins 
using traditional chemical method such as Edman protein sequencing. A method which is 
both sensitive and high-throughput for protein characterisation was in dire need during the 
1990s and this method came after two important technical breakthroughs. The first one 
came from the field of mass spectrometry and the other from the field of molecular 
biology. 
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Mass spectrometry has traditionally been used to identify the mass of a small molecule with 
high accuracy. However it was not widely used for protein analysis until the emergence of 
two new ionization techniques that allow the production of gas phase molecular ions of 
protein fragments, or peptides, ie. electrospray ionization (ESI) and matrix-assisted laser 
desorption ionization (MALDI; Section 1.3.1.2). Currently it is possible to measure even a 
subpicomole amount of a peptide with a mass accuracy better than 0.01% (Smith, 2002). 
The current general scheme for protein characterisation involves the identification of 
peptides after protease digestion of a purified protein and the search for peptide matches 
from protein databases. At the same time, the development of the polymerase chain 
reaction made both sequencing the whole genome and large scale mRNA analysis possible. 
The protein information derived from the human genome and the mRNA data enables 
researchers to search not only the primary databases, such as SWISSPROT and, now more 
commonly, International Protein Index (IPI), but also the genome and expressed sequence 
tag (EST) databases by in ü&v translation (Roepstorff, 1997; Neubauer et at., 1998a; Fenyo, 
2000; Pandey and Mann, 2000; Andersen et al., 2002). 
These advances in protein analysis have resulted in a huge catalogue of protein 
components from biochemical complexes, organelles and even whole organism proteomes. 
Different approaches were developed to identify a set of proteins purified with a specific 
function in mind. For example, spliceosomes were purified using streptavidin affinity 
chromatography to isolate biotinylated pre-mRNA substrates after in dim spliceosome 
assembly (Neubauer et al., 1998b; Rappsilber et at, 2002; Zhou et al., 2002b). Changes in 
protein composition during spliceosome activation were analysed by comparing the 
immunocomplexes from an in vitm splicing reaction and nuclear extract using antibodies 
raised against a specific splicing factor (Makarov et al., 2002). Similarly, antibodies raised 
against phosphotyrosine have been used to identify potential substrates in several receptor- 
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mediated signaling pathways by comparing the factors isolated from both unstimulated and 
growth factor-stimulated cell lysates (Conrads et al., 2002; Mann et A, 2002). 
A high throughput approach to identify the interaction partners of a protein, commonly 
known as `bait', is to express the protein fused with one or two cleavable high affinity tags 
(Rigaut et at, 1999). This approach is especially powerful in genetically amenable species, 
such as budding yeast large-scale interaction mapping has been performed to understand 
the ribosome maturation and DNA repair pathways (Gavin et at, 2002; Ho et at, 2002; 
Nissan et at, 2002). Once the composition of a complex is known, additional baits can be 
chosen from this known set of proteins and used to pull out other associated partners. By 
comparing the factors identified using different baits, this type of `complex walking' 
approach reveals a series of snapshots of the change in composition of a multi-protein 
complex as it either functions or proceeds along a pathway (e. g. Section 1.2.5.1) (Nissan et 
at, 2002; Shevchenko et at, 2002). 
L3.1.2 Ion source 
By definition, a mass spectrometer consists of an ion source, a mass analyzer and a detector 
(Roepstorff, 1997; Andersen and Mann, 2000; Smith, 2002). Generated ions are deflected 
by a magnetic field according to their mass/charge ratios and are measured and registered 
by the mass analyzer and the detector, respectively. In 1988, coincidentally, two different 
ionization techniques were developed to generate gas phase ions from a liquid source, i. e. 
MALDI and ESI. Table 1-2 summarises the differences between MALDI and ESI mass 
spectrometry. 
In MALDI, a protein solution embedded in a co-precipitate of light absorbing matrix 
(usually a-cyano-4-hydroxycinnarnic acid or dihydroxy benzoic acid) is irradiated in a 
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vacuum with a short pulse of UV light. Rapid sublimation of the analyte/matrix crystallites 
leads to the formation of protonated molecular ions in gas phase. In ESI, analyte solution 
is passed through a hypodermic needle head at high potential. Due to the high electric 
potential, the solution disperses into a mist of small, highly charged droplets (usually one 
proton per kDa) containing the analytes, which evaporate rapidly as the protonated 
molecular ions are released into gas phase. Due to the evaporation mechanism in this 
condition, there is only one analyte molecule per droplet formed at the needle tip. The 
introduction of the nanoelectrospray source allows as little as 0.50 of analyte solution for a 
stable spray lasting up to 30 minutes, gives rise to improved sensitivity and longer analysis 
time (Mann and Wiilm, 1995; Wilm and Mann, 1996). 
MALDI-MS ESI-MS 
Mass range (Da) 400 -2x 105 50 -105 
Mass accuracy (peptide) 0.1-0.001% 0.05-0.008% 
Sensitivity Low finol to pmol Low finol to pmol 
Resolution (peptide) 500-10000 1000-2000 
Tolerance to impurities Good Moderate 
LC-MS capability Offline Online 
MS/MS Some Yes 
Cost $$ $$$$ 
Mass analyzer (typical) Time-of-flight (TOP) Quadrupole mass filter 
Table 1-2 Comparison of MALDI and ESI mass spectrometry. LC-MS: liquid chromatography 
coupled mass spectrometry and MS/MS: tandem mass spectrometry commonly used for 
identification of amino acid sequence of peptides. Adapted from Mann and Wilm (1995). 
1.3.1.3 Mass analyzer and spectrum detector 
The advantage of mass spectrometry compared with all other methods in determining the 
mass of a molecule is its high accuracy and therefore the mass analyzer is arguably the 
crucial part of the technology. Proteomic measurements should mostly aim for high 
throughput; the ability to be coupled with other separation technologies such as liquid 
chromatography (LC), high sensitivity and large dynamic range and mass accuracy. 
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Currently 3 different types of mass analyzers are commonly used, namely Quadrupole 
Time-of-Flight (QTOF), Ion Trap (IT) or Fourier Transform Ion Cyclotron (FTIC). Table 
1-3 summarises the relative strengths of these mass analyzers. TOF analysis is basically a 
measure of the time required for a peptide ion to fly from the ion source to the detector, 
which varies according to the mass of the intact peptide. Based on the high mass accuracy 
of the analyzer, it is possible to deduce the composition of the peptide from reference to 
existing databases. The disadvantage of this technique is that it cannot identify proteins that 
have not previously been deposited in databases. Since this type of mass mapping (more 
commonly known as fingerprinting) requires a highly purified target protein, the technique 
is commonly used in conjunction with either one or two-dimensional gel electrophoresis to 
separate and purify proteins. Software is available to compare and analyse spots that vary 
between different gels (Fey and Larsen, 2001). 
Instrument Detection Dynamic Resolving Mass Cost 
Type limit (moles) Range Power Accuracy 
IT 1o-16-1O- 4 -102 -143 300-1000ppm $ 
QTOF 1o-15-10-13 -102 -104 5-40ppm $$ 
FTIC 10-19-10-15 -103 -105 <1-loppm $$$$ 
Table 1-3 Mass spectrometry performance in proteome measurement. IT. Ion trap; QTOF: 
Quadrupole Time-of-Flight; FTIC: Fourier Transform Ion Cyclotron. Adapted from Smith 
2002 
Currently, it is more common to couple protein separation, through one or two liquid 
chromatography steps such as ion exchange chromatography and gradient reversed-phase, 
with an ESI tandem mass spectrometry analysis, ie. LC-EST-MS/MS. In LC-ESI-MS/MS, 
an electrospray is often coupled to ion traps and triple quadrupole instruments (Smith, 
2002). This setup allows peptide sequencing by further generating fragment ion spectra, ie. 
collision induced dissociation spectra (CID), of peptide precursor ions selected from the 
first mass spectrometer. The fragmentation of the precursor peptide results in a nested set 
of peaks differing by amino acid residue masses and the peptide primary sequence can 
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hence be reconstructed (Mann and Wilm, 1995). The advantage of speed, high sensitivity 
and the ability to work from unseparated peptide mixtures effectively makes traditional 
Edman sequencing obsolete. The general scheme for protein identification by this 
approach can be summarized as follows: 
Protein recovery 4 En. Vmat c digestion 4 Liquid chromatography separation 1 Mass rßectmmehy 
sekcted peak subjected to MS/MS -i Database search from the mass/charge information 
4 Peptide (and protein) identification 
However, the increasing complexity of the samples analysed, for example from a whole 
organism, requires strategies to increase proteome coverage. This includes computer 
control methods to minimize subsequent re-analysis of peptides, multiple analyses of the 
same sample with attention focused on different mass/charge ranges and the automated 
adjustment of the LC rate based on the number of peptides co-eluted. Recently, it was 
proposed to use both the information from separation (e. g. LC elution times) and the high 
mass measurement accuracy achieved in FTIC (which extends to at least 0.1 ppm) for 
peptide identification. This information from both accurate mass and time (AMT) forms a 
tag for each peptide (Conrads et at, 2000; Lipton et al., 2002; Smith et at, 2002). In the 
AMT tag strategy, peptides are first tentatively identified in multiple runs by using LC- 
MS/MS. The tentatively identified peptides are then validated by high accuracy 
measurement of the peptides' predicted mass at the same relative elution time in LC 
separation. This strategy has been used for the identification of the Deinococcus radiodurans 
proteome, covering -61% of the open reading frames of which a quarter were previously 
assigned as either hypothetical, or conserved hypothetical (Lipton et at, 2002). 
The large variation in relative protein abundance within a sample, which could be as high 
as 10 orders of magnitude in the case of human plasma, presents a major challenge for 
proteomics (Anderson and Anderson, 2002). The dynamic range can be improved by the 
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aforementioned approach including liquid chromatography and the AMT strategy. In 
addition, the methodology known as Dynamic Range Enhancement Applied to Mass 
Spectrometry (DREAMS) have been reported recently to solve this issue, e. g. by removing 
the most abundant ion peaks found in previously obtained spectra (Belov et aL, 2001; Pasa- 
Tolic et aL, 2002). 
1.3.1.4 2uantitative prvteomics 
Because the main advantage of mass spectrometry is its mass accuracy, it is possible to add 
a quantitative dimension to proteomic experiments by adding reagents carrying an isotope 
with a molecular mass that is different from the isotope used in the control experiment 
(Flory et al., 2002). The chemically identical analytes with different stable isotope 
compositions can be differentiated by their mass differences and the signal intensities 
between the two forms can indicate their relative abundance ratio. Stable isotope tags have 
been introduced to samples post isolation via multiple techniques, including metabolic 
labeling using heavy salts, or amino acids (Conrads et al., 2002), enzymatically via transfer 
of 180 from water (Yao et al., 2001), or more commonly via chemical reactions using 
isotope coded affinity tags (ICAT) that covalently label a particular amino acid such as 
cysteine (Gygi et aL, 1999). Alternatively, stable isotope labeled amino acids such as "C 
arginine can be introduced in cells growing in a particular metabolic state, e. g. when 
transcription is inhibited before isolation (Ong et aL, 2002). 
1.3.2 Microscopy 
Knowledge concerning the biochemical constituents in a structure is crucial to understand 
how and where they act within the cell. Moreover, the localisation and the quantitative 
behaviour of molecules in cells is a critical part of their functions. Therefore, it is important 
to understand how molecules behave, especially in live cells. As cells are three-dimensional 
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structures, it requires multiple images with a defined depth-of-field taken at regular focus 
intervals, i. e. optical sections, to represent the sample. However, only a small fraction of the 
light that is illuminating through the sample and entering the lens, originates from the focal 
plane where features are in sharp focus. Therefore, the object in focus is often obscured by 
a blurry background due to the `out-of-focus' light. 
1.3.2.1 Hardware microscopy equipment 
There are two common ways used to solve the issue of the blurred image in biological 
samples, i. e. the laser scanning confocal microscope (I SK and the wide-field microscope 
(WFM; Figure 1-6). The principle of LSM is to use a focused laser to excite the sample 
point-by-point across the x-y plane and eliminate the out-of-focus light by imposing a 
Illumination Emission 
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Figure 1-6 High resolution Light Microscopes. The diagram shows a schematic diagram illustrating a 
typical layout of an objective lens, covetslip, cell and slide. The left hand side shows the 
volume of fluorescence excitation and the right hand side shows the corresponding 
fluorescence from each point source (Andrew et al., 2002). 
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pinhole before detecting the emitted fluorescence with a photomultiplier tube (Pawley, 
1995; Andrews et aL, 2002). Alternatively, a multiphoton microscope (MPM) can limit the 
laser-induced fluorescence excitation to a small volume by only allowing the absorption of 
two photons possessing half the energy, ie. twice the usual excitation wavelength As it 
requires high photon density at a focused point to excite the sample, out-of-focus 
fluorescence is negligible. In contrast, a WFM illuminates the whole sample simultaneously 
and records the emitted fluorescence with a charge-coupled device (CCD) camera 
(McNally et al., 1999; Andrews et al., 2002; Swedlow and Platani, 2002). To recover an 
estimate of the unblurred object from in-focus and out-of-focus signals, algorithms are 
developed to `deconvolute' the image based on the knowledge of how a point source light 
behaves in the corresponding 3D image, ie. the point spread function (PSF). 
The advantage of LSM and MPM is that they can be used in thick samples where the in- 
focus signals are overwhelmed by too much out-of-focus light in WFM. Moreover, the 
restored images obtained from WFM are often symmetrically elongated in the Z-axis as a 
consequence of nonconfocal imaging and also may be prone to artifacts, especially if the 
PSF is mismatched (McNally et at, 1999). Conversely, many signals emanating from the 
sample are discarded by the pinhole imposed in ISM, whilst all the signal information is 
preserved in WFM. Therefore, measurements with a ISM usually result in a lower signal- 
to-noise ratio, especially with dim samples (Swedlow et at, 2002). The situation in LSM is 
made worse by the noise fluctuation introduced in the gas laser as it scans the sample point 
by point. In contrast, the fluctuation of light illumination is delivered in parallel to all 
regions of the sample simultaneously by WFM, eliminating pixel-to-pixel differences in 
delivered illumination. 
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Although the high intensity of illumination by a focused laser may not be advantageous to 
the cells in LSM, it may be useful in some quantitative experiments; e. g. photobleaching in 
a short period of time (Section 1.3.2.3). In a live cell experiment, it may take a much longer 
exposure by the low illumination from a WFM light source in order to obtain the same 
signal intensity achieved by a shorter time interval, but higher powered laser pulse, in ISM 
(Andrews et al., 2002; Swedlow and Platani, 2002). Therefore, a compromise must be 
reached between the signal-to-noise ratio and the time required to excite the sample as 
both high intensity light and prolonged exposure are detrimental for cellular processes such 
as mitosis. In this thesis, a combination of both LSM and WFM has been employed, 
depending on the type of experiments as illustrated in Chapters IV and V. 
Figure 1-7 Crystal Structure of GFP and the sites of the 
fluorophore. Ribbon diagram of GFP drawn 
from the wild-type crystal structure. The buried 
chromophore, which is responsible for GI P's 
luminescence, is shown in full atomic detail. 
(http: / /www. npaci. edu/online/v4.14/gfp. htm). 
1.3.2.2 Live Cell Fluorophores 
l'raditionally, the localisation of a protein 
was investigated by immunofluorescence 
in which a protein is detected by the 
signal of a fluorophore that is coupled 
directly, or more often indirectly, via 
secondary antibodies, to a cognate 
antibody. The samples must therefore be 
fixed before binding the antibody. 
However, the cloning of the green 
fluorescent protein (GFP) from Aequot a 
tictoria has changed the field of cell 
biology (Tsien, 1998). The chromophore 
is a p-hydroxybenzylideneimidazolinone 
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formed from residues 65-67 (Figure 1-7), which are Ser-Tyr-Gly in the native protein, 
generated by cyclisation and oxidation steps after folding. GFP is an 11-stranded ß-barrel 
threaded by an a helix that runs up the axis of the cylinder and bears the chromophore 
(Yang et al., 1996). The structural stability and relative resistance to protease cleavage make 
it an ideal tool to express as a fusion protein with the protein of interest for localisation 
studies, due to its ability to self-generate a chromophore (Misteli and Spector, 1997; 
Lippincott-Schwartz et al., 2001; van Roessel and Brand, 2002). Moreover, the localisation 
can now be followed in live cells, thus avoiding any potential fixation artifacts, although it 
must always be borne in mind that the GFP tag can potentially influence the properties of 
the protein it is fused to. 
Apart from optimization of the codon usage and removal of cryptic splice sites within 
GFP, a series of site-directed mutants have been made to change the excitation and 
emission spectra of the chromophore (Figure 1-8). These mutations enhance its brightness 
and improve folding at 37°C, based on the essential knowledge of the X-ray crystal 
structure (Tsien, 1998). Wild type GFP normally exists as a mixed population of 
chromophores, namely the neutral phenols and anionic phenolates, which produce a major 
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Figure 1-8 Emission and Excitation spectra of Fluorescent proteins. (A) The emission and 
excitation spectra from ECFP, EGNT, EYFP, I)sRed and I icRed arc shown in blue, green, 
yellow, read and purple respectively. 'Ilhe figure was modified and compiled according to data 
obtained in Clontech. 
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397nm and a minor 475nm absorbance, respectively (Tsien, 1998). Upon intense 
illumination of the protein with 413 nm light, the chromophore population undergoes 
photoconversion and shifts the chromophore predominantly to the anionic form. This 
gives rise to an increase in the minor peak absorbance and consequently three fold increase 
in fluorescence emission upon excitation at 488nm. Patterson et al have recently generated 
a photoactivatable GFP whose minor absorbance peak was initially lower, such that the 
subsequent photoconversion by 413 nm irradiation produces an even greater increase in 
absorbance at the minor peak and -100 times brighter emission when excited by 488 nm 
irradiation (Patterson and Lippincott-Schwartz, 2002). The selective photoactivation of a 
region of interest within cells using 413nm light allows the movement of protein 
originating from a focused laser-irradiated region to be monitored. 
By using an ingenious PCR approach, other groups have identified GFP-like fluorophores 
from non-bioluminescent corals, such as DsRed from the sea anemone Discosoma striata, 
(Matz et al., 1999) and more recently, HcRed from Heteractis cri pa (Gurskaya et al., 2001). 
Both DsRed and HcRed are red fluorescent proteins (RFPs; Figure 1-8) and are potentially 
ideal for studying protein-protein interactions between GFP and RFP, similar to the way 
that has been used between cyan fluorescent protein (CFP) and yellow fluorescent protein 
(YFP), by fluorescence resonance energy transfer (FRET). This technique measures the 
degree of sensitised fluorescence emission from an acceptor, such as RFP, as a result of 
excitation of the donor, such as GFP (Truong and Ikura, 2001; van Roessel and Brand, 
2002). One of the criteria for FRET is that the emission spectrum of the donor must 
overlap with the excitation spectrum of the acceptor. The energy transfer efficiency is 
inversely proportional to the 6' power of the distance between the two pairs and therefore 
it is an ideal tool to study protein-protein interactions. So far, only the X-ray 
crystallographic structure of DsRed has been solved for the family of red fluorescent 
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proteins and the structure has a very similar 11 stranded (i-barrel fold to the GFP with the 
chromophore formed between residues 66-68 (Gln-Tyr-Gly-) (Wall et al., 2000). The red 
shift of the spectrum is caused by an additional oxidation step which forms an acylimine 
extension to the chromophore from neighbouring residues (Yarbrough et at, 2001). The 
original DsRed is very slow in folding and is a tetramer. Subsequent mutagenesis studies 
increased the rate of folding and monomerised the wild-type DsRed by reducing the 
monomer-monomer interactions (Campbell et al., 2002). Moreover, a mutant was 
generated such that there is a delay in the additional oxidation step responsible for the red 
shift (rersldkh et at, 2000). This mutant, known as `Fluorescent timer', requires a relatively 
longer period of time for the red-shift to occur and hence provides a time window to 
change from green to red fluorescence, thereby providing a way to distinguish newly 
expressed protein from the old ones. 
In addition, tagging fluorescent proteins (FPs) to different proteins/peptides increases their 
possible usage. For example, tagging FPs with the MS2-RNA binding protein or the lacI 
repressor enables researchers to study the movement of MS2-binding site-containing 
RNAs or a Lac operon cassettes integrated in DNA loci, respectively (Belmont and 
Straight, 1998; Bertrand et al., 1998). Systems have been established to study gene activity 
at the level of genome, mRNA expression and protein expression by a clever combination 
of these visualization tools (I sukamoto et at, 2000). Addition of a degradation domain 
renders FP destabilised and can be used to directly correlate gene induction with a 
biochemical change (Li et at, 1998). A large-scale `protein trap' strategy has tagged FP 
randomly, either to the 3' end, or within intron regions, of genes to identify their specific 
intracellular locations (Sutherland et at, 2001). 
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Another class of live cell fluorophores that can be genetically engineered to use in live cells 
is a reporter system called FlAsH (Griffin et al., 1998). This involves tagging of the protein 
of interest with a small motif (6-20 residues) that contains the sequence -Cys-Cys-X-X-Cys- 
Cys-, where the thiol groups of cysteine residues are arranged in a conformation to bind a 
membrane-permeant, nonfluorescent biarsenical derivative of fluorescien, i. e. 4', 5'- 
bis(1,3,2-dithioarsolan-2-yl)fluorescein. FlAsH becomes strongly green fluorescent when 
bound specifically to the tetracysteine motif. This system allows the target protein with a 
relatively short motif addition to be singled out inside live cells by staining with this small 
nonfluorescent dye. Recently, another biarsenical derivative of the red fluorescent 
resorufin, known as ReAsH, has been introduced (Gaietta et al., 2002). This has been used 
in parallel to label two temporally separated pools of connexins by administering the two 
reagents at different times. The ReAsH has the added advantage that it can photoconvert 
diaminobenzidine (DAB) to produce an electron dense product and hence allow the tagged 
protein to be imaged in both fluorescence and electron microscopy. 
I. 3.2.3 Quantitative Microscopy 
Apart from FRET, a technique discussed in the last section that can provide information 
about the distance between two proteins, fluorescence microscopy can also measure 
protein dynamics quantitatively by using photobleaching techniques (Lippincott-Schwartz 
et at, 2001; Misteli, 2001; Phair and Misteli, 2001; Reits and Neefjes, 2001). Photobleaching 
is a photo-induced alteration of a fluorophore that extinguishes its fluorescence 
irreversibly. GFP is an ideal tool with which to study protein dynamics because the 
chromophore has a high fluorescence yield and it is resistant to photobleaching at low 
illumination. However, when excited with high illumination levels, the GFP fluorophore 
can be irreversibly photobleached and this was used to study the movement of non- 
bleached GFP fusion protein into the bleached areas (Figure 1-9) 
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Figure 1-9 Microscopic experiments using photobleaching properties of GFP. (A) FRAP, (B) 
FLIP and (C) iFRAP. (A) In FRAP, an area is photobleached once and the fluorescence 
recovery is monitored in that area while (B) FLIP is simply a repetitive form of FRAP but the 
fluorescence level outside the bleached area is monitored and (C) iFRAP is to monitor the 
loss of fluorescence of a small unbleached area when all other areas are bleached (see text for 
details). Both (D) FRAP and (E) iFRAP can provide a quantitative measurement and a 
qualitative description of the protein mobility, suggested by the shape of the curve. For 
example, proteins accounting for curve I have a higher diffusion coefficient compared with 
proteins accounting for curve 2 and 3 whereas proteins accounting for curve 3 may be more 
confined to a separate compartment resulting in their inability to exchange with other non- 
bleached fluorescent molecules to recover the fluorescence loss. 
FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP) 
After photobleaching of the fluorescent molecule in a small area of the cell, FRAP 
monitors how fast/slow the fluorescence within the designated area recovers based on the 
diffusion of non-bleached fluorescent molecules into the bleached area (Figure I-9A). This 
method was initially used in the 1970s using fluorophores coupled to proteins and lipids to 
study their movement within the plasma membrane and is currently used extensively to 
study protein dynamics using GFP-fusion proteins. Two parameters can be deduced from 
FRAP: (a) the mobile/immobile fraction and (b) the rate of diffusion time T,,. The mobile 
fraction (MO is defined as follows: Mf=F- 
F° 
(Equation 1.1) 
F. - FO 
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where F,, is the fluorescence in the bleached region after fiill recovery (when the curve 
reaches a plateau), F; is the initial pre-bleaching fluorescence and FO is the fluorescence just 
after photobleaching. The immobile fraction is defined as 1-Mf and some of the possible 
scenarios are illustrated below (Figure I-9D). For example, the protein represented by 
curve 3 has a smaller Mf than those represented by curves 1 and 2, suggesting that (i) the 
protein may either bind to fixed molecules or form aggregates that are restricted in 
movement and/or (ii) the protein is confined to a compartment that cannot contribute to 
fluorescence recovery in a separate compartment. 
The mobility is often expressed as the diffusion coefficient D, which is related to the 
diffusion time TD and gives a measure of the rate of protein movement in the absence of 
either flow or active transport: 
D= 
6k 
R 
(Equation 1.2) 
M 
where T is the absolute temperature, rI is the viscosity of the solution, k is the Boltzmann 
constant and R is the hydrodynamic radius of the particle. Therefore, when the viscosity 
and temperature are unchanged, D is mainly determined by the radius of the molecule and 
is roughly the inverse of the cube root of molecular mass, assuming that the object has a 
spherical shape. D (n the #nit of pdi) reflects the mean square displacement that a protein 
explores through a random walk over time. For example, the increase in D (curve 1 
compared with curve 2 in Figure I-9D) may suggest either a loss in environment viscosity 
or a transient loss of interaction with either large or fixed molecules. To calculate the value 
of D, the fluorescence recovery data are usually fit to a variant of equation 1.2 by a non- 
linear least square technique using mathematical software such as SAAM II or Berkeley 
Madonna. 
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FLUORESCENCE Loss IN PHOTOBLEACHING (FLIP) 
Although FLIP is not quantitative, it provides a simple way to assess the continuity of 
compartments. FLIP is similar to FRAP; but instead of photobleaching once, the 
photobleached area is repetitively bleached and the fluorescence level outside the area is 
monitored (Figure I-9B). If the molecules are freely diffusible between two compartments, 
the continual movement of molecules exchanging between the unbleached and the 
bleached compartments will deplete the pool of fluorescent molecules in the unbleached 
compartment and therefore result in a decrease in fluorescence within the unbleached 
compartment 
INVERSE FRAP(IFRAP) 
Recently, a modified bleaching method known as iFRAP was introduced by the Misteli, 
group to study the elongation rate of RNA polymerase I (Dundr et al, 2002). In an iFRAP 
experiment, the entire cell, apart from the area of interest is photobleached such that a 
snapshot of fluorescent molecules at the time of bleaching is obtained and the subsequent 
loss of fluorescence over time in the non-bleached area allows the corresponding 
dissociation of the fluorescent molecules in that area represented by a constant, k (Figure 
I-9C). Figure I-9E shows a typical fluorescence decay curve from an iFRAP experiment 
and indicates the corresponding mobile and immobile fractions. To calculate the 
dissociation constant, the decay curve is fitted to a defined model based on our knowledge 
of the system analysed, such as the stochiometry of the complex. 
1.3.2.4 Other methods and microscopies 
Apart from these photobleaching methods and FRET, fluorescence correlation 
spectroscopy (FCS) is becoming more popular as it is now possible to define a very small 
sample volume (-1 femotolitre) using confocal microscopy. FCS provides an alternative 
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way to measure diffusion coefficients by monitoring the fluctuations in photons resulting 
from the movement of fluorescent molecules between the defined volume and the 
surroundings (Van Craenenbroeck and Engelborghs, 2000). Other than GFP and the 
FlAsH system, recent successes include the production of single chain antibodies that can 
be fused with an organelle-targeting sequence to label a compartment of interest (Farinas 
and Verkman, 1999). Continual development of software and hardware, such as the 4-Pi 
microscope and the ultrafast dynamics microscope increase spatial resolution by factors of 
-2-5 fold over the theoretical limit and certainly hold a promise to reveal greater details of 
the movement and localisation of proteins within subnuclear compartments (Nagorni and 
Hell, 1998; Klar et al., 2000; Thomann et al., 2002). 
I. 4 Aim of the Thesis 
The aim of my thesis is to present the results I collected during my PhD studies on the 
following three aspects of a subnudear compartment - ie. the Nucleolus - with a hope 
that the principles learnt from this particular organelle can be extended to our 
understanding of other subnudear compartments (Section I. 1.2-I. 1.3): 
1.4.1 Characterisation of Nucleolar Proteome 
As mentioned in Section 1.2.5, so far we have learnt very little about the machineries 
involved in ribosome assembly in human cells, even though the nucleolus was identified as 
a `ribosome factory' 40 years ago. Even less is known about what other roles may be played 
by the nucleolus. Our increasing knowledge of the functions in the nucleolus has mostly 
been initiated by fortuitous discoveries. The apparent question is, "what makes up the 
human nucleolus? ". To answer this question, our group initiated 5 years ago a proteomic 
approach to systematically analyse the protein components of this organelle. When I joined 
the group in October 1999, the protocol for the isolation of nucleoli had been optimized 
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and an initial round of mass spectrometry analysis had confirmed its purity. However, even 
at that time, there were a lot of novel/uncharacterised proteins identified whose 
localisations remain unknown and hence my first goal was to test the localisation of these 
putative nudeolar factors by tagging them with GFP (Chapter III). The study of one of 
these novel factors subsequently led to the identification of a novel nucleolar targeting 
pathway (Chapter V). At the same time, I compiled a catalogue of all known nucleolar 
proteins identified since 1978, when the age of molecular cloning began, to help classifying 
the factors identified in the project (Chapter III). 
As the project evolved, it became apparent that there exist at least 300-400 different 
proteins in the human nucleolus and a database was set up to archive both the primary 
information obtained from mass spectrometry and the secondary information derived from 
subsequent bioinformatics searches (Chapter III and http: //www. dundee. ac. uk/ 
lifesciences/lamonddatabase). Out of the -400 proteins, -30% of the proteins identified 
are classified as novel or uncharacterised. But because of the wealth of the secondary 
information, such as mRNA tissue distribution and homologues in other species, I 
attempted to use this derived data to classify the function of these novel factors and their 
potential relation to ribosome biogenesis (Chapter III). 
L4.2 Understanding of Subnucleolar domain dynamics 
Although different subnucleolar domains have been studied before, it has so far not been 
studied in live human cells how these subnucleolar domains move in relation to one 
another, especially during their mitotic breakdown and reassembly. With this in mind, I 
have established 24 separate HeLa cell lines stably expressing one or more FP-tagged 
markers corresponding to the 3 morphologically distinct domains within the nucleolus, i. e. 
the FC, the DFC and the GC (Section 1.2.4) and imaged nuclei from these cells from 
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prophase to early Gl (Chapter IV). These studies revealed that the breakdown and the 
assembly of the nucleolus may be initiated by the respective dissociation and recruitment of 
RNA polymerase Ito the NORs. This is surprising, because it was long thought that RNA 
polymerase I remains associated with the chromosomes during different stages of mitosis 
but, in Chapter IV, I have shown that there exists a period between prophase and 
metaphase when RNA polymerase I dissociates from the chromosomes. Moreover, I have 
established an in vivo technique to label one or more nucleoli non-invasively to study their 
dynamics in different metabolic states and, together with other results, I propose a 
plausible mechanism for how the number and size of the nucleoli are determined. This 
provides a testing ground to understand why some malignant cells have extremely large 
nucleoli 
1.4.3 More than one route to Nucleoli 
Another obvious question in studying nudeolar dynamics is, "how do proteins know 
where the nucleolus is and which part of the nucleolus they should go to? " In chapter V, I 
have demonstrated that, - even though two proteins, namely fibrillarin and NHPX, localise 
in the same subnudeolar domain, they move to the nucleolus using apparently different 
mechanisms after their nuclear entry. NHPX transiently travels to the splicing speckles 
before accumulating in the nucleolus of both primary and transformed cell lines. This 
pathway is RNA polymerase II transcription-dependent and may link to multiple RNA 
pathways within the cell. 
I. 5 
. 
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MATERIALS AND METHODS 
"Unless the Lord builds the house, 
its builders labour in vain. " 
Psalm, The Bible 
Page 56 
H. Materials and Methods 
II. 1 Bacterial strains and general solutions 
IL 1.1 Bacterial strains 
Epicurian coli® SoloPack supercompetent cells (Strategene #230350): TetRd(mcrA)183 
d(mcrCB-hsdSMR-mrr)173 em/A1 sußE44 thi-1 recA1 gyrA96 relA1 lac Hte (F proAB 
lacPZ dM15 Tn 10(Tet') Amy CamR). This bacterial strain is very efficient in bacterial 
transformation especially for ligated product (1) the absence of endonuclease (endAI) and 
recombinase (recA) improves the quality and stability of plasmid DNA miniprep, 
respectively; and (2) the lack of the restriction systems (mcrA mcrCB and m and the 
mutation in the endonuclease hsdR gene facilitates the introduction of DNA isolated from 
non-Escherichia coli organism. 
IL 1.2 General solutions 
50x TAE Buffer 
242g Tris base 
57.1 ml Glacial acetic acid 
100ml 0.5M EDTA (j2H8.0). 
_i IL Total 
10x TBE Buffer 
84g Tris base 
55g Boric acid 
40m1 0.5M EDTA (pH8.0) 
1L Total 
Luria-Bertani Medium (LB) 
10g Bacto-tryptone 
5g Bacto-yeast extract 
log NaCI 
950ml Subtotal (with MQ H2O) 
pH to 7.0 using 5MNaOH(0.2m1) 
adjust the volume to 1L with MQ H? O 
Solution autoclaved 
Terrific Broth (TB) 
12g Bacto-tryptone 
24g Bacto-yeast extract 
4ml Glycerol 
900m1 Subtotal ('with MQ H2O) 
Solution autoclaved 
100rn1 Sterile 0.17M KHR-Q4 
IL Total 
ate Buffer Saline (P 
8g NaCI 
0.2g KCI 
1.44g Na2HPO4 
O. 24g KH? PO1 
800m1 Total (with MQ H2O) 
PBS-T 
2.5m1 10% Tween-20 (w/vin PBS) 
500m1 PBS 
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11.2 Plasmidsgenerated and used 
Name Cloning sites Backbone vector Antibiotics Remarks 
EYFP-RPA39 Bg1II, Kpnl EYFP-C1 G418 
ECFP-RPA39 BglII, Kpnl ECFP-Cl G418 
EGFP-RPA39 BglII, Kpnl EGFP-CI G418 
EGFPx3-RPA39 BglII, Kpn1 EGFPx3-C1 G418 
EGFP-RL27 Bglli/BampII, EcoRl EGFP-Cl G418 
EYFP-RL27 BglII/Barn II, EcoRl EYFP-C1 G418 
ECFP-RL27 BgIII/BamHI, EcoRl ECFP-Cl G418 
DsRedl-RL27 BgllI/BamH1, EcoRl DsRedl-Cl G418 
DsRed2-RL27 EcoRl, BamHI DsRed2-Cl G418 
EYFP-FIB BglIl, Kpn1 EYFP-Cl G418 
ECFP-FIB BglI1, Kpnl ECFP-Cl G418 pAL118 
DsRedl-FIB BglII, KpnI DsRedl-C1 G418 
Bos EYFP-FIB Nod, BamHI pBos Blasticidin 
Bos ECFP-FIB Nod, BamHI pBos Blasticidin 
Bos EYFP-B23 Nod, BamHI pBos Blasticidin 
EYFP-B23 KpnI, BamHI EYFP-Cl G418 
ECFP-B23 KpnI, BamHI ECFP-CI G418 
DsRedl-B23 KpnI, BamHI DsRedl-C1 G418 
DsRcd2-B23 KpnI, BamHl DsRed2-C1 G418 
EYFP-NHPX BglII, Kpnl EYFP-C1 G418 pAL107 
ECFP-NHPX BglI, KpnI ECFP-Cl G418 pAL214 
EGFP-NHPX BglII, KpnI EGFP-Cl G418 
pTnnerl-NHPX BglI, Kpnl pTimerl-C1 G418 
H2B-EYFP Nod, BamHI pBos Blasticidin 
H2B-EGFP Nod, BamHI pBos Blasticidin Kind gift of Dr. T. Kanada 
H2B-ECFP Nod, BamHI pBos Blasticidin 
diHcRed-H2B G418 Kind gift of Dr. J. Elknberg 
EGFP-PWP1 EcoRI, BamHI EGFP-C1 G418 
EYFP-PWP1 EcoRl, BamHI EYFP-Cl G418 
EGFP-NGB HinDIII, EcoRl EGFP-Cl G418 
ECFP-NGB HinDIII, EcoRl ECFP-Cl G418 
EYFP-NGB HinDIII, EcoRI EYFP-C1 G418 
EYFP-2H9 KpnI, BamHI EYFP-Cl G418 
ECFP-MrDB KpnI, BamHI ECFP-C1 G418 
EYFP-MrDB KpnI, BamHl EYFP-Cl G418 
EYFP-PEST Bg1II, EcoRI EYFP-Cl G418 
UlA-DsRedl EcoRI, KpnI DsRedl-N1 G418 
YindgofDr. L Tiinkle- 
Mxlcahy 
EYFP-PWP2 HinDI1I, BamHI EYFP-Cl G418 
EYFP-WDR3 BglI, Kpnl EYIP-Cl G418 
EYFP-PBKI BglII/BamHI, EcoRI EYFP-Cl G418 
EYFP-SAZD BgIII, KpnI EYFP-C1 G418 
Table II-1 Table of plaamids generated and used. `Cloning sites' indicates the restriction enzyme 
sites used for ligation to the `backbone vector'. 'Antibiotics' indicates the drugs that can be 
used for generating a stable cell line. The vector maps are shown in Figure II-1. Apart from 
those indicated, all other plasmids were generated during the PhD and other plasmids that 
were not mentioned in this thesis but generated during the PhD were deposited to the 
Iatnond lab reagent database. Backbone vector EGFPa3-CI is a kind gift from Dr. J. 
Ellenberg. 
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blasticidir 
resistancc 
Xhol 
Col El 
EF1a proms 
B9u1 
Ase I 
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EcoO109 
(3854) 
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Nhe I (592) 
-- Eco47 III (597) 
Age I (roi 
BS/G I (1323) 
MCS 
(1330-1417) 
Stu 
(2577) 
Afl 11 (1638) 
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SECI Accl Aapfl11 Bsp1201 xmaI 
WINN SacN Saul 
Figure 11-1 Plasmid maps. (A) pBOS (6kbp) and (B) a general scheme for pFP-CI vectors (4.7kbp) 
including BYFP-C1, ECFP-C1, EGFP-C1, EGFPx3-C1, DsRedl-CI, DsRed2-CI 
(Clontech). Grey areas indicate the location of the fluorescent protein fusion. The multiple 
cloning sites for the pFP-C1 vector are shown below the map. 
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11.3 Cell lines generated and used 
Name Antibiotics Remarks 
HeLa NR EMBL strain 
htertl787 NR Kindgift of Dr. K Co! /inr 
Human Foreskin Fibroblast NR Klnd&ft of Dr. NPerkinr 
MCF7 NR 
HEK293 NR Kindo of Dr. N Perkins 
EYFP-RPA39 G418 
ECFP-RPA39 G418 
EGFP-RPA39 G418 
EGFPx3-RPA39 G418 
EGFP-RL27 G418 
EYFP-RL27 G418 
ECFP-RL27 G418 
EYFP-FIB G418 
ECFP-FIB G418 
EYFP-B23 G418 
ECFP-B23 G418 
EYFP-NHPX G418 
ECFP-NHPX G418 
EGFP-NHPX G418 
EYFP-H2B G418 
EGFP-H2B BOS Kordgift of Dr. T Kanada 
ECFP-SmB G418 Kinds/ t of Dr. J Skeman 
EYFP-PWPI G418 
EYFP-NGB G418 
EYFP-2H9 G418 
EYFP-RPA39/ECFP-FIB G418/BOS 
ECFP-RPA39/EYFP-FIB G418/BOS 
EYFP-RPA39/ECFP-B23 G418/BOS 
ECFP-RPA39/EYFP-B23 G418/BOS 
EYFP-RPA39/ECFP-H2B G418/BOS 
ECFP-RPA39/EYFP-H2B G418/BOS 
EYFP-FIB/ECFP-B23 G418/BOS 
ECFP-FIB/EYFP-B23 G418/BOS 
EYFP-FIB/ECFP-H2B G418/BOS 
ECFP-FIB/EYFP-H2B G418/BOS 
EYFP-B23/ECFP-H2B G418/BOS 
ECFP-B23/EYFP-142B G418/BOS 
Table 11-2 Table of cell lines generated and used. 'Antibiotics' indicates the drug used to generate 
the stable cell lines where BOS is a short form of blasticidin. Apart from those cell lines 
indicated in the remarks, all cell lines were generated during the PhD and other cell lines that 
were not mentioned in this thesis but generated during the PhD were deposited in the 
Lamond lab reagent database. 
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I1.4 Molecular Biology Techniques 
IL 4.1 "3-day" cloning strategies 
To facilitate the high throughput screening of potential components of nucleoli from the 
proteomic study, I have devised a cloning strategy that will allow multiple cloning to be 
performed within 72 hours. The scheme of the strategy is illustrated in Figure 11-2 and the 
protocol for each procedure will be explained in detail in the following sections (11.4.2- 
11.4.11) 
Day 0 Day 1 Day 2 Day 3 
Restriction Restncnun ('0l0m I'irkinc l/ürrýýiýyý 
Digesion I )igesion 
(2hr, 30min) (2hr) 
P(R . Crrcnine R, Ill/, ! 1,111 Imlh Nis 
\Ikalinr 
Phosphatas. ' 
(() 5111) S' (va 11, 
(cl purification 
Quantitation 
I 
PCR 3: 1 ratio Ligation (iroýk Bacteria 
(Overnight) 
(ý! " I(lýrrnr, thri 
I Key: - 
'i 
ert 
ranslü1ation 
r seit ri: i., "id .. i lilt r,., I 
Figure 11-2 Scheme of the "3-day" cloning strategies 
I1.4.2 Polymerase Chain Reaction (PCR) 
11.4.2.1 General 
To amplify the DNA fragments of interest to generate a C-terminal fusion protein as in 
most of the work presented in this study, two specific primers hybridising to the 5' and 3' 
end of the complementary DNA (cDNA) were designed with the following criteria: (1) 
G/C content of at least 50%; (2) the last 3' nucleotide is either G or C but the last three 
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nucleotides must not be the same; (3) length of about 24bp which has a perfect homology 
with the gene of interest; (4) the restriction site hanger (indicated in bold below) is located 
5' to the length of perfect homology with spacers (indicated with an underline below) to 
make sure that the protein of interest would be in frame with the N-terminal fusion and (5) 
extra nudeotides (indicated as italic below) were added 5' to the restriction site hanger to 
ensure optimal restriction digestion after the PCR. The number of nucleotides in italics 
depended on the enzymes in the restriction site hanger according to the manufacturer's 
suggestion. Moreover, the sequences are the inverse of the 3' end to avoid any possible 
hybridization. For example: 
5'-GGGGATCCXXATGCCAGAGCCAGCGAAGTCTAGG-3' 
ff. 4.2.2 Cloning f om aplasmid containing the template 
Where specific cDNAs were available, e. g. from IMAGE EST clones, PCR was carried out 
using a high-fidelity Pfu polymerase and the protocol was as follows: 
Materials. 
1-2ng plasmid template 
1µl Forward primer (10µM) 
1P Reverse primer (10µM) 
1 PI dNTP (l OmM) 
1µl pfu polymerase (2.5U/µl; Roche #600154-81) 
51 Ox pol; merase buffer 
50µ1 Total (with MQ H2O) 
-CYCIC; PnPCR 
95°C 5 min 
PCR 25 cycles 
95°C 1 min 
55-65°C 30 sec 
72°C x min 
(where x= length of the coding sequence -1 kbp/min) 
Post-PCR 
72°C x min (where x-- length of the coding sequence =1 kbp/min) 
4°C until use orkept at 20'C 
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The PCR product was purified using the QIAquick PCR purification kit and eluted in a 
volume of 30µ2 MQ H2O (QIAGEN #28104). 
11.4.2.3 Cloning from a cDNA library 
For those genes of interest that could not be cloned from an available EST source (e. g. 
IMAGE), the cDNA was fished out from a pre-made double stranded Marathon-Ready 
cDNA library (Clontech #K1802-1) as follows: 
Materials: 
5µl Marathon cDNA library (-0.1ng/ d) 
1µl Forward primer (10µM) 
1µl Reverse primer (10µM) 
1µl dNTP (10mM) 
1µl Advantage 2 Polymerase (Clontech #8430-1) 
S lOx polymerase buffer 
SO PI Total (with MQ H2O) 
Cycle: 
Pre PCR 
95°C 5 min 
PCR1 25 cycles 
95°C 1 min 
68°C x min (where x= length of the coding sequence -- 1 kbp/min) 
Port-PCR 
68°C x min (where x= length of the coding sequence =1 kbp/min) 
15°C 00 until ure or kept at 20°C 
The PCR product was diluted in 500-1000 fold and 50 of the dilution was subjected to 
another round of PCR using pfu polymerase as described in Section 11.4.2.2. 
H. 4.24 PCR screening 
To choose the right clone from the bacterial transformation (Section 11.4.8), screening was 
initially carried out by PC& A set of PCR primers was chosen such that one primer is 
hybridising to the backbone vector, whilst the other primer hybridises to the insert at the 
opposite end. In this way, both the orientation and size of the fragment cloned into the 
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vector could be selected. Another advantage of PCR screening is that bacterial colonies can 
be used as the starting material because the plasmid DNA is released during the first PCR 
step at 95°C for 5 minutes. This could save time and materials in producing unwanted 
minipreps. However, great care should be made in handling different bacteria clones to 
avoid cross-contamination. The following master mix was used: 
Materials: 
1 Bacterial clone 
0.5µl Forward vector-specific primer (10µM) 
0.50 Reverse insert-specific primer (10µ1V1) 
0.50 dNTP (10mM) 
0.25µl Advantage 2 Polymerase (Clontech #8430-I) 
2s5µ1 10x Polymerase buffer 
25µl Total (with MQ H2O) 
Cycle: 
P PCR 
95°C 5 min 
PCRI 10 cycles 
95°C 1 min 
68°C x min (where x= length of the coding sequence =1 kbp/min) 
PM 20 cycles 
95°C 5 sec 
68°C x min (where x= length of the coding sequence =1 khp/min) 
Post-PCR 
68°C x min (where x= length of the coding sequence = O. 5kbp/min) 
15°C 00 until use or kept at 20'C 
100 of resultant mixture was mixed with loading dye and visualized on the agarose gel as 
described in Section 11.4.5. 
I1.4.3 Restriction Digestion 
11.4.3.1 General 
For a digestion involving a single enzyme, the reaction was performed as suggested by the 
manufacturer's suggestion. However, for a digestion involving two enzymes, the reaction 
was carried out in a buffer such that both enzymes have at least 75% activity. However, if 
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such a buffer is not available or the enzymes involved are optimal for different 
temperatures (e. g. Sma. I is active at 25°C whereas most of the other enzymes work best at 
37°C), a sequential digestion was performed first with the buffer of lower salt 
concentration. To avoid star activity of some enzymes, according to the manufacturer's 
suggestions, BSA was added at a final concentration of 100µg/ml. 
I14.3.2 Digestion for subsequent ligation reactions 
Unless a digested backbone vector was available, the digestion of insert and backbone 
vector was carried out in parallel as described below: 
Backbone Vector 
2µg Backbone vector 
IOU restriction enzyme 1 
[1 OU restriction enzyme 2] 
[0.3µt BSA (10mg/ml)] 
3µl 1Ox enzyme buffer 
3O1i1 Total (with MQ H20) 
Insert 
1Oµg Insert 
IOU restriction enzyme 1 
[IOU restriction enzyme 2] 
[0.3µl BSA (10mg/mI)] 
3}d IOx enzyme buffer 
3Oµ1 Total (with MQ H20) 
The reactions of the backbone vector and insert were carried out at 37°C, unless specified, 
for 2.5 hours. For the last half hour in the backbone vector reaction, alkaline phosphatase 
was added to remove the 3' phosphate group to increase ligation efficiency (see Section 
II. 4.4 for details). 
II. 4.3.3 Digestion for restriction analysis 
Restriction analysis was carried out to further confirm the orientation if the results of PCR 
screening (Section II. 4.2.3) were not satisfactory. Protocol as follows: 
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Restriction analysis 
400ng Miniprep 
lOU restriction enzyme 1 
[IOU restriction enzyme 2] 
[0.2 BSA (l Omg/ml)] 
20 1Ox enzyme buffer 
2Oµ1 Total (with MQ H2O) 
The reaction was carried out at 37°C, unless specified, for 1 hour. The resulting mixtures 
were loaded onto 0.8%-1.5% agarose gel depending on the expected size of the DNA 
fragment (see Section II. 4.5 for details). 
11.4.4 Alkaline Phosphatase treatment of Plasmid DNA 
To avoid the self-ligation of the vector, if both ends are compatible, 3' phosphate groups 
were removed from the linearised vector by treating with alkaline phosphatase. 1µl of 
alkaline phosphatase (Roche #1097075) was added to the backbone vector reaction in the 
last half hour (Section 11.4.3.2). And the resultant mixture was immediately run on a 0.8%- 
1.5% agarose gel, depending on the expected size of the fragments, for purification (see 
Section 11.4.5 for details). 
11.4.5 Gel E1ectmphoi ss of DNA 
11.4.5.1 Loading dye 
The DNA loading dye was prepared as follows (Sambrook et alo. 
Ex DNA Loading Dye 
0.25% bromophenol blue 
0.25% xylene cyanol FF 
30% glycerol 
I14.5.2 Prýßaration of agaorsegel and running samples 
To prepare an agarose gel, depending on the percentage of agarose required (0.8-1.5%), the 
correct amount of powdered agarose (BDH #443665W) was added to a measured quantity 
of 1x TAE buffer (Section II. 1) in a glass flask. The slurry was heated in a microwave at 
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low power until dissolved without reaching the boiling point The mixture was cooled to 
about 60°C before adding Ethidium Bromide (EtBr) to a final concentration of about 
20ng/inl). The cooled mixture was poured into the mould maldng appropriate number of 
wells. The set gel was then submerged into 1x TAE buffer for loading and electrophoresis. 
The DNA samples after mixing with the loading dye were loaded onto the wells with one 
or more lanes dedicated for markers (Bioline #BIO-33026). Electric field was then applied 
at a final voltage of 80-100V for roughly 2 hour, depending on the expected size of the 
fragments. 
I1.4.5.3 Purification of DNA fmm agamse gels 
To recover the DNA fragments from agarose gel for ligation, the gel was illuminated by a 
light box emitting a filtered blue light (Clare Chemical Research Dark Reader DR-45M) 
and each fragment was cut out from the gel using a clean scalpel. The excised gel was 
weighed and DNA was extracted with 30µl MQ H2O using QlAquick gel extraction kit 
(QIAGEN #28704). 
I1.4.5.4 Preparation of `mini"DIVA gel for grrantitation 
To quantify the amount of fragments while saving most of the materials for subsequent 
ligation, a "mini" gel was made in a way similar to Section 11.4.5.2. Rather than pouring 
into a large mould, 25ml cooled slurry (without EtBr) was poured onto an ethanol-cleaned 
G"x4" glass plate with a small-teeth comb clamped perpendicularly, allowing the surface 
tension to spread the slurry evenly on top of the glass. 
11.4.6 Quantrtatzon of pla rmid : insert ratio 
The set mini-gel (Section 11.4.5.4) was then submerged in 1x TAE buffer and 10 of the 
resultant fragment DNA was loaded with dye onto the tiny wells. The gel was run at 80V 
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for 1 hour before staining by a highly sensitive DNA dye SYBR Green I (Molecular Probes 
#S-7563) for 15 minutes in the dark. The intensity of the DNA fragment was measured by 
Fujifilm Intelligent Dark Box LAS-1000 with a Fluorescence filter Y515-Di. 
114.7 L gation 
From the quantitation data, the intensity of each band was first subtracted from 
background and then normalized by the corresponding fragment size. A molar ratio of 3: 1 
for the amount of insert and backbone vectors is required for a ligation reaction. 
Ligation Reaction 
50ng linearised vector 
xd insert (xpl was added such that the insert : backbone vector molar ratio=3: 1) 
0.50 ligase (1 U/µ4 Roche #716359) 
(1 µ1 10mM ATP for coherit'e end ligation] 
101 1Ox 1 ease buffer 
10131 Total (with MQ H20) 
The ligation reaction was carried at 12-16°C for 2 hours. 
I1.4.8 Bacterial Transformation 
After the ligation, 10 of the resultant mixture was transformed into Epicurian 
Coli®SoloPack Gold supercompetent cells (Strategene #230350, Section II. 1.1) 
according to the manufacturer's suggestion and the transformed cells were plated on to LB 
plate containing the selected antibiotics: 
Antibiotics used 
Carbenicillin (Arnpicillin) 100µg/ml (f/c) 
Kanamycin 30µg/ml (f/c) 
II. 4.9 Preparation of plasmid DNA 
I14.9.1 Day 3 for `3-da "cloning strategies 
On Day 3 (Section 11.4.1), single colonies were picked individually using a P-200 Gilson 
pipette tip for 3 different purposes: (1) PCR screening (Section 11.4.2.3); (2) temporary 
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storage: by streaking selected clones on a new LB plate with appropriate antibiotics and (3) 
mini-preparation of the plasmid. The bacteria-containing tips were inoculated in 3m! LB 
with appropriate antibiotics in 15m1 sterile plastic tubes (Falcon #352059) and the tube 
were shaken at 250rpm at 37°C for 12-16 hours. The culture was harvested by QIAGEN 
Plasmid miniprep kit according to the manufacturer's suggestion (QIAGEN #27106), 
which is based on a modified alkaline lysis procedure (Sambrook et al. ). The resultant 
plasmid was eluted with 50µ1 MQ H2O and stored at -20°C until use. 
I1.4.9.2 Lage scale preparation of plasmid DNA 
A bacterial clone of interest was picked from the storing plate as mentioned in Section 
11.4.9.1 and was allowed to grow in 100ml TB (Section 11.1.2). After 12-16 hour incubation 
with shaking (300rpm) at 37°C, the plasmid was then harvested by QIAGEN Plasmid 
maxiprep kit according to the manufacturer's suggestion (QIAGEN #12163). The 
resultant plasmid was eluted with 500-1000µl MQ H20, depending on the size of the 
corresponding bacterial pellet and stored in aliquots at -20°C until use. 
11.4.10 Spectrophotometric determination of DNA concentration 
To determine the DNA concentration, the plasmid stock was diluted 100 fold with MQ 
H2O and measured by Gene QuantIl (Pharmacia Biotech) in triplicate. Absorbance at 
260nm and 280nm were taken to measure the DNA and protein concentration, 
respectively, in the sample, where a pure sample should have the ratio of A., /Ano 
between 1.8 and 2.0, using a quartz curvette (Hellma; light path=l0mm) 
II. 4.11 DNA sequencing 
The sequence of the insert at the junctions with the vector backbone was initially 
confirmed by using primers hybridized to both ends of the backbone vector. The internal 
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region, if required, was confirmed by designing primers with the following criteria: (1) 
-50% GC content; (2) length of about 17bp and (3) ends with G/C but both the first 
three and last three nucleotides should not be identical The DNA sequencing was 
performed using ABI Prism Big Dye Terminator cycle sequencing reaction by DNA 
sequencing service ((t: //wuw. dnaseg o /1 
Materials submitted 
300ng plasmid 
IM! specific primer (2pM) 
l0µ1 Total (with MQ H20) 
The results were analysed using program Sequencing Manager (Lasergene) to assemble a 
single contig and the resultant contig was checked both at the junction and with the known 
coding sequence. The latter sequence check was performed using the program BLAST2 
hip: //www. ncbinhnninggy/BLAST/ (Altschul et aL, 1990) and the locations of 
ambiguity were further examined on the sequencing profiles or by performing more 
sequencing using primers that hybridised to the alternate strand, if needed. 
11.5 Tissue Culture 
11.5.1 Basic cell culture protocols 
H. 5.1.1 Medium preparation 
In most of the cell lines, such as HeLa, MCF7 and HEK293 etc, that were grown in the 
laboratory for the purpose of this thesis, the following was used unless specified. 
Standard medium 
50m1 Fetal Bovine Serum (FCS; Invitrogen #10106-169) 
5m1 Penicillin-Streptomycin (PS; Invitrogen #15140-122) 
445ni1 Dulbecco's Modified Eara1e Medium (DMEM: Invitroeen #41966-052) 
500m1 Total 
For most of the HeLa cell lines stably expressing one or more fluorescent fusion proteins, 
the following selectable markers were used at the following concentrations after filter- 
sterilising (See Section 11.3 for details): 
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Specific antibiotics used for generating cell lines 
G418 200µg/ml (f/c; Roche #146-4981) 
Blasticidin 2µg/ml (f/c; Invitrogen #25-0205) 
I1.5.1.2 Generalgrowth condition: 
The cell lines were grown in 75cm2 flasks with filter caps (Greiner #658175) in a 
humidified incubator set at 5% CO. and 37°C. When the cells reached 70-100% 
confluency, the cells were split using 1ml Trypsin (Invitrogen #25300-054) per flask for 4 
minutes and neutralised with the standard medium. Subsequently, the cells were diluted 1 
in 10 for replacing. All tissue culture work was performed inside a laniinar flow hood. All 
medium and apparatus used were first sprayed with 70% ethanol before putting into the 
hood to avoid contamination. 
11.5.2 Tran. rfection 
Two different transfection procedures were commonly preformed in this study, depending 
on the cell types. HEK293 cells are best transfected with Calcium Phosphate Precipitation 
procedure while other cell lines are mostly transfected with Effectene Reagent (QIAGEN 
#301425). 
I1.5.2.1 Calcium Phosphate Precipitation Transfection 
Cells were split onto a 90mm dish (Merck #402/0322/18) or 140mm dish (Merck 
#402/0322/20) to -20-30% confluency at least 2 hours prior to transfection, allowing 
enough time for the cells to adhere. 2x HBS was thawed at room temperature and the 
transfection mixture prepared as follows: 
DNA/CaCly mix 
10µg DNA 
61p1 2M CaCI2 
500µl Total (with MQ H20) 
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2-x-HBS 
8mg NaCl 
0.2mg Na2HPO4.7H20 ([phosphate]=1.5mM) 
6.5mg HEPES 
500µ1 Total (with MQ H2O and pH7.0) 
All solutions used were filter-sterilised. To make the transfection precipitate, DNA/CaC12 
mix were added to the 2x HBS in a 15 ml falcon tube (WIS #TPP15) dropwise using a P- 
1000 Gilson pipette and mixed gently by slight tapping during the addition. The mixture 
was then added immediately to the cells slowly and evenly into the medium. Swirling 
should be avoided at this stage and the precipitate should have been mixed when the dishes 
were transferred back to the humidified incubator. 
115.2.2 Using Efectene 
The Effectene reagent is a non-liposomal lipid and was always used in conjunction with the 
Enhancer and the DNA-condensation buffer to achieve high transfection efficiency. The 
method is generally based on the manufacturer's suggestion and usually 1µg of plasmid was 
transfected per 60mm dish (Merck #402/0322/12) and 2µg per 90mm (Merck 
#402/0322/18). All of the cell lines generated in this study used this reagent (Section 
11.5.5). 
H. 5.3 Micniinjection 
To perform the microinjection of plasmids into cultured cells, high quality DNA is 
required and hence a large-scale, high quality plasmid preparation was made according to 
Section 11.4.9.2. The concentration was diluted to 20µg/ml for optimal expression using 
injection buffer as described below. In some experiments, 100-500ng/ml TexasRed fixable 
dextran (Sigma) was added to help locate microinjected cells. The diluted DNA was then 
spun at 14,000 rpm in a bench centrifuge for 15min at 4°C (Eppendorf 5415c) to avoid any 
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microparticulate matter that may block the injection needle (Eppendorf sterile Femtotips). 
The microinjection was performed using the microinjector (Eppendorf 5246) on a Zeiss 
Axiovert S100 on a heated stage at 37°C. The cells were seeded one day earlier on a grid 
coverslip (Eppendorf Celllocate® square size 175µm) in a 60mm dish (Merck 
#402/0322/12). The cells of interest were initially focused by a 10x lens (Zeiss Plan- 
NeoFluar 0,30) followed by a 40x lens (LD Achroplan 0,60, Korr Ph2) for fine 
adjustment. The microinjection was performed on about 300 cells/coverslip at a pressure 
between 80-11OPa. 
Injection Buffer 
14.7g Glutamic acid 
7.85g KOH 
1m1 iM MgSO4 
lml IM DIT 
IL Total (with MQ H20) 
pH to 7.2 with 1M citric acid 
11.5.4 Heterokaryon formation 
Two different cell lines were mixed in a 1: 1 ratio at a total of 50% confluency onto 90mm 
dish (Merck #402/0322/18) one day before the experiment. When the cells reached 
around 90-100% confluency, just enough polyethylene glycol (PEG; SIGMA #P7181) to 
cover the cells was added and the whole dish was rocked for 90 seconds to ensure 
thorough mixing. The cells were immediately washed with 5ml of standard medium thrice 
and replaced with a fresh 1 0m1 standard medium (Section II. 5.1.1). 
11.5.5 Establishment of HeLa cell lines rtably expres ng a ringle construct 
11.5.5.1 Tranrfection and Selection Phase 
Hela cells were seeded onto a 90mm dish (Merck #402/0322/018) and, when 70% 
confluency was reached, were transfected with the construct of interest using Effectene 
reagent (Section 11.5.2.2). The medium was replaced with standard medium containing 
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selected antibiotics two days after transfection (see Section II. 3 for details) and the medium 
was changed every 1-2 days until colonies were observed. 
I1.5.5.2 Subcloning Phase 
6ml of trypsin which has been diluted 1: 20 with PBS was used to release the cells from 
adhering to the plate slowly. 24 individual colonies were selected and picked using a P-200 
Gilson pipette. The suspended colonies were dispensed into marked wells in a 24-well plate 
(GreinerBio-one), each well containing 1.5m1 medium with selected antibiotics. To ensure 
that the colonies picked were expressing the fluorescent fusion protein of interest, both the 
localisation and general fluorescence intensity was checked under the Zeiss Axiovert S25 
using a 10x lens before picking. Apart from very bright colonies (in which the protein of 
interest may be overexpressed), a range of fluorescent intensities was chosen. After 5-6 
days, when the cells reached about 80% confluency, they were tcypsinised using 1000 1x 
trypsin for 4 minutes and neutralised with 5.5ml of medium with selected antibiotics. 5m1 
of the cell suspension was transferred to a well in a 6-well plate (GreinerBio-one) while the 
other 0.5m1 was transferred to a well, which contained a 13mm coverslip (Merck, 
thickness= 1.5µm) , 
in a new 24-well plate. 
II. 5.5.3 Enrichment Phase 
After 2-3 days, the cells, or when cells reached 80% confluency, the cells on the coverslip 
were fixed as described in Section 11.8.2.2. The colonies were ranked according to the 
percentage of homogeneity and the fluorescent level. The colonies were first ranked with 
the percentage of homogeneity and the highly homogenous colonies were considered 
further for their fluorescent level For those proteins where the endogenous protein levels 
are low such as RNA polymerase I subunit, the colonies of the low, yet detectable, 
fluorescent level were then chosen for further enrichment. But usually, 3 different colonies 
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(of low, medium and high fluorescent level) were chosen and frozen stocks were made by 
growing the cells seeded on the 6-well plate to a 75cm2 flask. If the cells colony had 
reached 100% homogeneity, 1% of the cell suspension derived from the 6-well plate was 
added to 10m1 medium with selected antibiotics in a new 90mm dish for further 
subcloning as in Section 11.5.5.2. 
Transfection 
& Selection 
'J 
Enrichment 
ý- 
rýý 
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Figure 11-3 Scheme for generation of cell line. I Isla cell lines were grown to 70% confluency were 
transfected with chosen plasnmid carrying a particular antibiotic-resistance gene. After 48 
hours of transfection, the cell lines were selected with antibiotics for 3 weeks. Clones with a 
range of fluorescent intensities were picked and enriched for future analyses. 
H. 5.6 Estimation of cell number 
The haemocytomer Iused (Mackay & Lynn Ltd # CM175-22; Improved Neubauer version 
BS748; depth=0. lmm) contains two chambers, each of which contains nine major squares. 
When filled and coverslipped, each square represents a volume of 0.1mm'. The cells were 
trypsinised as in Section 11.5.1.2 and two independent samples from the cell suspension 
was dilution by 1 in 10 and were counted. In each side, only those squares at the corners 
and the one at the centre were counted to give the number of cells in 1x 10 'm1. 
The number of cells per ml =no. of cells from 10 squares .x 
dilution factor .v 
1000. 
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The haemocytometer and coverslip was cleaned immediately after use by rinsing in MQ 
H2O followed by 70% etha. nol. 
115.7 FACS analysis 
I1.5.7.1 Day 1 &2 
FACS results can be misleading if the cell density varies between samples. To standardise 
the initial growth condition, 1x106 cells were plated in duplicate per 90mm dish. On day 2, 
1x106 cells were plated again in duplicate per 90mm dish for analysis. 
II. 5.7.2 Day 3 
The cells were harvested within 16-24 hour (^-one cell cycle) from Day 2 by trypsinisation 
(Section 11.5.1.2). The excess trypsin was neutralised by standard medium (Section 11.5.1.1) 
and collected in a 15ml falcon tube. The suspension was spun down using bench top 
centrifuge (Beckman GS-15) at 1000rpm for 4 min at room temperature. The excess 
medium was aspirated and the pellet was dispersed by slight tapping. Iml of PBS was 
added for resuspension, followed by another 9 ml of PBS, and the whole cell suspension 
was spun down again as before. The excess PBS was aspirated and the pellet was again 
dispersed by slight tapping. For fixation, Iml of ice-cold 70% Ethanol (m MQ H20) was 
added dropwise while vortexing at a low rate (setting=3). The suspension was left in ice for 
at least 3 hours until analysis. 
I15.7.3 Just before analysis 
The cell suspensions were spun down at 1000rpm for 5 min at 4°C using benchtop 
centrifuge (Beckman GS-15) and resuspend in Iml ice-cold PBS. The cell suspensions at 
this stage were always kept at 4°C to minimise DNA degradation. The cells were counted 
using a haemocytomer as described in Section 11.5.6. After counting the cells, the cells were 
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once again spun down and resuspend with ice-cold PBS containing 100µg/ml RNase A 
(Sigma) and 25µg/ml Propidium Iodide (Fluka) such that the final concentration is 5x105 
cells/ml. The cell suspension was incubated at 37°C in the dark for 30 minutes. 
Fluorescence was measured using a FACscan (FL2 channel; 543nm; Becton Dickinson). 
Cell debris and fixation artifacts were gated out. Data analysis was done using Cell Quest 
software (Becton Dickinson). 
I1.5.8 Cryopreservation of cell cultures 
Cells were grown at around 70-80% confluency in a 75cm2 flask and trypsinised and 
resuspended as described in Section 11.5.1.2. The resultant suspension was spun down at 
1000rpm for 4 minutes in room temperature using a benchtop centrifuge (Beckman GS- 
15). The excess medium was aspirated and the pellet was initially dispersed by slight 
tapping. im! of freezing medium (see below) was added for resuspension using a P-1000 
Gilson, followed by an additional 2 ml freezing medium. The cell suspension was aliquoted 
in 600µl amounts in cryovials (WTS T310-2A; 2m1) and stored in a -80°C freezer for at 
least I week before transferring to liquid nitrogen storage. 
Freezing Medium 
9m1 Standard medium (Section 11.5.1.1) 
Iml DMSO (Sigma #D2650) 
1Oml Total 
11.5.9 Thawing of cell cultures 
The frozen cells retrieved from storage were immediately warmed up at 37°C and 
resuspended in 5ml of standard medium with appropriate antibiotics in a small flask 
(GreinerBio-one; base area=25crn ). The cells were allowed to recover in a humidified 
incubator with 5% CO2 at 37°C for 4 hours before changing with another 5m1 of standard 
medium. When the cells reached 70-100% confluency, the cells were split as described in 
Section 11.5.1.2. 
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11.6 Protein analysis 
II. 6.1 Preparation of nuclear lysate firm adherent cells 
Cells were seeded in 90mm dishes (Merck #402/0322/18) or 140mm dishes (Merck 
#402/0322/20) and harvested at 70-80% confluency. The dishes were first rinsed thrice 
with ice-cold PBS on an ice-cold surface and the excess of PBS were removed by draining 
to a large beaker. The final' remnant of PBS was removed through absorption by a piece of 
tissue (Kimberly-Clarke #3020030) but great care was made to avoid the contamination of 
the sample. 0.5m1 of Lysis Buffer (as described below) was added per 90mm dish or 1.0mI 
per 140mm dish and left for 5 minutes on the ice-cold surface. The cells were immediately 
scraped off the dish with a sterile cell scraper (Greiner #541070) and transferred to 
1.5/2ml Eppendorf tubes. To remove clumps of genornic DNA, QlAshredder (QIAGEN 
#79654) was used according to the manufacturer's suggestion. Essentially, the cells are 
spun down through a filter to shear the DNA in a 4°C room centrifuge (Eppendorf 5415c; 
14000rpm; 2 minute). The filtrate was used for further analysis. 
Nuclear Lysis Buffer 
lml 500mM Tris, pH7.5 
1mi 5M NaCI 
1000 100% NP-40 
0. lg sodium deoxycholate 
100µl 10% SDS 
200µl 500mM EDTA (pH8.0) 
I mini-COMPLETE protease inhibitor (Roche #18361701 
10mI Total (with MQ H2O) 
kept at 4°C until use 
IL 6.2 P> aration of total cell lysate r from adherent cells 
Cells were seeded in 60mm dishes (Merck #402/0322/12) or 90mm dishes (Merck 
#402/0322/18) and harvested at 70-80% confluency. After washing thrice with PBS and 
the removal of excess PBS by aspiration, 200µ12x IDS (Invitrogen #NP0007) per 60mm 
dish or 500µl per 90mm dish was added to lyre the cells. The cell lysate was then subjected 
to QlAshredder as described in Section 11.6.1 before use for analysis. 
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11.6.3 Protein Concentration Measurement 
To measure the protein concentration, Coomassie® Protein Assay Reagent Kit (Pierce 
#23200) was used according to the manufacturer's suggestion with slight modification. 
Briefly, 100 of sample was diluted with 900 MQ H2O in the 1ml plastic curvette (VMR 
#307380004) by the addition of 1ml assay reagent. The absorbance at 595nm was then 
measured in duplicate and subtracted from the reading from the control To make a proper 
control, 100 of buffer in which the sample dissolved was used instead of the sample when 
measuring the absorbance as described above. The concentration is equal to the 
absorbance divided by a constant a where a was calculated from a standard curve using 
multiple defined amounts of BSA. 
11.6.4 SDS-Polyacrylamide Gel Electmphoresis (PAGE) 
Protein samples were denatured using 1x LDS (Invitrogen #NP0007) and reduced by 
0.05M DTT (f/c). The samples were heated at 70°C for 10 minutes before loading onto 
pre-cast NuPAGE 4-12% Bis-Tris gels (Invitrogen #NP0321-23). Gels were run in either 
MOPS SDS or MES SDS running buffer (Invitrogen #NP001 and NP002 respectively), 
depending on which molecular weight range required to be resolved. On the other hand, if 
a protein of very high molecular weight required resolution, a Tris-acetate gel system would 
be used instead (Invitrogen #LA0041). The gels were all run at a constant voltage of 200V 
according to the manufacturer's suggestion. 
11.6.5 Western Blotting 
116.5.1 General 
After the electrophoresis, the proteins separated on the gel were transferred to 
nitrocellulose (Amersham Hybond-C extra) using XCell SureLock'M Mini-Cell Blot Module 
(Invitrogen #EI0001) according to the manufacturer's suggestion on reduced samples. The 
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transfer was routinely carried out at a constant voltage of 30V for 2 hours using the 
following transfer buffer. 
Transfer buffer 
1.45g Tris base 
7.2g Glycine 
200m1 Methanol 
IL Total (nitb MQ H2O) 
After the transfer, the blot was routinely stained with a small amount of Ponceau S (Sigma 
#P7170), which is just sufficient to cover the blot, to reveal the quality of transfer and the 
overview of the protein pattern. After several washes with MQ H2O, the blot was recorded 
using a scanner (Canon; CanoScan D2400U) and stored electronically for future analysis. 
11.6.5.2 stripping of Western Blot 
Following immunoblotting (Section 11.6.6), the blot could be reused as many as five times 
by repeated stripping and reprobing. This is instrumental to compare the expression level 
of endogenous protein and fusion proteins by using sequentially the antibodies raised 
against the endogenous proteins and the fusion only (such as GFP) on the same blot. 
Stripping buffe 
0.35m1 14.3M (3-mercaptoethanol (BDH) 
10ml 10% SDS 
12.5ml 0.25M Tris, pH6.8 
50ml Total (with MQ H2O) 
The blot was incubated with the stripping buffer (above) at 50°C for 30 minutes with 
occasional shaking and was then washed twice with PBS-T (Section 11.1.2). The blot was 
reblocked with 5% milk in PBS-T overnight before reprobing with antibodies as usual. 
11.6.6 Immsrnological detection of proteins on nitrocellulose filters 
After the electrophoresis, the blot was blocked in 5% milk in PBS-T overnight The blot 
was probed with the primary antibodies diluted in 5% milk/PBS-T for 1 hour in a sealed 
plastic bag and then washed thrice with PBS-T every 10 minutes. The primary antibodies 
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used are listed in Table 11-3. The blot was reblocked with 5% milk in PBS-T for at least an 
hour before adding the secondary antibodies diluted in 5% milk/PBS-T for 30-45 minutes 
in a sealed plastic bag. The blot was washed thrice with PBS-T every 10 minutes. All the 
secondary antibodies used in this study are conjugated to horseradish peroxidase (HRP) 
and could therefore be detected using ECL PlusTm (Amersham Pharmacia biotech 
#RPN2132) according to the manufacturer's suggestion. The detected blots were either 
exposed to Kodak film or quantified using Fujifilm Intelligent Dark Box LAS-1000. 
117 Antibodies 
11.7.1 List of antibodies used in this study 
Antigen Name Properties IF IB Remarks 
p80-coilin 5p10 mouse monoclonal si 1 lab stock 
SC35 mouse monoclonal purchased firm Sigma 
NHPX rabbit polyclonal generated in this study 
GFP 2 mouse monoclonals purchased from Roche 
Fibrillarin 72B9 mouse monoclonal lab slack 
Fibrillarin rabbit polyclonal gift of Dr. F. Fuller pace 
Nucleolin 7G2 mouse monoclonal & ft of Dr. G. Dnc/ärs 
B23 goat polyclonal 4 purrhared firm Santa CruZ 
UBF rabbit polyclonal 4 purchased from Santa Cru 
B6-2 mouse monoclonal 4 gift of Dr. P. Cook 
RS6 rabbit polyclonal 4 i6 of Dr. J. Stahl 
UTA 856 rabbit polyclonal 4 0 of Dr. J. Hamm 
Y12 mouse monoclonal 4 gift of Dr. J. Steitz 
p80-coilin 204/10 rabbit polyclonal 4 lab stock 
nucleoporin 414 mouse monoclonal 4 purchased from Babco 
Table 11-3 List of primary antibodies used in this study. 'Antigen' indicates the target that the 
antibodies raised in a particular species as documented under Tzoperties'. Name' is provided 
for certain antibodies if a generalised name exists. `IF and 'IB' indicate whether the 
antibodies was used in immunofluorescence and immunoblot, respectively. The sources of 
the antibodies are indicated under 'Remarks'. Secondary antibodies conjugated with different 
fluorophores were purchased from Jackson Laboratories. 
IT 7.2 Generation and characterisation of antibodies 
To generate new antibodies raised against peptides, the first thing is to find a peptide 
region which is likely to be antigenic based on the following criteria: (1) The region is 
predicted to be exposed to the aqueous phase (according to ProtScale; www. expasy. ch); (2) 
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the region may contains one or few aromatic residues which increase the antigenicity and 
(3) the region is unique to the protein of interest The synthesis of peptides and antisera 
were carried out commercially by Eurogenetics. Briefly, the peptide region was chemically 
synthesized and conjugated to a carrier at either the N-terminus or C-terminus before 
injecting into two rabbits. The pre-immune serum and serum after different round of 
extraction were received and checked on a blot of total lysate of HeLa cell as described in 
Section 11.6.6. Serial dilution of each serum was compared with the corresponding 
preirnmune serum and the best dilution was selected empirically based on the highest 
specificity and the lowest background. The following peptides in bold were chosen in this 
study: 
PX N14 
MTEADVNPKAYPLADAHLTKKLLDLVQQSCNYKQLRKGANEATKTLNRGIS 
EFIVMAADAEPLEIILHLPLLCEDKNVPYVFVRSKQALGRACGVSRPVIACSVTIK 
EGSQLKQQIQSIQQSIERLLVMTEADVNPKAYPL 
H. 7.3 Immunoprecipitation Protocol 
II. 7.3.1 Preparation 
In this study, mouse monoclonal antibodies raised against GFP (Roche #1814460) were 
used and hence protein-G sepharose bead (Pharmacia Biotech #17-0618-01) were chosen 
for immunoprecipitation due to the higher affinity of mouse antibodies to protein-G 
compared to protein-A. The sepharose bead preswollen in 20% ethanol were washed with 
Im! PBS thrice before making a slurry with 1: 1 ratio of beads and PBS. 25µl anti-GFP 
(0.4mg/ml) was pre-incubated with 50µ1 protein G-sepharose beads in a 1.5m1 Eppendorf 
tube, shaking at 1000-1200rpm on a electronic vibrator (IKA VIBRATX) overnight at 4°C. 
11.7.3.2 Precipitation 
On the second day, the lysate was first precleared with PBS-washed protein-G sepharose 
beads in a 1.5m1 Eppendorf tube for 30 minutes at 4°C on a rotating wheel (Labinco 
Chapter II Materiale and Methode 
Page 82 
VX2E 528). After the pre-clearing step, the protein concentrations of different samples 
were measured (Section 11.6.3) and normalised. Different pre-cleared lysates of the same 
protein concentration were then added to the anti-GFP/bead premade the previous day 
and incubated at 4°C for 4 hours or overnight on a rotating wheel. 
11.7.3.3 JVashing 
The excess lysates were removed by centrifugation at 4°C using Eppendorf 5415c 
xnicrocentrifuge (14,000 rpm, 1min). The supernatant was kept for further analysis and the 
pellets were washed with PBS containing protease inhibitor cocktail Complete thrice. The 
proteins from the pellets were released by adding 1x LDS and boiled at 70°C for 10 
minutes and loaded onto a gel for analysis (Section 11.6.4). 
I1.8 Miavscopic analysis 
11.8.1 Hardware Specification 
The following microscopes were used in this studyT. 
Model Purposes 
Axiovert S25 Routine examination of cell culture during propagation and quality control 
during the isolation of nucleoli from cultured HeLa cells 
Axiovert S100 Examination of fluorescence level for both transient and stable transfection and 
for microinjection purposes (live cell). 
Axioplan Screening of fluorescence level in each clones of stable cell line (fixed cell) 
DeltaVision High resolution of live cell and fixed cell studies 
ISM 410 High resolution of live cell and fixed cell studies 
ISM 510 High resolution of live cell studies; especially photobleaching experiments 
Table 11-4 list of microscope used in this study. 
118.1.1 Delta Vision Restoration Microscope Configuration 
For obtaining high resolution images, a Zeiss-DeltaVision Restoration microscope 
(Applied Precision, Inc) equipped with a three dimensional motorised stage was used. Two 
CCD cameras were used for capturing the fluorescence images according to their readout 
speed and quality of the data: 
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Fixed cell Live cell 
Camera Photometrics CH350 MicroMax: 13000YHS 
Read noise Lower (6e" RMS) higher (8e" RMS) 
Readout speed Lower (0.5 MHz) Higher (5 MHz) 
Quantum efficiency max at 580-650 nm Max at 400-500 nun 
Table 11-5 CCD cameras used in DeltaVision Restoration microscope 
Microscope lamp shutter, focus movements and correct filter combinations are controlled 
by a Silicon Graphics O2 workstation using Softworx software. Images were collected using 
the 100x/NA1.4 Plan-Apochromat objective and recorded using a binning of 2x2 on 
CH350 CCD camera (fixed cell studies) and 3x3 on Micromax camera (live cell studies) , 
respectively. The immersion oils (Applied Precision Inc) used had a refractive index of 
1.514 for fixed cell and 1.518 for live cells. To distinguish different fluorophores, a 
combination of filter wheels and stationery beam splitters were used to capture the 
reflection and transmittance of more than two wavelengths and ensure minimal movement 
of microscope: 
Filter/Beam splitter Excitation Emission Fluorophores 
DAPI/PC P360/W 40 P457/W 50 DAPI 
FITC /PC P490/W 20 P528/W 38 Fluorescein (FITC), GFP, 
YFP 
RD-TR-PE/PC P555/W 28 P617/W 73 Rhodatnine, Texas Red, 
Cy3 
Cy5/PC P640/W 20 P685/W 40 Cy5 
CFP/JP4 P436/W 10 P470/W 30 CFP 
YFP/JP4 P500/W 14 P535/W 30 YFP 
Table 11-6 Filter set camera used in DeltaVision Restoration microscope. For excitation and 
Emission, P indicates the wavelength peak and W indicates the full band width of the filter. 
Two stationery beam splitters were used: Polychronic (PC) and JP4 (Chroma technologies 
#86000 and 86002, respectively) for recording the fluorescence of a single fluorophores 
whilst preventing bleedthrough from other fluorophores. 
I1.8.1.2 Zeiss LSM5 10 Confocal Microscope Confrgaration 
Three or more dimensional imaging was performed on a custom built Zeiss LSM510 
(EMBL, Heidelberg) equipped with a z-scanning stage (HRZ 200) for fast 4D acquisition 
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using a Plan Apochromat 63x DIC oil immersion objective. Triple-colour imaging of CFP, 
YFP and dsRed/HcRed was achieved by alternating the 413nm Kr, 514nm Ar and 543nm 
HeNe laser for selective excitation. Bidirectional scanning mode was used to achieve a high 
scan speed (0.88µs per pixel) without losing much of the quality. Detection for all channels 
was performed on the same photomultiplier in the microscope, where the emissions were 
first split with a primary NFT 560 dichroic to a LP560 emission filter (dsRed), and again 
with a secondary NFT 505 dichroic to a LP 525 (YFP) and a BP 440-505 emission (CFP), 
respectively (Chroma Technology). Crossover with this setup was below 1% in both 
channels, with minimized loss of emission from three fluorophores. The configuration 
required minimal mechanical movement other than the xy and Z scanner. Several macros 
were written by Mr. G. Rabut (EMBL, Heidelberg) to ensure fast acquisition after 
photobleaching, multi-point, multi-wavelength time-series scanning and autofocussing 
during multi-point time-series. 
Il. 8.2 Fixed cell analysis 
To capture a snapshot of the cell activity in sissy, cells are commonly fixed by the following 
three general methods: 
11.8.2.1 Methanol/Acetone fixation 
This method is based on dehydration and is useful for exposing buried epitopes. However, 
it is difficult to preserve the morphology after such a harsh treatment. The cells were fixed 
by adding 1: 1 ice-cold methanol/acetone for 5 minutes, followed by washing twice with Ix 
PBS. 
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I1.8.2.2 Paraformaldehyde fixation 
The cells were first washed thrice with ix PBS quickly and gently before fixing with 3.7% 
paraformaldehyde (PFA) in cytoskeletal (CSK) buffer (see below) for 10 minutes. The cells 
were then washed thrice with 1x PBS. This method is based on the rapid cross-]inking 
reagent PFA to stop the cell activity. Generally, the cell morphology is preserved using this 
method; however, because of the crosslinking, some of the antibodies cannot access and 
react to the epitope. 
2x PFA/CSK fix 
8m1 0.5M PIPES pH6.8 
8m1 5M NaCl 
47m1 2.55M Sucrose 
1.2m1 1M MgC12 
1 6ml 0.5M EDTA 
80m1 5x CSK buffer ('a th MQ H20) 
100mI 4xPFA 
200m1 Total (with MQ H20) 
aliquoted into 5x1 per 15m1 tubes and kept at 20°C 
add 5ml ofM2 H2O before use 
To make 4x PFA, 16g of paraformaldehyde (BDH) was weighed in a beaker and 80m1 MQ 
H2O was added. The mixture was constantly stirred on a heated plate (50-60'C) while the 
pH was brought up to 7 by adding l OM NaOH dropwise. The pH was checked constantly 
with pH papers with a range from pH 0-14 (Whatman) and the final volume was made up 
to 100ml using MQ HZO. 
11.8.2.3 Cell fixation for mitotic studies 
However, both methods mentioned above (Sections II. 8.2.1-II. 8.2.2) are not good at 
preserving the mitotic cell morphology and the following protocol was used. 
37% PFA 
1.85g PFA 
3.5m1 MQ H2O 
1_4W 1OM KOH 
5. Oml Total 
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2x PHEM buffer 
18.14g PIPES 
6.5g HEPES 
0.998 MgSO4 
3.8g EGTA 
500m1 Total (with MO H2O) 
pH to 7.0 with IOM KOH 
filtered and stored at 4°C 
Fixation Buffer 
25m1 2x PHEM buffer 
5ml 37%PFA 
50ml Total (with M, Q H? O) 
The 37% PFA must be made fresh every time before use. To dissolve the materials, they 
were mixed in a 50 ml Falcon tube with the cap loose in a 60-80°C water bath, with 
occasionally swirling for no longer than 5 minutes. The fixation buffer was warmed to 37°C 
and added directly to the cells slowly after pouring the media out of the dish. The cells was 
fixed for 10 minutes before being washed thrice with 1x PBS very gently (adding the PBS 
on the wall slowly). 
11.8.2.4 Immunofluore rcence 
Apart from those cells fixed by methanol/acetone (Section II. 8.2.1), the cells were first 
permeabilised before immunofluorescence by the addition of 1% Triton X-100 (BDH) 
diluted in 1xPBS for 10 minutes with (Section 11.8.2.2) or without (Section 11.8.2.3) shaking 
at room temperature. The cells seeded on coverslips were washed with PBS-T once before 
blocking with 100µ1 of 1% donkey serum (Jackson Laboratories) for 15 minutes in a 
humidified chamber. The serum was removed by draining on a piece of tissue (Kimberly- 
Clarke #3020030) and 100µ1 primary antibody was added immediately on the coverslip, 
leaving 1 hour for incubation. This was then washed thrice with PBS-T every 10 minutes 
before reblocking with 100µt of 1% donkey serum for 15 minutes. Secondary antibodies 
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was applied for 30 minutes and washed thrice every 5 minutes before mounting (see 
Section II. 8.2.6). All the washing steps in all experiments except for mitotic studies were 
carried out on a shaker at room temperature (30 rev/min; StuartScientific platform shaker 
STR6). 
11.8.2.5 Cell staining involving 2'-O-methyl RNA 
For 2'-O-methyl RNA hybridization (Casino-Fonseca et al., 1992), cells were permeabilised 
with 0.5% Triton-X-100 in CSK buffer containing protease inhibitor cocktail Complete on 
ice for 3 minutes and then were fixed in freshly prepared 3.7% paraformaldehyde in CSK 
buffer for 10 min at room temperature. Cells were washed 3 times in PBS, 1 time in 6X 
SSPE and prehybridised with 6x SSPE/5x Denhardt's solution containing yeast tRNA 
(0.5mg/ml) for 15 minutes. Cells were then hybridised with the same buffer with 
biotinylated 2'-O-methyl antisense oligonucleotide probe (2 µM) for 30 minutes and then 
were washed 3 times in 6x SSPE and rinsed with avidin wash buffer (0.03M HEPES, pH 
7.9,0.15M KCI, 0.05 % Tween-20,1 % Donkey serum) before incubating with TexasRed- 
conjugated avidin DCS (Vector Labs #A2016) at 2µg/ml for 30 minutes. They were then 
washed and mounted on slides for microscopic studies (see Section II. 8.2.6). 
20x SSPE buffer 
175.3g NaCl 
27.6g NaH2PO4. H20 
7.4g EDTA 
800m1 MQH2O 
pH to 7.4 with NaOH 
adjust to IL and autoclave beforr use 
SOx Denhardt's reagent 
5g Ficoll 
Sg Polyvinylpyrrolidone 
5g Bovine Serum Albumin (JISA) 
500m1 MQHZO 
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Probes used 
U3 probe 101t 5'- *C*CUUUCGGUGCUC*C*C - 3' 
U4 probe 1012: 5'- *C*CUGCCACUGCGCAAAGCU*C*C - 3' 
* denote biotinylated sites. 
118.2.6 Mounting 
Before the fixed cells were analysed on the microscope, the coverslips were mounted onto 
the slide using either Mowiol/Dabco or Vector Shield (Vector Labs #H1000). A glycerol 
base mounting reagent such as Vector Shield is required for the right refraction properties 
in using the DeltaVision wide field fluorescence microscope and coverslips were sealed 
with nail polish. 
II. 8.3 Live Cell analysis 
Both the temperature and the medium contents were instrumental in setting up the live cell 
analyses. 
11.8.3.1 Temperature contml devices 
The devices were setup according to the manufacturer's suggestions: 
Model Purposes 
LabtekH Chamber Used in TSM510 (EMBL, Heidelberg) for ultrafast 4D confocal imaging and the 
(Naperville, IL) temperature was kept using a home-built blower to keep the chamber at 37°C. 
POC Chamber Fitted for ISM410 and ISM510 for live cell studies and the temperature of the 
(Bachofer) chamber was electronically kept at 37°C by the in-built devices. 
FCS2 Chamber/ Fitted for DeltaVision Restoration microscope and the temperature of the 
Objective heater chamber and the objective was maintained individually at 37°C for maximal 
(Bioptech) growth, especially for mitotic studies 
Table 11-7 Temperature control devices used in this study 
Cells were grown on 42-mm glass coverslip (no. 1; Helmut Sauer) for POC chamber, 40 
mm diameter coverslips 1.5 thick for the FCS2 chamber or directly on LabtekII Chamber 
one day prior to the live cell experiment Imaging conditions were dependent on the 
microscopy used (Section 11.8.1) 
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I1.8.3.2 Medium 
A special medium that does not contain Phenol Red was ordered (Invitrogen #11880-028); 
otherwise, all medium is set up as in the general growing condition described in Section 
11.5.1.2). Usually, HEPES was added to give a final concentration of 20mM to buffer any 
pH change due to the release of CO2 during analysis. In mitotic studies, 20% FCS was 
commonly used with the addition of I-ascorbic acid (0.5mg/ml). For analysis that lasts for 
more than 8 hours in a FCS2 chamber on a DeltaVision microscope, a perfusion chamber 
was set up such that fresh nutrients were supplied and old medium were replaced at a flow 
rate of around 0.2-0.5m1/hour via a peristaltic pump, according to the manufacturer's 
suggestion. 
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THE NUCLEOLAR PROTEOME 
`Apßyng an updated vexrion of a 1960s technique, thy treated human nuclei with 
urgar and sound wams and, wring a centrifuge, separated the natively dense nucleolus 
from its gelatinous home in the nucleus. " 
- News of the week, Science 18" January, 2002 
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III. The Nucleolar Proteome 
III. 1 Introduction 
The nucleolus is known to be the site of ribosome subunit production. However, recent 
studies suggest that it may play additional roles. For example, several classes of proteins, 
including tumour suppressors, splicing and cell-cycle factors and viral proteins will 
accumulate in the nucleolus, either under certain metabolic conditions, or else at specific 
stages of the cell cycle (see Chapter 1). The biological roles of these facultative nucleolar 
interactions remain to be uncovered. To understand more about the functions of the 
human nucleolus, our group, in collaboration with Professor Matthias Mann and co- 
workers (University of Odense, Denmark), used mass spectrometry to identify the protein 
components of nucleoli isolated from HeLa cells and part of the work was published 
(Andersen et aL, 2002), which is attached in the Appendix Section. 
Nearly 300 nucleolar proteins were identified using MALDI-TOF and nanoelectrospray 
mass spectrometry on proteins separated by a combination of 1D and 2D gel analyses. 
Recently, we have extended our coverage of nucleolar proteins to 400 members by 
performing LC-MS/MS. Approximately 12% of the identified proteins were previously 
known to be nucleolar in human cells (Section 111.3 for details). Surprisingly, -30% 
represented either novel or uncharacterised proteins. As expected, nearly all of the known 
housekeeping proteins required for ribosomal biogenesis were identified in our analyses. 
So, the immediate question was: what are the remaining 88% proteins doing in the 
nucleolus? In this chapter, I present a bioinformatics analysis of the nucleolar proteome 
and suggest a novel way of assigning functions for uncharacterised proteins by mining of 
transcription profiles, protein-protein interaction data and the currently available, 
completed genome data from model organisms. 
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II1.2 Purification, Analysis and Verification 
Due to their inherent high density, nucleoli could be isolated by sucrose gradient 
centrifugation following the disruption of nuclei by sonication (Figure III-1). The purity of 
the sample was examined by a combination of conventional light microscopy, electron 
microscopy and immunoblot (Andersen et al., 2002). Immunoblot analyses showed that 
the sample contained nucleolar markers such as fibrillarin and nucleolin but not non- 
nucleolar NUP62 protein, a component of nuclear pore complex (Andersen et al., 2002). 
Moreover, the morphology and localisation of subnucleolar domain markers in isolated 
nucleoli were shown to be indistinguishable from those in situ at light and electron 
microscopy level (Andersen et al., 2002). The proteins in the sample were separated on 
either a 1D or 2D polyacrylamide gel, followed by in-gel trypsinisation, and the peptides 
were analysed by tandem mass spectrometry (MS/MS) to identify not only the peptide 
masses, but also their amino acid compositions (Chapter I). Alternatively, the isolated 
I D/2D gel-MS/MS 
Isolation or LC-MS/MS 
ýQf 
{ý 
0ý 
7 Protein Identification 
YFP-tagging 
(verification) 
Figure III-1 Scheme of the characterisation strategy. Nucleoli were first isolated by sonication and 
fractionation using a sucrose gradient. The proteins were either separated on a 
polyacrylamide gel prior to trypsinisation, or first leaved into peptides before separating 
using a liquid chromatography. The resultant peptides were analysed by tandem mass 
spectrometry to identify their masses and amino acid compositions (Chapter 1). The 
information is searched against either the NCBI protein database or human genome database 
to find the corresponding proteins. To verify the proteins are genuinely nucleolar, they are 
tagged with \'FP and transiently expressed in I-Lela cells to examine their localisation. 
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nucleoli were solubilised, then trypsinised in solution and the resulting peptides were 
separated through liquid chromatography before analysing by tandem mass spectrometry 
(LC-MS/MS). The identified peptides from both ID/2D gel-MS/MS and LC-MS/MS 
were then used to interrogate the NCBI database and, in some cases, the human genome 
database to identify the corresponding proteins. The strategy for our nucleolar proteome 
characterisation is summarised in Figure III-1. 
To verify the newly identified components are genuinely nucleolar, I cloned the cDNAs for 
10 novel or uncharacterised proteins (namely, NNP62, NNP43/SAZD, NNP42/PWP1, 
NHPX, PESI, DDX18, NNP51, NNP38, DDX10, NNP46; Table 111-3) and inserted into 
the pEYFPCI vector (Clontech) to produce a fusion protein of yellow fluorescent protein 
(YFP) at the amino terminus of each protein. The proteins selected were chosen to include 
a range of sizes, pI values and motifs. Following transient transfection and expression in 
HeLa cells, all except NNP46 were localised to the nucleolus showing a variety of patterns 
(Figure 111-2). For example, some localised to the nucleolus alone (Figure III-2A), while 
others also localised to an unknown class of nuclear bodies (Figure III-2B), the Cajal 
bodies (Figure III-2C) or the cytoplasm (Figure III-2D). 
Because I have used only one type of tag, ie. EYFP, and the chosen proteins were tagged 
at only one terminus, this tagged version of NNP46 may not truly reflect its endogenous 
localisation and the localisation need to be verified using a specific antibody raised against 
this protein or using an alternative tag. Moreover, nucleolar factor may continually cycle in 
and out of the nucleolus or accumulate to the nucleolus only at specific metabolic 
condition or else at specific cell cycle stage (Fox et aL, 2002). Therefore, I am confident 
that the majority, if not all, of the proteins identified, including those encoded by novel 
genes, are bona fide nucleolar factors (Andersen et al., 2002). 
Chapter III The Nudeolar Pmteome 
Page 94 
To facilitate a comparison of these localisation patterns with known subnucleolar domains 
(Chapter I), three HeLa cell lines were generated, which label, respectively, the fibrillar 
centres (EYFP-RPA39), dense fibrillar components (EYFP-FIB) and granular components 
(EYFP-B23). Surprisingly, a novel protein, NNP43/SAZD, localised to an unidentified 
subcompartment of nucleoli (Figure III-2E-H). The subcompartment is within the dense 
fibrillar compartment (Figure III-2F) but does not overlap with the fibrillar centre (Figure 
III-2G). Interestingly, the pattern is colocalised with SUMO-I within the nucleolus (Figure 
III-2H); however, the role of this subnucleolar domain remains to be elucidated. 
Figure 111-2 Characterisation of novel nudeolar protein localisation. I Iela cells were fixed after 16 
hours of transient transfection using plasmid that expresses (A) EYI P-PI: SI; (13) EYPP- 
NNP51. (C) EYFP-NHPX; (D) EYFP-PWPI; (E) EYFP-NNP43/SAZD. To identify the 
intranudeolar localisation of EYFP-NNP43/S. AZD, EY17P-SAID were transiently 
transfected to Hel a cells stably transfected with (t) ECIIP-FIB and (C) ECFP-RPA39. The 
transfection condition in (II) is the same as (E) but the tiansfected cells were further stained 
with an anti-SUM01 antibody. White arrowheads indicate nudeoli; blue and yellow arrows 
indicate unidentified nuclear body and Cajal body respectively; white arrows indicate the 
intranudeolar localisation of NNP43/SAZD. Scale bar = 5µtn. 
II1.3 Expansion of Known Nucleolar Proteome 
In order to compare our nucleolar proteome with the list of previously published nucleolar 
proteins, it was first necessary to define this comprehensive list. Known nucleolar proteins 
were identified and extracted from PubMed (1978-2002) using MESH keywords "amino 
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acid sequences" and word "nucleol*" in the abstract field. 123 nucleolar proteins were thus 
identified; however, 2 of these proteins were not annotated with amino acid sequences and 
hence were not compared with our mass spectrometry results. Table 111-1 lists the 
published, known nucleolar proteome as defined by this search. 
Examining Table III-1, I note that more than 90% human proteins that were previously 
reported to be involved in ribosomal biogenesis were identified multiple times, both from 
the 1 D/2D gel and the LC approaches (Table III-la, d). In general, the LC-MS/MS 
approach appears more sensitive than the ID/2D gel approach in detecting peptides and 
thus gave rise to a higher coverage of nudeolar proteins, indicated by ticks appearing in the 
LCMS column rather than the CB2002 column (see also Table 111-3). -70% of the 
proteins identified by ID/2D gel-MS/MS analyses were also detected by the LC-MS/MS. 
Even so, only less than 10% of proteins that are previously reported to be localised in 
nucleoli during only part of the cell cycle, or under certain metabolic conditions, were 
identified in our analyses (Table III-lb-c). This may be because the nucleoli we analysed 
were isolated from unsynchronized HeLa cells and hence facultative nucleolar proteins may 
only constitute a minor fraction of the proteins isolated. Although LC-MS/MS has already 
increased the sensitivity of detection, it may still not be sensitive enough to detect very low 
abundance factors. Future analyses will therefore focus on nucleoli isolated at specific cell 
cycle stage and under particular metabolic conditions. This should help to increase the total 
coverage of nucleolar proteins. 
Table lU-1 Known Nudeolar Proteome. Table III-la shows nucleolar proteins identified in more than 
one mass spectrometry analyses and most of these proteins, e. g. BRIX, were also found in 
another recent proteomic analysis of the human nucleolus (Schell et al, 2002). Proteins 
known to be localised in nucleoli during only part of the cell cycle and/or under certain 
metabolic conditions are shown in Table III-lb and Table III-1e respectively. Other known 
proteins localised in nucleoli are shown in Table III-Id. The column "Accession" shows the 
corresponding NCBI GI number of the protein. A tick in the column "CB2002" and 
"LCMS" signifies the identification of the protein in either ID/2D gel-MS/MS approach 
(Andersen et al, 2002) or in the LC-MS/MS approach, respectively. The literature regarding 
the nucleolar localisation of each protein is documented under the column "literature". Note 
that some proteins fall into multiple categories. 
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111.4 Bibinformafics Analyses 
II1.4.1 General 
111.4.1.1 Background 
The large amount of data acquired from the proteomic studies requires a systematic way to 
analyse and integrate it with the information already deposited in the databases publicly 
available (Table 111-2). To facilitate these analyses, several databases were downloaded to 
our UNIX server (bioinformatics. msiwtb. dundee. ac. uk) and were interrogated with 
software such as standalone BLAST (Altschul et al., 1990; Altschul et al., 1997) and 
customized PERL scripts I have written throughout my PhD studies (the scripts are 
deposited in the accompanying CD). The resulting information was presented in a 
searchable database written in Macromedia FLASH action script and published together 
with the Current Biology paper in January 2002 at http: //www. dundee. ac. uk/lifesciences/ 
lamonddatabase/ (a simplified version can be found in the accompanying CD). 
Website URL 
Retrieval of sequences and databases 
Swissprot http: //www. expasy. ch/ 
EBI http: //www. ebi. ac. uk/ 
Entrez http: //www. ncbi. nhn. nih. gov/Entrez/ 
mRNA expression and genome data 
Unigene http: //www. ncbi. nhn. nih. gov/Unigene/ 
SAGE http: //www. ncbi. nlm. nih. gov/SAGE/ 
LocusLink http: //www. ncbi. nlm. nih. gov/LocusLink/ 
Literature 
OMIM http: //www. ncbi. nlrn. nih. gov/OMIM/ 
PubMed http: //www. ncbi. nlm. nih. gov/PubNfed/ 
Homologues search 
BLAST http: //www. ncbi. nlm. nih. gov/BLAST/ 
SGD http: //genome-www. stanford. edu/Saccharomyces/ 
MIPS http: //mips. gsf. de/proj/yeast/CYGD/db/index. html 
Table 111-2 Public databases used in this study 
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The construction of nucleolar proteome database is summarised as follows: The peptide 
sequences obtained from the mass spectrometry were assigned to a particular protein 
sequence either by BLAST or by more commonly, MASCOT (http: //www. expasy. ch/). 
All the sequences were then retrieved by Batch Entrez from the NCBI database. The 
protein sequences were then assigned to their corresponding gene by BLAST analysis 
against the Unigene database. The Unigene entry provides a starting point leading to 
various other relevant databases, such as LocusLink and OMIM, to provide the cognate 
genomic and literature data, while the information deposited in the Swissprot database 
provides physical properties of each protein, such as isoelectric point (pI) and Molecular 
weight (Mw). A simplified version of the database is summarised in Table 111-3 and the full 
table can be found in the accompanying CD. 
111.4.1.2 Classification by known molifr and homologues 
Due to the large number of novel proteins, accounting for -30% of the total nucleolar 
proteome, existing information available from the database annotation is not enough to 
predict the functions of most of the proteins and hence their motifs and homologues were 
searched with the aim of getting more information for classification. The search of motifs 
and homologues was conducted via BLAST against Conserved Domain Database or CDD 
(Marchler-Bauer et al., 2002) and specific proteome databases of the model organisms 
including Saccharomycer cerevidae, Schirosaccbammycer Bombe, Drosophila melrrnogarter and 
Caenorbabditis elegans. The most abundant motifs were the RNA-binding RRM domain, 
DEAD box helicase domain and the WD domain. The motif distribution within the 
human nucleolar proteome is deposited in Supplementary Table III-SI in the 
accompanying CD. 
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Surprisingly, the subsequent addition of 136 newly identified nucleolar proteins from the 
LC-MS/MS data resulted in minimal change to the distribution of proteins between 
categories as previously assigned (Figure 111-3). From the knowledge of the functions of 
orthologues in other organisms, particularly in budding yeast, some of the proteins were 
then assigned to be related to ribosomal biogenesis and denoted in green in Figure 111-3. 
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Figure 111-3 Distribution of conserved motifs and putative functional categories of the identified 
proteins in the nucleolar proteome. (A) Current analysis and (B) 1D/2D gel analysis data 
(Andersen et al, 2002). The percentages in brackets indicate the maximum number of 
proteins that could possibly be classified in the category in question. For example, 22% of the 
proteins may be related to ribosomal biogenesis from the current analysis (A), due to their 
yeast orthologues being present in the ribosomal synthesis pathway. 
The ribosomal biogenesis pathway was so far studied mainly in yeast, while its 
characterisation in other eukaryotes, especially humans, lag far behind (Fatica and 
Tollervey, 2002). The accumulated knowledge of genetic defects in the yeast ribosome 
synthesis pathway during the last decade as well as the recent success in the identification 
of pre-ribosomes using mass spectrometry has expanded our understanding of the 
ribosome synthesis pathway dramatically (Figure 111-4 and http: //www. proteome. com). 
Clear human homologues identified from our analysis could be found in the pathway as 
illustrated in Table 111-4. In this way, our nucleolar proteome can annotate part of the 
human genome to be functionally related to ribosomal biogenesis. Future analysis of these 
human nucleolar proteins is likely to improve our understanding of human ribosomal 
synthesis pathway. 
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Drawing on published data, as well as identifying homologues from the yeast ribosome 
biogenesis pathway as shown in Figure 1114, we have found 92 homologues (Table III-4). 
Table 1114 shows all the possible 92 human homologues in the nucleolar proteome that 
could potentially be involved in ribosomal biogenesis. Proteins previously proven to be 
involved in the human ribosomal biogenesis such as POPO, FIB and NOP52 were shown 
to have similar functions as in yeast homologues and were organised according to how 
these proteins assist along the pathway. However, there are proteins, such as 
nucleophosmin (NPM/B23) or nucleolin, that have previously been shown to be involved 
in the human ribosomal biogenesis, are human-specific and thus were unavoidably 
excluded in this approach. 
Moreover, nearly 40 novel/uncharacterised proteins, constituting one-third of this category 
in the nucleolar proteome, could potentially have functions related to ribosomal biogenesis 
based on the function of their yeast homologues (Figure III-4). For other human proteins 
with limited characterisation, such as Bystin-like protein BYSL and many DEAD/H box 
helicases, we can now more precisely pinpoint their possible functions. This illustrates the 
potential for using the information from this study to further elucidate the human 
ribosomal biogenesis in the near future. 
Figure U14 
. 
Ribosomal biogenesis pathway in yeast. The 90S pre-ribosomal complex is proposed to 
contain the 35S rRNA and the U3 snoRNA. The early pre-rRNA cleavages at sites AO to A2 
lead to the separation of the pre-40S and pre-60S particles. In both pathways a series of 
predicted intermediates are drawn, which are designated early (E), middle (M) and late (L) 
according to their positions on the proposed pathway. The processing steps envisaged to be 
associated with each of these complexes are indicated, as is the likely time of export to the 
cytoplasm. Note that it is very probable that other pre-ribosomal complexes exist in addition 
to those shown, and it is not clear in what order the components are gained and lost between 
the complexes. The pre-60S pathway includes only proteins for which corroborating data 
exist supporting a direct role in nbosome synthesis. This figure is modified from Fatica and 
Tollervey, 2002. 
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111.4.1.3 Amino acid composition 
Taking advantage of the large nucleolar proteome described in this work, I analysed 
whether certain amino acids are enriched, as comparing with randomly generated 
sequences (Figure 111-5). For comparisons, I generated sets of protein sequences extracted 
from either the human-specific proteomes or the human, nuclear-specific proteomes and 
each set contains approximately the same number of sequences and amino acids as the 
identified nucleolar proteome. Apparently, charged amino acids such as glutamate, 
aspartate, lysine and arginine are more favoured, when compared with the randomly 
generated nuclear protein sequences, whilst neutral amino acids, such as proline and 
cysteine, are highly disfavoured. Surprisingly, the polar amino acids serine, threonine and 
tyrosine, which are important targets for phosphorylation were not common within the 
nucleolar protein sequences. This apparent amino acid bias may reflect nucleolar targeting 
10% 
9% 
8% 
7% 
6% 
5% 
4% 
3% 
2% 
1% 
Figure 111-5 Abundance of individual amino acids in the nudcolar protein sequence 
Dran dom 
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motifs, although these remain poorly characterised The initial search for such motifs using 
software such as MEME (Bailey and Elkan, 1994), was only sensitive enough to retrieve 
the motifs mentioned in Section III. 4.1.2. 
Whilst it was not possible to isolate new motifs, it was possible to search for other known 
short peptide motifs. The database was searched for all the possible tripeptides, 
tetrapeptides and pentapeptides within the nucleolar proteome using customised written 
scripts. For a protein sequence of n amino acids, it consists of n-2 tripeptides, n3 
tetrapeptides and n4 pentapeptides. For example, a pentapeptide sequence of MALAV has 
2 tetrapeptides (MALA and ALAV) and 3 tripeptides (MAL, ALA and LAN). 
Certain motifs show a specific enrichment in the human nucleolar proteome. The Protein 
Phosphatase 1 (PPl)-binding motif, [KR]-V-x-F, constitutes 0.032% of all tetrapeptide 
sequences present in the nucleolar proteome. This is -1.4 fold more common than in the 
nuclear proteome, suggesting that it is more common to have a protein that contains one 
or more PP1-binding site in the nucleolus than in other parts of the nucleus. In contrast, 
the SUMO-conjugation site, [IVLMF]-K-x-[ED], constitutes -0.2% of tetrapeptides in 
nucleolar protein sequences, a value similar to its frequency in other nuclear but non- 
nucleolar proteins. Interestingly, the tripeptide RG[GR] is enriched in the nucleolar 
proteome at least 2 fold as compared with other nuclear proteins and 128 out of 400 
proteins in the nudeolar proteome contain this motif at least once. This motif is also 
commonly found in RNA-binding proteins, such as nucleolar proteins GAR1 and 
fibrillarin, that interact with SMN, `survival motor neurons' protein, by a common 
mechanism involving this RG-rich domain (Paushkin et al., 2002; Terns and Tems, 2001). 
The enrichment of such motifs possibly reflects the unknown, functional properties of the 
human nucleolus that are distinct from other subnuclear structures. 
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II1.4.2 Profiling 
The bioinformatics analyses performed so far look at each protein or gene individually and 
determine whether it may contain certain motifs, or whether its orthologues in other model 
organisms perform certain functions. However, proteins can also be analysed either 
pairwise, or in clusters. For example, proteins that function in a common complex may be 
expressed co-ordinately in multiple organisms. This is a reasonable assumption based upon 
the fact that proteins rarely work alone and many pathways or complexes are crippled by 
the loss of individual components. Such phenomena have been observed in yeast, where 
co-inherited proteins are usually functionally related (Pellegrini et al., 1999). 
To analyse and present the homologues from 80 completed genome sequences (the 
complete list of organisms is available in Table III-S2), we can view them as a profile, 
where each profile is a single row consisting of 80 elements that individually encode either 
the presence (100% black), or absence (0% black), of sequence homologues in a particular 
genome. Each profile is a representation of the homologues across the tree of life; 
matching profiles identifies proteins with similar patterns of inheritance. When putting all 
the profiles parallel to one another, each row represents a single protein while each column 
represents a single genome and the blackness of each element represents the degree of 
homology between the human gene and orthologue from that particular organism (Figure 
III-6). Note that no homology in either primary sequence, or in tertiary structure, is 
required among the proteins with similar BLASTp profiles in this approach to reveal a 
possible functional relationship between two proteins. 
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Figure 111-6 Nucleolar proteome Profiling. The proteome profiled in terms of (top) its homology to 
other model organisms (BIJASTp), (middle) of where they are expressed in different tissues 
(Unigene) and (bottom) of how they were expressed in various cells (SAG); ). The data 
presented here represent a subset of 20 randomly chosen ribosomal proteins (See 
supplementary Table III-S2 for details) 
Likewise, proteins are often expressed at either the same time, or place, as functionally 
related proteins. By either choosing different cell tissues, or by varying the growth 
conditions of the cells, enough variation in gene expression can be observed to identify co- 
expressing genes. By mining public databases that store mRNA expression levels, e. g., 
either expressed sequence tag (EST) libraries (Boguski and Schuler, 1995), or serial analysis 
of gene expression, i. e. SAGE (Lash et al., 2000), similar profile clustering was performed 
on each nucleolar gene for 41 different tissues and 115 different growth conditions, as 
illustrated in Figure 111-6. 
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111.4.3 Visualisation of PotentialAssociations 
To analyse the profiles systematically, the Spearman rank correlation coefficient, r,, was 
calculated between each pair. Each nucleolar protein/gene was compared in a pairwise 
manner: first, the degree of similarity/expression level was ranked from the highest to the 
lowest; second, the differences in the rank order, d, for each n different 
species/tissue/condition were calculated as follows: 
6 d2 
rs =1- n3-n 
The Spearman rank correlation coefficient provides a measure of the association between 
two profiles of the nudeolar proteins/genes, with its limits being -1 and +1. If it takes the 
value +1, then the two profiles are the same; if it takes the value -1, then the profiles are 
opposite to one another. If it is zero, it implies that the profiles are independent of one 
another. 
To collate visually all this information about potential protein-protein associations, a 3- 
dimensional (3D) plot was designed to visualise the data (Figure III-7). The axes were 
assigned for the BLASTp, tissue and SAGE profile comparisons respectively. For example, 
those protein-protein associations that have very similar profiles in terms of (a) how they 
are inherited in different genomes, (b) where they are expressed and (c) how they are 
expressed, would be clustered around the (1,1,1) corner. Conversely, unrelated protein- 
protein pairs would be centred at (0,0,0) in the 3D space (Figure 111-7). Additional 
information content can be added by changing the shape of the object (e. g. from sphere to 
square), or by changing the colour or size (Figure 111-7, left). For example, known motif- 
motif interactions such as coiled-coiled domains and existing protein-protein interaction 
information, from either human, or other homologues, can be added to help evaluate the 
potential protein-protein associations. An example of this type of data is the two recent 
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high-throughput analyses of protein complex composition in Sacchammyces cereiiiiae (Bader 
et al., 2001; Gavin et al., 2002; Ho et al., 2002) or in http: //www. bind. ca/. 
400 nucleolar proteins were identified in our current analyses and hence there could 
potentially be 79,800 binary protein-protein associations (0.5x400x399), excluding self 
associations. Most of the potential associations, when put in the abovementioned 3D plot, 
are centred at origin (0,0,0) with a skewing towards the (1,1,1) comer (Figure 111-7). This 
plot suggests that most of the proteins are functionally independent from one another, 
whilst only a small fraction of proteins are related to each other in terms of (a) how they 
are inherited in different genomes, (b) where they are expressed and (c) how they are 
expressed. For example, in Figure 111-7, any protein-protein associations involving two 
(11 1,1) 
0 
BLAST 
lot. o. 1, a. n 
SAGE 
ýýa. 
a. 
C. 
02) 
Figure 111-7 Visualisation of the complex data related to all hypothetical nucleolar protein-protein 
associations. Different colour/shape can be changed for each spot to provide more 
dimensions of data on top of the 31) space (left). 79,8(X) potential protein-protein 
associations of the nucleolar proteome containing 4(Nl proteins were shown. Ribosomal 
protein-ribosomal protein associations are highlighted in red (right). 
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ribosomal proteins were highlighted in red (i. e. those possible associations found in the 
ribosome complex) and they are clustered at the (1,1,1) corner. 
1H. 5 In silico classification of Novel proteins 
The clustering of known ribosomal protein-ribosomal protein associations on the (1,1,1) 
corner prompts me to investigate whether it is possible to use this clustering in classifying 
proteins, especially the novel proteins. The idea behind this is that protein-protein 
associations in the same complex/pathway performing a specified function have similar 
properties, for example, where all the points that represent these associations locate in a 3- 
D plot as in Figure 111-7. For example, to identify all the potential associations that are 
related to the ribosome, I need to define first the 3D space R that was occupied by a 
subset of ribosomal protein-ribosomal protein associations. In this case, we chose 20 
different ribosomal proteins randomly while the other 27 ribosomal proteins were treated 
as an internal control. All points in the 3D plot were represented mathematically by vectors 
with the origin defined as (0,0,0). In this way, the boundaries of 3D space .0 
encompassing all the ribosomal protein-ribosomal protein associations were defined by the 
minimum and maximum magnitude of the vectors, the angle between the SAGE and 
Tissue axes, 0, and the angle between the BLASTp and the SAGE-Tissue plane, 0 (Figure 
111-8). 
Having deßned the 3D space where the potential protein-protein associations occur that is 
related to the ribosome, either in a complex or in a pathway, I asked how far the potential 
associations between the remaining 380 proteins and any one of the 20 ribosomal proteins 
deviated from this restricted 3D space D? All vectors that fall outside 12 are weighed 
according to how much they are deviated from the 3D space. For instance, the deviations 
of the vectors representing potential associations between protein A and every ribosomal 
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Figure 111-8 Methodologies behind the in siVco classification. (: 1)11 e restricted 31) space fl defined 
by the subset of 21 ribosomal proteins was highlighted in orange. The distribution of the (I3) 
magnitude and (C) the angle of those vectors encompassing the ribosomal-ribosomal protein 
associations within the subset. 
proteins within the defined subset were computed and averaged to give a score S., for 
protein A. Similarly, each ribosomal protein within the subset was compared with the other 
19 ribosomal proteins and each ribosomal protein was then given a score XR. Therefore, 
the range of XR acts as an internal control to indicate how much deviations of the vectors, 
which represent potential protein-protein associations, inherently exist within the ribosome 
and this range set the in si/ico standard for other proteins to be classified as being related to 
the ribosome. Detailed calculation procedures can be found in the supplementary 
information in the accompanying CD. 
The higher the score, S or X, the further away the protein-protein association is from the 
centre of the defined ribosomal 3D space. Hence, the maximum score derived from the set 
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of 20 ribosomal proteins, X. _, 
defines the upper limit of score S. Table 111-5 summarises 
those proteins that are possibly related to the ribosome, either in a complex or in a pathway 
with a score S which is smaller than or equal to X., 
(46/46) S6 RPL 1-ý. - i: PLi' kPL26' 
'", PL1UA, RPL32', RPLPO', RPL6, RPS18', RPS9', RPL9', RPL4', 
RPS5*, RPL8, RPS16', RPS6, RPL18A, RPL17', RPL35, RPL31. 
RPL14, RPL27, RPS12, RPL18, RPL36, RPL13, RPL34, RPL28, 
RPL22, RPL7, RPL35A, RPL27A, RPS27L, RPS14' 
Ribosomal Biogenesis v, r Rr'q: r ,; r»-, , Ný,;? c r, 
(10/31) 
Other Translation Factor ITGB4BP, EEF1A1, ETFI, EIF5A, EEF2, TPT1 
(6/15) 
Nucleic acid binding POLR2E, MCM2, MCM3, H2AFE, MCM6, H2BFG, H2AFZ, H1 F5, 
protein (11/95) MCM4, RNAC, SNRPD2 
DEAD box proteins (0/17) 
Others (4/47) ACTB, ACTG1, UBB 
Chaperone (1/16) CCT3 
Novel/uncharacterised PA2G4, NNP89, NNhizd, NNP127, NNP10, NNP125, vrý NNP82, 
proteins (9/123) NNP74, NNP15 
1. Ribosomal proteins or known homologues of ribosomal proteins in yeast are coloured in -; and those ribosomal proteins selected to form 
the basis of ribosomal protein-ribosomal protein association are marked with an asterisk 
2. Proteins involved in ribosomal biogenesis are coloured in 
3. Yeast or other homologues that are involved in ribosomal biogenesis are shown in bold; 
4. The number next to each category (alb) where a is the number of proteins that have similar profiles 
as ribosomal proteins and b is the total number of proteins in that category in the nucledar proteome 
5. The following 10 proteins were not included in this study due to incomplete dataset: 
RPS7, ASNA1, KHDRBS3, ASE-1, NNP97, SENP3, SMC4L1, NNP2. NOLA3, NNP1 
Table 111-5 Summary of proteins predicted to be related to ribosomes, either within the same 
complex or in a pathway involving ribosomes. 
87 out of 390 proteins in the nucleolar proteome were classified as being related to 
ribosomes based on their BLASTp, tissue and SAGE profile comparisons. 10 proteins, 
including ribosomal protein RPS7, were excluded from the analysis due to incomplete 
datasets. All the remaining ribosomal proteins were identified in Table 111-5, suggesting 
that this method could identify other components within the ribosome complex based on 
their profile-profile comparisons. On the other hand, more than one-third of the ribosomal 
biogenesis and translation factors were selected from the nucleolar proteome. This is 
reassuring because these factors are known to be related to either the formation and/or 
function of ribosomes. 
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Interestingly, none of the 17 DEAD box proteins were selected using this classification 
method. For some of the proteins, such as histones, replication factors and actins, their 
relationships with ribosomal proteins remain unclear. Unexpectedly, Ubiquitin (UBB) was 
classified to be related to ribosomes based on the profile-profile comparisons. Indeed, 
several ribosomal proteins have previously been shown to be co-transcribed with the 
ribosomal gene and poly-ubiquitination is important for the function for ribosomes during 
the cell cycle (Spence et al., 2000). 
There are 9 novel proteins that were included in this in filico classification (Table 111-6). 
Among those, three are clear homologues of yeast ribosomal proteins and another four 
proteins have potential homologues in different complexes involving in ribosomal 
biogenesis as illustrated in Figure 111-4. For example, yeast homologues of NNP10 and 
NNP125 are involved in the exosome and the formation of early pre-60S complexes, 
respectively. NNP127 is a human homologue of yeast histone H3. NNP82, NNP74 and 
Rank Gene Name Description Yeast GN Sc Sp Ce Dm Complex 
44 NNP89 Novel Nucleolar Protein 89 RPL30 Ribosome 
48 NNP128 Novel Nucleolar Protein 128 RPL23B Ribosome 
51 NNP127 Novel Nucleolar Protein 127 HHT2 
52 NNP10 Novel Nucleolar Protein 10 RRP4 Exosome 
70 NNP125 Novel Nucleolar Protein 125 RPF2 D, F 
72 NNP85 Novel Nucleolar Protein 85 RPL21A Ribosome 
75 NNP82 Novel Nucleolar Protein 82 YGR283C? 
80 NNP74 Novel Nucleolar Protein 74 SKI6? Exosome? 
84 NNP15 Novel Nucleolar Protein 15 RRP45? Exosome? 
Table 111-6 Summary of the novel proteins included in this in silico classification. The lower the 
value of 'Rank', the less its mean distance of deviation from the 31) space d?. 'Yeast GN' 
shows the dosest match of a yeast gene with the corresponding proteins. The shaded panels 
represent the results of BLASI'p searches for each protein against species-specific proteome 
database from EBI/SGD databases: Sarban, m)res eemüioe (. Sc), . 
Schilosarharomwcr pombe (Sp), 
Drosophila me/aaogarter (Dm) and C: aenorhabditis elegans (Ce). The results are shaded such that a 
black panel represents the expectancy value (e-value) of 0.0 and thus indicates a nearly perfect 
match; 80% grey for c-value < le ti"'; 50% for 1c "xý < c-value < Ic75; 40% for le75 < e- 
value < les' ; 25% for le 5° < e-value < lc 25 and a white panel for c-value > le 25. 'Complex' 
indicates the name of the complex as illustrated in Figure 111-4. It should be noted that the e- 
value between known yeast homologues of human proteins can be as low as le t". 
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NNP15 do not have clear homologues in yeast, but are rather higher organism-specific. 
Whether they are related to the ribosome complex, or to a pathway involving the 
ribosome, remains to be established. 
II1.6 Discussion 
In this chapter I reported and compiled the previously known and recently identified 
nudeolar proteins in human cells (c. f. Table III-1 & Table 111-3). This accounts for - 400 
proteins, which are encoded by roughly -0.5-2.5% of the human genome, if the current 
estimate of 15-80,000 human genes is correct, from an organelle that has been studied for 
more than 150 years. Even from this small sampling from a well-characterised structure, 
-30% of the proteins are still defined as either novel, or previously uncharacterised, 
according to their genome annotations. However, by mining the databases publicly 
available (Table 111-2), we could get a glimpse into the functions within the nucleolus. 
The nucleolus is known to be the place where ribosomal biogenesis occurs; however, the 
pathway of ribosome synthesis in human has not been studied in detail so far. By 
comparison with the known pathway from yeast (Figure III-4), mainly Saccbammyces 
ce, thiae, with its human homologues, 1 /3 of the novel or uncharacterised proteins were 
annotated to be related to ribosomal biogenesis (c. f. Table III-4). The future analyses of 
these putative ribosomal biogenesis factors based on homology to their yeast counterparts, 
i. e.. 20% of the nucleolar proteorne, should advance our understanding of how the 
ribosome forms in human cells. 
So, what are the functions of the remaining 80% proteins identified from the nucleolar 
proteome? It is surprising that the addition of 136 new proteins identified from LC- 
MS/MS data does not change the overall distribution of proteins in different categories 
present in the nucleolus (c. f. Figure 111-3). DNA and RNA binding proteins that are 
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involved in DNA repair, transcription, the unwinding of nucleic acid and RNA 
modification including splicing, constitute roughly one-quarter of the nucleolar proteome. 
The high protein complexity of the nucleolus implies that either the biogenesis of 
ribosomes is a surprisingly complex process and/or that the nucleolus carries out 
additional functions, consistent with the theory of a plurifunctional nucleolus (Pederson, 
1998). 
It is interesting to note the high abundance of RG-rich domains within the nucleolus and 
that 30% of the nucleolar proteins contain at least one RG(RG] motif (c. f. Section 
III. 4.1.3). Previous studies have suggested that SMN, a component of Cajal bodies, utilises 
this domain to interact with a range of proteins involved in pre-rRNA processing, 
ribosome production, pre-mRNA splicing, transcription and recruitment to Cajal bodies. 
The close association of Cajal body with the nucleolus has been well established since its 
discovery (See Chapter D. It is noted that Cajal body components containing this RG-rich 
domains, such as Sm proteins, have been shown to be trafficking through the nucleolus 
(Sleeman and Lamond, 1999). It remains to be established whether such trafficking 
behaviour is due to the involvement with various RG-containing proteins within the 
nucleolus. 
In general, nucleolar proteins show reduced levels of amino acids that could be potentially 
phosphorylated, such as serine, threonine and tyrosine, in their composition as compared 
with those that localised elsewhere in the nucleus (c. f. Section 111.4.1.3). On the other hand, 
nudeolar proteins are more likely than any other nuclear proteins to have PP1-binding 
domains (c. f. Section 111.4.1.3). In fact, from the current analyses, we identified all three 
isoforms of PP1 within the nucleolus (c. f. Table 111-3). It will be interesting to explore in 
the future whether the nucleolus is a preferential site for dephosphorylation within the 
nucleus. 
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To survive, cell requires energy and nucleotides such as ATP and GTP are utilised as the 
major currency. For example, nuclear import requires the establishment of a GTP/GDP 
gradient across the nuclear envelope and DEAD box helicases require ATP to unwind 
DNA/RNA. In this analysis, we identified more than one ATP transporters, such as 
ASNA1, a human homologue of a bacterial arsenite ATP-binding transporter arsA (c. f. 
Table 111-3). Similarly, putative GTPases such as NNP47, NNP51 and NNP57/NGB, are 
proposed to be involved in ribosomal biogenesis (c. f. Figure 111-4 & Table 111-4). 
Proteins rarely operate alone, but usually function together in a network/complex. To 
understand more about how proteins function together in the nucleolus, I proposed a way 
to visualise all the potential binary protein-protein associations within the proteome. 
Taking advantage of the huge amount of data available from the public domain, the 
potential associations were also profiled according to (a) how they are inherited in different 
genomes, (b) where they are expressed and (c) how they are expressed (c. f. Figure 111-6). 
The recent expanse of protein-protein interaction data in yeast, from large scale yeast-two- 
hybrid assays and high throughput mass spectrometry, provides a basis to evaluate the data 
of potential associations within the nucleolus (Gavin et aL, 2002; Ho et aL, 2002). 
Based on the existing data, here I propose a new way to classify proteins related to the 
ribosome within the nucleolar proteome in . rilico 
(c. f. Figure 111-8, Table 111-5 & Table 
111-6). This approach can be seen as an in , dito analogue of an "immunoprecipitation", 
using a set of 20 randomly chosen ribosomal proteins as bait. Within the 400 nucleolar 
proteins, 40% are related to ribosomes, including ribosomal proteins, proteins shown to be 
related to ribosomal biogenesis in human or other model organisms and translation-related 
factors (c. f. Figure 111-3). In our in . rilico 
"pull down", 80% of which have been shown to be 
related to the ribosome, using the same criteria, we achieved therefore a two-fold 
enrichment over random selection. Similar analyses can be used to help classifying large 
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numbers of proteins in other proteomic studies to predict and reveal new protein partners 
either in a complex or along a pathway. However, the caveat of this approach is that it 
requires the related proteins to have a highly coordinated expression in different organisms, 
tissues and growth conditions in order to be considered as part of a complex or 
functioning within a pathway. This coordination may not be necessary especially if 
particular protein is only required in certain species or tissue to enhance functional 
efficiency. For example, this method weighs against those human-specific proteins that are 
known to be related to ribosome such as B23, nucleolin or ribonuclease P subunits. 
Nevertheless, this method may be able to identify the core components of a 
pathway/complex that are related to a specific function. 
Currently, the 3D plot to visualise the potential protein-protein associations has one 
dimension related to the genome, while the other two relate to transcription (c. f. Figure 
111-7). However, the proteome is nothing but dynamic in that it changes at different stages 
of the cell cycle and under different metabolic conditions (c. f. Table III-lb-c). In future, it 
would become more powerful in classification/analyses if data concerning protein copy 
number under different conditions are compared and represented in a separate dimension 
such that three axes are independent from one another and represent the genome, 
transcriptome and proteome, respectively. 
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CHAPTER IV 
DYNAMICS OF 
SUBNUCLEOLAR DOMAINS 
`7n the beginning God created the heavens and the earth. The earth was withorit form, 
and void, and darkness was on the face of the deep. And the Spirit of God was hovering 
otter the face of the waters. Then God said, "Let there be light ; and there was kghi 
And God saw the light, that it wasgood, and God divided the light fmm the darkness" 
Genesis, The Bible 
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IV. Dynamics of Subnucleolar Domains 
IV. 1 Introduction 
As discussed in the last chapter, the protein composition within the nucleolus is very 
complex and the nucleolus is composed of at least 400 members. Yet, the nucleolus is not 
a homogenous soup of proteins; instead it has at least 3 different subnucleolar domains for 
defined functions. The subnucleolar domains, namely the fibrillar centre (FC), the dense 
fibrillar component (DFC) and the granular component (GC) (See Chapter I), were 
originally defined by their morphology and differential staining in the Transmission 
Electron Microscope (rEM). These subcompartments are interlinked: multiple FCs are 
surrounded by the DFC while the GC is the outermost region engulfing the FC/DFC 
regions. Subsequent immunostaining studies, using different antibodies raised against 
nudeolar antigens, have helped to define the functions of these morphologically distinct 
subnucleolar domains. For example, subunits of RNA polymerase I, that are responsible 
for rDNA transcription, and its related transcription initiation and termination factors are 
present in FCs, whilst rRNA processing factors such as fibrillarin, NHPX and GART are 
localised in DFCs and ribosomal proteins and chaperones are found in the GC (reviewed 
in Shaw and Jordan, 1995 and see below Figure IV-1). It was then hypothesised that 
ribosomal DNA transcription took place in FCs (or at the FC/DFC boundary) and that 
rRNA transcripts were subsequently processed and modified in the DFC (Huang, 2002; see 
Chapter I). The processed rRNA transcripts were then assembled with ribosomal proteins 
in the GC to form ribosomal subunits (Shaw and Jordan, 1995). The proposed functions of 
the respective subnudeolar domains are summarised in Table IV-1. 
During interphase nucleoli are stable structural entities which can be isolated in pure form 
for functional studies. However, they are disassembled in the transition from G2 to M 
phase and later precisely re-formed into the defined pattern of subnucleolar domains after 
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Subnucleolar Functions Components tagged 
Domains 
Fibrillar Centre (FC) Ribosomal DNA transcription RPA39 (C/Y/G/G3) 
Dense Fibrillar Component rRNA processing including 2'-O- FIB (C/Y); 
(DFC) methylation and pseudouridylation NHPX (C/Y) 
Granular Component (GC) Ribosomal proteins assemble with B23 (C/Y/Dj 
processed rRNA transcripts with the RL27 (C/Y/D) 
assistance of chaperones. 
Table N-1 Summary of known functions in 3 distinct subnucleolar domains. Column 
'Components tagged' indicates the proteins that were tagged with fluorescent proteins in this 
study C for cyan fluorescent protein, Y for yellow fluorescent protein, G for green 
fluorescent protein, G3 for tandem triple green fluorescent proteins, D for red fluorescent 
protein DsRed2 and * indicates the tagged versions that I have not been able to isolate as 
stable cell lines. 
every cell division in most of the eukaryotes. However, how the subnudeolar domains 
break down and re-form in relation to one another remains unknown. In this chapter, I 
report the use of a battery of HeLa cell lines stably expressing one or more nudeolar 
factors labelling distinct domains to examine (1) the timing of how newly transcribed 
ribosomal RNAs move through nucleoli in living cells and (2) how each subnucleolar 
structural domain disassembles and re-forms dynamically during mitosis. I propose a 
model that explains how the size and the number of nucleoli are defined by the interplay 
between the differential localisation of nudeolar factors and chromatin. 
IV. 2 Generation of HeLa cell lines e4ressing FP-tagged nucleolar factor(s) 
IV. 2.1 HeLa cell lines stably expressing a single FP-tagged nucleolarfactor 
The original definitions of different subnucleolar domains are based on the staining in 
fixed EM samples. In order to study their dynamic properties in living cells, I tagged 5 
different nucleolar proteins as markers for distinct subnucleolar domains, in some cases, 
with 4 different fluorescent protein tags, i. e. Cyan, Yellow, Green and Red (DsRed2) 
fluorescent proteins (Table N-1 and data not shown). 12 different stable HeLa cell lines, 
labelling individual subnudeolar domains with different fluorophores, were thereby 
generated and these are summarised in Table IV-1. The details of the cloning and the cell 
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line generation were documented in Chapter II and an example of 3 cell lines labelling 
distinct subnucleolar domains is illustrated in Figure IV-1. The generated cell lines were 
subsequently characterised with respect to their fluorescent patterns, their cell cycle 
behaviour, their expression levels, their localisation patterns in TEM and, if possible, also at 
the functional level. 
Figure I%*-1 Labelling of the 3 distinct subnucleolar domains in living cells. The pr teins tagged for 
FC, DFC and GC shown here are RPA39, NI IPX and 1323, respectively. The dotted ovals 
define the boundaries of nuclei Most of the DPC components are localised both in nucleoli 
and Cajal bodies (white arrowhead). Some of the GC proteins such as PWPI and ribosomal 
protein RL27 are localised both in nucleoli and the cytoplasm. Scale bar =5 µm. 
The fluorescent pattern of each subnucleolar domain was verified with the corresponding 
antibody staining and, in each case, all showed identical pattern (data not shown; e. g. see 
below Figure IV-7 and Chapter V). In the case of ribosomal protein RL27 and RNA 
polymerase I subunit RPA39, because the cognate antibodies were not available, antibodies 
raised against ribosomal protein RPS6 and RPA20 were used instead, respectively. 
Subsequent TEM studies (the work of Dr. C Lyon) using anti-GFP antibodies 
demonstrated that the FP-tagged ribosomal protein RL27 was found in nucleoli, ER 
membranes and in the cytoplasm, while the FP-tagged polymerase I subunit RPA39 was 
found specifically in fibrillar centres (Figure IV-2A and data not shown). 
To verify that the FP-tagged polymerase I subunit is functional, immunocomplexes 
isolated using anti-GFP antibodies from nuclear extracts of the FP-tagged RPA39 cell line 
were tested in mv for RNA polymerase I activity (Figure IV-213). Indeed, the 
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immunocomplexes isolated from nuclear extracts of the FP-tagged RPA39 cell line 
supported in vitro RNA polymerase I transcription (Figure IV-2B, lanes 3-7) whilst negative 
controls omitting the anti-GFP antibodies during the immunoprecipitation (lane 1), or 
using nuclear extracts of parental HeLa cell (lane 2) did not (The work of Dr. G Miller). 
Because the transcription factors UBF and SL1 were known to be loosely associated with 
RNA polymerase I holoenzyme and may be lost during the immunoprecipitation, the 
addition of recombinant proteins increased the RNA polymerase I activity, further 
strengthening the conclusion that the immunocomplexes specifically contained RNA 
polymerase I transcription activity. (Figure IV-2B, lanes 4-7). It was noted that extracts 
from both the parental HeLa and the FP-tagged RPA39 cell line had similar level of in t hn 
RNA polymerase I transcriptional activity (lanes 8 and 9, respectively). Therefore, because 
both nuclear extracts were active for transcription, while only the immunocomplexes from 
the extract of the FP-tagged RPA39 cell line supported RNA polymerase I-specific 
transcription, I conclude that the FP-tagged polymerase I subunit RPA39 must be 
functional. 
123456789 
pr. G beads +++++++_ 
aGFP -++++++_ 
RPA39 NE +++++++- 
HeLa NE -+------+ SL1 -++++- 
UBF -++ 
A B 
. ý. 
Figure IV-2 Characterisation of FP-RPA39 cell lines. (A) TEINT samples were vnmunolabclled with 
gold conjugated anti-GFI' antibodies and the red arrowhead indicates that FP-RPA39 was 
localised in the FC. Scale bar = 24im (B) In t by RN. polymerase I assay. The green 
arrowhead indicates the presence of specific transcription product. For assays involving 
imrnunopreeipitation, anti-GIP antibodies (aGFP) were coupled to protein-(, heads (pr. C 
beads) and used for immunoprecipitations from I Isla nuclear extracts (I icl a NE) or the 
nuclear extract made from Ilela cells stably expressing I'I'-RP: \39 (RPA39 NE). The 
immunoprecipitates were washed with 13BS thrice prior to performing the in iilm assays (see 
Miller et al., 2001 for details). 
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Examining the DNA content of the cells by FACS analyses had shown that, for all cell 
lines tested, the FP-tagged proteins did not block cell cycle progression. The 
characterisations of the cell lines are summarised in Table IV-2. A detailed example of cell 
line characterisation is also illustrated for FP-tagged NHPX in Chapter V. 
Cell line Immunostaining FACS Expression TEM 
RPA39 
FIB ' ND 4 
NHPX ND 
B23 
RL27 0 ND - 
'I 
Table N-2 Characterisation of HeLa cell lines expressing FP-tagged nucleolar 
proteins. Related antibodies were used for immunofluorescence studies if the 
antibody raised against a particular antigen was not available as detailed in text 
and indicated here as (1 . The expression of fluorescent protein tagged RPA39 
was examined with a RNA polymerase I transcription assay as detailed in text A 
tick under a column indicates the assay has been performed for the cell line 
indicated on the left `ND' indicates the result for the assay on that column was 
not determined '-' indicates that the experiment is not possible due to the 
unavailability of the reagents. 
1 V. 2.2 Generation of HeLa cell line r expressing more than one FP-tagged marker 
To observe more precisely how distinct subnucleolar domains move in live cells, both in 
relation to one another and to chromatin, I generated 12 HeLa cell lines stably expressing 
either two different FP-tagged nucleolar factors, or one FP-tagged nucleolar factor and FP- 
tagged histone H2B. The cell lines generated are summarised in Table IV-3. 
Parental 2nd expression I Parental 2nd expression 
ECFP-B23 EYFP-H2B EYFP-RPA39 ECFP-FIB 
ECFP-B23 EYFP-FIB EYFP-RPA39 ECFP-112B 
EYFP-B23 ECFP-H2B EGFP-RPA39 EYFP-112B 
EYFP-FIB ECFP-1-12B ECFP-RPA39 EYFP-112B 
ECFP-FIB EYFP-H2B ECFP-RPA39 EYFP-FIB 
ECFP-FIB EYFP-B23 ECFP-RPA39 EYFP-B23 
Table IV-3 Stable cell lines with double constructs generated in this study. 'Parental' 
HeLa cell line expressing a single construct was transfected with it '2-d expression' 
vector. See text for details. The analyses of the pairs shown in bold have been 
described in this chapter. 
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Briefly, a `parental' HeLa cell line grown in G418-containing medium and expressing a 
single FP-tagged nucleolar factor was transfected with a second construct as described in 
Table IV-3 using effectene (QIAGEN; Chapter II). After 48 hours of transfection, 
transfected cells were selected by treatment with the additional antibiotic blasticidin and 
subcloned as described in Chapter II for generating a HeLa cell line expressing a single 
construct The strategy for generating a HeLa cell line expressing two constructs (or 
hereafter `double stable' for simplicity) is summarised in Figure IV-3. Although the full 
characterisation of every cell line has not been performed yet, we are confident that the 
tagged proteins behave as their endogenous counterparts, based on our previous 
characterisation on the HeLa cell lines stably expressing the corresponding single construct 
alone. 
Transfection 
& Selection 
Intl 
Subcloning 
il&tzl' 
14, wt. 1 A. 
Enrichment 
I 
;% 
Figure N-3 Scheme of generating a `double stable'. The FP-cxpressing, 6418-resistant 1 Icl. a cells 
were transfected with a construct expressing either another FP-tagged nucleolar factor or FP- 
tagged histone I-12B. After 48 hours of transfection, the cells were selected with blasticidin 
and G418. Individual double antibiotic-resistant colonies were selected and picked manually 
under the fluorescence microscope to ensure that both IT-tagged proteins were localised 
property. Cell lines with suitable fluorescent intensities were used for live cell studies. 
1& Selection 
Set^ 
Subcloning 
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IV. 3 Timing of vectorial transport of rRNA transcripts 
To understand how rRNA transcripts move from their transcription sites, I used a method 
of BrUTP incorporation that was developed by Dr. YW Lam in our laboratory to label the 
transcripts in living cells (Figure IV-4). This method differs from those previously 
described for permeabilised cells in that it allows BrUTP to be delivered across the cell 
membrane by a mild hypotonic treatment while maintaining cell viability (see legend of 
Figure IV-4 for the method details). 
BrUTP incorporation experiments were performed in parallel on 3 stable cell lines, 
expressing markers for the FC (EYFP-RPA39), the DFC (E'YFP-FIB) and the GC (EYFP- 
RL27), respectively. This is to ensure that the experiments were performed under the same 
growth and fixation conditions and the images collected can therefore be correlated with 
one another with respect to the timing of incorporation (Figure IV-4). The ribosomal 
transcripts incorporating BrUTP were mostly localised outside the FC (Figure IV-4A) but 
within the boundaries of the DFC at 6 minutes after labelling (Figure IV-4B). Analysis of 
earlier time points was not possible partly due to the constraints of the incubation 
procedures and partly due to the low signal intensity; hence we could not currently 
determine the precise site of transcription. The labelled transcripts have already started to 
move out from the DFC at 10 minutes (Figure IV-4B). At 20 minutes after labelling, 
BrUTP was visualised near to the inner boundaries of the GC and was already completely 
colocalised with the GC at 1 hour (Figure IV-4C). Cytoplasmic BrUTP staining was 
observed at a later time point (3 hours; data not shown) and this suggests that the BrUTP 
incorporated transcripts are, by this time point, likely to be processed and assembled into 
ribosomes. From these time-course experiments, it appears that the ribosomal transcripts 
move vectorially from their transcription sites (FC) towards the processing sites (DFC) and 
then assembly sites (GC) in an orderly fashion in vivo. 
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A 
t=6min 
B 
t=6min 
t=10min 
C 
t=20min 
t=60min 
Figure IV'- Vectorial movement of rRNA transcript. The subnucleotar domains (. 1) FC, (11) DFC and 
(C) GC were labelled by E) P-RP: A39, EY P-FI13 and FN'l P-81.27 respectively. 'Ehe 
middle panel illustrates the localisation of accumulated BrU'IP at the defined times and the 
patterns of incorporation within nucleoli are shown in detail in the corresponding insets. 
Coverslips seeded with Hela cells were rinsed with hypotonic KI I buffer (30mM KCI, 
10mM HEPES pl-I7.4) briefly and incubated with 50µl KI I buffer containing 10mM Brl1TP 
(Sigma) for 5 minutes in a 5% CO2 incubator at 37ýC. The cells on eoverslips were 'chased' 
with DMEM with 20% FCS and G418 for a defined time (0,6,10,15,20,60 and 180 
minutes) in the incubator to chase the transcripts before fixation. Prior to methanol fixation 
for 20 minutes at -2(}1C, the covcrshps were rinsed with PBS. 'Ehe cells were then 
permeabilised with acetone for 30 seconds and air-dried for 10 minutes, followed by 
rehydration with PBS for 5 minutes and immunosraining using the anti-ßrdU (1: 5) antibody. 
The conditions developed for this method preferentially label the ribosomal transcripts, with 
a low visible level of RNA Polymerasc 11 transcripts especially at shorter time points. 
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IV. 4 On breakdown and biogene is daring mitosis 
I V. 4.1 DFC and GC breakdown 
In order to dissect the timing of the dynamic breakdown and biogenesis of the 3 
subnucleolar domains, in relation both to one another and to chromatin, a third vector was 
transiently transfected into some of the double stables generated with either a DsRed2- 
tagged nucleolar component or a diHcRed-tagged histone H2B. Four sets of '7- 
Dimensional' experiments (3D+Time+2 extra wavelengths+DIC) are presented here to 
delineate the relationship between each subnucleolar domain (Table IV-4). 
ECFP IINFP RFP(dilk RI U. RcýI2)* 
li I'M 
HB 
B23 I 11< 11213 
11'__i It I, 
-, 
- 
Table IV-4 Summary of triple-labelling time series experiments to delineate the 
timing of breakdown and re-formation of nucleoli during mitosis. 'I'hc 
construct for transient transfection was either ditIcRcd-i12B (tandem IIcRed- 
H2B) or DsRed2-RL27. Only 2 particular double stable pairs were selected out of 
the 12 as these two provided the highest intensity with the minimum laser power 
required. 
The 7D experiments presented here, unless otherwise specified, were carried out on a Zeiss 
LSM510 confocal microscope in Dr. Jan Ellenberg's laboratory (EMBL, Heidelberg), 
supported through a short-term EurALMF fellowship I received in the Spring 2(K)2. 
Because mitosis is both a light-sensitive and temperature-sensitive process, 2 double stable 
cell lines of sufficient brightness were chosen to minimise the power of laser illuminated 
while maintaining a high signal-to-noise ratio. The cells were grown in a CO, -independent 
imaging medium containing 0.5mg/ml L-ascorbic acid and 20%FCS for optimal growth 
and the imaging was performed using a temperature-regulated stage at 37°C. 
When a cell is ready to enter M-phase, the first visible indicator is that the chromosomes 
become progressively condensed (prophase). Due to the requirement for a chromosomal 
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marker (diHcRed-H2B) to distinguish early prophase cells, it was not possible to compare 
all 3 subnucleolar domains in the same cell. This is because there are only 3 spectra- 
distinguishable live cell fluorophores currently available and thus two sets of 7D 
experiments were performed to study two subnucleolar domains each time. Figure IV-5 
and Figure IV-6 show two examples of a triple labelling 3D time series studying the timing 
of the nucleolar breakdown and reassembly during mitosis. In both cases, the double 
stables were transiently transfected with diHcRed-H2B for 24 hours before imaging. 
It is apparent that each subnucleolar compartment remained intact while the chromosomes 
condensed (Figure IV-5,00: 00-14: 30 and Figure IV-6,00: 00-06: 04). Possibly, when FCs 
disappear (Figure IV-6,06: 04-09: 26), both DFCs and GCs disappeared together within a 
short period of time around 10 minutes (Figure N-5,22: 54-31: 48 and Figure N-6,09: 26- 
19: 54). I noted that immediately after the disappearance of FCs, represented by FP-tagged 
RNA polymerase I subunit RPA39, the DFC lost their characteristic punctate pattern 
(Figure IV 6,06: 04-09: 26; c. £ Figure IV 1). Whether such immediate nucleolar breakdown 
is due to either the degradation of the factors, or their diffusions to the extranucleolar pool, 
remains to be determined. 
In contrast with breakdown, the re-formation of both the DFC and GC compartments 
proceeded at different rates. DFC re-formed at around 5 minutes after anaphase, when the 
condensed chromosomes segregated to opposite poles (Figure N-5,50: 52-60: 53), whilst 
the GC took at least 20 minutes more before it reappeared (Figure IV-5,50: 52-80: 40). Both 
timings are also different from the relocation of the RNA polymerase I subunit RPA39 
after mitosis, as illustrated in Figure IV-7. 
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I V. 4.2 Structural and dynamic FC componentr 
Surprisingly, the polymerase I subunit RPA39 did not remain associated with 
chromosomes at all stages during mitosis, as previously reported (Figure IV-7A, 00: 00- 
42: 30; c. f. Scheer and Rose, 1984; Gilbert et al., 1995). Instead, the original spots diffused 
to the cellular pool during mitosis and did not re-form to spot-like structures (FC) until late 
metaphase (white arrow, Figure IV-7B). The number of FCs increased dramatically 
towards the end of telophase (Figure IV-7A, lowest panel). The dynamics during mitosis 
remained the same even when the same subunit was tagged with tandem triple EGFPs at 
the N-terminus to increase the resolution (data not shown). The same results were 
obtained both using a laser-scanning confocal microscope (Zeiss; data not shown) and a 
widefield epifluorescence deconvolution microscope (DeltaVision; Figure IV-7). 
Therefore, I next investigate whether other FC proteins also behaved in this manner. I 
examined the localisation of the transcription factor UBF and compared this with the 
localisation of EYFP-RPA39 and another endogenous RNA polymerase I subunit using a 
monoclonal antibody, B6-2 (Figure IV-7C). During interphase, EYFP-RPA39, the 
endogenous RNA polymerase I and UBF colocalised in FCs (Figure IV-7C, upper). 
However, only UBF was observed to remain in spot-like structures (possibly the NORs) 
during metaphase, but neither the FP-RPA39 nor the other endogenous polymerase 
subunit showed this pattern (Figure IV-7C, lower). This suggests that although both UBF 
and RNA polymerase I subunits localised in the FC during interphase, they may have 
different dynamic properties during mitosis. 
Figure N-7 A core subunit of polymerase I does not associate with chromosomes during mitosis. 
(A) A time series of maximal projection imaging of the EYFP-RPA39 cell line from early 
prophase until G1. The images shown are maximal projections of the whole Z-series and 
they are taken by a DeltaVision wide-field Deconvolution microscope; every time frame =3 
minutes. (B) The same series between early anaphase and telophase are shown in detail; every 
time frame = 30 seconds and each image is a maximal projection between a defined depth as 
indicated on the right White arrows followed the formation of a newly re-formed spot-like 
structure containing RNA polymerase I subunit (C) Comparison between UBF and RNA 
polymerase I subunit using EYFP-RPA39 (FP-RPA39) and monoclonal antibody B6-2 raised 
against RPA20 during interphase (upper) and metaphase (lower). Scale bar =5 µm. 
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In summary, when nucleoli break down, UBF remains associated with the chromosomes 
during all stages of mitosis, while RNA polymerase I subunits leave the chromosomes at a 
certain point during prophase, after the chromosomes begin to condense. This in turn is 
followed by the dissolution of the DFC and GC compartments in a short period of time. 
IV.. 4.3 Djnamicpropertiet q (a RNA polymerase I subunit 
The behaviour of RNA polymerase I subunit RPA39 during mitosis prompted me to 
investigate the dynamics of recruitment of RNA polymerase I components to endogenous 
ribosomal genes during interphase using fluorescence recovery after photobleaching 
(FRAP) analysis (Figure IV-8). Sites of rDNA transcription (FC) in cells expressing the 
tandem triple EGFPx3-RPA39 were bleached with the use of a short laser pulse that 
irreversibly quenches the GFP signal. The recovery of the signal in the bleached area 
(Figure IV-8, upper panel, blue open circle) and the loss of the signal in another FC of a 
different nucleolus (Figure N-8, upper panel, red open circle) were recorded by time-lapse 
confocal microscopy. 
The recovery is a biphasic process with a fast kinetic phase of 10s followed by a slow phase 
taking about 300s. The slow latter exchange phase possibly represents the transcribing 
RNA polymerases (Figure IV-8, lower panel) whilst the fast exchange may represent the 
diffusible RNA polymerases at that region. This behaviour was also observed in a recent 
study of dynamics of other RNA polymerase I subunits (Dundr et aL, 2002). Similar results 
were obtained from another HeLa cell line stably expressing a single ECFP-tagged RPA39 
(data not shown) and hence the slow process was not due to the additional copies of 
fluorescent protein tags in the tandem triple EGFPx3-RPA39 cell line. Moreover, I 
conclude that the RNA polymerase subunit travels from one FC to another continuously 
through the nucleoplasm, as indicated by the loss of fluorescence level in the FC of 
another nucleolus marked by a red open circle, whilst the fluorescence level in the FC 
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Figure IV-8 FRAI' of RNA polymerase I subunit RPA39. Cells expressing EGFPx3-RPA39 were 
imaged before and after photobleaching of the FC inside the nucleolus. The bleached area is 
indicated by a blue open circle. Both the fluorescence recovery in the bleached FC and the 
loss of fluorescence in another FC (red open circle) were monitored. The time after 
photobleaching is indicated on the corresponding upper panel image and the quantitation of 
recovery kinetics is represented on the lower panel. Relative intensity is defined as the 
intensity compared with the pre-bleach image after subtracting the background. The initial 
use of the fluorescence loss curve for the FC marked by a red open circle is due to the 
decrease in total fluorescence after photobleaching. Scale bar =5 µm. 
marked in blue recovered after photobleaching. It is apparent that the majority of FP- 
RPA39 molecules localised in the FC are likely in a transcriptionally active state, and only a 
small number of them are diffusible (Figure IV-8, lower panel; Dundr et al, 2002). Hence, 
the disappearance of RNA polymerase I in the FC/NOR (defined by UBF staining in 
Figure IV-7C) may be explained by the halt of transcription activities during mitosis. 
I V. 4.4 Establishment of nucleoli 
The resumption of transcription activities was inferred by the immediate re-formation of 
FCs post mitosis (Figure IV-7B & Figure IV-9). Interestingly, although both daughter cells 
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B 
Figure IV-9 Nucleolar reassembly. HeLa cells stably expressing both ECFP-FIB and EYTP-RP: \39 
were transiently transfected with DsRed2-RL27 and imaged after 24 hours. (A) Metaphase 
cells were located under the microscope using transmission light and images were taken every 
2-3 minutes. The series consists of the maximal projections of part of the experiments and 
the whole series can be found in movie IV-9 in the supplementary CD. Time indicated = 
min: sec. Scale bar = 5µm. (B) Differential localisations of the DFC and the GC with regard 
to the FC at an early stage of reassembly from an area denoted by a white square at t=08: 22 
in panel A. Arrowheads indicate the colocalisation of the RNA polymerase I subunit W: \39 
and the RNA processing factor fibrillarin. Scale bar =I sm. 
received identical genome, not only did the FCs appear at different times in each cell but 
also the number of FCs were different (Figure IV-9A, first row). It appears therefore that 
the process of reactivation of rDNA loci and the subsequent formation of FCs is 
stochastic. 
As noted earlier, FCs appeared just after the chromosomes segregated and DFCs appeared 
roughly 5 minutes later (Figure IV-5,50: 52-60: 53 & Figure IV-9A, white arrowheads in 
first and second row). Fibrillarin relocated mostly around chromosomes as spot like 
structures once the chromosomes were segregated (Figure IV-9A, 02: 09-04: 13) and some 
of them immediately surrounded any available FCs (Figure IV-9B, right half). Previous 
studies have described the structures represented by fibrillarin at this early stage termed as 
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prenucleolar bodies (or PNB; see Chapter 1). As previous studies are mostly performed on 
fixed cell studies, it is impossible to correlate two subnucleolar compartments temporally. 
Therefore, it may underestimate the connection existing between RNA polymerase I (FC) 
and RNA processing factors (DFC) at this stage as revealed in Figure IV-9B (right half, 
yellow arrowheads), in which both subnudeolar compartments are studied concurrently in 
live cells. 
However, at the same time, B23 and RL27 formed discrete bodies away from such 
prenudeolar structures (defined by FC and DFC markers) even though they were already 
re-imported into the nucleus after mitosis (Figure IV-9B, left half & Figure IV-10). At this 
stage, these discrete bodies never fused to the FC/DFC centres (Figure N-10); yet both 
non-ribosomal protein B23 and ribosomal protein RL27 located in the same non-nudeolar 
structures (for example, Figure IV-10 at 33: 22). 
As the number of FCs increased dramatically after the chromosomes segregated (Figure 
IV-7 & Figure N-9), the area of surrounding DFCs increased correspondingly (Figure 
N-9). At a certain stage the area occupied by a DFC overlapped with a neighbouring DFC 
and merged into one (Figure IV-10, white arrows at second row). As the re-formation of 
nucleoli carried on (at about 25 minutes after anaphase), the GC began to coat the 
FC/DFC centres (Figure IV-5, Figure IV-9 & Figure IV-10). Consequently, as the 
FC/DFC centres expanded and merged, the GC area increased and started to merge with 
neighbouring GCs (e. g. Figure IV-10 white arrows at third row between 16: 42-26: 42). 
Surprisingly, though both daughter cells acquired identical copies of the genome, both the 
number and size of nucleoli were different from one another (Figure IV-5, Figure IV-9 & 
Figure IV 10). Whether this is typical for all cells or a specific property of transformed cell 
lines remains to be determined. Note that although the images presented here are maximal 
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projections, the difference in the number of nucleoli between the two daughter cells has 
been checked and verified with the 3D datasets and by DIC images. 
I V. 4.5 Nucleolar Fusion 
Treatment of cells with the RNA polymerase II transcription inhibitor 5,6-dichloro-D- 
ribofuranosylbenzimidazole (DRB) reversibly causes nucleolar structural disruption and 
dispersal of DNA components inside the nucleolus, including rDNA and satellite 
sequences to single ribosomal transcription units (Scheer et al., 1984; Haaf et aL, 1991; 
Junera et al., 1995; Haaf and Ward, 1996). Nucleoli are re-formed after DRB is washed out 
within 1-2 hours. Therefore, this provides a good experimental window to study in detail 
how nucleoli re-form in vivo (Figure N-11). 
HeLa double stables expressing ECFP-FIB and EYFP-H2B were transiently transfected 
with diHcRed-H2B and treated with 100µM DRB for 10 hours before imaging. In 
interphase nuclei of mammalian cells, chromosomes are positioned non-randomly relative 
to the nuclear periphery according either to gene density or size (see Chapter 1). To study 
how the dispersed nucleolus re-forms, a mark is required for orienting the cells while the 
nuclei are reorganising within a live cell. The criterion for such a mark is that it should be 
stable enough not to be affected by cell movements and nuclear rotations. Therefore, FP- 
tagged histone H2B is a suitable candidate as it is stably associated with chromosomes 
(about 4 hours), according to the recent FRAP data (Phair and Misteli, 2000; Mistelf, 2001). 
The idea behind this is to label an area by irreversibly photobleaching one type of FP- 
tagged H2B while the photobleached region can be counter-revealed by the same histone, 
but one tagged with a different FP (Figure IV-11, prebleach; dotted lines surround the 
photobleached region). This is immediately followed by washing out DRB to observe the 
re-formation of nucleoli in relation to neighbouring chromatin (Figure IV-11, prebleach). 
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After the DRB treatment, fibrillarin became dispersed into the nucleoplasm with 
concentrated regions observed throughout the nucleus (Figure IV-11, arrowheads in 
prebleach). One-fifth of the nuclear chromatin was labelled near two such concentrated 
regions with a square photobleach mark (Figure N-11, green arrowheads at 00: 00). It 
should be noted that the ribosomal transcription was not affected by the addition of DRB 
and the fibrillarin concentrating regions contained one or more FCs (Scheer et al., 1984; 
Haaf et al., 1991; Junera et al., 1995 and data not shown). Once DRB were washed out, the 
fibrillarin-concentrating regions fused with one another (Figure IV-11, green and red 
arrowheads). The global organisation of the chromatin is relatively stable as shown by the 
relatively unchanged shape of the photobleach mark compared to the reorganisation of the 
nucleolar factors. Interestingly, I often observed that there were interchromosomal spaces 
before the neighbouring nucleoli were fused together as deduced from the staining by H2B 
(Figure IV-11, corresponding green and red arrows indicate the interchromosomal spaces). 
IV. 5 Discussion 
In this chapter, I reported using a battery of 24 HeLa cell lines expressing one or more 
nudeolar factors to study how nucleoli break down and re-form in live cells by labelling 3 
distinct subnucleolar domains and chromatin. The breakdown of the nucleoli began when 
RNA polymerase I left FCs (c. f. Figure IV 6). This finding apparently contradicts previous 
studies using fixed cells, which suggested that RNA polymerase I subunits were associated 
with the chromosomes at the NORs during all stages of mitosis (Scheer and Rose, 1984; 
Gilbert et al., 1995). However, according to this work, it seems that there exists a window 
between prophase and metaphase where RNA polymerase I does not localise at the NORs 
during mitosis. Also, I have shown that (1) the FP-tagged RNA polymerase I subunit 
behaved properly, both in terms of its localisation at the TEM level and its functional 
activity at the biochemical level (c. f. Figure IV-2) and (2) confirmed the non-association 
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with the chromosome during mitosis with antibodies staining another endogenous RNA 
polymerase I subunit (Figure IV-7c and data not shown). These data correlate well with the 
FRAP data I have obtained showing that most of the FP-RPA39 molecules localised in 
FCs are likely actively transcribing (Figure IV-8). The dissociation of RNA polymerase I 
from chromosomes may provide another level for regulating the transcriptional repression 
during mitosis. However, as shown by this and other studies (Roussel et al., 1993; 
Zatsepina et al, 1993; Gebrane-Younes et al., 1997), the transcription factor UBF remained 
associated with the NORs throughout mitosis. This may be due to its binding to multiple 
regions in the rDNA locus, including promoters, transcribed sequences and intergenic 
spacers (O'Sullivan et aL, 2002). 
The absence of RNA polymerase I in FCs between prophase and metaphase was in turn 
followed by the immediate breakdown of the DFCs and GCs within a short period of time 
(c. £ Figure IV-5 & Figure IV-6). The breakdown itself is not the result of chromosome 
condensation (c. f. Figure IV-5). However, it is observed at a similar period when the 
nuclear envelope breaks down (Beaudouin et al., 2002; Burke and Ellenberg, 2002) and, in 
this case, the timing of nuclear envelope breakdown and nudeolar disassembly is strikingly 
similar. Whether nucleolar disassembly is functionally linked to the nuclear envelope 
breakdown remains to be determined. Previous studies suggested that the cyclin B-cdkl 
kinase, the enzyme partly responsible for nuclear envelope breakdown, is also responsible 
for phosphorylation of RNA polymerase I specific transcription factors, UBF and SL1, to 
inhibit mitotic transcription (Klein and Grummt, 1999; Tuan et aL, 1999). However, 
whatever event(s) happened during this period, it must trigger the dissociation of RNA 
polymerase I complexes from FC and the subsequent DFC/GC breakdown in a short 
period of time. 
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Reassembly of nucleoli, in contrast with breakdown, seems to be more hierarchical and the 
timing of nucleolar re-formation was comparable with how pre-rRNA transcripts 
progressed through nucleoli during interphase (c. f. Figure IV-4 & Figure IV-9A). It began 
with the reassociation of RNA polymerase I to the NORs and the rapid increase in number 
of FCs towards telophase. Whether transcription begins at the same time as the association 
remains to be established. As soon as the chromosomes segregated, fibrillarin, a 
component of the DFC, reimported into the re-forming nucleus, appearing as multiple 
spots. Previous studies have suggested that fibrillarin was localised in a transient structure 
known as prenudeolar body (PNB) at this stage (Dundr et at, 2000; Savino et at, 2001). 
The PNB was suggested as a site of temporary storage when nucleolar re-formation was 
inhibited by the addition of anti-RNA polymerase I antibodies to mitotic cells (Benavente 
et at, 1987). However, I observed here that many of these spot-like structures were already 
associated with RNA polymerase I containing sites (c. f. Figure IV 9B). As these RNA 
polymerase I containing sites are rapidly fusing with one another to form the core of the 
FC and the fibrillarin containing spots fuse to form the DFC (c. f. Figure IV-9A), it is 
impossible to predict precisely whether during normal cell cycle progression RNA 
processing factors like fibrillarin are temporarily stored as defined structures, prior to their 
association with the FC. 
On the other hand, there are discrete non-nucleolar structures containing B23/RL27 that 
did not associate with the re-forming nucleoli at an early stage of nuclear re-formation (c. f. 
Figure IV-10). Such structures are similar to those foci that also contained pre-rRNAs 
synthesised at the G2/M phase of the previous cell cycle (Dousset et al., 2000). It is noted 
that DRB unravels the compact nucleoli to a necklace-like structure containing 
components from the FC and the DFC, while GC components disperse into the 
nucleoplasm, although ribosome biogenesis continue (Scheer et al., 1984). This suggests 
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that the association of GCs with the FC/DFC regions is not a prerequisite for ribosomal 
synthesis and it is tempting to speculate that these transient structures may be capable of 
assembling new ribosomes outside the nucleolus from existing, processed pre-rRNAs. 
Recent FRAP analyses have indicated that the nucleolar factors, including RNA 
polymerase I subunits, transcription factors, RNA processing factors, chaperones and 
ribosomal proteins, are continually cycling between nucleoli and the nucleoplasm (Dundr 
et aL, 2000; Phair and Misteli, 2000; Chen and Huang, 2001 and also Figure IV-8). The 
accumulation of these proteins at a specific nuclear structure is most likely due to ongoing 
molecular interactions. Pre-rRNA transcripts are a likely candidate for mediating such 
interactions in the re-formation of nucleoli after mitosis. The order of nucleolar re- 
formation is very similar to the timing of how pre-rRNA transcripts travel from the FC via 
the DFC to the GC during interphase (5 minutes for the DFC and 30 minutes for the GC; 
Thiry et al., 2000 and this work). It should be noted that it is the actual rRNA transcripts, 
rather than the rRNA transcription, that is more important for the re-formation of nucleoli 
(Dousset et at, 2000; Verheggen et al., 2000). For example, the recruitment of the rRNA 
processing machineries to the nucleolus is dependent on the recruitment of maternal pre- 
rRNAs, during Xenopus laevis embryogenesis, but independent of either zygotic rRNA 
transcription, or the presence of RNA polymerase I itself (Verheggen et at, 2000). 
Similarly, nucleoli can be re-formed from the pre-rRNAs synthesised from the previous 
cell cycle, even when a low amount of Actinomycin D was added to specifically inhibit 
RNA polymerase I transcription after mitosis (Dousset et al., 2000). Nevertheless, once 
transcription resumes after mitosis, the newly made transcripts may make a primary 
contribution to the physiological re-formation of nucleoli in dividing cells. 
But what determines the number and size of nucleoli? From this study, it is surprising to 
find that the two daughter cells differed in both the number and size of nucleoli after 
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mitosis (c. f. Figure IV-5, Figure N-9 & Figure IV-10). If the localisation of RNA 
polymerase I indicates the site of transcription (Scheer et aL, 1984; Haaf et aL, 1991), 
reactivation of transcription seems to take place in different nuclear locations after mitosis 
in respective daughter cells. This stochastic behaviour and the subsequent re-formation of 
the DFC/GC around such FCs may partly explain the differences within the pair of 
daughter cells. On the other hand, an interchromosomal space in between two nucleoli 
appears to be a prerequisite for the fusion event (Figure IV-11). Recent studies by Chubb 
et al suggested that the mobility of the chromatin near nucleoli is constrained during 
interphase. This constraint is released when cells are treated with DRB, but is resumed 
within 1-4 hours after the washout of DRB (Chubb et al., 2002). The increase in the 
number of cavities between chromosomes (interchromosomal space; c. £ Figure IV-11, 
prebleach) may be reflected in the increased chromosomal mobility when DRB is added. 
As many nucleolar proteins are continually exchanging between nucleoli and the 
nucleoplasm, such nucleolar proteins are constantly exploring the available 
interchromosomal space. Because the resolution of FRAP analyses does not reach the 
molecular level, the results represent the sum of movement of molecules in all of their 
possible forms: ie. bound, free, activated or inactivated. Therefore, the mobility of a 
substrate-bound complexed form may be overestimated in the current FRAP analyses. The 
fact that the diffusion rate is at least 10 fold lower in nucleoli than in the nucleoplasm may 
partly account for the differences in free and substrate-bound forms (Phair and Misteli, 
2000) and hence the proteins accumulate to areas where they find their molecular partners 
to perform specific functions. This may explain what happens when DRB is added to cells, 
which results in an increase in the available interchromosomal space (Figure IV-11, 
prebleach). As there is more interchromosmal space for nucleolar proteins to explore, the 
once compact nucleoli unravel to single transcription units and this results in the typical 
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appearance of necklace-like structures (Scheer et al., 1984; Haaf et at., 1991). Therefore, the 
number and size of nucleoli may be determined by the interplay between the 
interchromosomal space available and molecular diffusion rates of the nucleolar proteins, 
which decrease as a result of molecular interactions and hence localise nucleolar factors 
around the substrate, i. e. the pre-rRNA transcript. 
Although in this model, `self-organisation' is likely to have happened during nucleolar re- 
formation, it does not explain why isolated nucleoli that are transcriptionally active would 
not fall apart if all components are continually roaming in and out of nucleoli (Cheutin et 
al, 2002). It is likely that there may be some `adhesive elements' to maintain the structures. 
The high abundance of the proteins with RNA binding protein signature motifs RR[GR] 
(-30%) and RNA recognition motif RRM (-10%) and the protein-protein interaction 
domains WD (-5%) in the human nudeolar proteome, as deduced from Chapter III, 
suggests that RNA-protein and protein-protein interactions are crucial and they may play a 
part in maintaining the structural stability of the nucleolus. 
It is interesting to draw a parallel between nucleolar re-formation and the cell sorting 
mechanisms. When randomly mixed, disaggregated neural cells from frog embryos 
aggregate into the most compact form, i. e. a sphere, and then sort themselves into a pattern 
resembling the original tissue, with ectoderm surrounding the endoderm (Townes and 
Holtfreter, 1955). Many different cells sort similarly and this was explained by their 
inherent differences in adhesiveness to one another. The random movement creates initial 
contacts, while only those cells adhering strongly stay together, resulting in the distinctive 
clustering of cell types (Steinberg, 1964, Armstrong, 1989). Similarly, the nucleolar proteins 
may roam around the nucleus, by diffusion to find their substrates, while the resulting 
structures formed are maintained by `adhesive elements'. The molecular nature of such 
`adhesive elements' remains to be characterised. 
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During the cell cycle, chromosomal mobility was shown to be high during early G1 when 
chromosomes undergo considerable rearrangements (Neun et al., 2001 and Chubb, J. R. , 
personal communication). The re-initiation of RNA polymerase I transcription post 
mitosis generates new centres of substrates at the NOR-containing chromosomes (Figure 
IV-12). Subsequent localisations of RNA processing factors, chaperones and ribosomal 
proteins around the different processed forms of rRNA transcripts results in the apparent 
reassembly of nucleoli. The order of reappearance of different subnucleolar domains is 
hierarchical because the different processed forms of rRNA transcripts are available at 
different times as the transcripts are subsequently modified. The differences in nucleolar 
F ý' 
i DFC assembly 
Stochastic localisations of 
RNA polcmcrase i 
r' 
, 
ýý 
C; C assembly 
Difference in apparent number and size 
of nucleoli between daughter cells 
FC/DI--C centres determined by interplay 
between interchromosomal space 
and localisation of factors 
Figure IV-12 Model of nucleologenesis. After mitosis, the cells resume RNA transcription as shown by 
the stochastic localisation of RNA polymerase I within the nucleolus (this study). round 5 
minutes after the pre-rRNA is transcribed, the DFC appears. Though most of the nucleolar 
factors examined so far constantly exchanged with the nucleoplasm, the factors are 
accumulated to where the molecular interaction occurs, i. e. around the pre-rRN. \ transcript. 
However, the chromosomes present physical barriers for the localisation of nucleolar factors 
around the substrate and hence this may cause the differences in the number and size of 
nucleoli even within a pair of daughter cells during early (: 1. 
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re-formation in respective daughter cells may be partly explained by slight local differences 
in the non-random positioning of chromosomes between daughter cells. In other words, 
the chromatin between two nucleoli may present a temporal, yet physical, barrier for 
nucleolar fusions. The barriers are temporal because the chromosomes are dynamic and 
the interchromosomal spaces may change in response to different states of gene 
expression. 
Currently, it remains unclear why the number and size of nucleoli increase dramatically in 
some malignant cells (Derenzini et at, 2000). Are any of the 400 or more components 
identified in the nucleolar proteome responsible for the change in the number and site of 
nucleoli? Or is it the result of the differential state of surrounding chromatin? The current 
system may provide a means to analyse and understand nucleolar formation in cancer cells 
and hence answer these questions. 
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V. A Novel Nucleolar Targeting Pathway 
V. 1 Introduction 
The cell nucleus is the site where chromosomes are located and where DNA replication 
and gene expression are coordinated and regulated. Many nuclear factors are organized into 
specific structures termed "nuclear bodies/domains" (See Chapter I). Most subnuclear 
structures are dynamic, disassembling on entry to M phase and reassembling after mitosis 
as illustrated in the previous chapter. Unlike cytoplasmic organelles, subnuclear structures 
are not enclosed by membranes. Factors can move in and out of subnuclear structures 
(Misteli, 2001); and the bodies themselves can also move within the nucleoplasm 
(Boudonck et al., 1999; Platani et al., 2000; Snaar et al., 2000; Muratani et at., 2001). So, 
how do proteins know where to localise? 
The nucleus is separated by the nuclear envelope from the cytoplasm, where translation 
occurs (Burke and Ellenberg, 2002; Hetzer et aL, 2002). To enter nuclei, proteins 
containing nuclear localisation signals (NIS, usually one or more stretch of basic amino 
acids) are actively transported inward through the nuclear pore complexes by nuclear 
import receptors (Weis, 2002). The GTPase Ran creates a GTP/GDP gradient across the 
nuclear membrane during interphase and provides the directionality for nuclear transport. 
However, once proteins get into nuclei, how they localise to particular subnuclear structure 
remains unclear. Previous studies have shown that there are several nudeolar targeting 
signals identified (Hatanaka, 1990). The signals were shown to direct exogenous protein to 
nucleoli and are essential for function. For example, the proper localisation signal of 
adenovirus protein V, KKEEQDYKPRKLKRVKKKKK, is essential for viral replication 
(Okuwak et al., 2001). However, the mechanism behind how these signals function 
remained unclear. 
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The advent of green fluorescent protein (GFP) technology allows the visualisation of 
tagged proteins and their movement in living cells (Swedlow and Lamond, 2001). The use 
of photobleaching techniques with the GFP fusion proteins also allows analysis of protein 
dynamics (Phair and Misteli, 2001; Reits and Neefjes, 2001). In this chapter, I describe a 
novel nucleolar targeting pathway shown by the nucleolar factor NHPX, in which NHPX 
accumulates in nucleoli and show that it involves an unexpected, transient interaction with 
splicing speckles. The movement of NHPX from speckles to nucleoli is dependent on pre- 
mRNA transcription. These data suggest that NHPX may be involved in, and possibly link, 
several parallel RNA metabolic pathways that occur in distinct nuclear domains. 
V. 2 In vivo localisation of NHPX 
V. 2.1 NHPX is a highly concerned protein required in more than one RNA machinery 
The NHPX protein is highly conserved from human to plant (Figure V-1). It was originally 
identified as a putative human homologue of yeast NHP2p (Saito et al., 1996) and later 
independently as a 15.5kDa RNA-binding protein (Nottrott et al., 1999). Subsequent 
analyses indicated that NHPX is the human orthologue of the Sacchammyces cerevi. nae protein 
human 1 MTEAD 
C. elegans I MAD DG 
S. Dombe 1 MS 
S. cerevisiee 1 MSA 
D. melanogaster 1 MTEE 
A thabana 1 MTVEG 
human 45 
C. ekpens 46 
S. Ponybe 4 
S. Cerev e ae 4: 
D. melanoyaster 4S 
Athatiana 4E 
human 89 
C. elagans 90 
S. pombe 87 
S. cerevis'ae 88 
O melanogaster R9 
Athaliana 90 
Figure V-1 NHPX is highly conserved from human to plant. Protein sequences from 11. sapiens, 
C: ekgans, S. pomhe, S. irmisiae, 1). melanogaster and A. dwbuna were aligned using (Austad X 
software. The black boxes indicate identical residues while grey boxes indicate conserved 
substitutions. 
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Snul3p (Chang et al., 1999; Nottrott et al., 1999). It shares a common RNP structure that 
binds to both box C/D snoRNAs and spliceosomal U4 snRNA (Nottrott et al., 1999; 
Vidovic et al., 2000; Watkins et al., 2000). NHPX was selected for characterisation as part 
of the analysis of the human nucleolar proteome (Andersen et al., 2002). 
V. 2.2 NHPX localises in Nucleoli and Cajal bodies 
To address its in vivo localisation, the NHPX cDNA was isolated from a HeLa cDNA 
library and tagged at its amino-terminus with the enhanced yellow fluorescent protein 
(EYFP) gene to generate plasmid pAL107fY"''-"F°'X (see Chapter II). The localisation of the 
EYFP-NHPX fusion protein was analyzed by fluorescence microscopy following transient 
transfection of pAL107EYFP-NHPX in HeLa cells (Figure V-2), and compared with the 
A 
B 
C 
l` 
Figure V-2 NHPX localised in Nucleoli and Cajal bodies in living cells. I lela cells transiently 
transfeeted with pAL107'`%t`I'-N1°'X for 10 hours were fixed and counterstained with (A) anti- 
fibrillarin antibody 72B9 and arrowhead indicates (: B and arrow indicates nudcolus. 
Immunofluorescence labeling of I Iela cells using anti-NI IPX antibodies either (B) with or 
(C) without transient trtnsfection with pß\1.107' "'t-t' N10'`. Scale liar = 5µm 
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nucleolar protein fibrillarin (FIB; Figure V-2A). Transiently expressed EYFP-NHPX was 
colocalised with fibrillarin in the dense fibrillar component of nucleoli and also, 
unexpectedly, in Cajal bodies (CBs; Figure V-2A; arrow indicates nucleolus and arrowhead 
indicates CB). The CB localisation was confirmed by counterstaining with anti-coilin 
antibodies (data not shown, see Figure V-4A). The localisation of NHPX to CBs, as well as 
nucleoli, was also confirmed by inununofluorescence using anti-NHPX antibodies (Figure 
V-2B &C and data not shown). The tagged NHPX showed an identical localisation to its 
endogenous counterpart, suggesting that NHPX is a component of both nuclear structures 
(Figure V-2B & C). 
V. 23 Characterisation of a HeLa cell line stably expressing EYFP-NHPX 
To facilitate in vivo analysis of NHPX, I established a HeLa cell line stably expressing 
EYFP-NHPX (see Chapter II). As shown by fluorescence microscopy, the EYFP-NHPX 
protein localised specifically in nucleoli and CBs in the HeLa """ stable cell line (see 
below, Figure V-4). The HeLaE . NHI'X cell line grows and divides at the same rate as the 
parental HeLa cell line without any apparent cell cycle defect, as shown by FACS analysis 
(Figure V-3A and data not shown). The expression level of EYFP-NHPX is comparable to 
that of the endogenous NHPX protein in the HeLa'Y"n'X cell line (Figure V-3B). 
To confirm that the EYFP-NHPX fusion protein expressed in the HeLaEy"N}'"X cell line 
behaves biochemically as the endogenous protein, its in dtv RNA-binding specificity was 
investigated. An extract from HeLaE"" cells was immunoprecipitated using an anti- 
GFP antibody. RNAs in the immunoprecipitate were separated by urea-polyacrylamide gel 
electrophoresis, transferred to nylon membrane and hybridised with probes for Ul, U2, 
U4, U5 and U6 snRNAs and U3 snoRNA (Figure V-3C). This showed that U3 snoRNA 
and U4 snRNA, but not U1, U2, U5 or U6 snRNAs, were preferentially isolated with the 
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Figure V-3 Characterisation of HeIaE*, 'P-'HPX stable cell line. (A) DNA content of I lela'''-'' \'1''x 
cells was analyzed by FACS analysis and (B) its expression level by immunoblot using 
antiserum R86 and anti-GFP. (( The in thy RNA binding activity of FYIP-NI11'X was 
assayed by immunoprecipitation and the binding of snRNAs UI, U2. U4, U5 and L16 as well 
as snoRNA U3 were tested by northern hybridisation. 
anti-GFP antibody (lane 3). Control experiments, i. e. bead control and an HeLa'"""' cell 
extract, showed that although the anti-GFP antibody still pulled down the FP-fusion 
protein, it did not pull down any of the RNAs tested from these extracts (lane 1 and 2), 
while the same anti-GFP antibody pulled down each of the U1, U2, U4, U5 and U6 
snRNAs, but not U3 snoRNA, from a HeLa ""'""' cell extract (lane 4). These data show 
that the EYFP-NHPX fusion protein in tim is specifically complexed with the same RNA 
targets that NHPX was shown to bind directly in tit n (Nottrott et al., 1999; Watkins et al., 
2000). Given that U4 and U6 snRNAs usually exist as a duplex inside the nucleus, the 
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inmiunoprecipitation of U4 snRNA alone is surprising. The disruption of the U4/U6 
interaction in this assay is unlikely, because a non-Sm RNA, i. e. U6 snRNA, can be co- 
immunoprecipitated with U4 from the ECFP-SmB cell extract under the same 
experimental conditions and using the same anti-GFP antibody (Figure V-3C, lane 4). 
Another interesting observation is that only a small amount of the total U4 snRNA was 
pulled down in these experiments (Figure V-3C, land 3), even although U4 snRNA is 
present in similar abundance to U3 snoRNA inside HeLa cells (Reddy and Bush, 1988). 
This suggests that only a subset of U4, which is likely not bound to U6, may be interacting 
with NHPX in tiuo. Alternatively, the fraction of NHPX bound to the U4/U6 duplex could 
be inaccessible to the and-GFP antibodies. 
V. 24 NHPX colocalired with U3-snoRNP during steady, state interßhase and mitosis 
The ability of NHPX to bind both U3 snoRNA and U4 snRNA, which normally are 
located in different subnuclear structures, prompted us to investigate further the 
localisation of NHPX under different conditions (Figure V-4). The binding of NHPX to 
the spliceosomal U4 snRNA suggests that it should colocalise, at least in part, with other 
splicing factors. However, EYFP-NHPX in the HeLa " "x cell line does not show a 
speckled nuclear pattern similar to other human splicing factors such as SC35 and UTA 
(Figure V-4A; arrowhead indicates CB, arrow indicates nucleolus and broken arrow 
indicates speckles). The anti-NHPX antiserum also does not label speckles (Figure V-2B, 
Chang et aL, 1999). Instead, EYFP-NHPX is accumulated in nucleoli and CBs and 
colocalises with the snoRNP protein fibrillarin (Figure V-4A and C; see also Figure V-2A). 
Also, nucleolar segregation, caused by treating the cells with the transcription inhibitor 
actinomycin D, results in the relocation of NHPX to the nucleolar periphery along with 
fibrillarin, but does not cause it to colocalise with either SC35, or other splicing factors (see 
below Figure V-14B and data not shown). 
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Figure V-4 The patterns of EYFP-NHPX in HeIaE"'P-N"P" were analyzed (A) during interphase and 
(B, C) in different stages of mitosis. Anti-coilin 204/10 was used to denote CBs, anti-SC35 
to denote speckles and DAPI to show the condensed chromosome in mitotic stages. Arrowhead 
indicates CB, arrow indicates nucleolus and broken arrow indicates speckles. (C) Telophasc cells 
were stained with anti-Fibrillarin 72B9 antibodies. (D) The pattern of I: YFP-NIIPX in Hela""r 
` '7 during mitosis was followed after metaphase in a live cell imaged every 3 minutes. Scale 
bar=5µm. 
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Analysis of the HeLa "HPx cells at different stages of mitosis also showed no evidence 
for the association of NHPX with splicing factors (Figure V-4B). Time-lapse analysis of 
live HeLa -"px cells showed that NHPX associated with snoRNP-containing nucleoli 
immediately after the nuclear envelope reforms (Figure V-4C &D and data not shown). 
Combined with other immunofluorescence data of fixed cells counterstained with anti- 
fibrillarin (Figure V-4C & D), I conclude that EYFP-NHPX does not accumulate with 
snRNPs in speckles, but instead colocalises with the snoRNP protein fibrillarin at all cell 
cycle stages and metabolic conditions tested. The only colocalisation of NHPX with 
splicing snRNPs detected in tiro was specifically in CBs, structures known to accumulate 
newly imported snRNPs and snoRNPs when they first enter the nucleus. 
V. 3 A novel pathway involving transient interaction nvith splicing speckles 
V. 3.1 Evidence from microinjection of a plasmid expressing EYFPNHPX 
I next investigated the localisation of newly synthesised NHPX because recent data have 
shown a temporal pathway for snRNP and snoRNP localisation in nuclei (Carvalho et aL, 
1999; Narayanan et al., 1999a; Narayanan et aL, 1999b; Sleeman and Lamond, 1999; 
Sleeman et aL, 2001). To our surprise, microinjection of the expression vector pAL107E "- 
NHPx into the cultured cell lines, followed by examination in the fluorescence microscope, 
revealed that 1 hour after microinjection EYFP-NHPX is accumulated in splicing speckles 
and CBs (Figure V-5 and see below Figure V-11). 2-6 hours post-microinjection, EYFP- 
NHPX is also detected in nucleoli, whereas the level of EYFP-NHPX in speckles shows a 
concomitant decrease. At later time points, the signal in speckles can no longer be detected 
and EYFP-NHPX accumulates specifically in nucleoli and CBs, resembling the pattern 
observed in the HeLY""''"max cell line during interphase. 
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Figure V-5 Microinjection of pAL107EYP-NHIt into transformed cell line MCF7. 'I'hr microinjccted 
cells were fixed at different time points (Ihr, Ehr and 16hr) and counterstained with anti- 
SC35 to denote speckles and anti-coilin 204/10 to denote CI3s.: \rrowhcads indicate CBs, 
arrows indicate nudeoli and broken arrows indicate speckles. Scale bar=5µm. 
This novel nuclear pathway for NHPX was observed not only in parental HeLa cells (see 
below) but also when newly synthesised EYFP-NHPX was expressed following either 
microinjection, or transient transfection, in other transformed cell lines, including MCF7 
(Figure V-5; arrowhead indicates CB, arrow indicates nucleolus and broken arrow indicates 
speckles) and HEK293 and in primary cell lines, e. g. human foreskin fibroblasts and 
primary human fibroblasts expressing telomerase htertl787 (Figure V-6 and other data not 
shown). Some cell lines, e. g. htertl787, do not contain prominent CBs and therefore 
provide an opportunity to test whether the presence of CBs is required for the transport 
and/or localisation of NHPX in nucleoli. Microinjection of pAL1 U7FYI P NI II'X into htertl 787 
cells did not induce the formation of CBs and EYFP-NHPX still relocated in the same 
temporal sequence from speckles to nucleoli (Figure V-6; arrow indicates nucleolus and 
broken arrow indicates speckles). Therefore, the presence of CBs is apparently not required 
for the directional movement of NHPX from speckles to nucleoli. 
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The expression of exogenous NHPX raises the possibility that the target RNAs it binds to 
may be upregulated and thereby results in the observed temporal sequence of nuclear 
localisation. Therefore, I investigated the in vivo localisations of U3 and U4 RNAs in the 
HeLa cells that were microinjected with pAL107I'YH'-"! °'X using complementary 2'-O-methyl 
antisense RNAs (Figure V-7; reviewed in Lamond, 1993). The U3 in microinjected cells 
remained localised in the dense fibrillar component of nucleoli and CBs at both early and 
late time points, similar to control, non-microinjected cells (Figure V-7A and B, 
respectively, arrowhead indicates CB, arrow indicates nucleolus and broken arrow indicates 
speckles). The U4 snRNA was detected in speckles and CBs in both the microinjected cells 
at different time points and in control, non-microinjected cells (Figure V-7C and I)). 
Because the localisation of U3 and U4 remained unaltered, the differential localisation of 
NHPX at different time points is likely not due to the movement or relocalisation of either 
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Figure V-6 Microinjection of pAL107E' P-NHPX into primary cell line htert1787. I he rnicroinjccted 
cells were fixed at different time points (1hr, Ehr and 16hr) and countcrstained with anti- 
SC35 to denote speckles and anti-coilin 204/10 to denote CBs. Arrowheads indicate (: Bs, 
arrows indicate nucleoli and broken arrows indicate speckles. Scale har=5µm. 
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of these NHPX target RNAs. These data are consistent with NHPX binding U4 snRNA in 
speckles and U3 snoRNA in the nucleolus. However, I cannot exclude that NH1 X also 
binds to different and/or unknown target RNAs at the different nuclear structures. 
A 
B 
C 
D 
Figure V-7 Endogenous RNA localisation in cells microinjected with plasmid expressing EYFP- 
NHPX. pAL107"NI1'-NIIPX was microinjected into Ilcla cells and fixed after (A, C) 2 and 
(13, D) 24 hours. The cells were then counts stained with antiscnse 2'-O-Methyl RN, (A, B) 
U3 and (C, D) U4 and anti-SC35 to show the location of speckles. Arrowheads indicate CBs, 
arrows indicate nucleoli and broken arrows indicate speckles. Scale har=5µm 
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V. 3.2 Evidence from co-transfections of plasmids expressing EYFP-NHPX and ECFP-! 'I B 
I next examined whether the speckle localisation of newly synthesised NHPX is a 
consequence of a previously unknown behavior of U3 snoRNP. To test this, an expression 
vector, pAL118'I"''-'''s, encoding ECFP-tagged fibrillarin (FIB), a known U3 snoRNP 
component, was cotransfected with pAL107''Y 1'-N IPX into the parental HeLa cell line and 
analyzed at various time points post-transfection (Figure V-8). At 1 hour after transfection, 
ECFP-FIB already accumulated in nucleoli and CBs, whereas in the same cells EYFP- 
NHPX accumulated in speckles and CBs, but not in nucleoli (Figure V-8; arrow indicates 
nucleolus and broken arrow indicates speckles). Several hours later, EYFP-NHPX began 
to accumulate in nucleoli and the signal in speckles decreased while the ECFP-FIB 
remained specifically in nucleoli and both proteins were detected in CBs (data not shown). 
After one cell cycle, EYFP-NHPX and ECFP-FIB both quantitatively colocalised in the 
dense fibrillar component inside nucleoli and in CBs (Figure V-8; arrowhead indicates CB, 
arrow indicates nucleolus and broken arrow indicates speckles; see also Figure V-2A). 
Therefore, the transient presence of newly expressed NHPX in nuclear speckles is not 
explained by its association with U3 snoRNP. 
Figure \'-8 pAL107F. IFP-NHPX and pAL118EcE'r-HB were co-transfected into HeLa cells and fixed 
after (A) I and (B) 24 hours.. \rrowhcads indicate (71s, arrows indicate nucleoli an i broken 
arrows indicate speckles; Scale bar= 5µm. 
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V. 3.3 Evidence from betemkayon assays between HeLa stable cell lines 
The differential timing in the nucleolar entry of NHPX and fibrillarin is confirmed by 
analysis of heterokaryons formed between HeLa "*m and HeLaE"'N}" stable cell lines 
(Figure V-9). Formation of heterokaryons between two cell lines expressing FP-tagged 
proteins allows the gradual introduction of EYFP-NHPX into the HeLaECF''" cells and vice 
versa (Sleeman et al., 2001). The advantages of using this heterokaryon approach are that it 
minimizes the possible effect of overexpression that can occur in both microinjection and 
transient transfection assays and allows the dynamic exchange of two fluorophores to be 
observed under the same conditions. ECFP-FIB accumulated directly in nudeoli as soon as 
15 minutes after fusion, while EYFP-NHPX accumulated instead in speckles at the same 
time (Figure V-9B; arrowheads indicate CBs, arrows indicate nucleoli and broken arrows 
indicate speckles). This is followed by subsequent accumulation of EYFP-NHPX in 
nudeoli and loss of signals in speckles at later time points as observed in Section V. 3.1. 
Therefore, the NHPX protein detected in speckles is unlikely to be associated with U3 
snoRNP. 
V. 4 Directionality of the pathway 
V. 4.1 Reciprocal movement of two different nuclear proteins 
The NHPX pathway appears complementary to that previously described for Sm proteins 
(Figure V-10; Sleeman and Lamond, 1999; Sleeman et al., 2001). By making heterokaryons 
between HeLa"S" and HeLaEYFP. NtrnX, I observed that EYFP-NHPX entered into 
speckles directly, whereas ECFP-SmB accumulated specifically in CBs shortly after fusion 
(Figure V-10A and B; arrowheads indicate CBs, arrows indicate nucleoli and broken arrows 
indicate speckles). At 2 hours after fusion, ECFP-SmB remained in CBs while the EYFP- 
NHPX signal inside nucleoli increased (Figure V-10C; arrows indicate nucleoli). In some 
cells, ECFP-SmB was also detected inside nucleoli, as reported previously (Figure V-10D, 
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B 
C 
D 
Figure V-9 Heterokaryon assays between HeLa`'T""NHp" and HelaeC''''''''B. Bela"' and 11cl ä' 
' ýB were fused to form heterokaryon using polyethylene glycol (PEG) and were fired at 0,15,240 
and 480 minutes after fusion. In order to show the relative distribution of EYFP and ECFP 
components in each nucleus, the central panel shows the same two nuclei within a heterokaryon 
as the side panels, but in the opposite fluorescence channels. Arrowheads indicate CBs, arrows 
indicate nucleoli and broken arrows indicate speckles; dotted ovals outline nuclei in the hetcrokaryon 
in the central panel. Scale bar=5µm. 
A 
B 
C 
D 
E 
Figure V-10 Reciprocal movement of nuclear proteins NHPX and SmB. He1a""'' "k°'` and I 
SmB were fused to form heterokaryon using PEG and were fixed at different time points: (A) Ohr, 
(B) 0.5hr, (C) 2hr (D) 4hr and (E) 36hr. Panel representation as of Figure V-9. Arrowheads 
indicate CBs, arrows indicate nucleoli and broken arrows indicate speckles; dotted ovals outline 
nuclei of the heterokaryon in the central panel. Scale bar=5µm. 
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Sleeman and Lamond, 1999; Sleeman et al., 2001). At later time points (-36hrs), the 
ECFP-SmB signal in speckles increased while the EYFP-NHPX signal in speckles 
decreased to a very low/undetectable level (Figure V-10E and other data not shown). 
Therefore, I conclude that both nuclear pathways, though operating in different directions, 
function simultaneously inside a single cell nucleus. The pathways can also be observed by 
live cell imaging over a period of 12 hours (data not shown). This demonstrates the 
directed movement of proteins between separate, membrane free nuclear compartments. 
V. 4.2 Only newly e4resred NHPX proteins localise to speckles 
I next investigated whether the directed movement of NHPX is either restricted to newly 
synthesised proteins, or else is a reversible relocation of existing proteins (Figure V-11). To 
test this, pAL214`'ca-V>-NEmx was transfected into HeLa cells and left for 24 hours such that 
ECFP-NHPX was already accumulated in nucleoli and CBs before 
A 
B 
C 
Figure V-11 HeLa cells were transfected with pAL214ECFr-Nttrx for 24hrs before microinjecting 
pAL107EYFP-NHPX. The microinjected cells were fixed after (A) 1.5hr, (li) 4hr and (C) 24hr 
and counterstained with anti-SC35 to denote speckles. Arrowheads indicate (]ts, arrows 
indicate nucleoli and broken arrows indicate speckles. Scale bar= 5µm 
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microinjection of pAL107EY"-N' l'X. Microinjection of pAL107L'"-"' provided a pulse of 
newly synthesised EYFP-NHPX that accumulated in splicing speckles and CBs while the 
previously expressed ECFP-NHPX accumulated in nucleoli and CBs instead (Figure 
V-11A; arrowhead indicates CB, arrow indicates nucleolus and broken arrow indicates 
speckles). Gradually, EYFP-NHPX appeared in nucleoli, while the signal in speckles 
subsided. The nucleolar pattern of ECFP-NHPX remained unaltered after microinjection 
of pAL107EYF'"NHI'X (Figure V-11B; arrow indicates nucleolus). At 24 hours post- 
microinjection, EYFP-NHPX completely colocalised with the existing ECFP-NHPX 
(Figure V-11 C; arrowhead indicates CB and arrow indicates nucleolus). These data indicate 
that only newly synthesised NHPX accumulates in splicing speckles and further argue that 
this association is transient. The presence of NHPX in speckles is thus likely not a result of 
protein relocation due to exogenous expression. 
V. 4.3 NFiPX leaves speckles and does not return even when there are no nucleoli 
To test further whether or not pools of NHPX in speckles and nucleoli interchange, I 
generated micronuclei by treating the HeLa "N"px cells with the spindle-disrupting drug 
colcemid (Figure V-12). Colcemid inhibits the progress of mitosis and renders the 
segregation of chromosomes into many micronuclei without preventing DNA replication, 
mRNA transcription, splicing and protein translation (Ferreira et at, 1997). Nucleoli are 
assembled only on the nucleolar organizer regions (NORs) in 5 out of 23 chromosomes in 
human nuclei (see Chapter 1) and therefore the colcemid treatment allows the generation 
of a subset of micronuclei without nucleoli. To locate those micronuclei, I screened with an 
antibody specific for nucleolar antigen B23. If the two pools of NHPX in splicing speckles 
and nucleoli freely exchange, NHPX originally from nucleoli would be expected by default 
to accumulate back in splicing speckles in the micronuclei lacking nucleoli. Interestingly, 
EYFP-NHPX does not accumulate in splicing speckles, even in those micronuclei lacking 
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A 
B 
C 
Figure V-12 Localisation of NHPX in cells lacking nucleoli. (: \) I lel. A' '" ""-' culls wcrcc ti--"d ., Itc"r 
treating with colcemid for 31 hrs and counterstained with anti-SC35 to denote speckles and anti- 
B23 to denote nucleoli. (B-C) Parental Hel. a cells were treated with colccmid for 31 hr and 
microinjected with plasmid expressing EYFP-NI IPX. The cells were fixed at (B) 2 hr and (( ,)4 
hr after microinjection. Arrows indicate speckles while arrowheads indicate the locations of 
EYFP-NHPX; dotted ovals outline the micronuclei. Scale har=5µm. 
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nucleoli (Figure V-12A; arrows indicate speckles, arrowheads indicate NHPX localisations 
and the inset shows a micronucleus that lacks nucleoli); instead, they are localised in spot- 
like structures which also contain the snoRNP protein fibrillarin, but not the CB marker 
coilin (Figure V-12A, arrowheads and data not shown). Microinjection of pAL107EM-MIM 
into colcemid-treated parental HeLa cells showed the same temporal sequence of 
localisation in speckles prior to nucleoli as seen for untreated cells (Figure V-12B-C). 
Therefore, this differential localisation is apparently not a result of colcemid modifying the 
NHPX pathway and the pools of NHPX localised in splicing speckles and nucleoli appear 
not to interchange. 
V. 4.4 The NHPX pathway is unidirectional 
The non-cycling behavior of NHPX between speckles and nucleoli prompted me to 
investigate further the directionality of the localisation pathway. I performed FLIP 
(Fluorescence Loss In Photobleaching) analyses of different nuclear structures in the 
HeLa "N cells where one area of the cell is repeatedly bleached while collecting images 
of the entire cell (Figure V-13; see Chapter I). If fluorescent molecules from other regions 
of the cell diffuse into the bleached area (Figure V-13, bleach zone is shown by white 
circle), loss of fluorescence will occur from both places, indicating that molecules exchange 
between the regions (Reits and Neefjes, 2001). First, I tested whether NHPX inside 
speckles is moving into the nucleolus (Figure V-13A; a and c). The positions of speckles 
were defined by DsRED-U1A in live cells (Figure V-13A; b and d). The fluorescence 
intensity of EYFP-NHPX in speckles outside the bleached region decreased, indicating 
that NHPX diffuses between these nuclear domains (Figure V-13A; curve b). In 
comparison, the signals inside nucleoli only showed a minor decrease (Figure V-13A; curve 
a). This is consistent with the expected movement of NHPX from speckles to nucleoli. 
The small change in nucleolar fluorescence may be because the directed movement of 
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Figure V-13 FLIP analysis in Hela X. Cells were grown on 42-mm glass coverslips (no. 1; 
Helmut Sauer) in medium containing 200µg/ml G418. Cells were maintained at 37-C by use 
of a dosed perfusion chamber (Bachofer) in DMEM media (20mM HEPES, no phenol red; 
Invitrogen). Photobleaching experiments were carried out on a ZEISS ISM510 confocal 
laser scanning microscope equipped with an argon-krypton laser. The 488-nm laser and a 
63X plan Apo lens with a 1.4 NA and a laser power of 2.5% was used for image acquisition, 
and 25% was used for photobleaching. An area of 16x16 pixels was bleached with an 
iteration of 250 (duration of bleach was 3s). An image was collected after every bleaching 
event, with 20s intervals between each bleaching event over a period of 15 minutes. A region 
in the (A) speckles and (B) nucleolus was photobleached repeatedly every 20 seconds and the 
fluorescence intensities of EYFP-NHPX were analyzed over 15 minutes. The positions of 
speckles were located in the live cells using DsRED-UlA that was transfected into the cell 
lines for 24hrs before photobleaching and the selected region for photobleaching was 
highlighted by the white circle in the left panel. The fluorescence intensities of EYFP-NHPX 
in different regions of the bleached and non-bleached cells were compared in the right panel. 
(C) FLIP analysis of the newly imported EYFP-NHPX in speckles of the heterokaryon 
formed between HelaFy"-NHPX and parental Heia cells that were both transfected with 
pDsRED-UTA for 24 hours. The position of the nudeolus for photobleaching (white circle; 
left pane9 in the recipient nuclei were located by both phase cot: tcast microscopy and the 
absence of DsRED-UlA. The fluorescent intensities of EYFP-NIIPX in speckles of 
bleached and non-bleached nuclei of the heterokaiyon were analyzed and shown on the right 
panel. Dotted ovals outline nuclei in the heterokaryon. Scale bar=5µm. 
NHPX from speckles to nucleoli is slow (hours) compared with the experimental time 
((15 minutes) and/or because it accounts only for a small fraction of the total NHPX 
signal in nucleoli However, repeated photobleaching of the nucleolus (Figure V-13B; 
bleach zone is shown by white circle) resulted in the immediate loss of signal in 
neighboring nucleoli, indicating that the nucleolar pool of NHPX can cycle between 
different nucleoli (Figure V-13B; curve e). The constant level of fluorescence observed in 
the speckles in the same experiment further strengthens the argument in favor of a 
unidirectional movement of NHPX from speckles to nucleoli (Figure V-13B; curve f j. 
The difference in fluorescence intensity between speckles and nucleoli raises the possibility 
that the flow from nucleoli to speckles was not observable in the HeLaEYFP"N1°'x cells. To 
address this, I performed FLIP analysis on heterokaryons formed between Hel. aEYF'l'Px 
cells and the parental HeLa cells (Figure V-13C). The locations of nucleoli in the recipient 
nuclei were positioned both by phase contrast microscopy and by the absence of splicing 
factor U1A. Shortly after the fusion, as shown previously (see Figure V-9 and Figure V-10), 
EYFP-NHPX first appeared in splicing speckles but was absent from nucleoli in the 
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recipient nuclei. Repeated photobleaching of the nucleoli did not change the fluorescence 
level of EYFP-NHPX in the speckles of the recipient nuclei (Figure V-13C; curve i and 
bleach zone is shown by white circle). Therefore, NHPX either does not cycle from 
nucleoli to speckles, or else does so at a rate/level that cannot be detected in this assay. In 
summary, the photobleaching analyses, combined with the other data presented here, 
suggest a unidirectional movement of NHPX from splicing speckles to nucleoli However, 
pools of EYFP-NHPX appear freely diffusible between separate components of the same 
nuclear structure, indicating the regulated entry of nuclear proteins into different domains 
inside the nucleus. 
V. 4.5 The progresrion of NHPX from speckles to nucleoli is dependent on RNA po jymerase II but 
not RNA polymerase I transcription 
I next tested whether the progression of NHPX from speckles to nucleoli requires gene 
expression, including both RNA polymerase I and RNA polymerase II transcription 
(Figure V-14). I again employed the heterokaryon approach between HeIA " and 
HeLa "P"N'"x cells. At 4 hour post-fusion, only a small amount of EYFP-NHPX was in 
speckles whilst most accumulated in nucleoli (Figure V-14A; arrowheads indicate CBs, 
arrows indicate nucleoli and broken arrows indicate speckles; see also Figure V-10D). The 
heterokaryons formed between HeLa "NH'x and HdAEcF'"FM cells were subjected to 
transcription inhibitors targeted to specific polymerases. Low levels of actinomycin D 
cause the segregation of nucleoli and inhibit rRNA transcription, but not pre-mRNA 
transcription (see Chapter I). Newly synthesised EYFP-NHPX moved to the speckles of 
recipient HeLa`''m nuclei, prior to accumulating in the segregated nucleoli (Figure 
V-14B; arrows indicate segregated nucleoli and broken arrows indicate speckles), 
suggesting that RNA polymerase I transcription and/or ribosome biogenesis is not a 
prerequisite for the NHPX pathway. Similarly, the immunosuppressant rapamycin, which 
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inhibits transcription of a subset of ribosomal protein genes and hence ribosome assembly, 
gave the same results (data not shown). However, when RNA polymerasc II transcription 
was inhibited, either by cx-amanitin or DRB, progression of the newly synthesised NHPX 
from speckles to the nucleolus was blocked (Figure V-14C and data not shown; arrows 
indicate nucleoli and broken arrows indicate speckles). This suggests that one or more 
factors must be continually synthesised to allow the newly imported NHPX to move from 
speckles to nucleoli. 
A 
B 
C 
Figure V-14 The NHPX pathway is dependent on RNA polymerase II transcription. 
Heterokaryons formed between I kiest'" t"`10'ý and I lcl: a'"I "I'll' were treated with different 
transcription inhibitors: (A) contmI, (B) RN. \ polynierasc I inhibitor . 
\ctinomycin I) 
(0.04µg/ml) and (C) RNA polymerise II inhibitor l)RB (l(Nlµýt). Pand representation as of 
Figure V-9. Arrowheads indicate CBs, arrows indicate nucleoli and broken arrows indicate 
speckles; dotted ovals outline nuclei of the hcterokaryon in the central panel. Scale bar-5µm. 
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V. 5 Discussion 
In this chapter, I described a novel nuclear pathway that I discovered and published during 
my PhD studies (Leung and Lamond, 2002 and see Appendix). The pathway that leads to 
the nudeolar accumulation of the NHPX protein was detected in multiple mammalian 
cultured cell lines, including both primary and transformed cells. NHPX was analyzed in 
vivo, fused to either EYFP or ECFP fluorescent protein tags, and the resulting fusion 
proteins were shown to have similar localisation patterns and RNA binding specificities to 
the endogenous NHPX, A stably transformed HeLa cell line that expressed EYFP-NHPX 
was established and used to demonstrate that, upon its initial entry into the nucleus, newly 
expressed NHPX transiently accumulates in splicing speckles prior to a later, steady state 
accumulation in nucleoli. Further characterisation of HelaEyn'-N' 'Px cells indicated that the 
NHPX protein in speckles was not associated with U3 snoRNP and required RNA 
polymerase II transcription for efficient relocation to nucleoli Additional photobleaching 
experiments showed that the nudeolar pool of NHPX did not interchange with the pool in 
nuclear speckles, suggesting a unidirectional pathway. 
Our recent proteomic analysis of nucleoli isolated from cultured HeLa cells shows that 
they contain over 400 different proteins (Andersen et aL, 2002 and see Chapter III). So far 
there has been no nucleolar targeting motif identified common to all of these factors and it 
seems likely that multiple, parallel nucleolar localisation pathways can operate. Nonetheless, 
analyses of proteins that show a steady state accumulation in nucleoli have shown that they 
usually move rapidly into the nucleolus when they enter the nucleus. This is illustrated here 
by the rapid nudeolar accumulation of EYFP-fibrillarin when it is transiently expressed in 
vivo (cf. Figure V-8 & Figure V-9). The finding that newly expressed NHPX accumulates in 
nuclear speckles transiently before accumulating specifically in the nucleolus defines a new 
localisation pathway for nudeolar proteins. It is interesting to compare this with the 
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recently reported pathway for nucleolar localisation of snoRNAs, which showed that 
multiple snoRNAs accumulate in CBs prior to nucleoli upon initial entry into the nucleus 
(Narayanan et aL, 1999a; Narayanan et aL, 1999b; Verheggen et al., 2001). None of the 
snoRNAs, however, showed a transient accumulation in speckles, consistent with our 
finding that the snoRNP protein fibrillarin also does not transiently accumulate in speckles 
prior to nucleoli (cf. Figure V-8 & Figure V-9). I also observed that NHPX localises to CBs 
as well as speckles upon its initial entry into the nucleus, but unlike its transient association 
with speckles, NHPX is also detected in CBs at later stages of expression, when the bulk of 
the protein is concentrated in nucleoli. At present, I cannot distinguish whether NHPX 
either accumulates in CBs prior to speckles, or in both structures at the same time. 
However, the CB association does not appear to be obligatory for the NHPX localisation 
pathway because a similar transient association with speckles prior to nudeolar 
accumulation is observed in cell lines lacking prominent CBs (cf. Figure V-6). Yet, similar 
molecular events may occur, either within the nucleoplasm, or in CBs that are too small to 
detect. 
It is also interesting to compare the NHPX pathway with the recently identified nuclear 
pathway for splicing snRNPs, where FP-tagged snRNP Sm proteins accumulate in CBs 
and nucleoli, prior to speckles, upon their initial nuclear entry (Sleeman and Lamond, 1999; 
Sleeman et aL, 2001). This pathway therefore appears to be complementary to that of 
NHPX. By analyzing heterokaryons formed between separate stable HeLa cell lines 
expressing EYFP-NHPX and ECFP-SmB I could show that both these complementary 
pathways can operate simultaneously within the same nuclei (cf. Figure V-10). These data 
confirm the specificity of the pathways and highlight the dynamic mechanisms operating to 
organise the distribution of proteins and RNPs in the nucleus. The results also point to the 
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localisation specificity of the separate subnudear bodies, including nucleoli, CBs and 
speckles, even although they are not enclosed by membranes. 
In trying to answer why NHPX shows the observed transient accumulation in speckles 
prior to nucleoli, it may be important to consider that it is specifically newly expressed and 
imported NHPX protein that is detected in speckles. Several experiments showed that 
NHPX does not localise to speckles by default and that the nucleolar pool of NHPX does 
not cycle continually to and from speckles. For example, in micronuclei that lack NOR- 
containing chromosomes and hence do not have nucleoli, NHPX does not accumulate 
back in speckles or colocalise with splicing factors (cf. Figure V-12). FLIP photobleaching 
experiments also showed that while nudeolar EYFP-NHPX can exchange rapidly between 
separate nucleoli within the same nucleus, little or no exchange occurs with the pool of 
NHPX in speckles (cf. Figure V-13). This contrasts with the behavior of the nucleolar 
protein PSP1, which was recently shown to cycle continually between nucleoli and 
paraspecldes (Fox et al., 2002). 
Our data strongly indicate that the association of NHPX with speckles is a temporal 
phenomenon linked to the entry of newly expressed NHPX into the nucleus. For example, 
transient expression of EYFP-NHPX in HeIA cells expressing ECFP-NHPX, which 
already accumulated in nucleoli, shows a transient accumulation of the EYFP-NHPX in 
speckles before it later colocalises quantitatively with the existing nudeolar ECFP-NHPX 
(cf. Figure V-11). Also, when the HeIaE'' K cells undergo mitosis EYFP-NHPX 
immediately relocalises to the reforming nucleoli during telophase and does not accumulate 
in speckles in the post-mitotic nuclei (cf. Figure V-4). Therefore, the speckle association is 
not a result of nuclear import of NHPX per se, but rather relates to an effect specific for 
newly expressed protein. I propose that a likely explanation for this behavior of NHPX 
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could be related to it having a function required for the assembly or maturation of some 
form of nuclear protein or RNP complex, prior to its subsequent stable association with 
U3 and/or other nucleolar snoRNPs. This could imply either that the affinity of NHPX 
for different target RNAs changes after it enters the nucleus for the first time or that its 
access to bind snoRNA targets is initially restricted. 
Based upon the results of previous biochemical studies on the structure and binding 
specificity of NHPX, the U4 snRNA is a possible candidate target for NHPX in speckles. 
NHPX binds U4 snRNA in tim, via the 5' stem loop sequence (Nottrott et aL, 1999; 
Vidovic et al., 2000). Consistent with this idea, U4 snRNA has been localised to speckles in 
HeLa cells by hybridisation experiments (Carmo-Fonseca et al., 1992). The fact that I show 
here that EYFP-NHPX likely interacts in vivo with a form of U4 snRNA that is not stably 
associated with U6 snRNA suggests that NHPX may transiently interact in speckles with 
an intermediate form of U4 snRNP (cf. Figure V-2E). 
In mammalian cells, all snoRNAs that guide 2'-O-methylation or pseudouridylation of 
ribosomal RNAs are encoded within the introns of snoRNA host genes (Maxwell and 
Fournier, 1995; Weinstein and Steitz, 1999; Filipowicz and Pogacic, 2002). They are 
processed exonucleolytically after debranching of the excised introns (Kiss and Filipowicz, 
1993; Kiss and Filipowicz, 1995; Caffarelli et aL, 1996) and the distance (>41nt) from the 
snoRNA coding region to the branch point is crucial for the release of a snoRNA from its 
host intron before the first catalytic step, as illustrated in Figure V-15 (Hirose and Steitz, 
2001). It should be noted that NHPX is the nucleation factor for both the U4 splicing 
snRNP and also snoRNPs (Watkins et aL, 2000; Nottrott et aL, 2002; Watkins et aL, 2002). 
During the splicing cycle, U4/U6. U5 tri-snRNP was recruited to the exon-intron junction 
to activate the spliceosome for the first catalytic step. When U2 is base-paired with U6 
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snRNA, the U4/U6 base pairing must first be disassociated and the fate of the U4 snRNP 
remains unknown. Recently, the Steitz group showed that the binding of fibrillarin and 
NHPX proteins to the snoRNA coding region occurs before the first catalytic step, and 
that snoRNP assembly in vitro is completely abolished by shortening the distance between 
the snoRNA coding region to the branch point to less than 60nt. (Hirosc and Steitz 2001 
and personal communication). I showed here that NHPX to be relocated from splicing 
speckles to nucleoli requires ongoing pre-mRNA transcription (c. f. Figure V-14). 
Therefore, it is tempting to speculate that NHPX molecules may be transferred from the 
U4 snRNP to snoRNPs at the first catalytic step when splicing snoRN. \ containing introns 
and this may explain the localisation pathway of NHPX involving a transient interaction 
with splicing speckles. Future studies will aim to analyze further the molecular mechanism 
involved in the novel nucleolar localisation pathway detected for NHPX in tnao and to 
establish what biological role this may play. 
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CHAPTER VI 
PERSPECTIVES 
`[The characterisation of the human nucleolarpmteome] is a framework forfuture work 
bat it doesn't realy, answer any single question. " 
Tom Msstek; Science 184 January, 2002- 
*ýý**ý 
`The 1999 concept was the 'namk nHckiis: 
The 2000-2001 chapter asked, `the dynamics of what?: 
The 2002 question is born a these dynamics regulated? " 
Tboru Pederson, Nature cell biology December 2002- 
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VI Perspectives 
VI. I Summary of findings 
In this thesis I have presented 3 aspects of my PhD work on studying the human 
nucleolus, namely, the characterisation of the human nucleolar proteome (Chapter III), the 
relationship between subnucleolar domains during mitotic breakdown and reassembly 
(Chapter IV) and a novel nudeolar targeting pathway (Chapter V). Here is a summary of 
the major findings: 
Q 400 proteins were identified that copurified with human nucleoli isolated from 
HeLa cell nuclei using mass spectrometry and -30% of these represent proteins 
that are either novel, or else previously uncharacterised (Andersen et aL, 2002); 
Q Bioinformatics analyses were performed to integrate information from the 
nucleolar protein with the existing public databases and a dedicated, web-based, 
multi-platform database was built for public access at http: //www. dundee. ac. uk 
/lifesciences/lamonddatabase/; 
Q Secondary information, such as mRNA expression levels in 41 human tissues and 
115 growth conditions and protein homologues in 80 organisms were derived for 
over 400 nucleolar proteins and used to classify these proteins, especially the novel 
factors, for a possible relation to biosynthesis and function of the ribosome in silico; 
QA battery of 24 HeLa cell lines stably expressing one or more nucleolar factors 
labelling distinct subdomains were generated and used to study the disassembly and 
reassembly of the nucleolus in live cells; 
Cl There exist a window between prophase and metaphase when a core subunit of 
RNA polymerase I does not associate with the chromosomes in live human cells. 
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This finding is in contrast with previous fixed cell studies suggesting that RNA 
polymerase I associates with the chromosomes at all stages of mitosis; 
U An in vivo technique was developed to label one or more nucleoli non-invasively; 
QA novel nucleolar localization pathway, observed in primary and transformed cell 
lines, was discovered for NHPX, a new member that is localised in both the 
nucleolus and Cajal bodies (Leung and Lamond, 2002); 
U The NHPX pathway involves an unexpected transient interaction with splicing 
speckles prior to nucleolar accumulation; 
Q The pathway is dependent on pre-mRNA transcription and possibly links several 
parallel RNA metabolic pathways that occur in distinct subnuclear domains. 
VI. 2 On Post Proteomics 
The identification of the human nucleolar proteome itself may not, perhaps, answer any 
single question at the moment but it definitely provides a firm foundation to test new ideas 
and refute/confirm hypotheses based on these new data (Couzin, 2002; Dundr and Misteli, 
2002; Pederson, 2002b). For example, although the idea of mRNA translation in the 
nucleus is still very controversial (Iborra et aL, 2001; Pederson, 2001a), even back in the 
1960s, there was data showing that amino acids could be incorporated within isolated 
nucleoli (Birnstiel and Hyde, 1963; Birnstiel and Flamm, 1964; Maggio, 1966), The data 
described in this thesis and other studies shows that the presence in the nucleolus of 
translation factors, ribonucleoparticles/RNAs related to translation, such as SRP, tRNA 
and 5S RNA, and nearly all the ribosomal proteins, which in total accounting for -16% of 
the human nucleolar proteome (Pederson and Politz, 2000; Politz et al., 2000; Andersen et 
aL, 2002; Politz et at., 2002). Of course, the mere presence of these factors in nucleoli does 
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not necessarily mean that they function as a translation complex, as in the cytoplasm. One 
way to address the issue of nucleolar translation would be to repeat the amino acid 
incorporation experiment on isolated human nucleoli, except by using isotopically labeled 
amino adds. With the aid of the high sensitivity of mass spectrometry, perhaps, it may be 
possible to identify which proteins the amino acids are incorporated (Flory et al., 2002). 
Surprisingly, 30% of the nucleolar proteins are either uncharacterised or novel This partly 
reflects the poor status of the current human genome annotation and also presents a 
challenge for us to unravel the unknown functional complexity of the nucleolus (Andersen 
et al., 2002). However, if we pool information from different sources such as gene 
expression activity and information on homologues in other species, as demonstrated in 
Chapter III, this approach should help speed up our understanding of the human nucleolar 
proteome (Eisenberg et al., 2000; Marcotte, 2000; Vidal, 2001). The understanding of 
ribosome biogenesis from budding yeast provides testing materials for the human system 
(Fatica and Tollervey, 2002), especially now with their corresponding human homologues 
being mapped in the nucleolus (Chapter III). These putative ribosome biogenesis factors 
should then be tested rigourously by biochemical methods and these studies are currently 
underway. 
As proteins rarely work alone within the cell, nucleolar proteins may work in a pair or in a 
complex to perform a specified function. To understand the possible networks within the 
nucleolus, each nucleolar protein was profiled and compared with one another in this 
thesis, according to (a) how they are inherited in different genomes, (b) where they are 
expressed and (c) how they are expressed (c. f. Chapter III). Based on this method, I have 
classified the possible relationship of each nucleolar protein with the ribosome in silica. In 
particular, 9 novel/uncharacterised proteins were classified in this way and 7 of them have 
a homologue in yeast that is known to be related to the ribosome. 
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This profiling technique by incorporating a multitude of information deposited in public 
databases is a beginning to study biological process modularly, rather than individually 
(Hartwell et al., 1999; Pellegrini et aL, 1999; Eisenberg et al., 2000). The fortuitous 
discovery of nucleolar functions by studying a single protein requires a more systematic 
way to analyse its interaction partners, either along a pathway, or within a complex (Tong 
et al., 2002). Even though the number of the human nucleolar proteins is of the order of 
hundreds, it is still relatively simple to use computational methods in mapping its potential 
relationship with one another and studying possible functions within the proteome by 
mining the wealth of existing and continually expanding databases. However, this is not 
possible unless efforts are continuously exerted to develop good database structures and 
user-friendly interfaces (Aebersold and Watts, 2002; Stein, 2002). Good visualisation tools 
are also important especially for non-specialists from other fields to use the existing data. 
Moreover, standardization of the protocol for archiving data is crucial for transferring 
information between laboratories and this procedure can be modeled on existing systems 
provided, for example, by NCBI and EBI for genomic data and OME for microscopic 
data (http: //ncbi. nlm. nih. gov/; http: //www. ebi. ac. uk/; http: //www. openniicroscopy. 
org/). 
The nucleolar proteome is nothing but dynamic and therefore the 400 human nucleolar 
proteins identified forms the basis to understand how the nucleolus responds to change in 
metabolic environments. As demonstrated by our group, the inhibition of transcription, i. e. 
by Actinomycin D, causes an enrichment of a set of 11 proteins within the nucleolus (Fox 
et al, 2002). The advance in mass spectrometry allows quantitative measurement of the 
relative protein abundance (Flory et aL, 2002). This extended capability will certainly add 
another dimension to our understanding of how the composition of the nucleolus changes 
under different metabolic states and at specific cell cycle stages. This approach should also 
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be extended to other cell types, such as stem cells, or those cells, e. g. from brain, where 
alternative rRNA processing is known to occur (Akhmanova et at, 2000). Mass 
spectrometry has the added advantage of possibly identifying alternatively spliced forms of 
the nucleolar proteins. Moreover, quantitative, and even simply qualitative, comparisons 
between normal and tumour tissues might give insights into the mechanism behind the 
extremely large nudeoli observed in malignant cells (Derenzini et at, 2000). 
Another way of looking at changes to the nucleolar proteome would be to carry out 
parallel studies using microarray techniques. Gene chips can be tailor-made to contain the 
400 corresponding nucleolar cDNAs and study their changes in transcriptional level under 
different growth conditions. Correlative studies with the quantitative measurement of the 
relative protein abundance indicated from proteomic data may provide insights into 
possible post-transcriptional regulation of the nudeolar gene. Moreover, the panel of HeLa 
cell lines generated during this study that label multiple subcompartments within the 
nucleolus provides a good model system to study changes in transcription and protein 
levels as well as at the cellular level under different growth conditions. 
V13 On Nucleolar structural integrity 
As discussed in Chapter IV, the human nucleolus disassembles in the beginning of mitosis 
at a similar time when the nuclear envelope breaks down. Although nucleolar breakdown 
was studied between the 1970s and the early 1990s, most of the studies were performed in 
fixed cells (Lafontaine, 1968; Gautier et al., 1992; Shaw and Jordan, 1995), and therefore 
these experiments could not possibly identify the inter-relationships between each 
subnucleolar compartment within a single cell in a temporal sequence. In contrast, this 
thesis study may give, perhaps, the first insight regarding how the 3 subnucleolar domains 
move in relation with one another, as well as with the mitotic chromosomes in live cells. It 
is apparent that chromosome condensation does not play a major role in disrupting the 
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nucleolus but the breakdown is due to a rapid event that happens concurrently with the 
nuclear envelope breakdown. So, what is the molecular event that triggers nucleolar 
breakdown? Because nucleoli can be isolated biochemically as structurally intact and 
functional entities (Cheutin et al., 2002), this property makes the isolated nucleolus a good 
in vitro system to test which components, or complex, in the mitotic extract triggers the 
breakdown. 
Nucleoli are assembled on the NORs located in the five human chromosome pairs; 
however, it is often observed that there are less than 5 nucleoli within human cells, so how 
do these chromosomes arrange themselves among different nucleoli? This study illustrates 
that the nucleolar reformation initiates stochastically by relocation of RNA polymerase I 
and subsequent recruitment of other processing and assembly factors as newly pre-rRNA 
transcripts are made. The in vitro labelling technique developed as described in Chapter IV 
can also be used to label pre-mitotic chromosomal regions surrounding a single nucleolus 
and follow them as the cells progress through mitosis (e. g. Figure V1-1). Preliminary 
experiment suggests that the labelled chromosomal regions appear to be segregated to 
different nucleoli after mitosis and they do not reform to a single nucleolus even after 3 
hours of mitosis (data not shown). Therefore future analysis may focus on how these 
Figure VI-1 In vivo labelling of a nucleolus during mitosis. I IcJa cells stabhv expressing Ia IP 
RPA39 and ECFP-112B were transiently trtnsfected with dil lcRcd-I12R.: \ chromosomal 
region surrounding a single nucleolus was photobleached using :a 413 laser for F. (: 1 P with a 
square mark. Shown here is a prophase cell undergoing chromosomal condensation. 'Ihc 
images shown here from left to right are a series of optical sections of 1.2µm in the z-axis and 
only the signals for 112B are shown to illustrate the bleached mark. Yellow: overlapped 
signals from ECFP-11213 and diHcRed-11213 and Red: bleached region with signals from 
di-IcRed-112B only. Scale bar = 1(aun. 
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NOR-containing chromosomes are rearranged during the cell cycle, possibly using the lac 
operon-lacI-GFP system (Belmont and Straight, 1998). This is especially interesting as 
recent studies suggested that even a transcriptionally silent NOR-containing chromosome 
can be recruited to the nucleolus (Sullivan et al., 2001). 
T-74 On Nncleolar dynamics and non-dynamics 
Another interesting aspect of nucleoli is how this organelle is maintained, to an extent that 
it can be isolated as a functional complex, if most of the components studied so far are 
continually exchanged with the nudeoplasm (Shopland and Lawrence, 2000; Misteli, 2001 a; 
Misteli, 2001b; Pederson, 2001b). Indeed, the only way to explain the apparent `stability' of 
this and other subnuclear structures is to `envision that their composition at any given time 
includes so many stabilised molecules that the shuttling fraction does not materially affect 
the very existence of the particle' (Pederson, 2002a). For example, two components of 
PML bodies, PML and sp100 do not shuttle between the nucleoplasm and the PML body, 
while a third component, CBP, does (Boisvert et al., 2001). Could there be any similar non- 
shuttling factors to be found in the nucleolus? 
It is also possible that RNA molecules provide a structural framework for subnuclear 
structures. Xrrt RNA has recently been shown to play a structural role in stablising the 
inactive X chromosome (Clemson et at, 1996). The abundance of non-coding poly(A)+ 
RNA retained in splicing speckles within the nucleus has been speculated to have a 
structural role (Huang et al., 1994). Similarly, Cajal bodies have been shown to associate 
with U2 gene loci, surprisingly via its own transcript, U2 snRNA (Frey and Matera, 2001). 
Although a lot of nucleolar RNA species are currently known, what is needed is a further 
systematic analysis of RNAs from isolated human nucleoli. Any such study should 
especially focus on smaller RNAs, considering the recent expansion of a new RNA class 
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known as microRNAs which are of 21-23 nucleotides in length (Ambros, 2001; McManus 
and Sharp, 2002; Moss, 2002). 
Or is it the presence of a multitude of different protein-protein or protein-RNA interaction 
modules that holds the nucleolus together? It should be noted that about 10% of the 
human nucleolar proteome contains the RNA recognition motif RRM and, more 
surprisingly, 30% of the nucleolar proteins contains at least one RR[GR] motif (Chapter 
III). Potentially, the arginine residue in the RG sequences can be methylated and many 
RNA binding proteins such as SmB, SmD1, SmD3, Lsm5, fibrillarin, hnRNP U and 
hnRNP Q contain this motif (Paushkin et al., 2002). It is possible that this motif may be 
mediating interaction with other protein and/or RNA molecules. Moreover, are the 5% of 
nucleolar proteins containing the protein-protein interaction WD domain involved in 
binding other nucleolar proteins? Perhaps, nucleolar targeting is more like what happens in 
the ER where, instead of a particular signal peptide targeting proteins to the ER, proteins 
that flows away to the Golgi apparatus are retrieved back to the ER by the retention signal 
KDEL through a shuttling receptor. For example, viral proteins such as HIV-1 Tat and 
Rev are known to piggy-back to the nucleolus through the binding of the molecular 
chaperone B23 that shuttles between the nucleoplasm and the nucleolus (Hiscox, 2002). 
I proposed in Chapter IV that certain `adhesive elements', which could be either RNAs or 
proteins, hold the nucleolus together. If the appearance of the nucleolus is a direct effect of 
ongoing rRNA transcription, it is difficult to explain why the different subnucleolar 
domains still contain their usual components when transcription is inhibited, rather than 
dispersing to the nucleoplasm. So, what holds these factors in distinct subnucleolar 
domains, even without apparent transcriptional activity going on? The pre-rRNA transcript 
may be the initial nucleation factor for nucleolar assembly, but there may exist another 
mechanism to stabilise the nucleolus once it is formed. As discussed in Chapter IV, the 
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formation of the nucleolus may be similar to a mechanism where cells sort themselves into 
distinctive clusters according to the differential adhesiveness of different cell types 
(Steinberg, 1964; Armstrong, 1989; Steinberg and Takeichi, 1994). Different subnucleolar 
domains may have their own set of `adhesive elements' and hence arrange themselves into 
the most stable, and hence functionally efficient, configuration. Understanding the 
mechanism behind this may also help explain the change in the number and size of 
nucleoli, and other merging and splitting events observed in other subnuclear structures. 
Dynamics' of nuclear proteins has come to be synonymous with photobleaching 
experiments using FP-fusion protein expressed in live cell. Re-examination of the recent 
FRAP data collected for GFP fusions to nucleolar proteins revealed several interesting 
facts (Table VI-1). First, the transcription inhibition of RNA polymerase I by a low dose of 
Actinomycin D causes an increase in the diffusion coefficients of fibrillarin, nucleolin, 
Rpp29, B23 and RPS5, but not the transcription factor UBF (Dundr et al., 2000; Phair and 
Misteli, 2000; Snaar et al., 2000; Chen and Huang, 2001; Dundr et al., 2002). Second, there 
exist -10-20% immobile fractions of the nucleolar factors in the interphase nucleolus, but 
very tiny, if any, immobile fractions in the nucleoplasm. Third, the immobile fractions of 
some RNA polymerase I subunits measured are 0% during mitosis compared with 20% in 
the interphase (Dundr et aL, 2002). This is particularly revealing because in this study I 
observed that the RNA polymerase I is dissociated from the mitotic chromosomes 
between prophase and metaphase. 
Fourth, the data obtained for some proteins are different from one another in two 
independent studies; for example, both the diffusion coefficient D and notably the 
immobile fraction measured for GFP-fibrillarin differ by two-fold (Phair and Misteli, 2000; 
Snaar et al., 2000). The most notable difference, apart from using different cell lines, is that 
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Protein Conditions 
Cell 
line tV2 
Nucleolus 
D Immobile t1/2 
Nucleoplasm 
D Immobile Ref 
GFP-UBF1 I Crd HeI. a 9 0.13667 0 2.8 0.156786 0 [1] 
GFP-UBF1 I ActD Heia 25 0.05684 0.05 2.8 0.51786 0 [I] 
GFP-UBFI I Crtl CMT3** 5 ND 0 ND ND ND [2] 
GFP-UBF1 I Crt1 CMT3** 5 ND 0 ND ND ND [2] 
GFP-UBF1 M Crd CMT3** 5 ND 0 ND ND ND [2] 
GFP-UBF2 I Crd CMT3** 5 ND 0 ND ND ND [2] 
GFP-TAF48 I Crd CMT3** 3 ND 0.1 ND ND ND [2] 
GFP-PAF53 I Crtl CMT3** 10 ND 0.2 ND ND ND [2] 
GFP-PAF53 M Crtl CMT3** <5 ND 0.1 ND ND ND [2] 
GFP-RPA194 I Crd CMT3** 10 ND 0.1 ND ND ND [2] 
GFP-RPA194 I Crd CMT3** 10 ND 0.2 ND ND ND [2] 
GFP-RPA194 M Crd CMT3** <5 ND 0.05 ND ND ND [2] 
RPA43-GFP I Crtl CMT3** 10 ND 0.15 ND ND ND [2] 
RPA43-GFP I Crtl CMT3** 10 ND 0.2 ND ND ND [2] 
RPA43-GFP M Crtl CMT3** 5 ND 0.1 ND ND ND [2] 
RPA40-GFP I Crt CMT3** 10 ND 0.15 ND ND ND [2] 
RPA16-GFP I Crd CMT3** 10 ND 0.2 ND ND ND [2] 
FIB-GFP I Crtl BHK 20 0.046 0.25 3 0.53 0 [5] 
FIB-GFP I Crt1 U2OS* 10 0.02 0.47 ND ND ND [4] 
FIB-GFP I 23-C BIS ND ND ND 3 0.53 0 [5] 
FIB-GFP I - ATP BHK ND ND ND 3 0.53 0 [5] 
FIB-GFP I ActD BHK 10 ND 0.2 ND ND ND [5] 
FIB-GFP I PNB CMT3 3 ND 0.1 ND ND ND [3] 
FIB-GFP I NDF CMT3 3 ND 0.1 ND ND ND [3) 
GFP-nucleolin I Crtl HeLa 9 0.14444 0 1.3 1.15385 0 [1] 
GFP-nudeolin I Act) HeLa 8 0.152941 0 1 1.34657 0 [1] 
GFP-Rpp29 I Crtl Heia 18 0.075 0.05 1 1.5436 0 [1] 
GFP-Rpp29 I ActD HeLa 8 0.164706 0 1.4 1.25833 0 [1] 
GFP-B23 I Crtl HeLa 20 0.0785 0 1 1.51 0 [I] 
GFP-B23 I ActD HcU 17 0.085294 0 1 1.56748 0 [1] 
GFP-S5 I Crd HcLa 72 0.019028 0.4 1.2 1.258333 0 [1] 
GFP-S5 I ActD HeLa 32 0.042813 0.2 1 1.59 0 [1] 
Table VI-1 Summary of FRAP data of GFP-nucleolar components examined so far. 'Conditions' 
indicates the corresponding cell cycle state and metabolic state I for interphaae and M for 
metaphase; Crtl: control, 23°C: cells grown at 23°C, -ATP: cells depleted of ATP and ActD: 
0.04-0.05µg/ml of the transcription inhibitor. Actinomycin D was used at this concentration 
in these studies to specifically inhibit RNA polymerase I. 'Cell line' indicates the 
corresponding cell line: all results are obtained from transient transfections unless specified 
otherwise; * indicates stable teansfection and ** indicates the CMT3/I ISC/NI1I3T3 cell lines 
were used either stably or transiently transfected (which is not specified in the original 
publication); tI/2 indicates the time required to recover half of the fluorescence loss at the 
bleached area and some of the results are estimated from the given plots; D: Diffusion 
coefficient; `Immobile' indicates the immobile fraction; ND = not detennined. See Chapter I 
for the principle of FRAP. References (Req: [1] Chen and Huang, 2001; [2] Dundr et al, 
2002; [3] Dundr et al, 2000; [4] Snaar et al, 2000 and [5] Phair and Mistelf, 2000. 
the case that shows a smaller D and a larger immobile fraction (47%) used a stably 
transfected GFP-fibritlarin cell line. The discrepancy may thus be explained by the presence 
of higher protein level, due to the transient expression of exogenous protein in one case, 
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which could raise the apparent mobility if endogenous binding sites become saturated. 
Moreover, my FRAP data on RNA polymerase I subunit RPA39, using a stably transfected 
HeLa cell line, shows a much longer time for the cell to recover half of the fluorescence 
loss after photobleaching (-400s) compared with 3s obtained by another group, in which 
the report did not specify whether the experiments were performed on transiently or stably 
transfected cells (Dundr et al., 2002). Therefore, it would be better to consider the effect of 
`overexpression' with regard to the number of potential binding sites when interpreting the 
current results (Shopland and Lawrence, 2000), and, more importantly, confirm these 
results by other independent methods. 
Another problem of FRAP and other photobleaching techniques is that they cannot tell 
the molecular status of the protein represented by the data. The result is an integral of free 
or bound, activated or repressed and monomeric or complexed forms of the molecule of 
interest (Chen and Huang, 2001; Lippincott-Schwartz et al., 2001). T'herefore, it may not 
truly represent the diffusion rate of the substrate-bound active form of the molecule within 
a subnuclear structure, e. g. the nucleolus. Moreover, to what extent can we interpret the 
current existing data which contain an immobile fraction within the nucleolus, but not in 
the nucleoplasm, as dynamic? The fact that the protein can be dynamically exchanged 
between the nucleolus and the nucleoplasm does not exclude the possibility that a fraction 
of the molecule (47% in one case for fibrillarin) is either bound to an intranucleolar, 
fixed/stable structure, or else forms large complexes that are restricted in movement. 
VL5 On Integration of expression pathway 
Although subnuclear structures are not separated by membranes, it has been demonstrated 
in this thesis and other studies that directional pathways between structures exist for 
nuclear proteins (Sleeman and Lamond, 1999a; Leung and Lamond, 2002). It is important 
to understand what causes these nuclear proteins to enter a structure? or to leave a 
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structure? One way to understand these is to identify the molecular interaction partners of 
these proteins when they are localised in distinct domains. 
NHPX is known to be the initial nucleation factor that binds the RNA for both snoRNP 
and snRNP (Nottrott et at, 2002; Watkins et al., 2002). One of the possibilities is that 
NHPX changes its RNA partner as it progresses along the pathway. Spliceosomal snRNA 
is known to be exported to the cytoplasm for hypermethylation and is re-imported into the 
nucleus whereas the hypermethylation of snoRNAs occurs in the nucleus, not the 
cytoplasm (Nigg et al., 1991; Sleeman and Lamond, 1999b). Therefore, the 
hypermethylated form of U4 has a physical advantage to interact with the newly expressed 
NHPX in the cytoplasm before their nuclear entry and hence subsequent localisation in the 
splicing speckles. 
But what could possibly trigger the change of RNA partners? I have shown that the 
progression of the NHPX pathway requires ongoing pre-mRNA transcription. As 
discussed in chapter V, the progression may rely on splicing of those pre-mRNAs whose 
introns contain pre-snoRNAs (Weinstein and Steitz, 1999). It is feasible that the U4 
snRNP is disassembled after each round of splicing, and the factors, which form the 
complex, e. g. NHPX, are recycled. Therefore, NHPX may be released from the once- 
packed complex and is now able to bind to the nascent snoRNA (Hirose and Steitz, 2001). 
As all snoRNAs in vertebrates are housed within the introns of a family of 5' TOP pre- 
mRNA transcripts (see Chapter I), whose products are commonly ribosomal proteins or 
factors related to ribosomal biogenesis (Weinstein and Steitz, 1999), this model may link 
the splicing of gene transcripts that are related to ribosomal biogenesis to the production of 
snoRNAs that guide the modification of rRNAs. To test this model, in vif» assembled 
NHPX-U3 and -U4 RNPs can be microinjected into HeLa cells to examine and contrast 
their localisation and hence test whether the localisation is dependent on the RNA species 
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NHPX binds to. Moreover, it would be interesting to test whether splicing or transcription 
is more important for the progression of the NHPX pathway by inhibiting splicing rather 
than the transcription of pre-mRNA specifically in d w. 
Another interesting aspect of this pathway is the continual presence of NHPX in Cajal 
bodies, both at the early and late stage, although the pathway still progresses in cell lines 
lacking prominent Cajal bodies. As gems and Cajal bodies are often colocalised within 
human nuclei, it would be interesting to see which subnuclear compartment NHPX would 
go to at different stages in a cell line such as HeLa PV, that shows a separation of Cajal 
bodies and gems, or in coilin-knockout mouse cells (Liu and Dreyfuss, 1996; Tucker et al., 
2001). These approaches should give insights into understanding which protein 
components in Cajal bodies/gems are interacting with NHPX during the pathway 
progression. 
VI. 6 Final words 
As described by Valentin back in 1836, the nucleolus is like `a secondary nucleus within the 
nucleus'. In fact, its complexity revealed by its subcompartmentalisation may provide a 
good model to study how the nucleus is organised. The number of nucleolar proteins 
(-400-500) is ideal for identifying modular sets of proteins which perform specific 
functions by large-scale profiling of the proteins under many different conditions. The 
opportunity to isolate functionally intact nucleoli using a well-established protocol, possibly 
from the established Heia cell lines with fluorescently labeled subcompartinents, provides 
a reproducible in vitro system to test models both biochemically and microscopically. The 
current understanding of the human nudeolar proteome and dynamics may be nothing but 
a teaser trailer, yet we are all welcome to the show. 
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WW hen adult neurons are injured, 
myelin-associated glycoprotein 
(MAG) triggers signals to block the 
regrowth of axons, a process that is 
intensely frustrating to patients and 
researchers hoping to treat such injuries. 
On page 565, Yamashita et al. identify 
a receptor complex responsible for trans- 
ducing this signal, elucidate part of the 
associated intracellular signaling pathway, 
and uncover a novel molecular interaction 
that may help explain the diverse activities 
of a neurotrophin receptor. 
MAG signaling is known to inhibit 
axonal regrowth after injury, but the 
MAG receptor on neurons remained 
unknown. By analyzing neurons from 
wild-type and mutant mice, the authors 
discovered that p75NTR a glycoprotein on 
the surface of many types of neurons, 
transduces the MAG signal. Since p75NTR 
also binds to neurotrophins, which promote 
axonal outgrowth, the same receptor 
seems to be capable of transducing both 
growth and inhibitory signals. 
Rather than binding directly to p75N IR 
MAG interacts with a complex of p75" 
ä 
and the ganglioside GTI b. This is the first 
time a ganglioside has been shown to act 
as a coreceptor, a finding that may set a 
precedent for future analysis of these 
molecules. MAG binding to the complex 
activates RhoA, which has previously been 
shown to inhibit neurite extension. The 
results suggest that GT1b acts primarily 
as a binding partner, whereas p75N1 R is 
a signal transducing element for MAG. 
Since gangliosides are found in lipid 
rafts, an intriguing possibility is that 
p75NTR interacts with different factors in 
a raft to transduce opposite types of 
signals, depending on its interaction with 
MAG or neurotrophins. Molecules that 
target specific components of these pathways 
might be able to induce desired growth 
patterns in injured neurons.   
Nuclear proteins get around 
Protein trafficking be- tween the cytoplasm and 
the nucleus has been stud- 
ied extensively; but how do 
proteins move from one site 
to another within the nu- 
cleus? On page 615, 
Leung and Lamond focus 
on the intranucleartrafficking 
of the RNA-binding protein 
NHPX, and describe an 
elegant series of experi- 
ments that demonstrates the 
existence of multiple 
intranuclear accumulation 
pathways. The study pro- 
vides definitive evidence of 
protein sorting within 
the nucleus. 
Although previous studies 
have suggested that 
proteins might follow 
directed paths between 
intranuclear bodies, the 
new work provides a 
detailed analysis of this 
phenomenon. NHPX localizes primarily to nucleoli, but 
is capable of binding to both small nucleolar RNAs (snoRNAs) 
and the spliceosomal U4 small nuclear RNA (snRNA). 
The authors followed fluorescent fusion proteins to 
determine that newly expressed NHPX transiently visits 
splicing speckles in the nucleus before accumulating 
stably in the nucleolus, a pattern confirmed in multiple 
cell lines. The move from speckles to nucleolus is apparently 
unidirectional, and requires new mRNA transcription, 
suggesting that other factors must be expressed to allow 
NHPX to leave the speckles. 
Leung and Lamond also compare the trafficking of NHPX 
to that of the SmB protein. In contrast to NHPX, SmB 
accumulates first in Cajal bodies and in the nucleolus, 
before finally accumulating in speckles, indicating that the 
two proteins move through distinct sorting pathways with 
in the nucleus. 
The unidirectional movement of NHPX, combined with 
its previously observed binding properties, suggests that 
NHPX might interact with U4 snRNA in speckles, possibly 
facilitating the maturation of nuclear proteins or RNP 
complexes before moving to the nucleolus. The authors 
are now trying to determine whether other nuclear proteins 
share the separate trafficking routes used by NHPX and 
SmB, and they hope to identify the molecular mechanisms 
responsible for these pathways. "' 
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Turn-ons for axons 
Growth-blocking MAG (green) binds to the 
neurotrophin receptor p75"T` (red). 
A nucleolar protein (green) 
is first (top) found in splicing 
speckles (blue) before later mov- 
ing to nucleolar structures (red). 
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In vivo analysis of NHPX reveals a novel nucleolar 
localization pathway involving a transient 
accumulation in splicing speckles 
Anthony IGL Leong and Angus I. Lamond 
Wellcome Trust Biocentre, MSI/WTB Complex, University of Dundee, Dundee DDI 5EH, Scotland, UK 
The NHPX protein is a nucleolar factor that binds 
directly to a conserved RNA target sequence found 
in nucleolar box CID snoRNAs and in U4 snRNA. 
Using enhanced yellow fluorescent protein (EYFP)- and 
enhanced cyan fluorescent protein-NHPX fusions, we 
show here that NHPX is specifically accumulated in 
both nucleoli and Cajal bodies (CBs) in vivo. The fusion 
proteins display identical localization patterns and RNA 
binding specificities to the endogenous NHPX. Analysis 
of a HeLa cell line stably expressing EYFP-NHPX showed 
that the nucleolar accumulation of NHPX was preceded by 
its transient accumulation in splicing speckles. Only newly 
Introduction 
The cell nucleus is the site at which chromosomes are lo- 
cated, and at which DNA replication and gene expression are 
coordinated and regulated. Many nuclear factors are organized 
into specific structures termed nuclear bodies (for review see 
Lamond and Earnshaw, 1998; Schul et al., 1998; Matera, 
1999; Spector, 2001). Most nuclear bodies are dynamic, disas- 
sembling on entry to M phase and reassembling after mitosis 
(Dundr et al., 2000). Unlike cytoplasmic organelles, nuclear bodies are not enclosed by membranes. Factors can move in 
and out of nuclear bodies (for review see Misteli, 2001), and 
the bodies themselves can also move within the nudeoplasm 
(Boudonck et al., 1999; Platani et al., 2000; Snaar et al., 
2000; Muratani et al., 2001). 
The best-studied subnuclear body is the nucleolus (for 
reviews see Pederson, 1998; Scheer and Hock, 1999; Carmo-Fonseca et al., 2000; Olson et al., 2000; Visintin and Amon, 2000). Whereas -10% of protein-coding genes are 
active at any time, -80% of the total cellular transcription 
activity is devoted to expression of the conserved ribosomal 
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expressed NHPX accumulated in speckles, and the nucleolar 
pool of NHPX did not interchange with the pool in speckles, 
consistent with a unidirectional pathway. The transient 
accumulation of NHPX in speckles prior to nucleoli was 
observed in multiple cell lines, including primary cells that 
lack CBs. Inhibitor studies indicated that progression of 
newly expressed NHPX from speckles to nucleoli was 
dependent on RNA polymerase II transcription, but not on 
RNA polymerase I activity. The data show a specific temporal 
pathway involving the sequential and directed accumulation 
of NHPX in distinct subnuclear compartments, and define a 
novel mechanism for nucleolar localization. 
DNA (rDNA)* repeats in nucleoli by RNA polymerase I 
(Blobel and Potter, 1967). Multiple rDNA transcription 
units are joined together by nontranscribed intergenic spaces 
to form the so-called nudeolar organizing regions (NORs) 
located in human chromosomes 13,14,15,21, and 22. Nu- 
cleoli are assembled on these chromosomal NOR regions af- 
ter every round of mitosis. The rDNA-containing region is 
transcribed to yield a precursor, the 45S pre-rRNA, which is 
processed in a series of posttranscriptional cleavage and 
modification reactions to generate mature rRNA species that 
form the catalytic core of the ribosome (for review see 
Warner, 2001). Various small nucleolar RNAs (snoRNAs), 
for example U3 and U14, are needed for these separate 
rRNA cleavage steps, each snoRNA being required at spe- 
cific steps. The snoRNAs can be categorized into two main 
classes, box C/D (i. e., U3, U8, U14) and box H/ACA (i. e., 
U17, U19, U64), according to conserved sequence elements 
and the way in which they are assumed to fold into defused 
secondary structures (for review see Weinstein and Steitz, 
*Abbreviations used in this paper: CB, Cajal body; ECFP, enhanced cyan 
fluorescent protein; EYFP, enhanced yellow fluorescent protein; FIB, 
fibrillarin; FLIP, fluorescence loss in phoroblaching; GFP, green fluores- 
cent protein; NOR. nucleolar organizing regions; PEG, polyethene gly- 
col; rDNA. ribosomal DNA; snoRNA. small nucleolar RNA. 
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1999). These snoRNAs assemble together with protein fac- 
tors to form snoRNPs that have roles in guiding and cata- 
lyzing posttranscriptional RNA modifications. For exam- 
ple, box C/D snoRNPs direct 2'-O-ribose methylation and 
box H/ACA snoRNPs direct pseudouridylations of specific 
rRNA nucleotides (for review see Lafontaine and Tollervey, 
1998; Lewis and Tollervey, 2000). 
Several nudeolar proteins, including the snoRNP factor 
fibrillarin, have been found in Cajal bodies (CBs) (for review 
see Gall, 2000). These subnudear structures, originally called 
nucleolar accessory bodies, or coiled bodies, are often associ- 
ated with the nucleolar periphery, or even located inside the 
nucleolus (Malatesta et al., 1994; Ochs et al., 1994; Lyon et 
al., 1997; Sleeman et al., 1998). In addition to snoRNPs, they 
also contain splicing snRNPs and some transcription factors; 
however, they do not contain non-snRNP protein splicing 
factors or nascent pre-mRNA. Their snRNP components are 
specifically newly assembled particles (Carvalho et al., 1999; 
Gall et al., 1999; Sleeman and Lamond, 1999a; Sleeman et 
al., 2001). Fluorescently labeled U3, U8, and U14 snoRNAs, 
when microinjected into Xenopus oocytes, accumulate tran- 
siently in CBs prior to nudeoli, suggesting that newly im- 
ported snoRNAs flow from the CBs to nucleoli (Narayanan et 
al., 1999b). Therefore, CBs might be involved in transport 
and maturation of both snRNPs and snoRNPs. 
In higher eukaryotes, most pre-mRNAs must be spliced 
to generate functional mRNAs. Splicing is a nuclear pro- 
cess carried out by a complex RNA protein machine 
termed the spliceosome (for review see Staley and Guth- 
rie, 1998). Although splicing often occurs cotranscrip- 
tionally, the majority of pre-mRNA splicing factors are 
not localized at active transcription sites; instead, they are 
enriched in domains called speckles (for reviews see Slee- 
man and Lamond, 1999b; Misteli, 2000). Recruitment of 
splicing factors to sites of transcription is believed to in- 
volve a cycle of phosphorylation and dephosphorylation 
(for review see Misteli, 1999). 
The advent of green fluorescent protein (GFP) technology 
allows the visualization of tagged proteins and their move- 
ment in living cells (for review see Swedlow and Lamond, 
2001). The use of photobleaching techniques with the GFP 
fusion proteins also allows analysis of protein dynamics (Phair 
and Misteli, 2001; Reits and Neefjes, 2001). Here we describe 
a novel nuclear pathway shown by the nucleolar factor 
NHPX The NHPX protein was recently identified as a puta- 
tive human homologue of yeast NHP2p (Saito et al., 1996), 
and later, independently, as a 15.5-kD RNA-binding protein 
(Nottrott et al., 1999). Subsequent analyses indicated that 
NHPX is the human orthologue of the Saccharomyces cerevi- 
siae Snul3p (Chang et al., 1999; Nottrott et al., 1999). The 
human NHPX protein was also independently identified in a 
directed proteomic analysis of nucleoli isolated from cultured 
HeLa cells (Andersen et al., 2002); it shares a common RNP 
structure that binds to both box C/D snoRNAs and spliceoso- 
mal U4 snRNA (Nottrott et al., 1999; Vidovic et al., 2000; 
Watkins et al., 2000). However, NHPX localizes in nucleoli 
by immunofluorescence (Chang et al., 1999). Here we ana- 
lyze the in vivo pathway by which NHPX accumulates in nu- 
deoli, and show that it involves an unexpected, transient in- 
teraction with splicing speckles. The movement of NHPX 
from speckles to nucleoli is dependent on pre-mRNA tran- 
scription. These data suggest that NHPX may be involved in, 
and possibly link, several parallel RNA metabolic pathways 
that occur in distinct nuclear domains. 
Results 
NHPX is localized to nucleoli and CBs 
NHPX was selected for characterization as part of the anal- 
ysis of the human nucleolar proteome (Andersen et al., 
2002). To address its in vivo localization, the NHPX 
cDNA was isolated from a HeLa cDNA library and tagged 
at its NH2 terminus with the enhanced yellow fluorescent 
protein (EYFP) gene to generate plasmid pAL107EYFP-NHP) 
(see Materials and methods). The localization of the EYFP- 
NHPX fusion protein was analyzed by fluorescence micros- 
copy after transient transfection of pAL107E P-NHPX in 
HeLa cells (Fig. 1), and compared with the nucleolar pro- 
tein fibrillarin (FIB). Transiently expressed EYFP-NHPX 
was colocalized with FIB in the dense fibrillar component 
of nucleoli and also, unexpectedly, in CBs. (Fig. 1 A, arrow 
indicates nucleolus, arrowhead indicates CB). The CB lo- 
calization was confirmed by counterstaining with anti-coi- 
lin antibodies (Fig. 2 A; unpublished data). The localiza- 
tion of NHPX to CBs and nucleoli was also confirmed 
by immunofluorescence (Figs. 1B and S1, available at 
http: //www. jcb. org/cgi/content/full/200201120/DCI). The 
tagged NHPX showed an identical localization to its endog- 
enous counterpart, suggesting that NHPX is a component 
of both nuclear structures (Fig. 1 B). 
To facilitate in vivo analysis of NHPX, we established a 
HeLa cell line stably expressing EYFP-NHPX (see Materials 
and methods). As shown by fluorescence microscopy, the 
EYFP-NHPX protein localized specifically in nucleoli and 
CBs in the HeIAEYPP-NHPX stable cell line (Fig. 2). The 
HeLaEYPP--"Px cell line grows and divides at the same rate as 
the parental HeLa cell line without any apparent cell cycle 
defect, as shown by FACS analysis (Fig. I C; unpublished 
data). The expression level of EYFP-NHPX is comparable 
to that of the endogenous NHPX protein in the HeLa5` 
NHPX cell line (Fig. 1 D). 
To confirm that the EYFP-NHPX fusion protein expressed 
in the Hel, aErPP-r'HPx cell he behaves biochemically as the en- 
dogenous protein, its in vivo RNA-binding specificity was in- 
vestigated. An extract from HeLa" cells was immu- 
noprecipitated using an anti-GFP antibody. RNAs in the 
immunoprecipitate were separated by Urea-polyacrylamide gel 
electrophoresis, transferred to nylon membrane, and hybridized 
with probes for Ul, U2, U4, U5, and U6 snRNAs and U3 
snoRNA (Fig. 1 E). This showed that U3 snoRNA and U4 sn- 
RNA, but not U1, U2, U5, or U6 snRNAs, were preferentially 
isolated with the anti-GFP antibody (Fig. 1 E, lane 3). Control 
experiments, i. e., bead control and an HeLaEG"'--H2B cell ex- 
tract, showed that although the anti-GFP antibody still pulled 
down the fluorescent protein fusion protein (unpublished 
data), it did not pull down any of the RNAs tested from these 
extracts (Fig. 1 I. lane I and 2), whereas the same anti-GFP an- 
tibody pulled down each of the Ul, U2, U4, U5, and U6 sn- 
RNAs, but not U3 snoRNA, from a HeLaECPP-smE cell extract 
(Fig. 1 E, lane 4). These data show that the EYFP-NHPX fu- 
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Figure 1. Transient and stable expression of EYFP-NHPX in HeLa cell line. HeLa cells transiently transfected with pAt. 
107"" NIX for 16 h 
were fixed and counterstained with (A) anti-FIB antibody 72B9 and (B) affinity-purified anti-NHPX serum 
R86. Arrowhead indicates CB and 
arrow indicates nucleolus. (C) DNA content of HeLaIlIP-""rx cells were analyzed by FACS analysis and (D) 
its expression level by immunoblot 
using antiserum R86 and anti-GFP. (E) The in vivo RNA binding activity of EYFP-NHPX was assayed by immunoprecipitation and the 
binding 
of snRNAs U1, U2, U4, U5, and U6 as well as snoRNA U3 were tested by Northern hybridization. Bars, 
5µm. 
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Figure 2. Localization of NHPX during interphase and mitosis. The p. uterns of fYf l' NI IPX in I k't i"" 
"" werd in, il) i yl v' n Jw eng interphase 
and (B) in different stages of mitosis. Anti-coilin 204/10 was used to denote CBs, anti-SC35 to denote speckles and DAPI to show the condensed 
chromosome in mitotic stages. Arrowhead indicates CB, arrow indicates nucleolus, and broken arrow indicates speckles. (C) The pattern of 
EYFP-NHPX in HeLaFViP-NF P" during mitosis was followed after metaphase in a live cell imaged every 3 min. Bars, 5µm. 
lion protein in vivo is specifically complexed with the same and U6 snRNAs usually exist as a duplex inside the nucleus, the 
RNA targets that NHPX was shown to bind directly in vitro immunoprecipitation of U4 snRNA alone is surprising. The 
(Nottrott et al., 1999; Watkins et al., 2000). Given that U4 disruption of the U4/U6 interaction in this assay is unlikely, 
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because a non-Sm RNA, i. e., U6 snRNA, can be coimmuno- 
precipitated with U4 from the ECFP-SmB cell extract under 
the same experimental conditions and using the same anti-GFP 
antibody (Fig. 1 E, lane 4). Another interesting observation is 
that only a small amount of the total U4 snRNA was pulled 
down in these experiments (Fig. I E, lane 3), even though U4 
snRNA is present in similar abundance to U3 snoRNA inside 
HeLa cells (Reddy and Bush, 1988). This suggests that only a 
subset of U4, which is likely not bound to U6, may be interact- 
ing with NHPX in vivo. Alternatively, the fraction of NHPX 
bound to the U4/U6 duplex could be inaccessible to the anti- 
GFP antibodies. 
NHPX is colocalized with U3-containing snoRNPs, 
rather than U4-enriched splicing speckles, 
during interphase 
The ability of NHPX to bind both U3 snoRNA and U4 
snRNA, which normally are located in different subnuclear 
Figure 3. NHPX transiently accumulates 
in splicing speckles. Microinjection of 
pAL107° "NIlIX into (A) transformed 
cell line MCF7 and (B) primary fibroblast 
htertl 787. The microinjected cells 
were fixed at different time points (1 h, 
6h and 16 h) and counterstained with 
anti-SC35 to denote speckles and 
anti-coilin 204/10 to denote CBs. 
Arrowheads indicate CBs, arrows 
indicate nucleoli and broken arrows 
indicate speckles. Bars, 5µm. 
structures, prompted us to investigate further the localiza- 
tion of NHPX under different conditions (Fig. 2). The 
binding of NHPX to the spliceosomal U4 snRNA suggests 
that it should colocalize, at least in part, with other splicing 
factors. However, EYFP-NHPX in the HeLaHIT "t PX cell 
line does not show a speckled nuclear pattern similar to 
other human splicing factors such as SC35 and UIA (Fig. 
2 A, arrowhead indicates CB, arrow indicates nucleolus, 
broken arrow indicates speckles). The anti-NHPX antise- 
rum also does not label speckles (Fig. I B, Chang et al., 
1999). Instead, EYFP-NHPX is accumulated in nucleoli 
and CBs and colocalizes with the snoRNP protein FIB 
(Figs. IA and 2A; unpublished data). Also, nucleolar 
segregation, caused by treating the cells with the transcrip- 
tion inhibitor actinomycin D, results in the relocation of 
NHPX to the nucleolar periphery along with FIB, but does 
not cause it to colocalize with either SC35, or other splic- 
ing factors (unpublished data). 
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Figure 4. Separate targeting pathways A 
for nuclear factors. pAL107E'"FP-NHPX and 
pAL118ECFP-°'B were cotransfected into 
HeLa cells and fixed after (A) 1 and (B) 
24 h. (C) HeLaEYFP-NHPX and HeLaECFP-FIB 
were fused to form heterokaryon using 
PEG and were fixed at 15 min after 
fusion. To show the relative distribution 
of EYFP and ECFP components in each 
nucleus, the central panel shows the 
same two nuclei within a heterokaryon 
as the side panels, but in the opposite 
fluorescence channels. Arrowheads 
indicate CBs, arrows indicate nucleoli, 
and broken arrows indicate speckles; 
dotted ovals outline nuclei in the 
heterokaryon in the central panel. 
Bars, 5 µm. `` 
Analysis of the HeLaEYF'-NH'x cells at different stages of 
mitosis also showed no evidence for the association of 
NHPX with s licin factors (Fig. 2 B). Time-lapse analysis 
of live HeLaEeP-Nrx cells showed that NHPX associated 
with snoRNP-containing nucleoli immediately after the nu- 
clear envelope reforms (Fig. 2 C; unpublished data). Com- 
bined with other immunofluorescence data of fixed cells 
counterstained with anti-FIB (unpublished data), we con- 
clude that EYFP-NHPX does not accumulate with snRNPs 
in speckles, but instead colocalizes with the snoRNP protein 
FIB at all cell cycle stages and metabolic conditions tested. 
The only colocalization of NHPX with splicing snRNPs de- 
tected in vivo was specifically in CBs, structures known to 
accumulate newly imported snRNPs and snoRNPs when 
they first enter the nucleus. 
Newly imported NHPX transiently colocalizes 
with splicing factors 
Next, we investigated the localization of newly synthe- 
sized NHPX because recent data have shown a temporal 
pathway for snRNP and snoRNP localization in nuclei 
(Fig. 3; Carvalho et al., 1999; Narayanan et al., 1999a, 
1999b; Sleeman and Lamond, 1999a; Sleeman et al., 
2001). To our surprise, microinjection of the expression 
vector pAL107rvtr-NHPx into the cultured cell lines, fol- 
lowed by examination in the fluorescence microscope, re- 
vealed that Ih after microinjection, EYFP-NHPX is ac- 
cumulated in splicing speckles and CBs (Fig. 3). 2-6 h 
postmicroinjection, EYFP-NHPX is also detected in nu- 
cleoli, whereas the level of EYFP-NHPX in speckles 
shows a concomitant decrease. At later time points, the 
signal in speckles can no longer be detected and EYFP- 
NHPX accumulates specifically in nucleoli and CBs, re- 
sembling the pattern observed in the HeLaEYFr-NHrx cell 
line during interphase. 
This novel nuclear pathway for NHPX was observed not 
only in parental HeLa cells, but also when newly synthesized 
EYFP-NHPX was expressed after either microinjection or 
transient transfection in other transformed cell lines, in- 
cluding MCF7 (Fig. 3 A, arrowhead indicates CB, arrow 
indicates nucleolus, broken arrow indicates speckles) and 
HEK293 and in primary cell lines, i. e., human foreskin fi- 
broblasts and primary human fibroblasts expressing telom- 
erase htert1787 (Fig. 3 B; unpublished data). Some cell 
lines, i. e., htert1787, do not contain prominent CBs, and 
therefore provide an opportunity to test whether the pres- 
ence of CBs is required for the transport and/or localization 
of NHPX in nucleoli. Microinjection of pAL107tYFI'-"nrx 
into htert1787 cells did not induce the formation of CBs, 
and EYFP-NHPX still relocated in the same temporal se- 
quence from speckles to nucleoli (Fig. 3 B, arrow indicates 
nucleolus, broken arrow indicates speckles). Therefore, the 
presence of CBs is apparently not required for the direc- 
tional movement of NHPX from speckles to nucleoli. 
Newly synthesized NHPX does not colocalize with U3 
snoRNP in speckles 
Next, we examined whether the speckle localization of newly 
synthesized NHPX is a consequence of a previously un- 
known behavior of U3 snoRNP. To test this, an expres- 
sion vector, pALl l8ý`H' 
ESN, encoding ECFP-tagged FIB, a 
known U3 snoRNP component, was cotransfected with 
pAL107"YtP-""i'x into the parental Hel. a cell line and ana- 
lyzed at various time points posttransfection (Fig. 4). At Ih 
posttransfection, ECFP-FIB had already accumulated in 
nucleoli and CBs, whereas in the same cells, EYFP-NHPX 
accumulated in speckles and CBs, but not in nucleoli (Fig. 4 
A, arrow indicates nucleolus, broken arrow indicates speck- 
les). Several hours later, EYFP-NHPX began to accumulate 
in nucleoli and the signal in speckles decreased, whereas the 
Novel nucleolar localization pathway for NHPX I Leung and lamond 6: 1 
A 
B 
C 
D 
Figure 5. Localization of endogenous snRNPs and snoRNPs. pAL107rYFr ""P" was microinjected into HcLa cells and fixed after (A and C) 2 
and (B and D) 24 h. The cells were then counterstained with antisense 2'-O-methyl RNA (A and B) U3 and (C and D) U4 and anti-SC35 to 
show the location of speckles. Arrowheads indicate CBs, arrows indicate nucleoli, and broken arrows indicate speckles. Bars, 5 µm. 
ECFP-FIB remained specifically in nucleoli, and both pro- 
teins were detected in CBs (unpublished data). After one cell 
cycle, EYFP-NHPX and ECFP-FIB both quantitatively 
colocalized in the dense fibrillar component inside nucleoli 
and in CBs (Figs. 1A and 4 B, arrowhead indicates CB, ar- 
row indicates nucleolus, broken arrow indicates speckles; 
unpublished data). Therefore, the transient presence of 
newly expressed NHPX in nuclear speckles is not explained 
by its association with U3 snoRNP. 
The differential timing in the nucleolar entry of NHPX 
and FIB is confirmed by analysis of heterokaryons formed 
between HeLaE`Fj'-EIB and HeLaE'er-NHPX stable cell lines 
(Fig. 4 Q. Formation of heterokaryons between two cell 
lines expressing FP-tagged proteins allows the gradual intro- 
duction of EYFP-NHPX into the HeLaECF"-F11 cells and 
vice versa (Sleeman et al., 2001). The advantages of using 
this heterokaryon approach are that it minimizes the possi- 
ble effect of overexpression that can occur in both microin- 
jection and transient transfection assays, and allows the dy- 
namic exchange of two fluorophores to be observed under 
the same conditions. ECFP-FIB accumulated directly in 
nucleoli as soon as 15 nein after fusion, whereas EYFP- 
NHPX accumulated instead in speckles at the same time 
(Fig. 4 C, arrowheads indicate CBs, arrows indicate nucleoli, 
broken arrows indicate speckles; unpublished data). There- 
fore, the NHPX protein detected in speckles is unlikely to be 
associated with U3 snoRNP. 
The expression of exogenous NHPX raises the possibility 
that the target RNAs it binds to may be upregulated, and 
thereby results in the observed temporal sequence of nuclear 
localization. Therefore, we investigated the in vivo localiza- 
tions of U3 and U4 RNAs in the He[. a cells that were mi- 
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Figure 6. Reciprocal movement of nucleolar proteins SmB and NHPX. HeLa"'V ""'"and HcLa"'" 
"' were fused to form heterokaryon 
using PEG and were fixed at different time points: 0h (A); 0.5 h (B); 2h (C); 4h (D); and 36 
h (E). Panel representation as of I ig. 4 C. 
Arrowheads indicate CBs, arrows indicate nucleoli, and broken arrows indicate speckles; dotted ovals outline nuclei of the 
heterokaryon in 
the central panel. Bars, 5µm. 
croinjected with pAL107EYFP-NHI'X using complementary 2'- jetted cells (Fig. 5A and B, arrowhead indicates CB, arrow 
0-methyl antisense RNAs (Fig. 5; for review see Lamond, indicates nucleolus, broken arrow indicates speckles; unpub- 
1993). The U3 in microinjected cells remained localized in lished data). The U4 snRNA was 
detected in speckles and 
the dense fibrillar component of nucleoli and CBs at both CBs in both the microinjected cells at 
different time points 
early and late time points, similar to control, nonmicroin- and in control, nonmicroinjected cells 
(Fig. 5, C and 1)). 
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Figure 7. Newly expressed NHPX localizes to speckles. HeLa cells were transfected with pAL2141 fNIWX for 24 h lxdore nhIcroinjecting 
pAL107ErrP-NHPX and the microinjected cells were fixed after 1.5 h (A), 4h (B), and 24 h (C), and counterstained with anti-SC35 to denote 
speckles. Arrowheads indicate CBs, arrows indicate nucleoli, and broken arrows indicate speckles. Bars, 5 µm. 
Because the localization of U3 and U4 remained unaltered, 
the differential localization of NHPX at different time 
points is likely not due to the movement or relocalization of 
either of these NHPX target RNAs. These data are consis- 
tent with NHPX binding U4 snRNA in speckles and U3 
snoRNA in the nucleolus. However, we cannot exclude that 
NHPX also binds to different and/or unknown target RNAs 
at the different nuclear structures. 
Reciprocal movement of nuclear proteins 
The NHPX pathway appears complementary to that previ- 
ously described for Sm proteins (Fig. 6; Sleeman and La- 
mond, 1999a; Sleeman et al., 2001). By making heterokary- 
ons between HeLaecFP-Sma and HeLaEYFr-NHPX we observed that 
EYFP-NHPX entered into speckles directly, whereas ECFP- 
SmB accumulated specifically in CBs shortly after fusion (Fig. 
6, A and B; arrowheads indicate CBs, arrows indicate nucle- 
oli, broken arrows indicate speckles). At 2h after fusion, 
ECFP-SmB remained in CBs, whereas the EYFP-NHPX sig- 
nal inside nucleoli increased (Fig. 6 C, arrows indicate nucle- 
oli). In some cells, ECFP-SmB was also detected inside nucle- 
oli, as previously reported (Fig. 6 D; Sleeman and Lamond, 
1999a; Sleeman et al., 2001). At later time points (-36 h), 
the ECFP-SmB signal in speckles increased whereas the 
EYFP-NHPX signal in speckles decreased to a very low/unde- 
tectable level (Fig. 6 E; unpublished data). Therefore, we con- 
clude that both nuclear pathways, though operating in differ- 
ent directions, function simultaneously inside a single cell 
nucleus. The pathways can also be observed by live cell imag- 
ing over a period of 12 h (unpublished data). This demon- 
strates the directed movement of proteins between separate, 
membrane free nuclear compartments. 
Newly expressed NHPX localizes to speckles 
We next investigated whether the directed movement of 
NHPX is either restricted to newly synthesized proteins, or 
whether it is a reversible relocation of existing proteins (Fig. 
7). To test this, pAL214FC ti'-"rtrx was transfected into HeLa 
cells and left for 24 h, such that ECFP-NHPX was already 
accumulated in nucleoli and CBs before microinjection of 
pAL107F. YFIýNH'x. Microinjection of pAL107"''x pro- 
vided a pulse of newly synthesized EYFP-NHPX that accu- 
mulated in splicing speckles and CBs, whereas the previously 
expressed ECFP-NHPX accumulated instead in nucleoli 
and CBs (Fig. 7 A; arrowhead indicates CB, arrow indicates 
nucleolus and broken arrow indicates speckles). Gradually, 
EYFP-NHPX appeared in nucleoli, whereas the signal in 
speckles subsided. The nucleolar pattern of ECFP-NHPX 
remained unaltered after microinjection of pA1.107hYF''-""rx 
(Fig. 7 B, arrow indicates nucleolus). At 24 h postmicroin- 
jection, EYFP-NHPX completely colocalized with the exist- 
ing ECFP-NHPX (Fig. 7 C, arrowhead indicates CB, arrow 
indicates nucleolus). These data indicate that only newly 
synthesized NHPX accumulates in splicing speckles, and 
further argue that this association is transient. Thus, the 
presence of NHPX in speckles is likely not a result of protein 
relocation due to exogenous expression. 
To test further whether or not pools of NHPX in speckles 
and nucleoli interchange, we generated micronuclei by treat- 
ing the HeLars' i'-Nii''x cells with the spindle-disrupting drug 
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Figure 8. NHPX does not accumulate in speckles 
in micronuclei lacking nucleoli. (A) HeLaEVrP-NHVX 
cells were fixed after treating with colcemid for 
31 h and counterstained with anti-SC35 to denote 
speckles and anti-B23 to denote nucleoli. Arrows 
indicate speckles, whereas arrowheads indicate 
the locations of EYFP-NHPX; dotted ovals outline 
the micronuclei. Bar, 5 µm. 
colcemid (Fig. 8). Colcemid inhibits the progress of mitosis 
and renders the segregation of chromosomes into many mi- 
cronuclei without preventing DNA replication, mRNA 
transcription, splicing, and protein translation (Ferreira et 
al., 1997). Nucleoli are assembled only on the nucleolar or- 
ganizer regions in 5 out of 23 chromosomes in human nu- 
clei (Introduction), and therefore the colcemid treatment al- 
lows the generation of a subset of micronuclei without 
nucleoli. To locate those micronuclei, we screened with an 
antibody specific for nucleolar antigen B23. If the two pools 
of NHPX in splicing speckles and nucleoli freely exchange, 
NHPX originally from nucleoli would be expected by de- 
fault to accumulate back in splicing speckles in the micronu- 
clei lacking nucleoli. Interestingly, EYFP-NHPX does not 
accumulate in splicing speckles, even in those micronuclei 
lacking nucleoli (Fig. 8, arrows indicate speckles, arrowheads 
indicate NHPX localizations, inset shows a micronucleus 
that lacks nucleoli); instead, they are localized in spot-like 
structures that also contain the snoRNP protein FIB, but 
not the CB marker coilin (unpublished data). Microinjec- 
tion of pAL107EYFP-NHrx into colcemid-treated parental 
HeLa cells showed the same temporal sequence of localiza- 
tion in speckles prior to nucleoli as seen for untreated cells 
(unpublished data). Therefore, this differential localization 
is apparently not a result of colcemid modifying the NHPX 
pathway and the pools of NHPX localized in splicing speck- 
les and nucleoli appear not to interchange. 
The NHPX pathway is unidirectional 
The noncycling behavior of NHPX between speckles and 
nucleoli prompted us to further investigate the directionality 
of the localization pathway. We performed fluorescence loss 
in photobleachin (FLIP) analyses of different nuclear struc- 
tures in the HeLa YIP-N"i'x cells in which one area of the cell 
is repeatedly bleached while collecting images of the entire 
cell (Fig. 9). If fluorescent molecules from other regions of 
the cell diffuse into the bleached area (Fig. 9, white circle in- 
dicates bleach zone), loss of fluorescence will occur from 
both places, indicating that the regions are connected (for 
review see Reits and Neefjes, 2001). First, we tested whether 
NHPX inside speckles is moving into the nucleolus (Fig. 9 
A, a and c). The positions of speckles were defined by 
DsRED-UIA in live cells (Fig. 9 A, b and d). The fluores- 
cence intensity of EYFP-NHPX in speckles outside the 
bleached region decreased, indicating that NHPX diffuses 
between these nuclear domains (Fig. 9 A, curve b). In com- 
parison, the signals inside nucleoli only showed a minor de- 
crease (Fig. 9 A, curve a). This is consistent with the ex- 
pected movement of NHPX from speckles to nucleoli. The 
small change in nucleolar fluorescence may be because the 
directed movement of NHPX from speckles to nucleoli is 
slow (hours) compared with the experimental time (^-15 
min), and/or because it accounts only for a small fraction of 
the total NHPX signal in nucleoli. However, repeated pho- 
tobleaching of the nucleolus (Fig. 9 B, white circle indicates 
bleach zone) resulted in the immediate loss of signal in 
neighboring nucleoli, indicating that the nucleolar pool of 
NHPX can cycle between different nucleoli (Fig. 9 B, curve 
e). The constant level of fluorescence observed in the speck- 
les in the same experiment further strengthens the argument 
in favor of a unidirectional movement of NHPX from 
speckles to nucleoli (Fig. 9 B, curve 1). 
The difference in fluorescence intensity between speck- 
les and nucleoli raises the possibility that the flow from 
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nucleoli to speckles was not observable in the HeLaE"Fp- 
NHPx cells. To address this, we performed FLIP analysis on 
heterokaryons formed between HeLaIY11-NHrx cells and 
the parental HeLa cells (Fig. 9 Q. The locations of nucle- 
oli in the recipient nuclei were positioned both by phase 
contrast microscopy and by the absence of splicing factor 
UTA. Shortly after the fusion, as shown previously (Figs. 4 
C and 6, A-E), EYFP-NHPX first appeared in splicing 
speckles but was absent from nucleoli in the recipient nu- 
clei. Repeated photobleaching inside the nucleoli did not 
change the fluorescence level of EYFP-NHPX inside the 
speckles of the recipient nuclei (Fig. 9 C, curve i, white 
circle indicates bleach zone). Therefore, NHPX either 
does not cycle from nucleoli to speckles, or else does so at 
Figure 9. FLIP analysis of HeLaErrP-NHrx 
A region in the (A) speckles and (B) 
nucleolus was photobleached repetitively 
every 20 s and the fluorescence inten- 
sities of EYFP-NHPX were analyzed 
over 15 min. The positions of speckles 
were located in the live cells using 
DsRED-U 1A that were transfected into 
the cell lines for 24 h before photobleach- 
ing and the selected region for 
photobleaching were highlighted by 
the white circle in left panel. The 
fluorescence intensities of EYFP-NHPX 
in different regions of the bleached 
and nonbleached cells were com- 
pared in right panel. (C) FLIP analysis 
of the newly imported EYFP-NHPX in 
speckles of the heterokaryon formed 
between HeLarvrP-r, nrx and HeLa cells 
that were both transfected with 
pDsRED-U1A for 24 h. The position 
of the nucleolus for photobleaching 
(left panel, white circle) in the recipient 
nuclei were located by both phase 
contrast microscopy and the absence 
of DsRED-U1A. The fluorescent inten- 
sities of EYFP-NHPX in speckles of 
bleached and nonbleached nuclei 
of the heterokaryon were analyzed 
and shown on the right panel. Dotted 
ovals outline nuclei in the heterokaryon. 
Bars, 5 µm. 
a rate/level that cannot be detected in this assay. In sum- 
mary, the photobleaching analyses, combined with the 
other data presented here, suggest a unidirectional move- 
ment of NHPX from splicing speckles to nucleoli. How- 
ever, pools of EYFP-NHPX appear freely diffusible be- 
tween separate components of the same nuclear structure, 
indicating the regulated entry of nuclear proteins into dif- 
ferent domains inside the nucleus. 
The progression of NHPX from speckles to nucleoli is 
dependent on Pol II, but not Pol I transcription 
Next, we tested whether the progression of NHPX from 
speckles to nucleoli requires gene expression, including 
both Pol I and Pol 11 transcription (Fig. 10). We again em- 
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Figure 10. Transcription-dependent relocation of NHPX from speckles to nucleoli. Heterokaryon formed between HeLa" 
' ""'" and I ieLa"'" "" 
were treated with different transcription inhibitors: control (A); Pol I inhibitor Actinomycin D (0.04 µp/ml) (B); and Pol II inhibitor DRB (1(X) µM) (C). 
Panel representation as of Fig. 4 C. Arrowheads indicate CBs, arrows indicate nucleoli, and broken arrows indicate speckles; dotted ovals outline 
nuclei of the heterokaryon in the central panel. Bars, 5 µm. 
ployed the heterokaryon approach between HeLaECFr-FIB and 
HeLaevFP-NHex cells. At 4h postfusion, only a small amount 
of EYFP-NHPX was in speckles, whereas most accumulated 
in nucleoli (Figs. 6D and 10 A, arrowheads indicate CBs, ar- 
rows indicate nucleoli, broken arrows indicate speckles). The 
heterokaryons formed between Hei YFP-NFIPX and HeLa'" "- 
F'a cells were subjected to transcription inhibitors targeted to 
specific polymerases. Low levels of actinomycin D cause the 
segregation of nucleoli and inhibit rRNA transcription, but 
not pre-mRNA transcription. Newly synthesized EYFP- 
NHPX moved to the speckles of recipient HeLaECF''-F"' nu- 
clei, prior to accumulating in the segregated nucleoli (Fig. 10 
B, arrows indicate segregated nucleoli, broken arrows indicate 
speckles), suggesting that pol I transcription and/or ribosome 
biogenesis is not a prerequisite for the NHPX pathway. Simi- 
larly, the immunosuppressant rapamycin, which inhibits tran- 
scription of a subset of ribosomal protein genes and hence ri- 
bosome assembly, gave the same results (unpublished data). 
However, when RNA pol 11 transcription was inhibited, ei- 
ther by os-amanitin or DRB, progression of the newly synthe- 
sized NHPX from speckles to the nucleolus was blocked (Fig. 
10 C, arrows indicate nucleoli, broken arrows indicate speck- 
les; unpublished data). This suggests that one or more factors 
must be continually synthesized to allow the newly imported 
NHPX to move from speckles to nucleoli. 
Discussion 
In this study we have identified a novel nuclear pathway that 
leads to the nucleolar accumulation of the NHPX protein. 
The pathway was detected in multiple mammalian cultured 
cell lines, including both primary and transformed cells. 
NHPX was analyzed in vivo, fused to either EYFP or ECFP 
fluorescent protein tags, and the resulting fusion proteins 
were shown to have similar localization patterns and RNA 
binding specificities to the endogenous NHPX. A stably 
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transformed HeLa cell line that expressed EYFP-NHPX was 
established and used to demonstrate that, upon its initial en- 
try into the nucleus, newly expressed NHPX transiently 
accumulates in splicing speckles prior to a later, steady- 
state accumulation in nucleoli. Further characterization of- 
HeIaMP NHPX cells indicated that the NHPX protein in 
speckles was not associated with U3 snoRNP and required 
RNA pol II transcription for efficient relocation to nucleoli. 
Additional photobleaching experiments showed that the nu- 
cleolar pool of NHPX did not interchange with the pool in 
nuclear speckles, suggesting a unidirectional pathway. 
Our recent proteomic analysis of nucleoli isolated from 
cultured HeLa cells shows that they contain >270 differ- 
ent proteins (Andersen et al., 2002). So far there has been 
no nucleolar targeting motif identified common to all of 
these factors and it seems likely that multiple, parallel nu- 
cleolar localization pathways can operate. Nonetheless, 
analyses of proteins that show a steady-state accumulation 
in nucleoli have shown that they usually move rapidly into 
the nucleolus when they enter the nucleus. This is illus- 
trated here by the rapid nucleolar accumulation of EYFP- 
FIB when it is transiently expressed in vivo (Fig. 4). The 
finding that newly expressed NHPX accumulates in nu- 
clear speckles transiently before accumulating specifically 
in the nucleolus defines a new localization pathway for nu- 
cleolar proteins. It is interesting to compare this with the 
recently reported pathway for nudeolar localization of 
snoRNAs, which showed that multiple snoRNAs accumu- 
late in CBs prior to nucleoli upon initial entry into the nu- 
cleus (Narayanan et al., 1999a, 1999b; Verheggen et al., 
2001). However, none of the snoRNAs showed a transient 
accumulation in speckles, consistent with our finding that 
the snoRNP protein FIB also does not transiently accumu- late in speckles prior to nucleoli (Fig. 4). We also observed 
that NHPX localizes to CBs as well as speckles upon its 
initial entry into the nucleus, but unlike its transient asso- 
ciation with speckles, NHPX is also detected in CBs at 
later stages of expression when the bulk of the protein is 
concentrated in nucleoli. At present, we cannot distinguish 
whether NHPX accumulates in CBs prior to speckles, or in 
both structures at the same time. However, the CB associa- 
tion does not appear to be obligatory for the NHPX local- 
ization pathway because a similar transient association with 
speckles prior to nucleolar accumulation is observed in cell 
lines lacking prominent CBs (Fig. 3 B). However, similar 
molecular events may occur either within the nucleoplasm 
or in CBs that are too small to detect. 
It is also interesting to compare the NHPX pathway with 
the recently identified nuclear pathway for splicing snRNPs 
where FP-tagged snRNP Sm proteins accumulate in CBs, 
and nucleoli, prior to speckles, upon their initial nuclear en- 
try (Sleeman and Lamond, 1999a; Sleeman et al., 2001). Therefore, this pathway appears to be complementary to 
that of NHPX. By analyzing heterokaryons formed between 
separate stable HeLa cell lines expressing EYFP-NHPX and ECFP-SmB, we could show that both these complementary 
pathways can operate simultaneously within the same nuclei (Fig. 6). These data confirm the specificity of the pathways 
and highlight the dynamic mechanisms operating to orga- 
nize the distribution of proteins and RNPs in the nucleus. 
The results also point to the localization specificity of the 
separate subnuclear bodies, including nucleoli, CBs, and 
speckles, although they are not enclosed by membranes. 
In order to answer why NHPX shows the observed transient 
accumulation in speckles prior to nucleoli, it may be important 
to consider that it is specifically newly expressed and imported 
NHPX protein that is detected in speckles. Several experiments 
showed that NHPX does not localize to speckles by default, and 
that the nudeolar pool of NHPX does not cycle continually to 
and from speckles. For example, in micronuclei that lack NOR 
containing chromosomes (and hence do not have nudeoli), 
NHPX does not accumulate back in speckles or colocalize with 
splicing factors (Fig. 8). FLIP photobleaching experiments also 
showed that whereas nudeolar EYFP-NHPX can exchange 
rapidly between separate nudeoli within the same nucleus, little 
or no exchange occurs with the pool of NHPX in speckles (Fig. 
9). This contrasts with the behavior of the nudeolar protein 
PSPI, which was recently shown to cycle continually between 
nucleoli and paraspecIdes (Fox et al., 2002). 
Our data strongly indicate that the association of NHPX 
with speckles is a temporal phenomenon linked to the entry of 
newly expressed NHPX into the nucleus. For example, tran- 
sient expression of EYFP-NHPX in HeLa cells expressing 
ECFP-NHPX, which already accumulated in nucleoli, shows 
a transient accumulation of the EYFP-NHPX in speckles be- 
fore it later colocalizes quantitatively with the existing nude- 
olar ECFP-NHPX (Fig. 7). Also, when the HeIaE "" 
cells undergo mitosis, EYFP-NHPX immediately relocalizes to 
the reforming nucleoli during telophase and does not accumu- 
late in speckles in the postmitotic nuclei (Fig. 2). Therefore, 
the speckles association is not a result of nuclear import of 
NHPX per se, but rather relates to an effect specific for newly 
expressed protein. We propose that a likely explanation for this 
behavior of NHPX could be related to it having a function re- 
quired for the assembly or maturation of some form of nuclear 
protein or RNP complex, prior to its subsequent stable associa- 
tion with U3 and/or other nudeolar snoRNPs. This could im- 
ply either that the affinity of NHPX for different target RNAs 
changes after it enters the nucleus for the first time or that its 
access to bind snoRNA targets is initially restricted. 
Based upon the results of previous biochemical studies on 
the structure and binding specificity of NHPX, the U4 sn- 
RNA is a possible candidate target for NHPX in speckles. 
NHPX binds U4 snRNA in vitro via the 5' stem loop se- 
quence (Nottrott et al., 1999; Vidovic et al., 2000). Consis- 
tent with this idea, U4 snRNA has been localized to speckles 
in HeLa cells by hybridization experiments (Carmo-Fonseca 
et al., 1992; Fig. 5). The fact that we show here that EYFP- 
NHPX likely interacts in vivo with a form of U4 snRNA that 
is not stably associated with U6 snRNA suggests that NHPX 
may transiently interact in speckles with an immature form of 
U4 snRNP (Fig. 1 E). The observed requirement for gene ex- 
pression in order for NHPX to move from speckles to nudeoli 
might reflect a requirement for other factors to be expressed to 
allow NHPX to complete its transient role in speckles (Fig. 
10). Whether this is connected to U4 snRNP assembly and/or 
some other events remains to be established. Future studies 
will aim to analyze further the molecular mechanism involved 
in the novel nudeolar localization pathway detected for 
NHPX and to establish what biological role this may play. 
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Materials and methods 
Plasmid constructs 
NHPX cDNA (gi: 26185777) was isolated for PCR amplification from 
Marathon-Ready HeLa library (CLONTECH Laboratories, Inc. ) using spe- 
cific primers with Bglll and KpnI restriction site attached on the 5' and 3' 
primer, respectively. The amplified fragment was subsequently cloned to 
the Bglli-Kpnl fragment of EYFP-C1 and ECFP-C1 to form pAL1071YFP- 
NM°* and pALZ14mr"-1HP7, respectively, and verified by DNA sequencing. 
Cell culture, transfection, and establishment of stable cell line 
HeLa, MCF7, HEK293, and primary fibroblast htert1787 were grown in 
DME supplemented with 10% FCS and 100 U/ml penicillin and streptomy- 
cin (Invitrogen). 2 pg plasmid construct per 100-mm dish was used for 
transfection using Effectene (QIAGEN) according to the manufacturer's in- 
struction. EYFP-NHPX and EYFP-FIB stable cell lines were generated essen- 
tially as described in Sleeman et al. (2001). ECFP-SmB stable cell line 
(CFPSmBE8.8) was previously described (Sleeman et al., 2001). EGFP-H28 
stable cell line was a gift from T. Kanda (The Salk Institute for Biological 
Studies, La Jolla, CA) Wanda et al., 1998). Drug treatments were carried out 
as follows: Actinomycin D (0.04 µg/ml, 3 h; Sigma-Aldrich); DRS (100 p. M, 
4 h; Sigma-Aldrich); a-amanitin (40 µM, 4 h; Sigma-Aldrich); and colcemid 
(0.5 µg(ml, 31 h; Sigma-Aldrich). 
FACS analysis 
Parental Hela and HetaF''`"' H" cells were harvested by trypsinization, 
and fixed in 70% ethanol for 3h at 4°C. Cells were stained with PI (25 µg/ 
ml) containing RNase A (100 µg/ml). Fluorescence was measured using a 
FACScan (Becton Dickinson). Cell debris and fixation artifacts were gated 
out. Data analysis was done using Cell Quest software (Becton Dickinson). 
Immunoprecipitation and immunoblotting 
For immunoprecipitation, 100 pg protein G Sepharose (Amersham Phar- 
macia Biotech) was preincubated with 10 µg anti. GFP antibodies (Roche). 
Extracts were prepared using nuclear lysis buffer (Sleeman et al., 2001). Ex- 
tracts were precleared with 100 µg protein C Sepharose and then incu- bated with antibody-bound protein G Sepharose for 16 h. Beads were then 
washed three times with the lysis buffer, and bound RNAS were released 
by Proteinase K (2.24 mg/ml) in extraction buffer (0.63% SDS, 26.25 mM 
EDTA, 26.25 mM Tris-HCI, pH 8.0,0.28 mg/ml yeast tRNA) for 45 min at 
65°C. RNAS were precipitated by adding 7 vol of EtOH/NH4OAc (86% 
EtOH, 0.57 M NH4OAc), and washed once with 70% EtOH. Northern hy- 
bridizations were done by standard procedures (Lamond et al., 1989). 
For immunoblotting, protein samples were separated by 4-12% Bis-iris 
gels (Novex), and subsequently transferred onto nitrocellulose membrane 
using a submarine system (Novex). After blocking with 5% milk powder in 
PBS+0.05% Tween-20, the membranes were incubated with either rabbit 
anti-NHPX R86 (1: 100; Chang et al., 1999) or mouse monoclonal anti- 
GFP (1: 1,000; Roche), and the bound antibody was then probed using 
anti-rabbit HRP (1: 2,000; Pierce Chemical Co. ) and anti-mouse HRP con- 
jugate, respectively (1: 5,000; Pierce Chemical Co. ) in PBS containing 5% 
milk powder and 0.05% Tween-20, and detected via chemiluminescence 
with ECL Plus (Amersham Pharmacia Biotech). 
Immunostaining and 2'. O-methyl RNA hybridization 
Cells grown on coverslips were washed in PBS and fixed for 10 min in 
3.7% (wtivol) paraformaldehyde in CSK buffer (10 mM Pipes, pH 6.8,10 
mM NaCI, 300 mM sucrose, 3 mM MgCl2,2 mM EDTA) at RT, permeabi- lized with 1% Triton X-100 in PBS for 10 min at room temperature, 
mounted onto glass slides using VectorShield (Vector Lab), and imaged 
as described below. Antibodies used were anti-FIB monoclonal 72b9 
(1: 10; Turley et al., 1993); anti-NHPX peptide antibody R86 (1: 100; 
Chang et al., 1999); anti-SC35 monoclonal (1: 500; Sigma-Aldrich); anti- 
coilin 204/10 (1: 300; Bohmann et al., 1995); anti-623 (1: 75; Santa Cruz 
Biotechnology); and TRITC-, Texas red-, and Cy5-conjugated secondary 
antibodies (Jackson Laboratories). Before being mounted on slides, cov- 
erslips were incubated with I µM DAPI (Sigma-Aldrich) for 30 s to stain DNA. Fluorescence microscopy of fixed cells was carried out using a 
100X NA 1.4 Plan-Apochromat objective. Three-dimensional Images 
and sections were recorded either on a LSM410 Confocal microscope 
(ZEISS) or on a Zeiss DeltaVision Restoration microscope (Applied Preci- 
sion, Inc. ). Images presented here are maximal intensity projections of 
the entire nuclear fluorescence. 
For 2'-O-Methyl RNA hybridization (Carmo-Fonseca et al., 1992), 
cells were permeabilized with 0.5% Triton X-1 00 in CSK buffer contain. 
Ing Complete (Roche) on ice for 3 min, and were then fixed in freshly 
prepared 3.7% paraformaldehyde in CSK buffer for 10 min at room tem- 
perature. Cells were washed three times in PBS, one time with 6x SSPE, 
and prehybridized with 6x SSPE/5 X Denhardt's solution containing 
yeast tRNA (0.5 mg/ml) for 15 min. Cells were then hybridized with the 
same buffer with biotinylated 2'-O-methyl antisense oligonucleotide 
probe (2 µM) for 30 min, and then were washed three times with 6x 
SSPE and rinsed with avidin wash buffer (0.03 M Hepes, pH 7.9,0.15 M 
KCI, 0.05%Tween-20,1% donkey serum) before Incubating with Texas 
red-conjugated avidin DCS (Vector labs) at 2 p. glml for 30 min. They 
were then washed and mounted on slides for microscopic studies as 
above. (U3 probe 1011: 5' - 'C'CUUUCGCUCCUC'C"C - 3'; U4 
probe 1012: 5' - 'C'CUGCCACUGCGCAAAGCU'C"C - 3'; ' denotes 
biotinylated sites). 
Mitotic studies of living cells 
Cells were grown on 40-mm glass coverslips (Intracel) in medium contain- 
ing 200 µg/mI G418. Cells were maintained at 37'C by use of a closed- 
system perfusion chamber (Bioptech) in DME media (20 mM Hepes, with- 
out Phenol red; Invitrogen). Images were collected using the 100X NA 1.4 
Plan-Apochromat objective on the Zeiss-DeltaVision Restoration micro- 
scope. For each nucleus, 20-30 optical sections in the z-axis were re- 
corded. The Hg lamp was attenuated with a 0.5-OD neutral density filter, 
and images were recorded every 3 min over a time period of 2h (3 X3 
binning). Time-lapse images were viewed as maximal intensity projections 
of each time point (SoftWoRx; Applied Precision, Inc. ). 
Microinjection and heterokaryon formation 
For microinjection, pAL107 was diluted to 20 µg/ml with injection buffer 
(100 mM glutamic acid, pH 7.2 [with citric acid], 140 mM KOH, 1 mM 
MgSO4, and 1 mM DTT) prior to Injection into living cells using an Eppen- 
dorf 5242 microinjector. For heterokaryon formation, two different cell 
lines expressing fluorescent proteins were mixed in a ratio of 1: 1 In 100- 
mm diameter petri dishes containing coverslips and cultured until 80-90% 
confluent. The culture medium was drained, and 1.5 ml of S0% Polyethyl- 
ene Glycol (PEG hybrimax; Sigma-Aldrich) was added. The dishes were 
rocked gently for 90 s and washed thoroughly by several changes of fresh 
culture medium (a modification of Sleeman et at. 2001). 
Photobleaching analysis 
Cells were grown on 42-mm glass coverslips (no. 1; Helmut Sauer) In 
medium containing 200 µg/mI 0418. Cells were maintained at 37'C by 
use of a closed perfusion chamber (Bachofer) in DME media (20 mM 
Hepes, no Phenol red; Invitrogen). Photobleaching experiments were 
carried out on a Zeiss 510 confocal laser scanning microscope equipped 
with an argon-krypton laser (ZEISS). The 488-nm laser and a 63X plan 
Apolens with a 1.4 NA and a laser power of 2.5% was used for image 
acquisition, and 2S% was used for photobleaching. An area of 16 X 16 
pixels was bleached with an iteration of 250 (duration of bleach was 
3 s). An image was collected after every bleaching event, with 20-s Inter- 
vals between each bleaching event over a period of 15 min. To locate 
splicing speckles in vivo, plasmid pDsRED-U1A was transfected Into the 
cells 24-36 h before imaging. Speckles were defined by red fluores. 
cence, whereas nucleoli were defined by both phase contrast and the 
absence of UTA. 
Online supplemental material 
Fig. 51 (available at httpJAvww. jcb. org/cgi/content4ull/2OO2Oll2O/DCl) 
depicts immunofluorescence labeling of HeLa cells using anti-NHPX anti. 
bodies either with (A) or without (B) transient transfection with pAL107t''F" 
NMP% Panel A is identical to Fig. 18 In the text. 
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Yeast Pescadillo is required for multiple activities 
during 60S ribosomal subunit synthesis 
MARLENE OEFFINGER, 1 ANTHONY LEUNG, 2 ANGUS LAMOND, 2 and DAVID TOLLERVEY' 
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ABSTRACT 
The Pescadillo protein was identified via a developmental defect and Implicated In cell cycle progression. Here we 
report that human Peccadillo and its yeast homolog (Yphip or Nop7p) are localized to the nucleolus. Depletion of 
Nop7p leads to nuclear accumulation of pre-60S particles, Indicating a defect In subunit export, and it Interacts 
genetically with a tagged form of the ribosomal protein Rp125p, consistent with a role In subunit assembly. Two 
pre-rRNA processing pathways generate alternative forms of the 5.8S rRNA, designated 5.8SL and 5.8S9. In cells 
depleted for Nop7p, the 27SA3 pre-rRNA accumulated, whereas later processing intermediates and the mature 5.8Ss 
rRNA were depleted. Less depletion was seen for the 5.8SL pathway. TAP-tagged Nop7p coprecipitated precursors to 
both 5.8SL and 5.8S$ but not the mature rRNAs. We conclude that Nop7p is required for efficient exonucleolytic 
processing of the 27SA3 pre-rRNA and has additional functions in 60S subunit assembly and transport. Nop7p Is a 
component of at least three different pre-60S particles, and we propose that it carries out distinct functions In each 
of these complexes. 
Keywords: nucleolus; pre-rRNA; ribosome; RNA processing 
INTRODUCTION 
Most steps in ribosome synthesis take place within the 
nucleolus, a specialized subnuclear structure. During 
ribosome synthesis, a complex processing pathway con- 
verts a large pre-rRNA to the mature 18S, 5.8S, and 
25S/28S rRNAs (see Fig. 1 B). In addition, the mature 
rRNA sequences within the pre-RNA undergo exten- 
sive covalent nucleotide modification and assembly with 
the 80 ribosomal proteins. More than 80 nonribosomal 
proteins that are required for ribosome synthesis have 
been Identified by genetic and biochemical approaches 
In yeast (see Kressler et al., 1999; Venema & Tollervey, 
1999; Warner, 2001). Biochemical analyses in human 
cells have Identified an even larger number of nucleo- 
lar proteins (Anderson et al., 2002), although In most 
cases, their function in ribosome synthesis has not yet 
been directly addressed. Subdomains of the human 
nucleolus can be identified microscopically. Transcrip- 
tion of the rDNA is believed to occur at the boundaries 
of the fibrillar centers with Initial processing and pre- 
ribosome assembly occurring In the associated dense 
fibrillar component (DFC) regions. Later processing and 
Reprint requests to: David Tollervey, Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, EH9 3JR, United Kingdom; e-mail: d. tollervey©ed. ac. uk. 
assembly of the pre-ribosomes occurs in the surround- 
ing granular component (GC) of the nucleolus (see, 
e. g., Shaw & Jordan, 1995; Scheer & Hock, 1999; Lyon 
& Lamond, 2000). Most analyses of subnuclear struc- 
ture have been performed on vertebrates and plants, 
but similar structures are present in yeast (Leger- 
Silvestre at al., 1997,1999). 
During pre-rRNA processing, the 27SA2 pre-rRNA 
can be processed by two alternative pathways (Henry 
et al., 1994; see Fig. 1 B). In the major pathway, the 
pre-rRNA is cleaved at site A3 by RNase MRP, forming 
the 27SA3 pre-rRNA. Subsequent exonuclease diges- 
tion to site B, s requires the two known 5' -+ 3' exo- 
nucleases, Xrn1 p and Ratt p, and generates the 5' end 
of the 27SBs pre-rRNA and mature 5.8Ss rRNA (Henry 
et al., 1994). An alternative, poorly understood, path- 
way processes the pre-rRNA at site BIL, the 5' end of 
the 27SBL pre-rRNA. Both 27SB pre-rRNAs are sub- 
sequently processed, by apparently Identical path- 
ways, to generate the mature 25S rRNA and either the 
5.8Ss or 5.8SL rRNAs (see Fig. 1). The ratio between 
the two forms of 5.8S shows some variation between 
strains, but around 75-80% of the population Is nor- 
mally made up of 5.8S5, which is 8 nt shorter than 
5.8SL. Similar 5' heterogeneity Is seen for 5.8S rRNA 
from many other Eukaryotes, including humans, Xen- 
opus, Drosophila, and plants (Henry et al., 1994), sug- 
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FIGURE 1. Pre-rRNA processing in S. carevisiae. A: Structure and 
processing sites of the 35S pre-rRNA. This precursor contains the 
sequences for the mature 18S, 5.8S, and 25S, which are separated 
by the two internal transcribed spacers ITS1 and ITS2 and flanked 
by the two external transcribed spacers WETS and 3'ETS. The po- 
sitions of the oligonucleotide probes utilized in northern hybridization 
and primer extension analyses are Indicated B: Pre-rRNA process- 
Ing pathway. The 35S pre-rRNA is generated by 3' cleavage at site 
Bo. 35S is then cleaved at site Ao to produce the 33S pre-rRNA, 
which is rapidly cleaved at site A,, producing the 32S pre-rRNA. 32S 
Is cleaved at site A2, separating the precursors to the 40S and 60S 
subunits, the 20S and 27SA2 pre-rRNAs, respectively. 27SA2 is pro- 
cessed via two alternative pathways. In the major pathway, cleavage 
at site As by RNase MRP produces 27SA3, which is then trimmed to 
site Bis by the 5' to 3' exonucleases Rat1 p and Xrn 1 p, producing the 
27SBs pre-rRNA. Alternatively, 27SAZ can be processed to 27SBL by 
an undetermined mechanism. 27SBs and 27SBL are matured to the 
5.8$ and 25S by identical pathways. Trimming to site B2 generates 
the mature 3' end of the 25S rRNA. Cleavage at site C2 and exonu- 
clease digestion by Rat1 p and Xrnl p generates the 5' end of mature 
25S. The 3' end of the 5.8S is generated by 3' to 5' exonuclease 
digestion from site C2 to E. For reviews on pre-rRNA processing and 
trans-acting factors see Kressler at at. (1999). Lafontaine and Tol- 
lervey (2001), and Venema and Tollervey (1999). 
gesting that the existence of two processing pathways 
Is both conserved and functionally significant. 
The Pescadillo gene was initially identified in Zebra- 
fish as the site of retrovirus Insertion, which resulted in 
defects In embryonic development (Allende et al., 1996). 
Pescadillo mRNA showed widespread expression in 
developing mouse embryo brain with Increased protein 
levels in replicating cells (Kinoshita et al., 2001). Pro- 
tein levels were also Increased In malignant cells (Kino- 
shita et al., 2001), possibly related to previous reports 
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of increased nucleolar size and ribosome synthesis In 
such cells. Pescadillo was localized to the nucleolus In 
Hela cells (Kinoshita et al., 2001) and the Schizosac- 
charomycespambehomolog, SPBC19F5.05c, was also 
found to be nucleolar In a high throughput screen for 
subcellular localization of GFP fusion proteins (Ding 
et al., 2000). While this work was in progress, charac- 
terization of the yeast Pescadillo homolog Yph 1 p/Nop7p 
(YGR1 03w) was reported. YGR1 03w was originally pub- 
lished under the name of YPH1(Kinoshita et al., 2001), 
but has been designated as NOP7 by the Saccharo- 
myces genetic database. Nop7p is essential for viabil- 
ity and two temperature-sensitive (ts) lethal mutant 
alleles were reported to block growth at different steps 
in the cell-cycle; yph1-24 led to arrest In G1, whereas 
the yphl-45 allele caused G2 arrest (Kinoshita et al., 
2001). G1 arrest Is expected for mutations defective In 
ribosome synthesis, which are unable to pass the "Start" 
checkpoint control, but G2 arrest would not normally be 
predicted for a ribosome synthesis defect. In addition, 
Pescadillo was observed to contain a BRCT domain 
(Haque et al., 2000), which was originally identified in 
the breast and ovarian cancer gene BRCA1 and has 
been identified In several proteins Involved In cell-cycle 
checkpoints and DNA repair (reviewed In Bork et at., 
1997). Based on these observations, Pescadillo and 
Yphlp/Nop7p were proposed to perform some cell- 
cycle specific function. 
A proteomic analysis of the human nucleolus identi- 
fied 271 putative nucleoiar proteins Including Pesca- 
dillo (Anderson et al., 2002), the nucleolar localization 
of which was confirmed by YFP-tagging. A database 
search clearly identified YGR103w as the probable yeast 
homolog and we therefore analyzed Its role in ribo- 
some synthesis. While this work was in progress, the 
purification of a precursor to the 60S ribosomal subunit 
was reported that made use of a tagged form of Nop7p 
(Harnpicharnchal et at., 2001). This analysis did not, 
however, describe the effects of depletion of Yph1p/ 
Nop7p on pre-rRNA processing or ribosome synthesis. 
Here we show that Nop7p Is required for formation of 
27SBs, and therefore of the mature 5.8Ss rRNA, from 
the 27SA3 pre-rRNA and has additional functions in 
subunit assembly or export. 
RESULTS 
Human Pescadillo and yeast Nop7p 
are localized to the nucleolus 
A proteomic analysis of purified human nucleoli Identi- 
fied 271 proteins, one of which was Pescadillo (Ander- 
son et at., 2002). To confirm this localization, an eYFP- 
Pescadillo construct was expressed In Hela cells by 
transient transfection (Fig. 2A). Comparison of the lo- 
calization of eYFP-Pescadillo (shown In green; Fig. 2A4) 
to a DIC Image (Fig. 2A1) showed Its predominant lo- 
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FIGURE 2. Nucleolar localization of Pescadillo and Nop7p. A: Localization of human Pescadillo compared with known 
nucleolar markers. (1,4) Hela cells were fixed 16 h after transfection with EYFP-Pescadillo. Comparison to the DIC image 
(1) shows localization of eYFP-Pescadillo (4; green) to nucleoli (arrowheads). 2,3,5, and 6: As markers for subnucleolar 
distribution, the EYFP-Pescadillo transfected cells (2; green) were cotransfected with the granular component protein 
ECFP-B23 (3; blue) and decorated with antibodies directed against the dense fibrillar component (DFC) protein fibrillarin 
(5; red). Scale bar = 5µm. B: Localization of Nop7p. The GAL:: nop7-TAP strain also expressing the nucleolar marker 
DsRedNopl p was examined by indirect immunofluorescence using an anti-protein A antibody coupled to FITC. Also shown 
is the position of the nucleus visualized by DAPI staining and a wild-type control strain. 
calization to nucleoli (indicated by arrowheads) with a 
low level of nucleoplasmic staining. 
The subnucleolar distribution of eYFP-Pescadillo 
(Fig. 2A2) was compared to the GC marker eCFP- 
tagged B23/nucleophosmin (Npml) (shown in blue; 
Fig. 2A3) and the DFC marker fibrillarin (shown in red; 
Fig. 2A5). Fibrillarin is a component of the box C+D 
snoRNAs (Schimmang et al., 1989) that function early 
in ribosome synthesis, whereas B23 is a putative as- 
sembly factor and nuclease that is believed to act later 
in ribosome synthesis (Biggiogera et al., 1990; Savkur 
& Olson, 1998). In vitro, B23 is reported to cleave a 
pre-rRNA reporter within ITS2 (Savkur & Olson, 1998), 
at a site potentially equivalent to C2 in the yeast pre- 
rRNA. Fibrillarin is concentrated in the DFC whereas 
B23 was reported to localize to the periphery of the 
DFC and the GC based on immuno-EM (Biggiogera 
et al., 1990), consistent with a later role for B23 in 
nucleolar ribosome maturation. The distribution of 
eYFP-Pescadillo resembled that of eCFP-B23, but was 
distinct from that of fibrillarin. eYFP-Pescadillo and 
eCFP-B23 were largely excluded from the DFCs (one 
Yeast Pescadillo is a pre-rRNA processing factor 
of which is indicated by an arrow) and concentrated in 
the surrounding area, which presumably corresponds 
to the GC. The distribution of eYFP-Pescadillo is con- 
sistent with a late role in nucleolar ribosome synthesis. 
The essential yeast protein Nop7p (YGA103w) is 40% 
identical to human Pescadillo. To determine whether 
Nop7p is also nucleolar, it was epitope tagged with a 
tandem-affinity purification (TAP) construct (Rigaut et al., 
1999) using a one-step PCR protocol (see Materials 
and Methods). The tagged construct was integrated at 
the NOP7 locus under the control of the GAL 10 pro- 
moter and is the only source of Nop7p. The host strain, 
YDL401, has reduced galactose permease activity lead- 
ing to reduced GAL induction (Lafontaine & Tollervey, 
1996). This eliminates the overexpression generally 
seen with GAL-regulated constructs and allows faster 
appearance of phenotypes following transfer to glucose 
medium. The GAL:: nop7-TAP cells exhibited no detect- 
able growth defect on permissive RSG medium, show- 
ing the fusion construct to be fully functional (data not 
shown). 
To determine the location of Nop7-TAP, cells were 
examined by indirect immunofluorescence (Fig. 2B) 
using a rabbit anti-protein A and a secondary FITC- 
coupled goat anti-rabbit antibody to detect the protein 
A region of the TAP tag (Rigaut et al., 1999). As a 
marker for the nucleolus, a DsRed fusion with the nu- 
cleolar protein Nopi p (the yeast homolog of fibrillarin) 
was coexpressed as previously described (Gadal et al., 
2001 b), and the nucleoplasm was identified by DAPI 
staining. Anti-protein A preferentially decorated the nu- 
629 
cleolus, with a weaker signal over the nucleoplasm. No 
cytoplasmic signal was detected. We conclude that 
Nop7p is localized to the nucleus with nucleolar enrich- 
ment. The significant nucleoplasmic staining would be 
consistent with association with late pre-ribosomes that 
have been released from the nucleolus (see Milkereit 
et al., 2001). 
Yeast Nop7p is required for 60S subunit 
export and interacts genetically with 
GFP-tagged Rp125p 
To examine the possible functions of Nop7p in ribo- 
some synthesis, its expression was placed under the 
control of a repressible GAL 10 promoter using a one- 
step PCR technique in strain YDL401 (see Materials 
and Methods). Growth of the GAL:: nop7 strain was not 
clearly different from the isogenic wild-type strain on 
RGS medium, but was progressively slowed following 
transfer to glucose medium, commencing around 6h 
after transfer (Fig. 3A). The yph1-45 allele of NOP7 is 
reported to lead to a G2 arrest phenotype, consistent 
with a specific cell-cycle defect (Kinoshita et al., 2001). 
However, microscopic inspection of the GAL:: nop7strain 
following transfer to glucose medium showed only the 
accumulation of unbudded cells, even after 24 h, indi- 
cating arrest in G1 (data not shown). This is the ex- 
pected phenotype for a defect in ribosome synthesis 
that results in the inability to pass the "Start" checkpoint. 
Several recent studies have made use of fusions 
between ribosomal proteins and GFP to follow the ex- 
A 1300000 
100009 
1001 
Iooq 
O 100; 
9 " 
G.. 4L:. aup7/Rot25.10- 
G. 4 : nop7/Rprls. 4-c FIGURE 3. Nop7p is required for 60S subunit export and 10 
1 GAL-ýpý 
interacts genetically with GFP-tagged Rpl25p. A: Growth 
curves of GAL:: nop7 strains following transfer to glucose 
-, A medium, 
with and without expression of Rpl25p-eGFP. 
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Strains were pregrown in RGS medium and transferred 
m for the times indi medi Strain ated l 3 10 ýO u c . s were ucose to g 
hows in glee maintained 
in exponential growth by dilution with pre- 
warmed medium. Cell densities measured by ODD are 
B shown corrected for dilution. (fa) Wild-type; (") GAL:: nop7; 
DAPI Rp125 GFP Merge 
(") GAL:: nop7; rp125.10-GFP; (A) GAL:: nop7; rpl25.4- 
GFP. B: Subcellular distribution of Rpl25-eGFP in a 
GAL:: nop7 strain. Rpl25-eGFP was examined by fluores- 
Z, cence microscopy during growth in RGS medium and fol- 
RSG lowing transfer to glucose medium for 2 and 8 h. The 
position of the nucleus was visualized by DAPI staining, 
which also stains the cytoplasm more weakly due to the 
presence of mitochondria. In the merged image, DAPI stain- 
ing is shown in red and Rpl25-GFP is in green. 
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port of 60S ribosomal subunits from the nucleus to the 
cytoplasm (Stage-Zimmermann et al., 2000; Baßler 
et al., 2001; Gadal et al., 2001a, 2001b; Milkereit 
et al., 2001; Fatica et al., 2002). To look for 60S subunit 
export defects, Rpl25p-eGFP (Gadal et al., 2001b) 
was expressed from a plasmid in the wild-type and 
GAL:: nop7 strains. As previously reported, expression 
of this construct had little effect on the growth of the 
wild-type strain (Gadal et al., 2001 b) or the GAL:: nop7 
strain on galactose medium (data not shown). Unexpect- 
edly, growth of the GAL:: nop7/Rpl25p-eGFP strain was 
very rapidly inhibited following transfer to glucose me- 
dium (Fig. 3; two independent transformants are shown). 
These strains also express the wild-type Rp125p, show- 
ing that the Rpl25p-eGFP fusion is dominant negative 
for growth in strains with a reduced level of Nop7p. The 
growth inhibition is much more rapid than would have 
been expected for a strain that is simply unable to syn- 
thesize new ribosomes (see Discussion) and we con- 
clude that Nop7p has a role in 60S ribosomal subunit 
assembly. 
The distribution of Rpl25p-eGFP was followed dur- 
ing depletion of Nop7p (Fig. 3B). During growth of the 
GAL:: nop7strain on RSG medium, Rpl25-eGFP showed 
the normal, predominantly cytoplasmic distribution. 
After transfer to glucose medium for 2 h, increased 
nuclear staining of Rpl25-eGFP was already visible, 
and accumulation was strong after 8 h. The distribution 
of Rpl25-eGFP fluorescence matched that of DAPI stain- 
ing, indicating that it was not restricted to the nucleolus. 
We conclude that Nop7p is required to allow the export 
of precursors to the 60S ribosomal subunit from the 
nucleoplasm to the cytoplasm. 
Nop7p is required for pre-rRNA processing 
The effects of depletion of Nop7p were assessed by 
Northern hybridization (Fig. 4), primer extension (Fig. 5), 
and pulse-chase labeling (Fig. 6). 
Depletion of Nop7p resulted in mild accumulation of 
the 35S primary transcript and the appearance of low 
levels of the 23S RNA, but had little impact on levels of 
the 27SA2 or 20S pre-rRNAs, or the mature 18S rRNA 
(Fig. 4A). In contrast, the level of the 27SB pre-rRNAs 
was clearly reduced by 8h after transfer to glucose 
medium and the mature 25S rRNA was depleted over 
time. 
Analysis of low-molecular-weight RNAs showed pro- 
gressive reduction in the levels of the 7S and 6S pre- 
rRNAs following transfer of the GAL:: nop7 strain to 
glucose medium (Fig. 4Bb). The level of the mature 
5.8S was also reduced (Fig. 4Bc), and the reduction in 
5.8Ss appeared slightly greater than for 5.8SL. The pre- 
rRNA that extends from A2 to C2 was not accumulated 
during Nop7p depletion (Fig. 4Ba), in contrast to the 
recently reported effects of depletion of another pro- 
cessing factor, Ssf1p (Fatica at al., 2002). 
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FIGURE 4. Northern analysis of the effects of Nop7p depletion on 
pre-rRNA processing. Lanes 1 and 2: wild-type strain in RGS me- 
dium and 24 h after transfer to glucose. Lanes 3-7: GAL:: nop7strain 
in RGS medium and after transfer to glucose medium for the times 
indicated. A: (a) Hybridization of probe 003, complementary to ITS1 
upstream of A3. (b) Hybridization with probe 020, complementary to 
the 5.8S/ITS2 boundary. (c) Hybridization with probe 007, comple- 
mentary to the 25S rRNA. (d) Hybridization with probe 002, comple- 
mentary to ITS1 upstream of A2. (e) Hybridization with probe 008, 
complementary to 18S rRNA. B: (a) Hybridization with probe 003, 
complementary to ITS1 upstream of A3. (b) Hybridization with probe 
020, complementary to the 5.8S/ITS2 boundary. (c) Hybridization 
with probe 017, complementary to 5.8S rRNA. (d) Hybridization with 
probe 041, complementary to 5S rRNA. RNA was separated on a 
1.2% agarose/formaldehyde gel (A) or 8% polyacrylamide/urea gel 
(B). Probe names are indicated in parentheses on the left. 
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FIGURE 5. Primer extension analysis of pre-rRNA processing. 
Lanes 1 and 2: wild-type strain in RGS medium and 24 h after trans- 
fer to glucose medium. Lanes 3 and 4: GAL:: nop7 strain in RGS 
medium and 24 h after transfer to glucose medium. A: Primer ex- 
tension using oligo 006, which hybridizes within ITS2,3' to site C2. 
Primer extension stops at sites A2, A3, Bis, and BIL show the levels 
of the 27SA2,27SA3,27SBL, and 27SBs pre-rRNAs, respectively. 
B: Primer extension using oligo 007, which hybridizes within 25S 
rRNA. The primer extension stop at C2 shows the level of the 26S 
pre-rRNA. 
5.8S5 is processed from the 27SBs pre-rRNA, 
whereas 5.8SL is processed from 27SBL (see Fig. 1 B). 
To determine the levels of the 27SB species, they were 
analyzed by primer extension (Fig. 5A) using an oligo 
hybridizing within the 3' region of ITS2 (oligo 006; see 
Fig. 1 A). Following growth of the GAL:: nop7 strain on 
glucose medium, the level of 27SBs was clearly re- 
duced relative to 27SBL, as shown by the primer ex- 
tension stops at Bjs and BIL, respectively (Fig. 5A, 
lane 4). Consistent with the northern analysis, little al- 
teration was seen in the level of 27SA2, as shown by 
the primer extension stop at site A2. In contrast, the 
level of 27SA3, shown by the stop at site A3, was sub- 
stantially elevated. Using a primer hybridizing within 
the mature 25S rRNA (oligo 007; see Fig. 1 A), slight 
accumulation was seen for the primer extension stop 
at site C2, the 5' end of the 26S pre-rRNA (Fig. 5B). 
This effect was weak, however, and its significance is 
unclear. 
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FIGURE 6. Pulse-chase analysis of rRNA synthesis. Pre-rRNA was 
pulse labeled with [3H]uracil for 2 min at 30°C and chased with a 
large excess of unlabeled uracil for the times indicated. Labeling was 
performed for the GAL:: nop7strain (lanes 1-6) and a wild-type strain 
(lanes 7-12) 16 h after transfer to glucose medium. 
Pulse-chase analysis with [H3]-uracil was performed 
16 h after transfer to glucose minimal medium (Fig. 6). 
Comparison of the wild-type and GAL:: nop7 strains 
showed that accumulation of the 5.8S rRNA was mildly 
delayed. 
Together these data show that depletion of Nop7p 
resulted in reduced exonuclease digestion from site A3 
to site 131s. In consequence, the level of the 27SA3 
pre-rRNA was substantially increased, whereas the 
27SBs pre-rRNA was depleted together with the 7Ss 
and 6Ss pre-rRNAs, leading to reduced accumulation 
of the mature 5.8Ss rRNA. The 5' end of the 25S rRNA 
is also generated by exonuclease digestion (Geerlings 
et al., 2000; see Fig. 1 B), but this did not appear to be 
strongly affected, as only a small increase was seen in 
the primer extension stop at site C2. The mild effects on 
35S processing are likely to be indirect, as many mu- 
tations that inhibit synthesis of 60S subunits result in 
partial inhibition of the early pre-rRNA processing steps 
(for further discussion see Venema & Tollervey, 1999). 
Nop7p is associated with pre-rRNAs 
from both processing pathways 
To determine whether Nop7p associated specifically 
with the 27SBs branch of the processing pathway, co- 
precipitated RNAs were analyzed by northern analysis 
and primer extension. Northern hybridization (Fig. 7A, B) 
showed that the 27SB and 7S pre-rRNAs coprecipi- 
tated with Nop7-TAP, but were not detectably recov- 
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FIGURE 7. Analysis of RNAs coprecipitated with TAP-tagged Nop7p. 
Lane 1: Total RNA control (5 µg). Lane 2: Precipitate from a wild-type 
control strain. Lane 3: Precipitate from a strain expressing Nop7-TAP. 
A: Northern hybridization of high-molecular-weight RNA separated 
on a 1.2% agarose/formaldehyde gel. B: Northern hybridization of 
low-molecular-weight RNA separated on an 8% polyacrylamide/urea 
gel. C: Primer extension analysis. Nop7-TAP was immunoprecipi- 
tated from cell lysates using IgG agarose, with release of bound 
RNA-protein complexes by cleavage of the protein A linker by TEV 
protease. RNA was recovered from the released material, and from 
a mock-treated, isogenic wild-type control strain. Oligonucleotides 
used are indicated in parentheses. The preparation used in C is 
different from that used for A and gave lower recovery efficiency. 
ered in the mock precipitation from the nontagged 
wild-type strain. In contrast, the 27SA2 and 6S pre- 
rRNAs were not detectably coprecipitated. The 25S 
rRNA gave the same background signal in both the 
wild-type and Nop7-TAP precipitates. Inspection of the 
original figure showed that both the 7SL and 7Ss pre- 
rRNAs were coprecipitated. 27SBL and 27SBs cannot 
be resolved by northern hybridization, but primer ex- 
tension from oligo 006 in ITS2 (see Fig. 1A) showed 
that both the 27SBL and 27SBs pre-RNAs were copre- 
cipitated with Nop7-TAP (Fig. 7C). 
Nop7p has a specific role in formation of the 27SBs 
pre-rRNA but is associated with pre-rRNAs in both pro- 
cessing pathways, consistent with the conclusion that 
it has additional roles in 60S subunit assembly and 
export. 
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DISCUSSION 
We show here that the yeast homolog of Pescadillo is 
required for the 5' to 3' exonuclease digestion that 
generates the 5' end of the major, short form of the 
5.8S rRNA. Depletion of Nop7p also resulted in strong 
synergistic inhibition of growth in the presence of a 
GFP-tagged form of ribosomal protein Rp125p, indicat- 
ing an additional role in 60S ribosome assembly. Nu- 
clear accumulation of Rpl25-eGFP has been used as a 
marker for a defect in nuclear export of pre-60S ribo- 
somal particles (ribosome export or rix phenotype; 
Gadal et al., 2001 b), and this was also observed fol- 
lowing Nop7p depletion. We conclude that Nop7p is 
required for a specific pre-rRNA processing step as 
well as correct pre-60S assembly and nuclear export. 
During the course of this work, Nop7p was shown to 
be a component of at least three different pre-ribosomal 
complexes with substantially different protein compo- 
sition, as well as differences in pre-rRNA components 
(Baßler et al., 2001; Harnpicharnchai et al., 2001; Fatica 
et al. 2002; see Fig. 8). These analyses allow us to 
propose a correlation between the pre-ribosomal par- 
ticles with which Nop7p is associated and the distinct 
defects in ribosome synthesis that are seen on its 
depletion. 
The earliest pre-60S particle with which Nop7p is 
known to be associated is pre-60S E,. This complex is 
also associated with the 27SA2,27SA3, and 27SB pre- 
rRNAs (Fatica et al., 2002) and it is therefore very likely 
that Nop7p is required for processing from 27SA3 to 
27SB within the pre-60S E, particle. 
A fast acting, dominant negative phenotype is asso- 
ciated with the expression of a GFP-tagged form of the 
ribosomal protein Rp125p in strains depleted of Nop7p. 
The fact that expression of Rpl25-GFP is dominant in- 
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0 -- -- O FIGURE 8. Model for the roles of Nop7p in 60S subunit biogenesis. 
Outline pathway of biogenesis of 60S and 40S ribosomal subunits. 
modified from Felice at al. (2002). This model indicates the presence 
of Nop7p in three different pre-60S complexes designated E,, E2, 
and M, which can be correlated with the different functions deduced 
for Nop7p. PrefOS E, contains the 27SA3 pre-rRNA, the processing 
of which is defective in strains lacking Nop7p. Rp125p is not present 
in pre-60S E,, but joins the pre-60S E2 particle, and the defect in 
Rp125p assembly is therefore predicted to occur at this step. The 
pre-60S M complex contains numerous factors required for 60S sub- 
unit export as judged by the nuclear retention of a Rpl25-GFP re- 
porter construct, and Nop7p is likely to be required during the 
acquisition of export competence within this complex. 
Yeast Pescadillo is a pre-rRNA processing factor 
dicates that, in its presence, the wild-type Rp125p is no 
longer able to support growth. Notably, the inhibition of 
growth was much more rapid and complete than would 
be expected for a strain that was simply unable to syn- 
thesize new ribosomes due to pre-rRNA processing 
defects. Many such mutants have been analyzed (re- 
viewed In Venema & Tollervey, 1999) and predomi- 
nantly show a gradual increase in doubling time, as 
preformed ribosomes are depleted by growth. The very 
rapid onset of growth inhibition, seen in the Nop7p- 
depleted strain expressing RIp25-GFP, indicates that 
this does not require substantial depletion of the pre- 
existing ribosome pool. We speculate that production 
of defective subunits prevents the remaining, other- 
wise functional, ribosomes from carrying out efficient 
translation. The pre-60S E, complex lacks RpI25p, which 
Is added only to the pre-60 E2 particle (Harnpicharn- 
chai et al., 2001; Fatica et al., 2002). We therefore 
predict that the genetic interaction between GAL:: nop7 
and Rp125-GFP reflects a requirement for Nop7p in the 
correct assembly of Rpl25p, and perhaps other factors, 
with the pre-60S E2 complex. 
Several recent studies have made use of a fusion 
between Rp125p and GFP to follow the export of 60S 
ribosomal subunits from the nucleus to the cytoplasm 
(Baßler et al., 2001; Gadal et al., 2001 a, 2001b; Ho 
et al., 2000; Milkereit et al., 2001; Fatica et al., 2002). 
There Is considerable data showing that free r-proteins 
do not accumulate in the absence of ribosome synthe- 
sis. The accumulation of RIp25-GFP has therefore been 
taken as evidence for the accumulation of pre-ribosomal 
particles in the nucleoplasm, indicating a defect In their 
export. This assay has defined a late pre-ribosomal 
particle (pre-60S M in Fig. 8), all tested components of 
which are required for 60S subunit export. These in- 
clude Nugi p, Nug2p, Noc2p, Noc3p, and Rixi p as well 
as Nop7p itself (Baßler et al., 2001; Gadal et al., 2001 a, 
2001 b; Milkereit et al., 2001). Mutations in any of these 
proteins leads to defects in export, suggesting a re- 
quirement for the intact structure of this pre-ribosomal 
particle. Because multiple components of this complex 
are required for subunit export, we predict that export 
competence is established within this particle, and that 
this activity requires Nop7p. 
Mutations in Nugip, Nug2p, Noc2p, Noc3p, or Rix1p 
did not result in pre-rRNA processing defects similar 
to Nop7p depletion or synergistic interactions with 
Rp125-GFP (Baßler et al., 2001; Milkereit et al., 2001) 
Indicating that these are distinct activities. Moreover, 
Nug1-TAP did not coprecipitate 27SA2 or 27SA3 (Baßler 
et al., 2001; E. Petfalski & D. Tollervey, unpubl. obser- 
vations) Indicating that it associates with the pre-rRNA 
particle only after processing at these sites is com- 
plete. Depletion of a specific component of the pre-60S 
E, complex, Ssf 1 p, also did not interact genetically with 
Rp125-GFP and did not inhibit subunit export as judged 
by nuclear accumulation of Rp125-GFP (Fatica et al., 
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2002). We therefore propose that the roles of Nop7p In 
pre-rRNA processing, assembly, and export are dis- 
tinct and performed within different pre-ribosomal par- 
ticles (see Fig. 8). 
Pescadillo Is a multifunctional protein 
Pescadillo was isolated as a mutation affecting embry- 
onic development (Allende et at., 1996) and a mutant 
allele of the yeast gene resulted in growth arrest in G2 
(Kinoshita et al., 2001), consistent with a specific de- 
fect in cell-cycle progression. Yeast Yhpl p/Nop7p is 
also reported to Interact with Yvhlp (Sakumoto et at., 
2001), a protein-tyrosine phosphatase with a postu- 
lated role in the regulation of sporulation and meiosis. 
There are clear precedents for proteins that function 
both in cell-cycle progression and ribosome synthesis. 
Exit from mitosis In budding yeast requires a group of 
proteins, including the phosphatase Cdcl4p, which 
down-regulate cyclin-dependent kinase activity. Cdcl4p 
is sequestered in the nucleolus In the RENT regulator 
of nucieolar silencing and telophase) complex with Sir2p 
and Neti p, which serves to anchor the complex (Shou 
et al., 1999). In addition, Neti p is required for the main- 
tenance of normal nucleotar structure and its binding 
stimulates RNA polymerase I (Shou et al., 1999,2001). 
These nucleolus-specific functions of Nett p can be sep- 
arated genetically from Its cell-cycle functions In the 
RENT complex. In human cells, the nucleolar p14/ARF 
protein binds and sequesters the negative regulator of 
p53 activity, Mdm2 (Tao & Levine, 1999; Weber et at., 
1999; Zhang & Xiong, 1999). Free Mdm2 ubiquitinates 
p53 and transports it to the cytoplasm where It is de- 
graded by the proteosome (Fuchs et at., 1998; Geyer 
et at., 2000), and the nucleolar sequestration of Mdm2 
contributes to the inhibition of this activity by ARF. Mouse 
Pescadillo was Identified by Its up-regulation In cells 
lacking p53 (Kinoshita et at., 2001), but other inter- 
actions with the p53 system have not been reported. 
The available data suggest that yeast Nop7p may 
function both In ribosome synthesis and In cell-cycle 
regulation. Whether its role In the cell cycle Involves 
other protein components of the pre-ribosomal parti- 
cles or a different set of Interactions remains to be 
determined. 
MATERIALS AND METHODS 
Strains 
Growth and handling of Saccharomyces cerevislae were by 
standard techniques. GAL-regulated strains were pregrown 
In RGS medium, containing 2% raffinose, 2% galactose, and 
2% sucrose, and harvested at intervals following a shift to 
medium containing 2% glucose. Strains for pulse-chase analy- 
sis were pregrown In minimal RGS medium lacking uracil and 
shifted to minimal glucose medium lacking uracil. Strains for 
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Immunofluorescence studies were grown in minimal glucose 
medium lacking leucine. 
Yeast strains used and constructed in this study are listed 
in Table 1. Conditional mutants under the control of the re- 
pressible GAL 10 promoter were generated by one-step PCR 
strategy In the strains YDL401 and BMA64 (Lafontaine & 
Tollervey, 1996). Transformants were selected for HIS+ proto- 
trophy and screened by PCR. TAP-tagged strains were con- 
structed by one-step PCR strategy In the GAL-mediated strain 
GAL. nop7(Rigaut et al., 1999). Transformants were screened 
by Immunoblotting and PCR. 
TAP-tagged strains were transformed with pUN100Ds 
RedNOP1 (kindly provided by E Hurt and U. Heidelberg) to 
allow ready identification of the nucleolus, and pYEplacl95- 
L25-eGFP to look at nuclear export of 60S ribosomal subunits. 
For construction of eYFP-PES, complementary DNA of 
human Pescadillo gene (GI: 2194202) was isolated by PCR 
amplification from Marathon-Ready Hela cDNA library (Clon- 
tech) using specific primers with Bgll i and EcoRI restriction 
sites attached to the 5' and 3' primer, respectively. The am- 
plified fragment was subsequently cloned to the Bglli-EcoRI 
fragment of eYFP-C1 and verified by DNA sequencing. 
RNA extraction, northern hybridization, 
and primer extension 
RNA was extracted as described previously (Tollervey & 
Mattaj, 1987). For high-molecular-weight RNA analysis, 7µg 
of total RNA were separated on a 1.2% agarose gel contain- 
Ing formaldehyde and transferred for northern hybridization 
as described previously (Tollervey, 1987). Standard 6% or 
8% acrylamide-8 M urea gels were used to analyze low- 
molecular-weight RNA species and primer extension reac- 
tions. Primer extensions were performed as described 
previously (Beltrame & Tollervey, 1992) on 5 Ag of total RNA 
using primers 007 and 006. 
For pre-rRNA and rRNA analysis the following oligonucle- 
otides were used: 
002: 5'-GCTCTTTGCTCTTGCC; 
003: 5'-TGTTACCTCTGGGCCC; 
006: 5'-AGATTAGCCGCAGTTGG 
007: 5'-CTCCGCTTATTGATATGC; 
008: 5'-CATGGCTTAATCTTTGAGAC; 
017: 5'-GCGTTGTTCATCGATGC; 
TABLE 1. Yeast strains used and constructed in this study. 
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020: 5'-TGAGAAGGAAATGACGCT; 
041: 5'-CTACTCGGTCAGGCTC. 
Immunofluorescence 
For localization of yeast Nop7p, cells were grown In selective 
medium to midexponential phase, fixed by Incubation In 4% 
(v/v) formaldehyde for 30 min at 25°C, and spheroplasted. 
Immunofluorescence was then performed as described pre- 
viously (Grands at al., 1993; Bergbs at al., 1994). Protein A 
fusions were detected with a rabbit anti-Protein A antibody 
(Sigma) and a secondary goat anti-rabbit antibody coupled 
to FITC (Sigma) at 1: 1,000 and 1: 200 dilutions, respectively. 
To stain nuclear DNA, DAPI was Included In the mounting 
medium (Vectashield, Vector Laboratories). Cells were viewed 
on a Zeiss Axioscop microscope. 
Cells containing pYE195-Rpl25-eGFP were grown In SD- 
LEU to midexponential phase, fixed In 4% (v/v) formaldehyde 
for 30 min, and pelleted. Cells were resuspended In 100 mM 
KH2Ac/K2HAc/1.1 M sorbitol and mounted onto slides using 
moviol, containing DAPI. To detect Rpl25-eGFP In vivo In the 
fluorescence microscope, the GFP-signal was examined In 
the fluorescein channel of a Zeiss Axioscop microscope (Hurt 
at al., 1999). Pictures were obtained with SmartCapture VP. 
The localization of eYFP-Pescadillo was determined after 
transient transfection Into Hela cells. EYFP-PES and eCFP- 
B23 were cotransfected for 6h using Effectene (Qulagen) 
according to the manufacturer's protocol and fixed after 42 h 
using 3.7% paraformaldehyde in CSK buffer. Cells were per- 
meabilized and decorated with antibodies against dense fi- 
brillar component marker fibrillarin (7289) and the granular 
component marker B23 (anti-B23). Cells were Imaged using 
a Zeiss LSM41 0 confocal microscope or a Zeiss Delta Vision 
Restoration microscope (Applied Precision, Inc. ). Images pre- 
sented here are maximal projections of the entire nuclear 
fluorescence. 
Immunoprecipitation of GAL:: nop7-TAP 
For immunoprecipitation of GAL": nop7-TAP, cells were grown 
in YPgaI to ODD -2 and lysed In buffer A (150 mM KAc, 
20 mM Tris-Ac, pH 7.5,5 mM MgAc) with 1 mM DTT, 0.5% 
Triton X-100,2.5 mM vanadyl-ribonucleoslde complexes 
(VRC), and 5 mM PMSF (phenylmethylsuiphonylfluoride) at 
Strain Genotype Rererenos 
YDL401 MATa his=00 leu221 trpI ura3-52 galt gala 108 Lafontaine & Tollervey, 1996 
YMOI as YDL401 but GAL10:: nop7-H! S3 This work 
YM02 as YDL401 but GAL10:: nop7-TAP-TRP1 This work 
YM03 as YM02 but pUN100-DsRednopl LEU1 This work 
YM04 as YM01 but pRS315-Rp125-eGFP This work 
BMA64 MATa ade2-1 hls3-11, -151eu2-3, -112 UP 14, ura3.1 F. Lacroute YM05 as BMA64 but pA3ura3 This work 
YM06 as SMA64 but GAL10:: nap7, pA3ura3 This work 
YCA31 as YDL401 but GAL10:: prot. A-RRP4, RRP6: (K! )TRPI Allmang at al., 1999 
GAL:: DOB1 MATa ura3-1 ade2-1 his3.11, -15Ieu2-3,412 tip 1.1 
Dobl:: HIS3MX6 +[pAS24-DOBI] de la Cruz at at,, 1998 
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4 °C using glass beads (Sigma). Immunoprecipitation with 
rabbit IgG agarose beads and subsequent TEV cleavage 
were performed as described (Rigaut et aL, 1999). RNA was 
extracted with buffer AE/phenol-chloroform, ethanol precipi- 
tated (Schmitt et al., 1990), and analyzed by northern hybrid- 
ization and primer extension. 
Pulse-chase labeling experiments 
Pulse-chase labeling of pre-rRNA was performed as previ- 
ously described (Tollervey at al., 1993) using 100 µCi [5,6- 3H]uracil (Amersham) for 2 min at 30°C. Unlabeled uracil 
was added to a final concentration of 240 µgmL- '. Samples 
(1 mL) were taken, transferred to microcentrifuge tubes at 
room temperature, and spun for 10 s at full speed in an 
Eppendorf centrifuge. Cell pellets were frozen In liquid N2. 
Total RNA was extracted with buffer AE/phenol-chloroform 
and ethanol precipitated (Schmitt et al., 1990). [H3]-labeled 
pre-rRNA and rRNA was resolved on 1.2% agarose gels for 
high-molecular-weight RNAs and 8% acrylamide-8 M urea 
gels for low-molecular-weight RNAs. RNA was transferred to 
Hybond-N+ Nylon membranes (Amersham), dried, and ex- 
posed to X-ray film for 10 days at -80 °C with an intensifying 
screen. 
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Summary 
Background: The nucleolus Is a subnuclear organelle 
containing the ribosomal RNA gene clusters and ribo- 
some biogenesis factors. Recent studies suggest it may 
also have roles in RNA transport, RNA modification, and 
cell cycle regulation. Despite over 150 years of research 
Into nucleoli, many aspects of their structure and func- 
tion remain uncharacterized. 
Results: We report a proteomic analysis of human 
nucleoli. Using a combination of mass spectrometry 
(MS) and sequence database searches, Including online 
analysis of the draft human genome sequence, 271 pro- 
teins were identified. Over 30% of the nucleolar proteins 
were encoded by novel or uncharacterized genes, while 
the known proteins Included several unexpected factors 
with no previously known nucleolar functions. MS analy- 
sis of nucleoli Isolated from HeLa cells In which tran- 
scription had been Inhibited showed that a subset of 
proteins was enriched. These data highlight the dynamic 
nature of the nucleolar proteome and show that proteins 
can either associate with nucleoli transiently or accumu- 
late only under specific metabolic conditions. 
Conclusions: This extensive proteomic analysis shows 
that nucleoli have a surprisingly large protein complex- 
. The many novel factors and separate classes of 
proteins Identified support the view that the nucleolus 
may perform additional functions beyond Its known role 
In ribosome subunit biogenesis. The data also show that 
the protein composition of nucleoli Is not static and can 
alter significantly In response to the metabolic state of 
the cell. 
'Correspondence: a. i. lamondOdundee. ac. uk (A. I. L), mannObmb. 
sdu. dk (M. M. ) 
Introduction 
Many studies have shown that the cell nucleus contains 
distinct and often dynamic compartments [1-4]. Chro- 
mosome territories are separated by the Interchromatin 
space, which contains discrete nuclear bodies, Includ- 
ing nucleoli, Cajal bodies, speckles, gems, and promy- 
elocytic leukemia (PML) bodies that have mainly been 
characterized at the morphological level [5]. Nuclear 
bodies contain complexes of proteins and/or RNPs but 
are not separated by membranes from the surrounding 
nucleopiasm. In vivo experiments using fluorescence 
photobleaching (FRAP and FLIP) techniques have shown 
that their protein components move by passive diffusion 
and are in continuous flux between nuclear compartments 
[6,7]. Self-organization has been suggested as a mecha- 
nism for nuclear body formation and maintenance [8]. 
In addition, nuclear bodies themselves can move in the 
nucleoplasm. For example, the mobility of Cajal bodies 
[9] may also Involve diffusion, although active and di- 
rected mechanisms could also play a role [10]. 
In most cases, the biological roles of nuclear bodies 
are still not well understood, and their molecular constit- 
uents have not been comprehensively Identified. Recent 
advances In MS techniques, coupled with the accumula- 
tion of genomic and EST DNA sequence databases, 
have facilitated the global characterization of protein 
complexes and organelles [11-14]. In the case of the 
nucleus, a recent study has applied MS to analyze the 
protein composition of fractions from mouse liver cells 
enriched In interchromatin granule clusters (IGCs) [15]. 
Previous work from our own laboratories and from other 
groups has employed proteomic methods to character- 
Ize the protein composition of a variety of multiprotein 
complexes and subcellular organelles from yeast to hu- 
man, Including U1 snRNPs [16], spliceosomes [17], and 
nuclear pore complexes [18]. 
The best-studied example of a membrane-free nuclear 
subdomaln Is the nucleolus, a "cellular factory" In which 
28$, 185, and 5.8$ ribosomal RNAs (rRNAs) are tran- 
scribed and together with SS rRNA are processed and 
assembled Into the ribosome subunits. The nucleolus 
Is a dynamic structure that disassembles and reforms 
during each cell cycle around the rRNA gene clusters 
[19]. Within the nucleolus, three distinct subcompart- 
ments have been described based on their morphology 
In the electron microscope. These correspond to the 
fibrillar centers (FC), dense fibrillar components (DFC), 
and granular components (GC). The current consensus 
view is that rDNA transcription is restricted to the periph- 
ery of the FC, while transient accumulation, modifica- 
tion, and processing of primary rRNA transcripts occurs 
In the DFC, and later processing and rRNA assembly 
Into ribosomal subunits occurs In the GC [20-23]. 
While It Is clear that the major role of the nucleolus 
Is in ribosome subunit biogenesis, It Is Interesting that 
recent studies suggest that there may be additional 
functions for the nucleolus [24-26]. For example, It may 
also be a site for the biogenesis and/or maturation of 
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other ribonucleoprotein machines, Including the signal 
recognition particle [27], the spliceosomal small nuclear 
RNPs [28], and telomerase [29]. The nucleolus may also 
participate In processing or export of some mRNAs and 
tRNAs [26,30] and can control the activities of specific 
regulatory factors by a sequestration mechanism (31]. 
Moreover, association between the nucleolus and other 
nuclear bodies, such as the perinucleolar compartment 
(PNC) [32] and the Cajal body [33], also raises the possi- 
bility that nucleoli have additional functions. 
Here we present an analysis of the proteome of puri- 
fied human nucleoli, using MS and computer searches 
In sequence databases, Including the draft human ge- 
nome. Over 30% of the 271 nucleolar proteins Identified 
are encoded by novel human genes, and a subset of 
factors are shown to accumulate In nucleoli specifically 
when transcription is inhibited. 
Results 
Isolation of Nucleon 
It was essential to have highly purified preparations of 
nucleoli as a source material for direct protein analysis. 
The inherent density of nucleoli [34] facilitated their iso- 
lation from cultured cells, using a combination of sonica- 
tion and sucrose density centrifugation (see Experimen- 
tal Procedures). Thus, nucleoli were Isolated from HeLa 
cell nuclei, and their purity and integrity were analyzed 
using both light and electron microscopy and protein 
blotting (Figure 1). As judged by light microscopy, over 
95% of the particles detected also stained positive with 
the RNA-specific dye Pyronin Y and were Immunola- 
beled with antibodies to nucleolar proteins (Figure 1A). 
The isolated nucleoli were embedded In resin, sec- 
tioned, and examined in the electron microscope (Figure 
1 B), showing that they had typical nucleolar morphol- 
ogy, as seen in sections through Intact nuclei (Figure 
1 B, compare nucleoli In situ [1 Bi] with Isolated nucleoli 
[panels 1 Bii-1 Biv]). At the highest magnification, the in- 
ternal nucleolar substructures, corresponding to the FC, 
DFC, and GC, are clearly visible in sections of the Iso- 
lated nucleoli (Figure 1 Biv). To address the purity of 
the Isolated nucleoli using a biochemical assay, protein 
samples from (1) unfractionated nuclear extract, (2) nu- 
cleoplasmic fraction, and (3) purified nucleoli were sepa- 
rated by SDS PAGE, transferred to a nitrocellulose mem- 
brane, and probed with antibodies specific for either 
nucleolin, fibrlllarin, Lamin B, or NUP 62 (Figure 1 C). This 
shows that both nucleolar proteins tested, i. e., nucleolin 
and fibrillarin, are highly enriched In the nucleolar frac- 
tion (compare lanes 2 and 3). In contrast, two nuclear 
proteins that do not accumulate In nucleoli, I. e., lamin 
B and NUP62, are not detected In the purified nucleolar 
fraction. 
To evaluate the suitability of these purified samples 
for large-scale MS characterization, a preliminary MS 
analysis was conducted following separation of the puri- 
fied nucleolar proteins by one-dimensional (1 D) SDS 
PAGE. Gel lanes were completely sliced, In-gel digested 
with trypsin, and the resulting peptides analyzed auto- 
matically by high mass-accuracy peptide-mass map- 
ping using MALDI-MS (Figure 2 and data not shown). 
These data were screened against a human-specific 
nonredundant protein database (nrdb). The resulting list 
of 80 proteins Included many known nucleolar proteins 
without obvious major protein contaminants (see be- 
low). We conclude that the isolation procedure yields 
intact preparations of HeLa cell nucleoli that are suffi- 
ciently pure for use In proteomic analysis. 
Identification and Characterization 
of Nucleolar Proteins 
The purified nucleoli were used in a large-scale MS anal- 
ysis, involving the identification of proteins separated 
by both 1D and 2D SDS PAGE (Figure 2; Table S1 [Table 
S1 is included as a special reprint of this article and as 
Supplementary Material available online]). A variety of 
different gel/buffer systems, which each have advan- 
tages for resolving different types of proteins (for exam- 
ple, compare Figures 2A and 2B), were used to ensure 
maximal coverage of nucleolar proteins. However, it was 
not necessary to resolve every individual protein compo- 
nent prior to MS analysis, because nanoelectrospray 
(nanoES) tandem MS could Identify separate proteins 
even In complex mixtures, including up to eight different 
factors (Figure 3A). The majority of nucleolar proteins 
could therefore be Identified by analyzing proteins sepa- 
rated using the different 1D SDS PAGE systems followed 
by nanoES sequencing of proteins In individual gel slices. 
To facilitate the analysis of the complex range of nu- 
cleolar proteins, a layered analytical strategy [351 was 
refined to allow online interrogation of complex peptide 
mixtures and to identify proteins directly in genome se- 
quences (Figure 3). Peptide sequence tags [36] assigned 
from fragmentation spectra of peptide signals were 
searched against various sequence databases in "real 
time" during data acquisition. The sequences of other 
expected peptides in the mixture were then Identified on 
the basis of already identified proteins. These peptides 
were labeled and excluded from further sequencing, 
thereby sequentially reducing the complexity of the pep- 
tide mixture. This approach, termed "directed sequenc- 
ing, " proved to be highly efficient at allocating sequenc- 
Ing time to the Identification of the largest number of 
proteins from each sample (Figure 3B). Unambiguous 
sequence Identification was established by directed se- 
quencing of a minimum of two peptides for each protein, 
followed by matching expected and measured peptide 
fragment ions. Directed sequencing of key peptides was 
particularly useful In (1) the Identification of low abun- 
dance proteins, (2) the Identification of proteins repre- 
sented by limited sequence Information, e. g., EST's, and 
(3) to differentiate between protein Isoforms, for exam- 
ple, PSP1 where sequencing of the peptide ALESAVGESE 
PAAAAAMALALAGEPAPPAPAPPEDHPDEEMGFTI 
DIK was required to confirm the N-terminal extended 
form [37]. 
The 1D PAGE analyses showed that the majority of 
nucleolar proteins were In the size range' 25-100 kDa. 
2D gel electrophoresis was used to expand the separa- 
tion of proteins In this size range (Figure 2C). Individual 
spots from the 2D gels were detected as described In 
Experimental Procedures, excised, and In-gel digested 
with trypsin prior to MS analysis. These data confirmed 
The Human Nucleolar Proteome 
3 
123 
Nucleolin -- %m 
Fibrillarin - -o- 
Lamin B -- - 
NUP62. ý 
the identification of many of the factors detected in the 
1D gel systems and identified 20 additional proteins 
(Table Si). However, many basic proteins identified by 
1D PAGE analyses were not resolved in the 2D gel 
system. 
The peptide sequence tag search algorithm [36] was 
adapted to allow protein identification directly in the 
draft genome sequence [38]. Protein identity was con- 
finned by detecting two or more peptides matching 
within either a single exon or within different exons con- 
fined to the same genomic region. Examples of direct 
MS gene identification in the unannotated human ge- 
nome are shown in Figures 3C-3E. In the first example, a 
peptide sequence tag (underlined in Figure 3D) matched 
exclusively a novel exon located in the genome se- 
quence within chromosome 16. Directed sequencing 
of three additional peptides (underlined in Figure 3D), 
predicted from the same exon, confirmed the identifica- 
tion. The coding sequence of this unusual large axon, 
encoding a putative exoribonuclease, had a calculated 
M, of 25.993 kDa, consistent with the observed M, of 26 
Figure 1. Nucleoli Can Be Isolated from HeLa 
Cells in Large Quantities and with High Purity 
The purity of the isolated nucleolar prepara- 
tions was monitored using several methods. 
(A) Light microscopy can demonstrate the pu- 
rity of purified HeLa nucleoli. Panel (Al) shows 
an Intact HeLa cell stained with two nucleolar- 
specific labels: Pyronin Y (red) and nucleolln 
antibody (green). These reagents were also 
used to stain purified nucleoli (nucleolin in 
panel [Ail] and Pyronin Y in panel [Ails]). DIC 
imaging of the purified material (Aiv) also 
shows that it does not contain significant 
amounts of nonnucleolar particles. (B) TEM 
Images of thin sections of a HeLa cell nucleus 
with two nucleoli in situ, marked by arrows 
(Bi). Panels (BiiHBly) show TEM images of 
sections of isolated nucleoli in increasing 
magnification. These clearly show that the 
Isolated nucleoli are morphologically Intact; 
they contain clearly defined granular compo- 
nent (GC), dense fibrillar component (DFC), 
and fibrillar centers (FC). (C) Proteins from 
preparations of sonicated whole nuclei, nu- 
cleoplasm, and nucleoli were separated by 
gel electrophoresis, transfered to nitrocellu- 
lose, and immunolabeled with anti-nucleolin, 
anti-flbrillarin, anti-lamin B, and anti-Nup 62. 
The nucleolar fraction Is enriched in nucleolin 
and fibrillarin but not In the nonnucleolar pro- 
teins. 
kDa for the cognate gel band. The second example 
illustrates genome searching combined with gene pre- 
diction (Figure 3E). In this case, three peptides that were 
identified all mapped to a short region of the genome, 
spanning -100 kb within chromosome 12. This region 
was therefore used as a constraint for further analysis. 
Sequencing of additional peptides that either lay within 
or spanned exons from this region allowed us to refine 
the predicted gene structure at this locus, including the 
identification of an additional axon. Importantly, this MS 
analysis also identified the N-acetylated N-terminal pep- 
tide that includes the initiating methionine. A total of 14 
novel proteins that copurify with nucleoli were identified 
directly by analysis of the human genome sequence 
(Table S1). In other cases, peptides identified and 
matched to the genome sequence allowed us to revise 
the structures of predicted genes retrieved from a nonre- 
dundant database (for example, GCN1L1, SAID, and 
BING4). The above examples show how the MS data, 
combined with direct analysis of the human genome 
sequence, facilitate the identification of novel nucleolar 
Current Biology 
4 
& 200 
-116 
-97 
«.... w -66 
16-55 
X36 
_""_.. 
31 
. w21 
Figure 2. Proteins from Isolated Nucleoli Were Resolved by Both 1D and 2D SDS/PAGE to Maximize the Coverage of Nucleolar-Associated Proteins 
(A and B) Representative Coomassle-stained 1D SDS/PAGE of nucleolar proteins separated utilizing after a tris-glycine (A) or a Iris-acetate 
buffer system (B), respectively. Molecular weight size markers (kDa) are shown to the left of each gel, and rulers used for excising gel slices 
are shown at right. 
(C) Silver-stained 2D gel of nucleolar samples focused in the first dimension using a 3-10 strip then subsequently electrophoresed on a 12.5% 
SDS gel. Molecular weight size markers are shown at right (kDa). 
proteins and simultaneously improve the annotation of 
the draft human genome sequence. Altogether, a total 
of 271 separate gene products were identified from the 
nucleolar preparations (Table Si). 
Characterization of Identified Nucleolar Proteins 
Many of the genes identified above encoded known 
proteins that had previously been shown to localize to 
nucleoli in human cells or else had close homologs that 
had been shown to localize to nucleoli in other species 
(Table Si). However, over 30% of the genes encoded 
novel or uncharacterized proteins whose localization 
was unknown. In addition, some of the known gene 
products identified had not been reported as nucleolar 
factors. To address whether these classes of proteins 
are genuine nucleolar components in vivo, we adopted 
the strategy, as in our previous study of the spliceosome 
[171, of tagging them with fluorescent proteins and ex- 
amining their localization in the fluorescence micro- 
scope following transient expression in cultured cells 
(Figure 4). Due to the large number of proteins involved, 
it was beyond the scope of this study to isolate and 
tag full-length cDNA clones for every gene identified. 
Therefore, we selected for analysis 18 examples of pro- 
teins that were either novel, or not known to be nucleolar, 
isolated cDNA clones and fused them to yellow fluores- 
cent protein (YFP) at their amino termini in the pEYFPC1 
expression vector (see Experimental Procedures). The 
proteins selected were chosen to include a range of 
sizes, pi values, and motifs. Following transient transfec- 
tion and expression in HeLa cells, 15 of the fusion pro- 
teins localized to nucleoli, showing a variety of different 
patterns (Figure 4 and data not shown). Some of the 
proteins localized exclusively to nucleoli, whereas oth- 
ers were detected in nucleoli but also accumulated at 
other nuclear and/or cytoplasmic structures. For exam- 
ple, the human Pescadillo homolog (PES1) localized 
specifically to nucleoli (Figure 4A), whereas the PWPI 
protein showed extensive cytoplasmic localization as 
well as accumulating in nucleoli (Figure 4D). Some pro- 
teins were detected within distinct subregions of the 
nucleolus, such as the novel protein SAID (Figure 4E). 
The variety of localization patterns observed with the 
YFP-fusion proteins is consistent with the wide spec- 
trum of nucleolar labeling patterns detected previously 
for known nucleolar proteins. During the course of our 
analyses, several recent studies have independently re- 
ported the nucleolar localization of some of the proteins 
we have identified by MS (for example, NOH61 [39] and 
Bop1 [40]). As discussed below, the YFP-tagging data 
support the view that the majority of the novel proteins 
detected here by MS can interact with nucleoli in vivo. 
Some or all of the tagged proteins that could not be 
confirmed here as nucleolar may also interact with 
nucleoli in vivo (see Discussion). 
An overview of the separate classes of proteins identi- 
fied in the purified nucleoli reported in Table S1 is pre- 
sented in the form of a pie chart in Figure 5. The largest 
single category (-31%) represents the group of novel 
and previously uncharacterized factors, including those 
whose function cannot be readily inferred based upon 
recognizable homology to known proteins. The next 
largest category (24%) corresponds to proteins that bind 
to nucleic acid and/or to nucleotides, consistent with 
the known role of the nucleolus In ribosome biogenesis 
and the presence in nucleoli of large amounts of rRNA 
and the rRNA repeat gene clusters. Other classes listed 
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also include families of RNA or nucleotide binding pro- 
teins whose functions are more clearly defined. For ex- 
ample, the DEAD box motif that is characteristic of the 
superfamily of RNA-dependent ATPases and helicases 
[411 is found in 8% of the total nucleolar proteins, includ- 
ing 3% of the novel factors. The ribosomal proteins and 
other translation factors comprise a similar fraction of 
nucleolar proteins as do the RNA modifying enzymes 
(including snoRNP proteins) and chaperones. The cate- 
gory listed as "others" includes proteins with a wide 
range of known motifs and disparate functions. Collec- 
tively, these data illustrate the surprisingly high com- 
plexity of the nucleolar proteome. 
Actinomycin D Treatment Changes 
the Nucleolar Proteome 
We analyzed whether the nucleolar proteome was af- 
fected by treatment of HeLa cells with Actinomycin D, 
which is known to affect the structure of the nucleus, 
the localization pattern of nuclear proteins, and the in- 
tegrity of the nucleolus [42]. The efficacy of Actinomycin 
D treatment was confirmed by double labeling treated 
and control HeLa cells with both pyronin Y and anti- 
coilin antibodies (Figures 6A and 6B). As expected [43, 
44], Actinomycin D-treated cells showed a relocalization 
of coilin to form caps at the nucleolar periphery (cf. 
panels 6A and 6B, green label shows coilin and red foci 
indicate nucleoli). Additional experiments to monitor the 
incorporation of Br-UTP before and after Actinomycin 
D treatment indicated that both RNA polymerase I and 
II activities had been inhibited by the drug treatment 
(data not shown). Therefore, we isolated quantitative prep- 
arations of nucleoli from Actinomycin-treated cells to allow 
for direct MS analysis of their protein composition (Figure 
6). Double labeling of the nucleoli isolated from Actino- 
mycin-treated cells with anti-coilin antibodies and pyro- 
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Figure 4. Tagged Nucleolar Candidate Pro- 
teins, Identified by MS, Accumulate within 
Nucleoli in HeLa Cells, Albeit with Varying 
Patterns 
Each panel shows a confocal fluorescence 
micrograph of HeLa cells expressing YFP fu- 
sion proteins, with the corresponding Nomarski 
image shown on the left. Constructs expressed 
were as follows (names and accession num- 
bers in brackets): (A) YFP-PES1 (Pescadlllo, 
Hs. 1 3501), (B) YFP-NGB (GTP binding protein, 
Hs. 215766), (C) YFP-NHPX (Hs. 182255), (D) 
YFP-PWP1 (nuclear phosphoprotein similar to 
S. ceredslae PWP1, Hs. 172589), (E) YFP-SAZD 
(Hs. 114416), and (F) YFP-HP1y (Heterochro- 
mafin Protein 1y isofonn, Hs. 278554). Small 
arrows indicate nucleoli, large arrowheads in- 
dicate the localization of the fusion proteins 
within the nucleoli, and open arrowheads 
highlight small nuclear bodies also labeled by 
the fusion proteins (In the case of YFP-NGB 
and YFP-NHPX). Scale bars, 5 µm. 
nin Y confirmed that they had an identical morphology 
to the nucleoli in intact Actinomycin D-treated cells (cf. 
panels 6C and 6D with 6B, green label shows coilin, and 
red foci indicate nucleoli). The purity and morphology of 
these Actinomycin-treated nucleolar preparations was 
also confirmed and analyzed in the electron microscope 
and will be presented in detail elsewhere (C. E. L. at al., 
unpublished data). 
Proteins from nucleoli isolated from both control and 
Actinomycin D-treated HeLa cells were separated by 
1D SDS PAGE and stained with Coomassie dye (Figure 
6G). The total proteomes are similar for both control and 
Actinomycin D-treated nucleoli as seen by SDS-PAGE 
(Figure 6G) and by additional MS analysis (data not 
shown). However, there were some protein bands whose 
intensity in the Actinomycin-treated nucleoli was in- 
creased relative to the control nucleoli (Figure 6G, cf. 
Lanes 1 and 2, arrows). These bands were excised, in- 
clrueweon of , wcMar proven. 
Nud. o . -OMWirq 
and Ný n. ad 
bf Ordwl. 
22% 2% 174x) 
Figure 5. Distribution of Conserved Motifs and Putative Functional 
Categories of the Identified Proteins 
The proteins from Table Si were divided Into groups as Indicated 
above. The percentages in brackets indicate the number of proteins, 
Including those classed as novel/uncharacterized, that contain the 
motif in question. 
gel digested with trypsin, and analyzed by both MALDI 
peptide mapping and nanoES MS. This identified 11 
proteins as major candidates for factors whose abun- 
dance in the nucleolar proteome was increased follow- 
ing Actinomycin D treatment (Figure 6G, proteins listed 
beside arrows). This included the protein p80 coilin (run- 
ning at -66 kDa in both extracts in this gel system), 
which was shown by immunocytochemical analysis to 
have increased association with nucleoli following Acti- 
nomycin D treatment (see also Figures 6A-6D). Interest- 
ingly, the other ten proteins identified were members of 
three separate protein families, i. e., DEAD box proteins 
(DDX9, p72, and p68), hnRNP proteins (hnRNPs K, G, 
and A2/B1), and a group of related RNA binding proteins 
(PSF, PSP2/CoAA, PSP1, and p54/nrb). We therefore 
selected a number of proteins from two of these families 
(i. e., p68, p72, p54/nrb, PSP1, and PSP2/CoAA), tagged 
them with YFP, and compared their localization in both 
control and Actinomycin-treated cells (Figures 6E and 
6F show one example where the green signal shows 
YFP-p68 and the red channel Pyronin Y; see also [37] 
and other data not shown). Surprisingly, all the proteins 
analyzed were predominantly nucleoplasmic but relo- 
cated to the nucleolar periphery following Actinomycin 
D treatment (a detailed analysis of the localization and 
behavior of PSP1 is reported in [37]). Furthermore, con- 
sistent with this MS identification, a recent study has 
reported that GFP-PSF also relocalizes to the nucleolar 
periphery following Actinomycin D treatment [45]. 
In summary, we conclude that metabolic perturba- 
tions, as induced here by Actinomycin D treatment, can 
induce changes in the relative abundance of a subset 
of the nucleolar proteome. 
Discussion 
We have reported here a characterization of the pro- 
teome of nucleoli isolated from cultured human cells. 
This study represents the largest proteomic analysis 
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Figure 6. Changes in Nucleolar Structure 
and Composition after Actinomycin D Treat- 
mont of HeLa Cells 
Following incubation of HeLa cells with Acti- 
nomycln D (see Experimental Procedures), 
coilin (as detected with anti-coilin antiserum, 
green) relocalized from Cajal bodies, as seen 
in untreated cells (A), to caps, labeled by Pyr- 
onin Y (red, [B]). These perinucleolar collln 
caps remained detectable in nucleoli isolated 
from Actinomycin D-treated cells (C). (D) A 
magnified view of one of the isolated nucleoli. 
(G) Proteins from nucleoli isolated from Acti- 
nomycin D-treated cells (lane 1) and the 
untreated control nucleoli (lane 2) were sepa- 
rated by SDS-PAGE and stained with Coo- 
massie blue. Proteins that are more abundant 
in lane 1 were analyzed by MS and identified 
as labeled (numbers In brackets are 
SwiasProt accession numbers). One of the 
identified proteins, p68, was tagged with YFP 
and expressed in HeLa cells. YFP-p68 (green 
signal) was not significantly detectable in 
nucleoli isolated from the YFP-p68 stable cell 
line (red signal is Pyronin Y staining) (E) but 
was found at caps following Actinomycin D 
treatment (F). Scale bars, 10 u. m (A and B); 
25 µm (C); and 15 µm (E and F). 
reported so far for a single organelle and identifies 80 
novel human genes that encode putative nucleolar pro- 
teins. Importantly, the proteomic analysis of nucleoli 
isolated from cells in which transcription had been inhib- 
ited revealed the dynamic nature of the nucleolar pro- 
teome. A subset of 11 nucleolar proteins was shown to 
increase their association with nucleoli following treat- 
ment of cells with Actinomycin D. This analysis provides 
new insights into the complexity of proteins in the nucle- 
olus and identifies many nucleolar factors that are con- 
served in evolution from budding yeast to humans. The 
data indicate that the nucleolus is an organelle with a 
high degree of functional complexity. 
The large-scale characterization and identification of 
nucleolar proteins required the application of a variety 
of parallel approaches for both the effective separation 
of different classes of proteins and their subsequent 
analysis by both MALDI TOF and nanoES MS. The identi- 
ties of the proteins included in the nucleolar database 
were each confirmed through the detection of at least 
two independent peptides. Furthermore, in many cases, 
genes were identified from the MS data through direct 
online searching of the draft human genome sequence. 
The strategy used, involving real-time database search- 
ing during data acquisition, facilitated the identification 
of proteins in complex peptide mixtures. This provided 
major practical advantages in dealing with such a large- 
scale analysis as that involved in determining the nucle- 
olar proteome. Previously, we demonstrated that 18 
novel human proteins analyzed in a large-scale proteo- 
mic study of the spliceosome could be identified by 
screening EST databases [17]. Now, with access to the 
human genome sequence, we have demonstrated that 
searches directly in the human genome can be advanta- 
geous when identifying novel proteins from peptide mix- 
tures. In these searches, different peptides were imme- 
diately linked by mapping to a confined region in the 
genome. In addition, the resulting information, which 
defines detailed gene structures, can play an important 
role in both extending and refining the annotation of 
the human genome. In this way, the predicted coding 
products of the genome can be compared with the ac- 
tual primary structures of the cognate proteins ex- 
pressed in vivo. 
For over half of the known proteins identified in the 
purified nucleoli, evidence exists in the literature to sup- 
port their nucleolar association. We are confident that 
the majority of the additional proteins identified, includ- 
ing those encoded by novel genes, are also bona fide 
nucleolar factors. Few known contaminants were de- 
tected in the nucleolar preparations, and among the 
novel proteins we observed low scores for signal pep- 
tide sequences that could be indicative of contaminating 
cytoplasmic and ER proteins. The surprisingly high pro- 
portion of novel proteins also argue for highly enriched 
preparations. Furthermore, transient transfection analy- 
sis of 18 selected genes from the list in Table S1, each 
tagged with YFP, showed that 15 associated with 
nucleoli, as judged by fluorescence microscopy. Extrap- 
olating from this YFP-tagging analysis, we estimate that 
at least 80% of the unverified genes are likely to encode 
nucleolar proteins. In fact, this figure may underestimate 
the fraction of genes encoding genuine nucleolar pro- 
teins for several reasons. First, the presence of the YFP 
tag in the fusion protein may interfere with nucleolar 
localization. Second, some proteins are known only to 
localize to nucleoli at specific stages of the cell cycle (46, 
31] or under specific metabolic conditions (this study). 
Third, because of the high sensitivity of protein detection 
by MS, our analysis may have identified proteins where 
ActD control 
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only a small fraction of the total protein is localized to 
nucleoli at one specific time and therefore may not be 
readily detected by fluorescence microscopy (for exam- 
ple, see [37]). Therefore, at least some of the proteins 
analyzed here that did not show obvious accumulation 
In nucleoli when fused to YFP may nonetheless corre- 
spond to endogenous nucleolar factors. Correspond- 
ingly. we anticipate that the great majority, if not all, of 
the proteins listed In Table S1 are nucleolar proteins. 
The nucleolar proteome includes a wide range of dif- 
ferent proteins (see Figure 5 and Table Si). The most 
common motifs found In these proteins are nucleic acid 
and nucleotide binding domains. The DEAD-box hell- 
case motifs characteristic of the superfamily of RNA- 
dependent ATPases were present in 22 proteins, sug- 
gesting that the control of RNA base pairing interactions 
may be an important feature of nucleolar function. This 
conclusion Is supported by the recent work of Bickmore 
and colleagues who found using a gene-trap method 
that the DEAD box motif was the most common motif 
found in the pool of nucleolar proteins detected [47]. A 
more detailed bioinformatic analysis of the nucleolar 
proteome Is currently In progress and will be presented 
elsewhere. However, preliminary analysis indicates that 
there are no simple targeting motifs shared by all the 
nucleolar proteins, suggesting that their localization to 
the nucleolus involves a variety of mechanisms. 
The major function known for the nucleolus Is the 
transcription and processing of rRNAs and their subse- 
quent assembly Into ribosomal subunits. Consistent 
with this, the nucleolar proteome Includes many ribo- 
somal proteins, processing factors, and components 
required for transcription of the rRNA gene clusters, as 
well as homologs of genes involved In these processes 
In other organisms. This analysis has also Identified 
novel proteins that may be involved In these processes, 
such as NNP8, a protein related to the yeast pre-rRNA 
processing factor Ski6p, and the putative exoribo- 
nucleases NNP15 and NNP1 1. However, not all the pro- 
teins appear to have functions associated with the 
known roles of the nucleolus. For example, we have also 
Identified several protein translation factors, Including 
eIF4A, eIF5A, eIF6, and ETF1 (peptide chain release fac- 
tor subunit 1), which bind to active ribosomes In the 
cytoplasm but were not known to preassemble In the 
nucleolus with the Individual ribosomal subunits [48]. 
Interestingly, eIF6 was recently reported to localize to 
nucleoli in mast cells [49], consistent with the observa- 
tion reported here for HeLa cells. The presence of these 
translation factors raises the Interesting possibility of 
nucleolar/nuclear translation activity 150,51]. 
The high protein complexity of the nucleolus revealed 
In Table S1 Implies that either the biogenesis of ribo- 
somes Is a surprisingly complex process and/or that the 
nucleolus carries out additional functions, consistent 
with the theory of a plurifunctional nucleolus [24,26]. 
One of these additional roles may be In regulating the localization of nuclear factors In a cell cycle-dependent 
manner and thereby controlling their access to Interac- 
tion partners [22,31]. The purified nucleoli studied In this project were Isolated from unsynchronized cells and 
therefore the proteins listed In Table S1 will Include fac- 
tors that may associate with nucleoli only at specific 
stages of the cell cycle. For example, among the proteins 
identified, the DEAD box protein p68 associates with 
nucleoli specifically at telophase [52], while the Bloom's 
Syndrome factor (BLM) specifically accumulates In 
nucleoli only during S phase [53]. It will be Interesting 
in future to determine whether any of the novel protein 
factors show similar properties. 
In addition to cell cycle-specific associations, other 
nuclear factors can show facultative Interactions with 
the nucleolus that depend upon the metabolic state of 
the cell. This was illustrated In this study by the 11 
proteins that associate with nucleoli after treatment of 
cells with the transcription inhibitor Actinomycin D. In 
the accompanying article by Fox et al. (this Issue of 
Current Biology), we describe the detailed characteriza- 
tion of one such protein Identified here, the novel factor 
PSP1(37]. PSP1 shows a nucleolar relationship affected 
by the transcription state of the cell. Photobleaching 
analyses have revealed that PSP1 constantly traffics 
through the nucleolus yet has a steady-state accumula- 
tion within novel nucleoplasmic structures called "para- 
speckles. " However, when transcription Is Inhibited, 
PSP1 rapidly relocalizes to the nucleolar periphery 
where It accumulates within perinucleolar caps. This Is 
consistent with the MS data reported here showing 
PSP1 Is enriched In preparations of purified nucleoli 
from Actinomycin D-treated cells (Figure 6). These data 
are also In agreement with recent evidence showing 
other nuclear proteins are dynamic and can traffic rap- 
idly between different nuclear compartments [8]. It Is 
Interesting that the 11 proteins found here enriched in 
the preparations of nucleoli purified from Actinomycin 
D-treated cells have obvious features in common. Many 
of the proteins have RNA binding motifs, and several 
have been Implicated In similar modes of transcriptional 
control. For example, p72 and p68 can act as estrogen 
receptor coactivators [54,55]; PSF (56] and p54nrb can 
act as corepressors Interacting with the DNA binding 
domains of nuclear hormone receptors; and PSP2 (also 
called CoAA) coactivates transcription and Interacts 
with a thyroid hormone receptor binding protein [57]. 
These data suggest a possible novel role for the nucleo- 
lus, involving the cycling of transcription factors, and it 
will be Interesting to Investigate this further In the future. 
It is likely that further analysis will also identify additional 
factors whose association with nucleoli Is either in- 
creased or decreased by Actinomycin D treatment. 
The proteins listed In Table S1 represent a core of 
major nucleolar proteins, most of which were detected 
multiple times in Independent preparations of nucleoli. 
Clearly, It does not Include every human protein that 
may associate or Interact with nucleoli in vivo, and some 
previously reported nucleolar proteins were not de- 
tected. Weakly associated factors may be lost during 
the purification protocol, while other proteins may inter- 
act with nucleoli only under specific metabolic condi- 
tions that were not sampled In our study. Very low abun- 
dance proteins or factors with unusual structures or 
modifications may have escaped detection with the 
methods we have used so far. Our analysis of HeLa 
cell nucleoli will also exclude some cell type-specific 
nucleoiar proteins. We Intend to extend our coverage of 
nucleolar proteins by further proteomic analysis of nucleoli 
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purified from a variety of sources, including primary cells 
and cell lines derived from different tissues. In addition, It 
is anticipated that future improvements in the sensitivity 
of protein detection and analysis methods will enable the 
identification of additional nucleolar proteins. 
In conclusion, although more work remains to be 
done, we believe that the nucleolar proteome detailed 
here already represents a significant advance toward 
defining a comprehensive inventory of nucleolar pro- 
teins. These data should be of value for future studies 
on the range of biological roles performed by the nucleo- 
lus as well as the mechanisms Involved in its assembly 
and function. 
Expsrlmer al Procedures 
Nucleolar Isolation 
Nucleoli were prepared from HeLa cell nuclei (Computer Cell Culture 
Centre, Belgium), using a method based on that first described by 
Muramatsu and coworkers In 1963 (58]. Aliquots (250 µß containing 
-1 x 10' nuclei were washed three times with PBS, resuspended 
In 5 ml buffer A (10 mM HEPES-KOH (pH 7.91,1.5 mM MgCy6 10 
mM KCL, 0.5 mM DTT), and dounce homogenized ten times using 
a tight pestle. Dounced nuclei were centrifuged at 228 Xg for 5 
min at 4°C. The nuclear pellet was resuspended in 3 ml 0.25 M 
sucrose, 10 mM MgCI*, and layered over 3 ml 0.35 M sucrose, 0.5 
mM MgCI and centrifuged at 1430 xg for 5 min at 4°C. The clean, 
pelleted nuclei were resuspended In 3 ml 0.35 M sucrose, 0.5 mM 
MgCI and sonicated for 6x 10 s using a microtip probe and a 
Misonbt XL 2020 sonkator at power setting S. The sonicate was 
checked using phase contrast microscopy, ensuring that there were 
no Intact cells and that the nucleoli were readily observed as dense, 
retractile bodies. The son sated sample was then layered over 3 ml 
0.88 M sucrose, 0.5 mM MgCl and centrifuged at 2800 Xg for 10 
min at 4°C. The pellet contained the nucleoli, while the supernatant 
consisted of the nucleoplasmic fraction. The nucleoli were then 
washed by resuspension in 500 d of 0.35 M sucrose, 0.5 mM MgCl, 
followed by centrifugation at 2000 x9 for 2 min at 4°C. 
Microscopy and Immunostaining of Samples 
Whole HeLa cells were grown on coverslips, washed In PBS, than 
fixed for 5 min with paraformaldehyde (4% In 10 mM pipes (pH 6.81, 
100 mM NaCI, 300 mM sucrose, 3 mM MgCIb and 2 mM EDTA) and 
Immunolabeled. Permeabillzation was performed with 1% Triton 
X-100 In PBS for 15 min at room temperature. Immunofluorescence 
labeling was carried out on fixed permeabilized cells by 1 hr Incuba- 
tion In 100 µl primary antibody (diluted In PBST (PBS plus 0.05% 
Tween 20)), followed by three washes In PBST and incubation for 
1 hr In 100 pJ secondary antibody (diluted In PBST) followed by 
three washes In PBST. Antibodies used were anti-p80 collin mono- 
clonal 5P10 (dilution 1: 10) and anti-nucleolin 7G2 (1: 1000, kindly 
provided by G. Dreyfuss) and anti-mouse FITC-conjugated second- 
ary antibody (Jackson Lab, 1: 250). Prior to mounting, samples were 
stained with 0.68 mM Pyronin Y (Sigma) for 2 s, then mounted using 
DABCO containing Mowlol. Purified nucleoli were Immobilized on 
poly-L-lysine slides (BDH) and air dried. After rehydretion with PBS 
(5 min), the nucleoli were incubated with monoclonal anti-nucleolln 
antibody 7G2 (1: 100) or monoclonal antl-collin antibody 5P1 0 (1: 5) 
for 30 min. The slides were washed with PBS (3 x5 min) and 
Incubated with FITC-conjugated secondary antibody (Jackson Lab, 
1: 250) for 30 min. The nucleoli were counterstalned with 0.66 mM 
Pyronin Y (Sigma) for I min. After washing as above, the nucleoli 
were embedded In DABCO containing Mowlol. Images were ob- 
tained using a Zeiss LSM 410 confocal laser scanning microscope. 
Isolated nucleoli were processed for transmission electron ml- 
oroecopy using standard methods. In brief, nucleoli were centri- 
fuged at 5000 rpm for 2 min. The pelleted nucleoli were washed 
briefly In PBS, fixed In 3.7% paraformaldehyde In PBS for 20 min 
at room temperature, washed three times In PBS, washed In water, 
postfixed in 1% osmium tetroxide In water for 15 min it room tem- 
perature, washed three times In water, dehydrated In 70% ethanol 
for 2X5 min, contrasted with 3% uranyl acetate In 70% ethanol 
for 15 min at room temperature, washed In 70% ethanol further 
dehydrated through 90% ethanol, IX5 min, 100% ethanol. 3x5 
min, propylene oxide, 2x5 min, 50: 50 propylene oxlde: epoxy resin 
mix for 2 hr at room temperature before embedding In epoxy resin. 
Sections were cut using a Relchart ultracut ultramicrotome and 
visualized In a JOEL 1200EX TEM. 
Electrophoresis and Immunoblotting 
For 1D SOS/PAGE, purified nucleoli were dissolved in 1x LOS sample 
bufer(Nove)o + 100 mM DTT and heated at 70'C for 10 min. Nucleolar 
proteins were then separated on 3%-B% SOS Trls-Acetate gels and 
4%-12% Bie-Tris gels (Novex) and stained with Coomassie colloidal 
blue according to the manufacturer's Instructions (Novex). For 2D 
SDS/PAGE, IPG strips (Pharmacia) were In-gel rehydrated with Sam- 
ples dissolved In 2M thiourea, 6M urea, 1% CHAPS. 0.4% DTT, 
and 0.5% Pharmalyte (either 3-10 or 4-7). Proteins were focused for 
40000 V In the first dimension, separated on vertical 12.5% SOS 
gels in the second dimension, and stained with silver. Protein slices/ 
spots were excised, deposited In 96-well plates, in-gel reduced, 
aikylated with lodoacetamide, and digested with trypsin as pre- 
viously described [59). The resulting peptides were analyzed by 
MALDI-MS and nanoES tandem MS (see below). 
For Immunoblotting, protein samples separated by 1D SDS/PAGE 
(see above) were subsequently transferred onto nitrocellulose mem- 
brane using a submarine system (Novex) and buffer containing 12 
mM Tris, 100 mM glycine, and 20% methanol. Following blocking 
with 5% milk powder In PBS + 0.05% Tween 20, the membranes 
were Incubated with one of the following antibodies: rabbit anti- 
fibrillarin, Fib 42 (1: 10000, gift from F. Fuller-Pace), mouse mono- 
clonal anti-nucleolin, 7G2 (1: 1000, G. Dreyfuss), mouse monoclonal 
anti-L. amin B. LN43.2, (gilt from E. B. Lane), and nucleoporin NUP62 
was detected using mouse monoclonal 414 (1: 5000, Babco), then 
bound antibody was probed using anti-rabbit HRP conjugate (1: 2000 
dilution) or anti-mouse HRP conjugate (1: 5000 dilution) (Pierce 
Chemical Co. ) In PBS containing 5% milk powder and 0.05% Tween 
20, and detected via chemlluminescence with ECL (Amersham Phar- 
macia Biotech). 
Mass Spectrometry 
MALDI mass spectra were acquired automatically on a Bruker RE- 
FLEX III reflectron time of flight (TOF) mass spectrometer (Broker. 
Franzen, Bremen, Germany) as previously described [60,61]. Pep- 
tides were also analyzed by nenoES tandem MS on a quadrupole 
time-of-flight mass spectrometer (OSTAR Pulsar, PE Sclex, Toronto, 
Canada) equipped with a nanoES Ion source (MDS-Proteomlcs, 
Denmark). The peptide mixtures from In-gel digests were purified 
and concentrated prior to nanoESMS as described (62], except that 
the remaining supematant were loaded on columns In parallel from 
86-well plates. 
Databases and Searching 
Nonredundant (nrdb), predicted (IPM), expressed sequence tags 
and finished and unfinished human penoms sequences (phases 0-3) 
wer. downloaded (ftp: t/ncbl. nkn. nih. gov/genbank and ftpJ/ftp. 
ensembl. orgAPI/) and converted Into FASTA formatted sequence 
index files accepted by the PepSea database search software sys- 
tem (MDS proteomlcs, Denmark). Peptide massen measured by 
MALDI-MS were searched with 40 ppm mass accuracy, and "used" 
peptide masses were subtracted prior to repeated rounds of data- 
base searches. Peptda sequence taps (36] were assigned from 
tandem mass spectra assisted by the Inspector software (MOS Pro- 
teomks, Denmark) and used for database searching In real time 
against the respective databases using PepSea software. Calcu- 
lated peptide Ion and fragment Ion masses of retrieved sequences 
were displayed in the mass spectra to establish unambiguous Identt- 
flcation and to Identify additional proteins by selection of unex- 
plained peeks for MS/MS. Genoma searching were performed as 
recently described (38). 
Gone Pradotion 
Two WWW-based gene prediction programs were employed for 
further characterization of Identified coding regions of the human 
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genome: GENSCAN, at the Massachusetts Institute of Technology 
(MIT, Boston, http: //genes. mit. edu/GENSCAN. htmQ, and HMMgene, 
at the Centre or Biological Sequence Analysis (CBS, The Technical 
University of Denmark, Lyngby, Denmark, httpJ/www. cbe. dtu. dk/ 
services/HMMgene). Nucleotide sequences corresponding to Iden- 
tiffed peptides were defined as coding and used as constraints 
in HMMgene predictions. The GPMAW software (Lighthouse Data, 
Denmark) were modified to calculate mh values of exon-exon span- 
ning peptides. 
Cloning Nucleolar Proteins, Tagging with Fluorescent 
Protein, and Expression in HeLa Calls 
Full-length cDNAs encoding selected nucieolar candidate proteins 
were amplified by PCR using specific ESTs (UK HGMP Resource 
Centre) or Hefe cDNA library (Clontech) as templates. Each con- 
struct was cloned Into the pEYFP-C1 vector (Clontech), using re- 
striction sites engineered onto the 5' ends of each amplification 
Primer. Details of ESTs, primer sequences, and restriction sites are 
available on request. 
HeLa cells were grown In DMEM supplemented with 10% fetal 
Call serum and 1% penicillin streptomycin (Life Technologies). Fluo- 
rescent protein fusion constructs were transfected Into HeLa cells 
seeded onto coveralips using Effectene reagent (Qiagen). At 16-18 
hr posttransfection, the cells were washed In PBS and fixed in para- 
formaldehyde as above. Coversllps were mounted In MowiolDabco 
onto slides for Imaging. Images were obtained using a Zeiss LSM 
410 confocal laser scanning microscope. 
Actinomycln D Treatment of HeLa Cells 
To study the changes In nucleolar composition caused by Inhibition 
of transcription, we Incubated HeLa cells In 5 µg/ml Actlnomycln D 
(Sigma) diluted In DMEM (Gibco) with 10% fetal calf serum (Gibco). 
After 3 hr, the 0e119 were harvested by trypsinitation, washed three 
times with cold PBS, then resuspended at -5 x 10'/ml with 10 mM 
HEPES-KOH (pH 7.9), 10 mM KCI, 1.5 mM MgCI2,0.5 mM DTT. The 
cell suspension was Incubated on ice for 5 min and then disrupted 
by dounce homogenation Ren strokes) on Ice. The nuclei released 
by homogenation were pelleted by centrifugation at 1000 xg for 5 
min. Nucleoli were lactated from these nuclei as described above. 
Supplementary Material 
Supplementary Material including a table of proteins Identified from 
nucleoli isolated from cultured human cells can be found at http // 
Images. cellpress. com/supmat/aupmatin. htm. 
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Summary 
Background: The cell nucleus contains distinct classes 
of subnuclear bodies, including nucleoli, splicing speck- 
les, Cajal bodies, gems, and PML bodies. Many nuclear 
proteins are known to interact dynamically with one or 
other of these bodies, and disruption of the specific 
organization of nuclear proteins can result in defects in 
cell functions and may cause molecular disease. 
Results: A proteomic study of purified human nucleoli 
has identified novel proteins, including Paraspeckle Pro- 
tein 1 (PSP1) (see accompanying article, this issue of 
Current Biology). Here we show that PSP1 accumulates 
in a new nucleoplasmic compartment, termed para- 
speckles, that also contains at least two other protein 
components: PSP2 and p54/nrb. A similar pattern of 
typically 10 to 20 paraspeckles was detected in all hu- 
man cell types analyzed, including primary and trans- 
formed cells. Paraspeckles correspond to discrete bod- 
ies in the interchromatin nucleoplasmic space that are 
often located adjacent to splicing speckles. A stable cell 
line expressing YFP-PSP1 has been established and 
used to demonstrate that PSP1 interacts dynamically 
with nucleoli and paraspeckles in living cells. The three 
paraspeckle proteins relocalize quantitatively to unique 
cap structures at the nucleolar periphery when tran- 
scription is inhibited. 
Conclusions: We have identified a novel nuclear com- 
partment, termed paraspeckles, found in both primary 
and transformed human cells. Paraspeckles contain at 
least three RNA binding proteins that all interact dynami- 
cally with the nucleolus in a transcription-dependent 
fashion. 
'Correspondence: a. i. lamond®dundee. ac. uk 
Introduction 
The nucleus is a complex organelle with an internal 
structure and component organization that is not fully 
characterized [1,2]. Within the nucleus, protein and RNP 
complexes can move to and from chromatin through 
the interchromatin nucleoplasmic space, primarily by a 
diffusion mechanism [3,4]. In addition, many nuclear 
factors are able to form or interact with different classes 
of subnuclear bodies, which are either attached to chro- 
matin or located in the interchromatin space. These nu- 
clear bodies, or "compartments, " include nucleoli, splic- 
ing speckles, Cajal bodies, gems, and PML bodies [5]. 
They are not enclosed by membranes, yet are distinct 
from the surrounding nucleoplasm and contain proteins 
involved in different nuclear activities, such as ribosome 
biogenesis, transcription, and RNA splicing. Further, 
many observations indicate that the accurate mainte- 
nance of subnuclear organization has important conse- 
quences for cellular function [6-14]. 
There is increasing evidence that the internal organi- 
zation of the nucleus and many of the protein and RNP 
factors within it are highly dynamic. The recent use of 
photobleaching techniques to analyze GFP-tagged pro- 
teins expressed in live cells has shown that nuclear 
proteins can diffuse rapidly and traffic at high rates 
between separate compartments [15-18]. The nuclear 
localization pattern of many proteins and, as a conse- 
quence, the overall structure of the nucleus has been 
shown to change during the cell cycle and in response 
to changes in cellular metabolic activity. For example, 
inhibiting transcription with drugs such as Actinomycin 
D, 5,6-dichloro-l -lt-D-ribofuranosylbenzimadizole (DRB), 
or a amanitin all cause a significant redistribution of 
many nuclear factors and alter the morphologies of 
nucleoli and splicing speckles [19,20]. 
Recent studies have started to provide clues concern- 
ing the specific roles of individual forms of nuclear bod- 
ies. The interchromatin granule clusters (speckles) that 
contain snRNPs and other spliceosome components 
may be sites for storage or recycling of splicing factors, 
although in some cases they may also be more directly 
involved in the splicing mechanism [21-23]. Cajal bodies 
specifically accumulate snRNPs and nucleolar snoRNPs 
that have recently been imported into the nucleus and 
are likely undergoing maturation [24-27]. Cajal bodies 
may have a role in RNA modification and transport and 
may also be involved in the feedback regulation of gene 
expression from snRNA gene loci [28]. In the case of 
nucleoli, it is known that they are sites for the transcrip- 
tion of rRNA genes and the subsequent processing of 
rRNA precursors and assembly of ribosomal subunits. 
Interestingly, there is also evidence that nucleoli may 
perform additional nuclear functions, such as controlling 
the activity of regulatory molecules by a sequestration 
mechanism and participating in the biogenesis of other 
RNP complexes [29-31]. 
The ability to purify large quantities of relatively pure 
nucleoli makes it an ideal candidate for biochemical 
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A Figure 1. The Sequence and Expression of 
Paraspeckle Protein 1 
MMLRGNLKQVRIEKNPARLRALESAVGESEPAAAAAMALALAGEPAPPAP 50 (A) Amino acid sequence of PSP1. Prepubli- 
RRM1 cation accession numbers for PSP1: Gen- 
APPEDHPDEEMGFTIDIKSFLKPGEKTYTQRCR VGNLPTDITEEDFKR 100 bank FW10955 and ENSEMBL gene ID 
ENSG00000121390. The arrowhead after res- 
LFERYGEPSE'FINRDRGFGFIR:. ESRTLAEIAKAELDGTILKSRPLR R 150 idue 386 Indicates the final common residue 
RRM2 for both splice forms of PSP1. The shorter 
FATHGAAL KNLSPVVSNELLEQAFSQFGPVEKAV'VVDDRGRATGKGF 200 form (PSP1-ß) has an additional 7 residues 
(GDKRKCG, a translation of axon 7), making 
VEFAAKPPARKALER DGAFLLTTTPRPVIVEPMEQFDDEDGLPEKLMQ 250 it a total of 393 residues long. The remaining 
residues C-terminal to the arrowhead are the 
KTQQYHKnREQPPRFAQPGTFEFEYASRWKALDEMEKQQREQVDRNIREA 300 extent of the longer splice variant PSP1-a 
23 residues y composed and 
350 9 as defined bb 9 by tgenomic the c annotation. . Red 
RHEEEHRRREEEMIRHREQEELRRQQEGFKPNYMEN"REQEMRMGDMGPRG 400 
blue text indicates tryptic pe and kJen- 
with tHied using MS on PSP1 copurHied with HeLa 
AINMGDAFSPAPAGNQGPPPMMGMNMNNRATIPGPPMGPGPAMGPEGAAN 450 nucleoli. For further details of PSP1 splice 
forms, see Supplementary Material. The pep- 
MGTPMMPDNGAVHNDRFPQGPPSQMGSPMGSRTGSETPQAPMSGVGPVSG 500 tide at the N-terminus of PSP1 that the PSP1 
antibody was generated against Is shown in 
GPGGFGRGSQGGNFEGPNKRRRY 523 bold; this sequence is In a region of the pro- 
tein with low similarity to p54/nrb and is thus 
BCa, unique to PSP1. The RNA-binding domains 
are boxed. 
4 
(B) Human Northern blot probed for PSP1. A 
, 
3- human muhitissue Northern blot (Clontech) 
9ý E. ?m%a+ was hybridized with a "P-radiolabeled cDNA 
'1 2 m°-' c3 probe for PSP1 (see Experimental Proce- 
Kb dures) (upper panel), then stripped and re- 
44- 123 probed with a 
p-actin probe to show approxi- 
mately equal loading of mRNA In each lane 
97 
2.4 
`1r 
(lower panel), as per the manufacturer's in- 
43t 
structions. The hybridized radioactivity was 
visualized using a Phosphoimager. Tissue 
1 35 PSP1 sources 
for the mRNA in each lane are Indl- 
. PSP1 probe 52- cated on 
the figure. We note that the signal 
123 
for the PSP1 probe was considerably weaker 45678 
than for the ß-actin probe, possibly indicating 
33 that this is a low-abundance transcript. 
24- (C) 
PSP1 protein in HeLa extract. HeLa cells 
] 
were lysed and the resultant extract subjected 
L 
21 to SDS/PAGE and transfer to nitrocellulose. 
actin probe The blot was divided into three and probed 
HeLa cell extract as 
follows: rabbit preimmune serum (PI) pans 
1), a ti-PSP1 antiserum (lane 2), or anti-PSP1 
antiserum preincubated with a 10 molar excess of cognate peptide (lane 3). These treatments were followed by incubation with HRP-conJugated 
anti-rabbit antibody and detection by chemiluminescence using ECL plus substrate (Amersham Pharmacla Biotech). The arrow indicates the 
major band of -60 kDa in size that is detected specifically by the anti-PSP1 antiserum. 
analysis in vitro. A major proteomic analysis of nucleoli 
isolated from cultured human cells has therefore been 
undertaken to characterize the protein composition of 
this important subnuclear body [32]. This study identi- 
fied 271 human nucleolar proteins using MS, including 
80 proteins encoded by novel or uncharacterized human 
genes. Here we report the characterization of one of the 
novel human nucleolar factors-Paraspeckle Protein 1 
(PSP1). We show that PSP1 accumulates within a new 
form of nuclear compartment in the interchromatin 
space, termed paraspeckles. This analysis reveals a new 
level of structural complexity within the nucleus and 
highlights the dynamic nature of nuclear body proteins. 
Results 
PSP1: A Novel Protein from the Human Nucleolar 
Proteome that Localizes to a Punctate Pattern 
in the Nucleus 
PSP1 was initially chosen for detailed analysis because 
we observed that it belonged to a subset of human 
nucleolarproteinsthat were enriched in nucleoli isolated 
from cells treated with the transcription inhibitor Actino- 
mycin D [32]. Based upon a combination of cDNA se- 
quence analysis and direct mass spectrometric Identifi- 
cation of tryptic peptides, we deduce that the major 
form of PSP1 is a basic protein of 523 amino acids with 
a predicted Mr of 58.7 kDa (Figure 1A). As judged by 
probing a human multitissue Northern blot, PSP1 is en- 
coded by several ubiquitously expressed mRNAs of 
-2.5 kb, including alternatively spliced forms (Figure 
1 B). We have named the two major expressed isoforms 
PSP1-a and PSP1-I (see Figure 1 and Supplementary 
Material available with this article online). The primary 
amino acid sequence of PSP1 contains two conserved 
RNA binding domains (RRMs) located at the amino ter- 
minus of both isoforms and is most closely related to 
the nuclear protein p54/nrb [33,34]. PSP1 is highly con- 
served in mammals, with a mouse ortholog showing 
greater than 95% identity at the amino acid level (Gen- 
pept accession number BAB27509). However, in lower 
organisms it is difficult to define clear orthologs, be- 
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Figure 2. PSP1 Has a Punctate Nuclear Lo- 
calization In Human Cells 
The confocal fluorescence micrographs show 
PSPI antiserum staining in the transformed 
cell lines (A) HeLa, (B) MCF7. (C) Hek293, and 
in the "primary" (D) DFSF1 and (E) 1787htert 
cells. An overlay of the Nomarakl image for 
each cell type and the PSP1 immunostalning 
is shown In (B)-(E). The HeLa cells in (A) have 
also been Immunostained using anti-fibrillarin 
antiserum (shown in panel [AIII]), and the 
overlay of the Nomarskl image for the cells 
as well as the fibrillarin and PSP1 signals is 
shown in panel (Alv). Each fluorescent image 
is a stack of confocal sections. Arrowheads 
indicate nucleoli as seen in Nomarski and fl- 
brillarin staining, and arrows indicate punc- 
tate PSP1 spots. Scale bars, 5 µm. 
cause similar proteins appear to be equally divergent 
with both PSP1 and p54/nrb in D. melanogaster and C. 
elegans. 
To analyze the cellular localization of PSP1, a rabbit 
polyclonal antibody was generated against a unique 
peptide sequence located near the amino terminus 
(shown bold in Figure 1A). The resulting antiserum was 
affinity purified using the cognate peptide and both the 
preimmune and affinity-purified sera used to detect 
HeLa proteins that had been separated by SDS-PAGE 
and transferred to a nitrocellulose membrane (Figure 
1 C, lanes 1 and 2). The preimmune serum showed only 
nonspecific binding (lane 1). In contrast, the affinity- 
purified antiserum predominantly detected a major band 
of -60 kDa (lane 2), corresponding to the predicted size 
of PSP1 -a, the longer isoform of PSP1. Longer exposure 
of the membrane revealed an additional band of the 
expected size for the smaller PSP1 isoform, PSP1-ß 
(data not shown). The specific PSP1 bands were no 
longer detected when the affinity-purified antiserum was 
preblocked with the PSP1 peptide (lane 3). 
Having established the specificity of the anti-PSP1 
serum, we used it for indirect immunofluorescence 
staining of HeLa cells (Figure 2A). The anti-PSP1 antise- 
rum specifically labeled HeLa nuclei in a punctate pat- 
tern, with some diffuse nucleoplasmic labeling (arrows 
in Figures 2Aii and 2Aiv). Surprisingly, although PSP1 
was identified through proteomic analysis of nucleoli, 
the anti-PSP1 antiserum did not label nucleoli signifi- 
cantly, as shown by double-labeling experiments using 
an anti-fibrillarin antibody to detect nucleoli (Figures 2Ai, 
2Aiii, and 2Aiv). The anti-PSP1 antiserum typically la- 
beled instead 10 to 20 bright punctate structures scat- 
tered throughout the nucleoplasm. 
The anti-PSP1 antiserum also labeled a similar pattern 
of punctate, nucleoplasmic structures, with varying lev- 
els of diffuse nucleoplasmic labeling but no significant 
nucleolar staining, in both primary and transformed hu- 
man cell lines (Figures 2B-2E). These included trans- 
formed lines derived from either breast (MCF7, Figure 
2B) or kidney cells (hek293, Figure 2C) and primary cells 
corresponding to foreskin fibroblasts (DFSF1, Figure 2D) 
or human fibroblasts extended in proliferative life span 
by retroviral expression of telomerase reverse tran- 
scriptase (1 787htert, Figure 2E). 
Tagged PSP1 Shows the Same Punctate 
Localization as Endogenous PSP1 
To confirm that the punctate nuclear staining pattern 
observed with anti-PSP1 antiserum in primary and trans- 
formed human cells genuinely reflected the localization 
of PSP1, we transiently expressed exogenous PSP1 in 
HeLa cells fused with either a yellow fluorescent protein 
(YFP), or myc peptide tag (Figure 3). Both tagged forms 
of PSP1 showed a similar pattern to that seen with the 
anti-PSP1 antiserum in untransfected cells, including 
bright punctate nuclear structures. The tagged proteins 
did not accumulate in nucleoli, as detected by either 
DIC microscopy or immunolabeling with an anti-fibril- 
larin antibody (Figures 3A and 3B; arrowheads denote 
nucleoli; arrows denote tagged PSP1). 
We next established stable HeLa cell lines expressing 
YFP-PSP1 (Figure 4). Separate cell lines were isolated 
for the two predominant splice forms of PSP1. As both 
isoforms gave identical results, subsequent data are 
presented only for the PSP1-p isoform. Immunolabeling 
both the parental and HeLa`vP °S°'-" cell lines with anti- 
PSP1 antiserum detected a similar pattern of punctate, 
nucleoplasmic structures and diffuse nucleoplasmic 
staining (Figure 4, cf. panels 4Aiii and 4Biii). Analysis of 
50 labeled cells from both the parental and stable cell 
lines showed that there was no statistical difference in 
the average number of punctate PSP1 structures labeled 
with PSP1 antiserum or YFP fluorescence ('--15 per nu- 
cleus, data not shown; for example, Figure 4. panels 
4Bii and 4Biii). 
Proteins from both the parental and HeLa.. P$°' cells 
were separated by SDS-PAGE, transferred to nitrocellu- 
lose membrane, and probed with either anti-GFP (Figure 
4C, lanes 1 and 2) or anti-PSP1 antiserum (Figure 4C, 
lanes 3-6). A single band was detected with the anti- 
GFP antibody specifically in the HeLa`"I°"cells (lane 
2). In contrast, the major endogenous PSP1 band was 
detected in both cell lines using the anti-PSP1 antiserum 
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Figure 3. Tagged PSP1 Localizes to Punctate Foci in HeLa Nuclei 
Confocal fluorescence micrographs are shown on the right, with 
the corresponding Nomarski images to the left. HeLa cells were 
transiently transfected with YFP-PSPI (A) or myc-PSP1 (B) and fixed 
16 hr after transfection. Panel (A) shows direct fluorescence of the 
YFP-PSP1 protein (green) and immunofluorescence staining for fi- 
brillarin (red). Panel (B) shows HeLa nuclei Immunostained with anti- 
myc antiserum (green). Large arrowheads indicate nucleoli, and 
arrows indicate the punctate YFP-PSP1 and myc-PSP1. Scale bars, 
5 µm. 
(lanes 3 and 4) but was absent when the antiserum was 
preblocked with the cognate peptide (lanes 5 and 6). 
We observe that the YFP-PSP1 fusion protein is ex- 
pressed at -4-fold higher levels than the endogenous 
PSP1 protein in HeLa`FP'SP1-13 cells (Figure 4C, lane 4 and 
other data not shown). However, the relative level of 
endogenous PSP1 appears higher in the parental cell 
line, suggesting that some degree of downregulation of 
endogenous PSP1 may have occurred to compensate 
for expression of the fusion protein (Figure 4C, cf. lanes 
3 and 4). 
We compared the physical properties of the endoge- 
nous and YFP-tagged PSP1 proteins in the parental and 
HeLaYFP-°S°'-ß cell lines (Figure 4D). Cultured cells were 
extracted sequentially with buffers containing varying 
concentrations of salt and detergent, and the resulting 
protein samples were separated by SIDS-PAGE, trans- 
ferred to nitrocellulose, and probed with anti-PSPI anti- 
serum. In both the parental and stable cell lines, PSP1 
was quantitatively recovered in the second fraction (Figure 
4D, lanes 2 and 6). Furthermore, both the YFP-tagged 
and endogenous PSP1 were recovered in the same frac- 
tion from the YFP-PSPI-11 cells (Figure 4D, lane 6). Thus, 
the tagged and endogenous PSP1 proteins have similar 
properties. Further comparison of the parental and 
HeLa`'FP-05P1- cell lines showed no apparent change in 
their respective viability or rate of cell division (data not 
shown). We therefore conclude that the HeLa`FP'°S°'$ cell 
line is viable and expresses a single tagged YFP-PSP1 
fusion protein that has a similar localization pattern and 
physical properties to the endogenous PSP1. 
PSP1 Localizes in a Novel Nuclear Compartment 
We next sought to identify which of the known sub- 
nuclear compartments PSP1 was accumulated in. 
Therefore, double-labeling experiments were carried out 
using the HeLarFP-vsP, -P cell line to detect PSP1 and im- 
munolabeling with characterized antisera to detect 
marker proteins for separate nuclear bodies (Figures 
5A-5D). Antibodies specific for snRNPs (anti-2,2,7-tri- 
methylguanosine-cap structure) and for the non-snRNP 
splicing factor SC35 were both used to detect splicing 
speckles (Figures 5A and 5B). We observed no overlap 
in the localization of PSP1 and splicing speckles using 
either of these antibodies (Figures 5Aiii and 5Biii; in each 
panel, arrows indicate YFP-PSP1, and arrowheads indi- 
cate known nuclear markers, e. g., speckles). The 
brighter foci detected with the snRNP marker also did 
not colocalize with YFP-PSP1 (Figures 5Aii and 5Aiii, 
broken arrows indicate bright foci). It is most likely that 
these bright snRNP foci represent Cajal bodies [20]. A 
double-labeling experiment with anti-coilin antiserum (a 
marker for Cajal bodies) confirmed that there is no over- 
lap or colocalization with YFP-PSP1 (Figure 5Ciii). We 
also detected no colocalization of YFP-PSP1 either with 
the bodies labeled using an anti-SMN antiserum, which 
detects both Cajal bodies and gems [9] (data not shown), 
or with an anti-U1A antibody, which should label inter- 
chromatin granule associated zones [35] as well as 
speckles (data not shown). The other major class of 
subnuclear bodies that have been studied contain the 
cellular RING finger protein PML [6-8,36]. Double label- 
ing using an anti-PML antiserum showed that the YFP- 
PSP1 signal also does not localize or associate with 
PML bodies (Figure 5Diii). We next compared the local- 
ization of YFP-PSP1 with the major sites of RNA synthe- 
sis, as detected by pulsed incorporation of Br-UTP (Fig- 
ure 5E). Despite the extensive nucleoplasmic labeling 
detected with the anti-BrdUTP antiserum, we again ob- 
served no obvious colocalization with the punctate YFP- 
PSP1 signal (Figure 5Eiii). 
Finally, we used a triple-labeling protocol to compare 
the localization of YFP-PSP1 with both bulk chromatin, 
as detected by DAPI staining, and splicing speckles, 
as detected using anti-SC35 antiserum (Figure 6). This 
showed that the YFP-PSP1 localized predominantly to 
interchromatin regions that have little or no DAPI signal 
(Figure 6, DAPI-poor regions indicated by arrowheads). 
A similar result was obtained using a fluorescently 
tagged histone H2B and the anti-PSP1 antiserum (data 
not shown). Interestingly, although we still detected no 
colocalization of YFP-PSP1 with the SC35 domains, 
which also localize to the interchromatin regions, analy- 
sis of optical z sections of the triple-labeled nuclei showed 
that the YFP-PSP1 structures were frequently juxtaposed 
beside SC35 speckles (Figure 6, lower panels; arrows indi- 
cate YFP-PSP1, and arrowheads indicate SC35 speckles 
in DAPI-poor regions). 
In conclusion, PSP1 concentrates in a novel form of 
punctate subnuclear structure that localizes to the inter- 
chromatin space. Considering both the speckled ap- 
pearance of the PSP1 -containing structures and their 
frequent localization adjacent to SC35 speckles, we 
have termed this novel compartment "paraspeckles. " 
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DAPI YFP anti-PSP1 
Figure 4. Stable Expression of YFP-PSP1 in 
HeLa Cells Results in the Same Punctate Pat- 
tern of PSP1 Localization in the Nucleus 
Fluorescent micrographs of HeLe (A) and 
HeLa`'P-"$°'-a (B). The extent of the nucleus is 
shown with DAPI staining in panels (Ai)-(BI), 
the fluorescence from the exogenously ex- 
pressed YFP-PSP1 in panels (Ail)-(Bll), and 
the staining pattern for endogenous PSP1 as 
determined by staining with anti-PSP1 anti- 
parental HeLa 
In panels (Aiii)-(BiIQ. All images are 
maximum intensity projections of stacks de- 
convolved using the deftavision Softworx 
software. Arrows point to examples of the 
same foci detected with the PSP1 antibody 
as appear in the YFP fluorescence channel. 
Scale bars, 5 run. (C) Anti-PSP1 antiserum rec- 
ognizes both the endogenous and fusion PSP1 
proteins, while anti-GFP antiserum only recog- 
nizes YFP-PSP1. Equal amounts of HeLa cell 
extract (lanes 1,3, and 5) and HeLa"P" p 
stable cell extract (lanes 2,4, and 6) were 
electrophoresed, transferred to nitrocellu- 
lose, 
D 
lose, then immunoblotted with anti-GFP anti- 
PSPIp 
+++ 
body (lanes 1 and 2), anti-PSP1 antibody 
HBLBVFP (lanes 3 and 4), or anti-PSP1 antibody pre- 
parental HeLa +++ blocked by incubation with 10-fold excess of 
123456 
gý cognate peptide 
(lanes 5 and 6). An anti-rab- 
12345678 bit peroxidase conjugated secondary anti- 
YFP-PSP 1_ " body was employed to detect antibody bind- 
endogenous . 4W - 64 M f-YFP-PSP1 ýerdog. PSPI 
in9, and this in turn was detected using ECL 
PSP7 
plus (Amemham Pharmacia Biotech). (D) Bio- 
51 chemical behavior of e ous PSP1 and 
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parental HeLa HeLevFP PsPIý YFP-PSP1. HeLa`''0. P'P 
ells 
(samples in 
anti- anti- anti- 
lanes 5-8) and parental HeLa cells (samples 
GFP PSP1 PSP1 + in lanes 1-4) were 
both extracted in several 
peptide buffers containing different concentrations of 
salts and detergents (see Experimental Pro- 
cedures). Equivalent protein samples from 
each sequential extract were loaded onto a gel, electrophoreaed, transferred to nitrocellulose, and Immunoblotted with anti-PSP1 antibody. 
The following extracts were loaded In each lane: supernatant A (lanes 1 and 5), supernatant B Panes 2 and 6), supernatant C (lanes 3 and 7), 
and pellet C (lanes 4 and 8). Both endogenous and YFP-PSP1 are specifically released from the YFP-PSP1 cells in supernatant B (lane 6), 
and the endogenous PSP1 from parental HeLa is also specifically released in supernatant B pane 2). Arrows indicate endogenous PSP1 and 
exogenous YFP-PSP1 proteins. 
PSP1 Relocalizes to the Nucleolus When 
Transcription Is Blocked 
We next examined how the localization of PSP1 was 
affected by ongoing gene expression, which is known 
to alter the structure of other subnuclear bodies. After 
treatment of the HeLa`FP4s"$ cell line with Actinomycin 
D, which halts elongation by RNA polymerases, we ob- 
served a dramatic reorganization of PSP1 from a pattern 
of paraspeckles to discrete caps formed at the nucleolar 
periphery (Figure 7A, cf. panels 7Ai and 7Ai). This re- 
sponse contrasts with the behavior of splicing speckle 
proteins, which concentrate in enlarged speckles in the 
nucleoplasm after Actinomycin D treatment, as shown 
here for SC35 (Figure 7Aiii and 7Aiv; arrows indicate PSP1, 
and arrowheads indicate SC35). A similar effect was ob- 
served upon treating cells with a separate inhibitor of RNA 
synthesis, DRB, indicating that it most likely results from 
an inhibition of transcription (data not shown). Analysis 
of PSP1 localization in a live HeLa'FP"-O cell at multiple 
time points after addition of Actinomycin D to the culture 
medium showed a progressive loss of PSP1 signal from 
nucleoplasmic paraspeckles and a concomitant appear- 
ante of PSP1 signal at the nucleolus (Figure 7B). We never 
observed the direct movement of whole paraspeckles to 
the nucleolus, suggesting that the PSP1 protein can flux 
out of the paraspeckles and accumulate at a separate 
nuclear location when transcription is inhibited. 
The data above are consistent with the proteomic 
analysis of nucleoli, which showed that a subset of 11 
proteins, including PSP1, was enriched in nucleoli fol- 
lowing treatment of cells with Actinomycin D [32]. We 
asked if any of these 11 proteins shared a paraspeckle 
localization with PSP1. However, for most of these en- 
riched proteins, previous studies have reported that they 
localize to known nuclear structures [37-40]. For exam- 
ple, our analysis of YFP-tagged p68 and p72 showed 
that they did not localize to paraspeckles (data not 
shown) but rather displayed a diffuse punctate nucleo- 
plasmic pattern as previously described [38]. However, 
transient expression of YFP-tagged p54/nrb, the most 
closely related PSP1 homolog, showed that it was also 
a paraspeckle protein as judged by double labeling with 
the anti-PSP1 antiserum (data not shown). Interestingly, 
another novel protein identified in the proteomic study 
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Figure 5. PSPI Localizes to a Novel Sub- 
nuclear Compartment 
HeLaY°-08°'O cells were fixed and immuno- 
stained with antibodies against nuclear mark- 
ers (red, panels [Aii)-[Dii)), the YFP-PSP1 fluo- 
rescence is shown in green in panels (AfHEI), 
and the overlay in panels (AiiIIHEii). The fol- 
lowing proteins were labeled: (A) snRNP 
splicing speckles as defined by staining with 
anti-5'-trimethy1guanosine antiserum, (B) SC35 
splicing speckles, (C) p80-collin labeling Cajal 
bodies, and (D) PML labeling PML bodies. In 
(E), the transcription sites in HeLa"" °w1 " 
cells were labeled using Br-UTP incorpora- 
tion, followed by detection with anti-BrdUTP 
antiserum (panel (Eli)), and the overlay is 
shown in panel (Eiii). Each panel shows maxi- 
mum intensity projections of deconvolved 
sections acquired using a deltavision system. 
The nuclei are outlined with hand-drawn 
dashed lines to indicate the nuclear periph- 
ery. Scale bars, 5µm. Large arrowheads indi- 
cate the known nuclear structures, broken 
arrows indicate Cajal bodies in panels (AiQ 
and (Alii), and small arrows indicate YFP- 
PSP1 foci. 
as enriched in nucleoli from Actinomycin D-treated cells 
also localized to paraspeckles and therefore has been 
named "PSP2" (Figure 7C). Unlike p54/nrb, PSP2 shows 
minimal homology to PSP1, although it also contains 
two amino-terminal RNA binding domains. Transient ex- 
pression of YFP-tagged PSP2 and double labeling with 
anti-PSP1 antiserum revealed that it accumulates in para- 
speckles and shows diffuse nuclear staining and, like 
PSP1, also relocalizes to perinucleolar caps following 
Actinomycin D treatment (Figure 7C). Furthermore, all 
three paraspeckle proteins, i. e., PSP1, PSP2, and p54/ 
nrb, colocalize in the same perinucleolar caps after Acti- 
nomycin D treatment (data not shown). 
Other nuclear proteins, including fibrillarin and p80 coi- 
[in, are also known to relocalize into perinucleolar caps 
following treatment of cells with transcription inhibitors 
[20,32,41,42]. We therefore performed triple-labeling 
experiments in Actinomycin D-treated HeLa`''P-°9P1P cells 
with anti-p80 coilin and anti-fibrillarin antibodies (Figure 
713). This showed that all three proteins localize to differ- 
ent and distinct cap structures at the nucleolar periphery 
(Figure 7Div). 
The twin observations that PSP1 can be detected, 
albeit in low amounts, in purified nucleoli and that it 
becomes enriched in nucleoli after Actinomycin D treat- 
ment ([32] and this study, Figure 7A), suggest the possi- 
bility that it cycles continually between paraspeckles 
and the nucleolus. To add support to this hypothesis, 
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Figure 6. Paraspecklee Are Found In Inter- 
chromosomal Spaces, Often Next to SC35 
Speckles 
Upper panels indicate single sections 
through three representative HeLa"" °'"' 1' nu- 
clei (A-C) stained with DAPI to highlight chro- 
matin. The arrowheads indicate the DAPI- 
poor staining Interchromosomal regions. The 
lower panels show DAPI staining (blue), YFP- 
PSP1 fluorescence (green), and SC35 immu- 
nostaining (red) from the same sections from 
the same nuclei as shown in the upper panels. 
The sections were obtained using the Deltavi- 
slon system and the Images were decon- 
volved using Softworx. Small arrows indicate 
paraspeckles, and arrowheads Indicate SC35 
clusters that reside within the dark, low- 
stained DAPI areas. Scale bar, 5µm. 
we performed a fluorescence loss in photobleaching 
(FLIP) experiment, using the HeLa`'F°-"s"-P cell line, to 
see if photobleaching of the nucleolus affects the fluo- 
rescence signal of YFP-PSP1 in paraspeckles (Figure 
8). Several cells were imaged over the course of the 
experiment, while pulse photobleaching a region of in- 
terest inside the nucleolus of one cell only. The nucleo- 
plasmic fluorescence of the cell in which the nucleolus 
was bleached decreased over the time course of the 
experiment, as compared with the unbleached cell (Fig- 
ure 8A). This indicates that nucleoplasmic PSP1 was 
moving into the nucleolus where it became subject to 
bleaching. We measured the fluorescence intensity of 
the individual paraspeckles within the bleached cell and 
compared this with paraspeckles from an adjacent, un- 
bleached control cell (Figure 8B). This showed a sequen- 
tial loss of fluorescence in the paraspeckles of the cell 
in which the nucleolus was bleached. We conclude that 
the most likely explanation of this result is that PSP1 
cycles between the paraspeckles and nucleolus. 
Discussion 
We have identified in this study a novel nuclear compart- 
ment (paraspeckles) and shown that at least three nu- 
clear proteins, i. e., PSP1, PSP2, and p54/nrb, accumu- 
late in these structures. The paraspeckles were detected 
in both primary and transformed human cell lines and 
are different from other well-characterized types of sub- 
nuclear bodies. They are dynamic structures containing 
proteins that can cycle to and from nucleoli. The identifi- 
cation of paraspeckles underlines the high degree of 
organization of nuclear factors and the potential to seg- 
regate proteins within the nucleoplasm into biochemi- 
cally and spatially distinct structures. 
Considering that PSP1 was first identified using MS 
as a nucleolar factor [32], it was initially surprising that 
localization studies did not detect it accumulated in 
nucleoli. However, as reported above, it is likely that 
PSP1 cycles between paraspeckles and nucleoli, thus 
explaining its detection in nucleolar preparations by MS. 
The fact that proteins that may interact dynamically or 
transiently with nucleoli were nonetheless detected by 
MS analysis illustrates the utility of large-scale proteo- 
mic analyses of purified cellular structures. Furthermore, 
the MS data showing that PSP1, PSP2, and p54/nrb are 
all members of a group of proteins enriched in nucleoli 
isolated from Actinomycin D-treated cells also supports 
the fluorescence microscopy data in this study, showing 
that these proteins accumulate at the nucleolar periph- 
ery when cells are exposed to Actinomycin D. While we 
have identified here three separate paraspeckle pro- 
teins, it may in the future be possible to use a proteomic 
approach to characterize the full range of proteins local- 
ized in paraspeckles if a suitable isolation procedure 
can be developed. In this regard, the recent report de- 
scribing the identification of proteins associated with a 
purified interchromatin granule cluster (speckle) fraction 
from mouse liver cells [43) is encouraging for future 
efforts in purifying subnuclear bodies. 
The present data show that the distribution patterns of 
the three paraspeckle proteins likely reflect steady state 
accumulations rather than static localizations, consistent 
with the dynamic behavior reported also for other nuclear 
factors (reviewed in [3,4]). Using the HeLaIFP. PSP1. (t 
cell line, we observed that photobleaching of nucleoli 
led to a progressive loss of the YFP-PSP1 signal from 
paraspeckles. Several recent studies have also reported 
the converse phenomenon, i. e., bleaching of the nucleo- 
plasm leading to a loss of fluorescent signal for a variety 
of nucleolar proteins [15-17]. These data collectively 
reveal that, for both factors accumulated in nucleoli and 
factors in nucleoplasmic structures, a high level of ex- 
change can occur between compartments. This empha- 
sizes the importance of dynamic studies and time-lapse 
analyses in order to understand the significance of local- 
ization patterns revealed by fluorescence microscopy. 
Although the nucleolus is known to be the site of rRNA 
synthesis and ribosomal subunit assembly, It has been 
suggested that nucleoli can also perform other functions 
[30,31,44]. In this regard it is interesting that we have 
detected three proteins with no known connection to 
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Figure 7. Inhibition of RNA Polymerase II Transcription Results in the Relocalization of PSP1 and Other Paraspockle Proteins to the Nucleolus 
(A) Fluorescence micrograph of sections through HeLaPFppB' I' cells untreated (Al and AIII) and following Incubation with media containing 
Actinomycin D (1 pg/ml) for 4 hr (Ali and Aiv). YFP-PSP1 fluorescence is shown In green in all panels. For other colors, panels (AQ and (All) 
show cellular RNA (including nucleoli) by staining with Pyronin Y (red), and panels (AIII) and (Aiv) show DNA as indicated by DAPI staining 
(blue) and SC35 as indicated by immunostaining with anti-SC35 antiserum (red). Small arrows indicate YFP-PSP1 paraspeckles and relocalized 
YFP-PSP1 at the nucleolar periphery. Arrowheads indicate SC35 clusters In untreated cells and relocalized SC35 enlarged speckles after 
treatment with Actinomycin D. 
(8) PSP1 relocalizes in response to transcription Inhibition In live cells. The panels show a series of time points demonstrating the gradual 
relocalization of PSP1 from paraspeckies to nucleoli from a movie of a live HeLal`' a cell imaged following the addition of media containing 
1 pg/ml Actinomycin D. The cell was imaged as described in Experimental Procedures, every 10 min over a3 hr period. 
(C) PSP2 is another paraspeckle protein. HeLa cells were transiently transfected with an expression vector for YFP-PSP2 and were fixed and 
immunostained using anti-PSP1 antiserum 16 hr later. Nomarski Images of cells are shown in panels (Cl) and (Cv). The confocal fluorescence 
micrographs show YFP-PSP2 fluorescence in panels (Cif) and (Cvq, PSP1 immunostalned signal In panels (Ciii) and (Cvii), and the overlays 
of the two channels are shown In panels (Civ) and (Cviii). Arrows indicate examples of the structures/paraspeckles that contain both PSP1 
and PSP2. Panels (CIHCiv) depict an untreated HeLa cell, while panels (Cv){Cvlli) show HeLa cells that were incubated with Actinomycin D 
prior to fixation and Immunostaining for PSP1. Note that one of the cells in panels (CvHCvIll) does not have an YFP-PSP2 signal, presumably 
as it did not take up the expression plasmld In the transient transfection. 
(D) Fibrillarin, collin, and PSP1 are in distinct domains around the nucleolus when transcription Is Inhibited. Panels show a 3D reconstruction 
of a HeLav'`TM -5 cell that has been fixed and immunostained for collin (DII) and fibrillarln (Dill) following Incubation with Actlnomycin D (1 µg/ 
ml for 4 hr). YFP-PSP1 fluorescence is shown in (DI). and the overlay of the three signals Is shown In (Div), note that, due to displaying a 3D 
structure In 2D, some artificial overlap of the colors is apparent. The insets in each panel are shown to more clearly demonstrate the distribution 
of the proteins around the nucleolar space. The Images are 3D volume views of a stack of 60 x 0.2 pm sections deconvolved using the 
Softworx package. The nucleus Is outlined with a hand-drawn dashed line. Scale bars, 5 pm. 
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Figure S. FLIP Experiments after Bleaching of Nucleoli in Hel-aý4""-" Cells Demonstrate that YFP-PSP1 Cycles between the Nucleolus and 
Nucleoplasmic Structures 
(A) Following the acquisition of a prebleach image, a HeLaYF° "31-11 cell was periodically bleached inside the outlined area within the nucleolus. 
Images were collected before and after bleaching. The images shown here are time points occurring every minute for a5 min experiment. 
The repeated bleach pulses do not affect a neighboring cell nucleus. Scale bar, 5 lun. 
(B) Quantitation of changes in fluorescence intensity within selected paraspeckles in the bleached and unbleached cells (shown in [A]) over 
the course of a5 min experiment. 
ribosome biogenesis that associate with both nucleoli 
and paraspeckles. This may reflect that PSP1, PSP2, 
and p54/nrb have hitherto unknown roles in ribosome 
assembly or function or that the nucleolus is involved 
in other nuclear functions. Data from the proteomic anal- 
ysis of purified nucleoli also raised the possibility of 
additional nucleolar functions [32]. PSP1 is a novel pro- 
tein whose cellular function is not known. In the case of 
p54/nrb, previous studies have implicated it in multiple 
processes, including transcriptional regulation, splicing, 
apoptosis, and dsRNA processing [45-49]. In particular, 
p54/nrb has recently been implicated, in partnership 
with other proteins, in cotranscriptional control through 
an interaction with steroid hormone nuclear receptors 
[50]. Interestingly, despite being uncharacterized at the 
time of its identification in the nucleolar proteome, PSP2 
has recently been identified independently and reported 
to be a "coactivator activator" (CoAA) that coactivates 
transcription by association with the thyroid hormone 
receptor binding protein [51 ]. These related functions of 
p54/nrb and PSP2, in combination with the data showing 
that paraspeckle proteins accumulate at nucleoli when 
transcription is inhibited, suggest a possible role for the 
paraspeckle proteins in transcriptional control and also 
implicate the nucleolus in these processes. 
The fact that all three paraspeckle proteins contain 
related RNA binding domains suggests that their func- 
tion may be connected to RNA metabolism. It will be 
interesting, therefore, to determine which RNA sub- 
strates PSP1 and PSP2 can interact with and to see 
whether any other protein components of the para- 
speckles contain similar RNA binding motifs. However, 
we note that the PSP1 RNA binding motif is unlikely to 
be sufficient to target proteins to paraspeckles, because 
our preliminary data indicate that the RNA binding region 
of PSP1 alone is unable to cause accumulation of YFP 
in paraspeckles (data not shown). Both PSP1 and p54/ 
nrb also show homology to the RNA binding and car- 
boxy-terminal regions of the splicing factor PSF [37]. 
Like the paraspeckle proteins, PSF was identified by 
MS as one of the factors that accumulated in nucleoli 
after Actinomycin D treatment [32). This is consistent 
with the recent report that GFP-tagged PSF relocalizes 
predominantly to perinucleolar clusters following Acti- 
nomycin D treatment (52]. However, unlike the para- 
speckle proteins, PSF was reported to colocalize with 
splicing factors in the nucleus when transcription is ac- 
tive (37,52]. Proteins in the PSP1 family may have roles 
in various aspects of nuclear organization concerned 
with RNA processing. For example, p54/nrb was re- 
cently isolated in a complex with PSF and matrin 3 (a 
putative component of the nuclear matrix) that bound 
and retained double-stranded inosine-containing RNA 
inside the nucleus [49]. Furthermore, a C. tentans pro- 
tein, hrp65, which has ^-36% identity with both the hu- 
man PSP1 and p54/nrb proteins, localizes to fine fibers 
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that Interact with Balbiani ring pre-mRNP particles In- 
side the nucleoplasm of insect cells, as judged by elec- 
tron microscopy [53]. Interestingly, hrp65 structures do 
not associate with pre-mRNA cotranscriptionally. Con- 
sidering that paraspeckles are distinct from sites of Br- 
UTP Incorporation in mammalian cell nuclei, It Is possi- 
ble these hrp65 fibers represent Insect cell structures 
related to paraspeckles. 
In addition to the major classes of subnuclear bodies 
that are shown here not to colocalize with paraspeckles, 
there have been reports of other types of punctate sub- 
nuclear structures that so far have been studied In less 
detail (54-611. Although we have not compared these 
structures directly with paraspeckles, based upon their 
reported properties it seems unlikely that any of them 
correspond to paraspeckles. For example, unlike para- 
speckles, YT bodies are not found in MCF7 cells and 
colocalize with sites of BrUTP Incorporation [61], while 
the perinucleolar compartment (PNC) is not found in all 
cell types and Is only present when transcription Is active 
(reviewed In [62]). Nonetheless, we cannot exclude that 
some proteins that have been reported previously to 
have a punctate nuclear staining pattern may In future 
be shown to be components of paraspeckles. 
lt is unclear how and why, after inhibiting transcription, 
some nuclear proteins segregate Into distinct peri- 
nucleolar cap structures (as seen in Figure 7D). Interest- 
ingly, the paraspeckle proteins all reside within the same 
nucleolar cap (and appear excluded from the collin or 
fibrillarin caps). Further to this, we have observed that 
the DEAD box factors p68 and p72 (also found enriched 
in nucleoli Isolated from cells treated with Actinomycin 
D [32]) also colocalize with PSP1 In perinucleolar caps 
following treatment of cells with Actinomycin D (data 
not shown, see Supplementary Material). Thus, p68 and 
p72 may be either functionally or biochemically related 
to the paraspeckle proteins. 
In conclusion, we have Identified a novel nucleoplas- 
mic structure, termed paraspeckles, detected In all hu- 
man cell types analyzed and shown to contain at least 
three separate proteins. These proteins appear to cycle 
continually between paraspeckles and the nucleolus, 
but all three accumulate In perinucleolarcaps when tran- 
scription Is Inhibited. The prevalence of paraspeckles 
and their dynamic relationship to the nucleolus provides 
a new challenge for the ongoing effort to understand 
the functional complexity of nuclear structure. 
Experimental Procedures 
Plasmld Constructs and Antibody Production 
The two main species of ESTs for PSPI and thus the most often 
expressed farina corresponded to the two different PSP1 lsoforms 
(PSP1-)t residues 1-393) and (PSP1-a residues 1-523). To clone 
these. PSP1-p was amplified by PCR using the EST IMAGE 3634993 
(UK HGMP Resource Centre), and PSP1-a was amplified using the 
overlapping templates EST IMAGE 2440134 and IMAGE 3634993. 
In both cases, the fragments were purified, digested with EcoRl and 
BamHI, and Iigated Into pEYFP-C1 (Clontech). 
To make a myc-tagged fusion of PSP1, PSPI-ß was amplified 
using IMAGE 3634993 as a template; the product was digested with 
Samfli and HIndII1 and subcloned Into pSG9M [631. YFP-p54/nrb 
was made by amplification of p54/nrb from a HeLa mRNA library 
(Clontech). The amplified product was digested with HlndIII and 
BamHI and ligated Into pEYFP-C1. YFP-PSP2 was made by ampllfl- 
cation of the full-length cDNA constructed using the overlapping 
ESTs IMAGE 2350028 and 3505412. The resultant product was then 
digested with EcoRl and BamHI and llgated Into pEYFP. C1. 
For probing the muRklasue Northam blot, a cDNA probe con- 
taining sequence corresponding to 107-702 bp of PSP1 was redlola- 
beled and purified prior to hybridization according to the manufac- 
turer's Instructions (Clontech). 
An affinity-purified peptide antibody against PSP1 was generated 
in rabbit, using the sequence APPAPAPPEDHPDEEM (Eurogentes). 
This sequence was chosen as It Ilse within a region of PSP1 with 
little or no similarity with other protein and Is thus unique to PSP1. 
Coll Cullum and Tranafsctbn Assays, 
Generation of Stable Cell Une 
HeLa cells, obtained from ATCC, were grown in Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 10% total calf serum 
(FCS) and 100 U/mi penicillin and streptomycin (Ute Technologies). 
For detection of fluorescent fusion proteins with fluorescence ml. 
croscopy, cells were grown on coverslips and transfected with the 
appropriate construct, using Eftectens reagent (Diagen) according 
to the manufacturer's Instructions. At 12-16 hr posttransfeetion, the 
cells were fixed for 7 min hi 3.7% (w/v) parafonnaldehyde in CSK 
buffer (10 mM PIPES (pH 6.81,10 mM NaCl, 300 mM sucrose, 3 mM 
MgCI 2 mM EDTA) at room temperature, mounted on to glass 
slides, and imaged under microscopes as described below. For 
both forms of YFP-PSPI and the myc-PSP1 expression vectors, 
these were transient transfections. Thus, there was variation In the 
expression levels of the fusion proteins, resulting In variation In the 
number and intensity of PSP1 foci observed, with overexpre. sing 
cells showing numerous (>100) bright nuclear and cytoplasmic foci 
and with low expressors resembling the anti-PSP1 antiserum stain. 
Ing pattern. Thus, we concluded that the low-expressing pattern 
reflected the genuine localization of PSP1. 
The YFP-PSP1 stable cell lines were generated essentially as 
described In (64]. These stable cells showed a pattern of YFP-PSPI 
localization that resembled the low-expressing transiently bwns- 
fected cells. 
Drug treatments were carried out as follows: Actinomycin D (1 
µg/mq (Sigma) or DRB (100 p M) (Calblochem) In DMEM Incubated 
for 4 hr followed by fixation and fluorescence microscopy. 
Preparation of Cell Lyestes and Immunoblotting 
Confluent 10 cm dishes of cells were washed with PBS and tysed 
using lx LDS sample buffer (Hovex). Lysates were passed through 
a Olashredder (Olagen) before being denatured using 100 mM DTT 
and heating at 70°C, then eiectrophoresed on a1 mm, 4%-12% 
trio-glyclne polyacrylamlde gel (Novex) with MOPS buffer (Novex). 
Proteine were subsequently transferred onto nitrocellulose mem. 
brans (Schleicher and Schuell) using a submarine system (Novex) 
and buffer containing 12 mM Trio, 100 mM gycka, and 20% metha- 
nol. Following blocking with 6% milk powder In PBS + 0.05%Tween 
20, the membranes were Incubated with rabbit antl-PSP1 antibody 
(1: 2000 dilution) or mouse anal-OFP antibody (Roche, 1: 1000 dilu- 
tion) detected using rabbit HRP conjugate (1: 2000 dilution) or mouse 
HRP conjugate (1: 5000 dilution) (both Pierce Chemical Co. ) In PBS 
containing 5% milk powder and 0.05% Tween 20, and detected via 
chemiluminescence with ECL plus (Amersham Pha, macls Biotech). 
Saft and detergent extraction of HeLa and HsLa"*""'4 cells was 
performed as described In (651. Approximately equal amounts of 
protein were loaded in each lane, as estimated by Ponceau staining 
of proteins transferred to nitrocellulose membrane in pilot experi- 
ments. Samples were then subjected to Immunobiotting as de- 
scribed above, with anti-PSP1 antiserum and anti rabbit HRP con- 
jugate. 
Immunotluorsso. m» Microscopy 
Cells were washed In PBS and fixed (as above) at room t. mpsrstur.. 
P. rmeabllizatlon was performed with 1% Triton X-100 in PBS for 
15 min of room temperature. Immunofluoraosnos gaining was car. 
Ned out using standard techniques. Antibodies used wer* *AI-PSP1 
rabbit peptide antibody (dilution 1: 60), anti-flbrlllsrln monoclonal 
72b9 (dilution 1: 10, (66D, anti-myo monoclonal 9E10 (dilution 1: 100, 
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(67h, antiSC35 monoclonal (dilution 1: 1000, Sigma), anti-2,2,7-trf- 
methy-guanosine monoclonal (dilution 1: 10, Calblochem), anti-p80 
collin monoclonal 5P10 (dilution 1: 10), antl-PML monoclonal PGM3 
(dilution 1: 10, Santa Cruz), anti-SMN monoclonal (dilution 1: 60, 
Tranoduction Laboratories), and FITC and TRITC conjugated sec- 
ondary antibodies (Jackson Laboratories). Transcription sites were 
visualized In live cells using previously described methods [68), and 
the resultant Br-UTP-conta(ning mRNA was detected using anti- 
Bromo-dUTP antibody (dilution 1: 5, Roche). Prior to mounting on 
slides, coverslips were sometimes soaked in DAPI (1 µM In water 
for 1 min) to stain DNA and/or followed by soaking in Pyronin Y 
(0.66 mM in water for 2 s) to stain RNA. Cells were mounted in either 
Mowiol/Dabco (for the confocal microscope) or 0.5% p-phenylene- 
diamine in 20 mM Trio (pH 8.8), 90% glycerol (for the deltavision 
system). 
Fluorescence microscopy of fixed cells was carried out using a 
40x NA 1.3,63x NA 1.4, or a 100X NA 1A Plan-Apochromat objec- 
tive. Three-dimensional Images and sections were recorded either 
on a LSM410 confocal microscope (Zeiss) or on a Zeiss DeltaVislon 
Restoration microscope (Applied Precision, Inc. ). Images presented 
here are projections of the entire nuclear fluorescence, unless other- 
wise stated. 
Observation of Live Colic and Photobleaching Analysis 
For live cell Imaging, cells were grown on 42 mm glass coverslips 
(no. 1; Helmut Sauer) In medium containing 200 pg/ml G418. Cells 
were maintained at 37'C by use of a closed Perfusion chamber 
(Bachofer) In DMEM media without phenol red (Life Technologies) 
but with the addition of 20 mM HEPES. Images were collected using 
the 100X NA 1.4 Plan-Apochromat objective on the DeltaVision 
microscope. For each nucleus, 20 to 30 optical sections were re- 
corded. The Hg lamp was attenuated with a 0.5 OD neutral density 
filter, and Images were recorded using a binning of 3X3. Images 
were recorded every 10 min over a time period of 3 hr. Time-lapse 
Images were viewed as 3D maximum Intensity projections of each 
time point (SoftWoRx, Applied Precision. Inc. ). 
Photobleaching experiments were carried out on a ZEISS 510 
confocal laser scanning microscope equipped with an argon-kryp- 
ton laser (ZEISS). The 488 nm laser and a 63x plan Apolens with a 
1A NA were used. A laser power of 2.5% was used in Image acquisi- 
tions, and 25% was used for photobleaching. An area of 16 x 18 
pixels was bleached with an Iteration of 250 (duration of bleach was 
3 a). An Image was collected before and after every bleaching event, 
with 30 a Intervals between each bleaching event. 
Supplementary Material 
The Supplementary Material contains two figures: (1) a diagram 
detailing the gene structure of human PSP1, Including a representa- 
tion of which axons we Included In the major splice forms of PSPI, 
and (2) fluorescence micrographs showing that In HeLa cells treated 
with the transcription Inhibitor Actinomycln D. YFP-p88 localizes to 
the same perinucleolar cap structure as PSPI. The Supplementary 
Material can be found at httpJAmagee. celiprees. com/aupmat/ 
supmatin. htm. 
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been deposited as AF448795 and AF449627, respectively. 
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